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ABSTRACT 
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Ph.D. thesis, School of Pharmacy, University of the Western Cape 
 
South Africa’s White Paper for the transformation of the health care system in 
South Africa (DOH, 2007) acknowledges major disparities and inequalities as a 
result of an imprint by apartheid policies. In its transition to democracy, health 
promotion strategies have been initiated to address these disparities. However, 
such strategies have been narrowed and “favoured target audiences that are 
literate, urban-based and who have easy access to print and audio-visual media” 
(DOH, 1997). This implies that many vulnerable and marginalised groupings in 
South Africa, including the Deaf community are excluded from health promotion 
endeavours. 
 
Deaf people in South Africa communicate using South African Sign Language 
(SASL) and majority of the Deaf community exhibit poor literacy levels. 
Deafness is a significant communication barrier which limits a Deaf person’s 
prospect to attain the best possible health care (Barnett, et al 2011). Various 
means of communication including spoken language, written instructions and the 
use of pictograms are used by healthcare workers to communicate health-related 
information. For many members of the Deaf community who communicate 
primarily in sign language, these methods are a sub-standard and prevent the 
attainment of optimum therapeutic outcomes. With regard to pharmaco-
therapeutic services, Deaf people cannot hear the spoken language used by 
pharmacists during patient counselling, and their compromised functional literacy 
hinders the ability to read instructions on medicine labels. With both the spoken 
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and written means of communication compromised, the Deaf patient’s ability to 
comprehend instruction by pharmacists on how to use their medicines is 
inadequate and as a result, a Deaf patient may leave the pharmacy with medicine, 
but a poor understanding of how to use the medicine safely and effectively. 
 
Previous researchers have worked on building a technology base, including 
industrial design and computer science expertise to conceptualize the groundwork 
of a mobile phone application called SignSupport to facilitate communication 
between medical doctors and Deaf individuals. The particulars of the pharmacy 
scenario however, require a pharmacy-specific device to be of use in the 
dispensing of medicines to a Deaf patient in a pharmacy.  The over-arching goal 
of this thesis is to design and evaluate a mobile phone application to facilitate the 
communication of medicine instructions between a Deaf patient and a pharmacist.  
 
Qualitative, participatory action research and community-based co-design 
strategies were directed toward Deaf participants, senior pharmacy students and 
pharmacists to create a prototype of the afore-mentioned mobile phone 
application. Preliminary results indicated that the application was suitable to 
pharmacists and Deaf community. Furthermore, both sets of users approved the 
overall design and were receptive to and keen on the practical uses of the 
application. Inadequacies pointed out by the Deaf community and pharmacists 
were addressed as an iterative modification to the prototype and culminated in 
version 2 which was deployed in an actual hospital pharmacy in 2015. Hospital 
usability studies generated largely positive results from both Deaf users and 
pharmacists, indicating that SignSupport is able to facilitate communication 
between pharmacists and Deaf patients.  Next steps include advancing the 
application to a market–ready version that is downloadable and available as an 
application on the play stores of commercially available smart phones.   
 
November 2015 
 
 
iii 
 
 
 
 
 
 DECLARATION 
 
I declare that Pharmacy perspectives in the design and implementation of a 
mobile cellular phone application as a communication aid for dispensing 
medicines to Deaf people in the South African context is my own work (except 
where acknowledgements indicate otherwise), that it has not been submitted for 
any degree or examination in any other university, and that all the sources I have 
used or quoted have been indicated and acknowledged by complete references. 
 
 
Mariam B. Parker 
November 2015 
 
Signed .........................................  
 
iv 
 
 
 
 
 
 DEDICATION 
 
 
To my moms- Najmunissa and Zaibunissa, for your prayers, resilience and 
unwavering support.  
 
To Mazhar- for filling my shoes as well as yours, and for letting me be me. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
v 
 
 
 
 
 
ACKNOWLEDGEMENTS 
 
To my Almighty creator, who gently nudges and pushes me in directions of which I 
can only dream, who has opened the doors of academia which so innately suits my 
very fiber, who has equipped me with the strength and capability to do this work.   
 
To my family, my parents who are ever supporting and prayerful, my husband who 
built my strength and courage in the moments that I have felt fractured, and my 
colleagues, particularly Nadine Butler and Dr. Kim Ward,  and my  friends for their 
unwavering support and encouragement. You have brought this thesis to 
completion.  
 
To my supervisors and colleagues: Professors Angeni Bheekie, William Tucker. I 
am humbled by your support and guidance and want to thank you for the excellent 
guidance, wisdom, intuition and understanding of the research process and for your 
unlimited encouragement and confidence in me.  
 
This research would not have been possible without my team members, Prang and 
Michael, my research assistants (B..Pharm. IV student research groups 2012, 2013 
and 2015) and the participants who selflessly gave of their time and knowledge to 
bring SignSupport to fruition. Thank you for sharing of yourselves and for your 
dedication to deliver your best.  
   
To the funders of this work, the National Research Foundation and University of 
the Western Cape, Deputy Vice Chancellor, for affording me the necessary 
resources to bring this thesis to completion.   
 
 
 
 
 
 
 
vi 
 
 
 
 
 
LIST OF TABLES 
 
Table 1: Research partners and affiliations 
Table 2:  Barnett’s multi-factorial causes of low literacy among Deaf people 
Table 3:  The significance of five types of information requested from 
patients with regards to new and repeat prescriptions  
Table 4: Percentages of mystery shoppers receiving aspects of medicine-
related information  
Table 5: Patients’ and doctors’ ranking of importance of medicine 
information aspects  
Table 6:  Elements of pharmaceutical care 
Table 7: Summary of lessons elicited from the literature 
Table 8: List of major themes and subthemes from focus groups and key 
informant interviews 
Table 9:  Communication script for SignSupport 
Table 10: Modifying the original communication script 
Table 11:  SignSupport communication script 
Table 12:  Progressive development of SignSupport components 
Table 13:   Symptoms and illnesses list for SignSupport 
Table 14:  SignSupport dispensing time per item and per prescription 
Table 15:  SignSupport dispensing time per item and per prescription 
Table 16:         Usability questionnaire responses: Pharmacy students 
Table 17:   Usability questionnaire responses: Deaf participants 
Table 18:  SignSupport dispensing time per item and per prescription 
Table 19:  Hospital experiment questionnaire responses: pharmacists 
Table 20:  Comparison of Deaf participant responses obtained for pilot study 
(n=8) and hospital experiment (n=6) 
 
 
 
 
vii 
 
 
 
 
 
LIST OF FIGURES 
 
Figure 1: Sequence of research activities 
Figure 2: WHO hearing impairment classification scale 
Figure 3:  A transactional communication model 
Figure 4: Volcano model of cultural competency 
Figure 5a:  SignSupport pre-requisites 
Figure 5b: SignSupport pre-requisites 
Figure 6:  Methodological influences for SignSupport research  
and development 
Figure 7: Hughes concept of participatory action research 
Figure 8: Research framework 
Figure 9:   Domains to be evaluated in this study 
Figure 10:  Outline of study design and research methods used 
Figure 11:  Research timeline 
Figure 12:  Research phase progression 
Figure 13:  Highest completed educational level of participants 
Figure 14:  Use of public versus private healthcare services 
Figure 15: Steps in the data analysis process for focus groups and key 
informant interviews 
Figure 16:  Example of an OSCE 
Figure 17:  Frequency scores of similar sentences/phrases spoken during the 
role-play session between the pharmacy students (n=18, 100%) and 
simulated patient 
Figure 18: Application of SignSupport in an institutional pharmacy 
Figure 19: SignSupport communication flow: Pharmacist interface 
Figure 20: Iterative processes for evaluation of SignSupport  
Figure 21: Study design for usability evaluation 1 
Figure 22: Simulated dispensary for the pilot study 
Figure 23: Data sets generated by usability evaluation activities 
Figure 24:  Data sets generated by usability evaluation activities 
viii 
 
 
 
 
 
Figure 25:  Graphical representation of positive, negative and neutral responses: 
pharmacist questionnaire 
Figure 26:  Graphical representation of positive, negative and neutral responses: 
Deaf participant questionnaire 
Figure 27:  Study design for hospital usability evaluation 
Figure 28:  Experimental procedure: dispensing interaction between a 
pharmacist and Deaf patient at Tygerberg hospital pharmacy  
Figure 29:  Data sets generated from hospital study activities 
Figure 30:  Comparative graphical representation of positive, negative and 
neutral responses: pharmacist questionnaire 
Figure 30:  Graphical representation of positive and negative responses 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
ix 
 
 
 
 
 
LIST OF ACRONYMS 
 
SASL:   South African Sign Language 
DeafSA:  Deaf Federation of South Africa 
SASLI:  South African Sign Language Interpreter 
UWC:   University of the Western Cape 
TU Delft:  Delft University of Technology 
DCCT:  Deaf Community of Cape Town 
NRF:   National Research Foundation 
WHO:  World Health Organization 
FIP:  International Pharmaceutical Federation 
US:   United States 
SAPC:  South African Pharmacy Council 
OSCE:  Objective Structured Clinical Evaluation 
OSDE:  Objective Structured Dispensing Evaluation 
WFD:   World Federation of the Deaf 
WASLi:  World Association of Sign Language interpreters 
SADA:  South African Disability Alliance 
SANCD:  South African National Council of the Deaf 
DOH:   Department of Health 
NAD:   National Association of the Deaf 
NDP:   National Drug Policy 
SMCR: Sender-Message-Channel-Receiver 
SMS:  Short Messaging Service 
HCD:   Human Centered Design 
ICT:  Information and Communication Technology 
OTC:  Over-the-Counter (medicine) 
PC:   Personal Computer 
GPP:   Good Pharmacy Practice 
PAR:   Participatory Action Research  
 
 
 
x 
 
 
 
 
 
TERMS AND DEFINITIONS 
 
deaf: (lower-case ‘d’) refers to individuals who 
experience hearing loss from moderate to 
severe, and use mainly spoken language to 
communicate. 
Deaf:  (uppercase ‘D’) refers to those individuals 
who experience profound hearing loss and 
use South African Sign Language as their 
main means of communication. They identify 
with Deaf culture. 
 
Deaf culture: a cultural grouping associated with Deafness 
and the primary use of sign language as the 
main means of communication. 
 
Dispensing Phase 3:  “Provision of information and instructions to 
the patient to ensure safe and effective use of 
medicines.” (SAPC, 2010) 
 
 
Patient counselling: “A one-to-one interaction between a 
pharmacist and a patient and/or caregiver. It 
is interactive in nature. It should include an 
assessment of whether or not the information 
was received as intended and that the patient 
understands how to use the information to 
improve the probability of positive 
therapeutic outcomes.” (Beardsley, 1997) 
 
SignSupport: A mobile phone assistive technology to 
facilitate communication between a 
pharmacist and a Deaf patient. 
 
Multi-disciplinary collaboration: the collective efforts of a pharmacist, 
computer programmer, industrial design 
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engineer and Deaf community toward 
realizing SignSupport. 
 
Dispensing dialogue pattern: a collective order-of-sentences elicited from 
studying the communication between a 
pharmacist and patient. 
 
Communication script: the dispensing dialogue pattern converted into 
a format to be coded in SignSupport. 
 
Pharmacy student participants: final year pharmacy students as research 
participants selected on the basis of a non-
randomized sampling strategy.  
 
Research assistants: final year pharmacy students as research 
assistants selected on the basis of their 
curriculum requisites to complete a research 
project.  
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CHAPTER 1 
INTRODUCING THE RESEARCH 
____________________________________________________________ 
More than two decades into the emergence of a democratic South Africa, the 
aftermath of historical injustice and inequality lingers in the country’s healthcare 
system. The public health sector in particular has inherited a highly under-
resourced and fragmented state of affairs (Dayi & Gray, 2006). While the 
impoverished and needy are recognized daily as casualties of this fragmented 
system, marginalized groups may be at greater risk.  In a health system fraught 
with a lack of resources and an over-stretched capacity (Dayi & Gray, 2006), the 
disabled become victims of poor service delivery and failure to address their 
special needs (DOH, 2007). 
The need for effective verbal, written or electronic communication is imperative in 
the provision of healthcare. This is particularly important during a pharmacist-
patient interaction in which the patient is given medicine dosage and administration 
instructions (Beardsley et al., 2008). If miscommunication occurs, patients may 
understand instructions incorrectly which in turn can have potentially dangerous 
consequences (Beardsley et al., 2007 in Tietze, 2004). Typically, the intended 
therapeutic outcome is compromised, which could result in a potentially life-
threatening situation for the patient, placing a further burden on the already 
overstretched health system. On special needs and effective communication in a 
pharmacy setting, the Deaf community may be especially vulnerable. 
South Africa is home to an approximated range of  600 000 to 1.5 million  
profoundly deaf people who use South African Sign Language (SASL)  as a first 
language and identify with the Deaf culture (DeafSA, 2011).   Deaf people often 
exhibit literacy impediments because they have not acquired spoken language at a 
pre-lingual age (Barnett, 1999). The absence of auditory stimuli impedes phonic 
development and is causal to their literacy insufficiencies (Fellinger et al., 2012). 
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Deaf individuals are often termed “functionally illiterate”, i.e. have marked 
limitations in their capacity to read and write. Functional illiteracy renders 
medicine labels and traditional verbal medicine instruction/counselling unviable 
options for Deaf patients, since neither option can be understood with sufficient 
accuracy required for medicine instruction (Steinberg et al., 2006). This 
communication difficulty may pose a significant barrier to achieving intended 
therapeutic outcomes of prescribed medicines. The challenges in communication 
between Deaf people and health care professionals have been widely shown to 
result in a poor medicine use (Reeves et al., 2002).  The gravity of these problems 
creates a critical need for a concise and clear communication medium for the 
transfer of medicine instruction between a pharmacist and Deaf patient. 
 
The past decade has seen an international and ever-expanding impetus toward 
looking to emerging technologies to counter social quandaries in every shape and 
form.  The world of communication has been transformed by the emergence of 
networks and applications that allow for real-time relay of access to information. 
Many individuals, corporations and governments are employing technologies not 
only as a means of development but also as a medium to empower marginalised 
communities in areas of health, education and social reform. This dissertation 
presents a possible solution to enable the effective communication of medicine 
instructions between a pharmacist and a Deaf person collecting medicines at a 
pharmacy.  
 
1.1 Personal interests and experiences 
As a pharmacy student and intern pharmacist, I was naturally drawn to matters 
concerning effective communication between pharmacists and patients/clients. 
Working in a public tertiary hospital in a country diverse with eleven official 
languages, I was often privy to the bottlenecks which arose when a patient 
receiving medicine instructions was unable to understand the language the 
instruction was given in, for example an isiXhosa-speaking patient and an 
Afrikaans-speaking pharmacist. The possibility of a person being placed at risk of 
under-dosing or overdosing on medicines simply because they did not understand 
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instruction was an issue that needed urgent attention. This led to my first 
independent research endeavour which aimed to bridge the linguistic gaps in 
medicine instruction. The study involved crafting a manual solution as a dosage 
translation tool which allows pharmacists to translate medicine instructions 
dynamically between English, Afrikaans and isiXhosa (Parker & McCrae, 2008). 
This research directed me to academia which in turn led to social studies and 
qualitative research, in particular community-centred and participatory action 
research.  
The umbrella project described in this thesis was not self-initiated, but referred to 
myself by a colleague who was aware of my background and interest. I was 
approached by an international research group to be the pharmacy arm of a multi-
disciplinary project in which the expertise and professional training and experience 
of a pharmacist was needed. Since the project was aligned with my interests, 
participation was inevitable.  Thrust into an unfamiliar world of sign-language, 
computer programming and android interfaces, the prospect of creating a solution 
for Deaf people to understand how to use their medicines without having to rely on 
interpreters, family or friends to administer doses was sufficiently enticing to 
ensure my continued efforts.  
 
1.2 Multidisciplinary Collaboration 
The final outcome of this research was envisioned to be a mobile phone 
prototype application that would allow communication of medicine instructions 
between a hearing pharmacist and a Deaf person, without the Deaf person having 
to rely on interpretation or assistance. Instead, medicine instructions would be 
available for the Deaf person in their preferred language i.e. South African Sign 
Language (SASL). For this outcome to be realised, a mobile phone interface would 
need to translate instructions keyed in by a pharmacist into SASL (e.g. Take two 
tablets three times a day after meals). To make this a reality, collaboration of 
various stakeholders with different expertise was crucial. In brief, the following 
expertise was needed: 
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1. Pharmacist: to contribute all pharmacy-related communication needs for 
implementation into the mobile phone application. 
2. Computer programmer: to contribute technical expertise to code the 
application onto a mobile phone interface in a manner that was usable and 
functional. 
3. Industrial design engineer: to design interface icons and flow in a manner 
that would be understood by the Deaf community. In addition, she advised 
the team with regard to suitable evaluation techniques to assess the usability 
of the application.  
4. Deaf community and interpreters. The Deaf community were the drivers 
of the design; they dictated what would be suitable for them. Interpreters 
bridged the communication gap between the researchers and Deaf 
community at every step of the research. 
 
1.3 Partners, affiliations and interests, funders 
Since this collaboration involved team members from different fields of expertise, 
each team member was affiliated to different partners, funders, centers and co-
researchers. Academic partners included the University of the Western Cape 
(UWC) School of Pharmacy and Department of Computer Science and the Delft 
University of Technology (TU Delft), Netherlands. Deaf community partners 
included the Deaf Community of Cape Town (DCCT) and the Deaf Federation of 
South Africa (DeafSA).  During the research, three teams A, B and C (team details 
in Appendix A) of senior pharmacy students participated as research assistants 
working under my supervision during separate study phases. Table 1 below 
outlines the specific role of each member outlined in the study.  
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Table 1: Research partners and affiliations 
Partner Role    Affiliation Co-researchers 
Pharmacy Pharmacist Member 
UWC School 
of Pharmacy 
Assistant  researchers: 
Team  
A 
Team 
B Team C 
Computer 
Science 
Computer 
programmer 
UWC 
Computer 
Science 
n/a 
Industrial 
Design  
Industrial design 
member 
TU Delft 
(Netherlands) n/a 
Deaf 
community  
Input in design, 
preliminary 
testing 
DCCT n/a 
Paarl 
DEAFSA Hospital testing DEAFSA n/a 
 
Funding for the study was granted by the South Africa-Netherlands Research 
Programme on Alternatives in Development (SANPAD), the National Research 
Foundation (NRF) and the University of the Western Cape (UWC) and used for 
costs incurred in running the experiments, research assistance and staff relief.  
 
1.4 Research context 
In order to realise the outcome of a purposeful mobile phone application prototype, 
the active engagement of two groups of study participants was necessary, viz.  
pharmacists and Deaf persons, who were the intended end-users of the mobile 
phone application. Participant groups were obtained at various centres within the 
Western Cape province of South Africa, with pharmacists being from the city of 
Cape Town and Deaf participants from both Cape Town and Paarl, a town on the 
outskirts of Cape Town. 
 
1.4.1 Pharmacists 
Pharmacists were needed in the study because ultimately, they are intended to use 
the application to key in medicine instructions for the benefit of the Deaf patient. 
For this reason, the application had to be designed to specifically meet their 
professional and practical needs at the point of care, namely the time required to 
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dispense, adhering to the pharmacist’s code of practice and fitting in to their 
professional and work contexts. Their contribution on whether the application was 
user-friendly, applicable, accurate and complete was what would drive study 
iterations.  
Since the Deaf communities we were working with mostly made use of public 
rather than private health services, and in particular tertiary hospital pharmacies to 
collect their medicine, we worked with pharmacy participants who were familiar 
with and had experience at tertiary hospital pharmacies. The final empirical 
procedures of this dissertation were also conducted at a tertiary hospital pharmacy 
since this was the site where Deaf participants would regularly engage with 
pharmacists to receive their medicine. Our main focus was to test the mobile phone 
application in a real-world context that mimicked the pharmacist-patient interaction 
in a hospital setting.  
Public sector pharmacies are often fraught with severe human resource constraints, 
often being short-staffed and working over-time to meet patient load. In this way, 
the time commitment required from pharmacists would be minimised. The initial 
iterations used senior (fourth year) pharmacy students from the UWC School of 
Pharmacy in place of pharmacists,  based on the criteria that they must have had 
prior experience in supervised dispensing at a public hospital pharmacy. Later in 
the study, pharmacists employed at Tygerberg hospital pharmacy were used to test 
the application with Deaf participants in a real-world setting.  
 
1.4.2 Deaf participants 
The mobile application was envisioned to be of use for South African Deaf 
persons. Thus, they were another target sample of the study. Deaf patients 
experience difficulties during a pharmacy consultation because traditional means of 
communicating medicine instruction are not feasible for them: spoken instructions 
are not audible and written or typed instructions on a medicine label present a 
problem to Deaf persons with limited literacy.  The Deaf community primarily 
dictated the design of the application: what would suit their needs in a format that 
was most appropriate for them was at the forefront of the design process. Initial 
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design, subsequent iteration and final experimentation were conducted with Deaf 
people. 
 
1.5 Research Origin 
The main outcome of this study, a mobile phone application for Deaf persons, 
emerged from prior work by Looijestein (2009), Mutemwa (2011) and Chinithorn 
(2011). Looijestien designed a program on a personal computer that allowed a Deaf 
person and a doctor to communicate with each other using sign language videos. 
This program was called SignSupport (Version 1). 
SignSupport was implemented on a mobile phone by Mutemwa (2011). He 
expanded on Looijestein’s (2009) version by using an organised composite of 
SASL videos and English text. This format enabled a Deaf patient to communicate 
to the doctor which symptoms he/she was experiencing and the symptom duration. 
Testing of Mutemwa’s version revealed that while the format was functional, it was 
not feasible to use in the context of a medical consultation. Chininthorn (2011) 
went on to investigate the way Deaf people use mobile phones to communicate 
with both hearing and Deaf people. With input from a local Deaf community, she 
re-oriented SignSupport toward pharmacy, and realised that they required the 
expertise and experience of a pharmacist to bring the pharmacy version of 
SignSupport to realisation. My involvement in this study, and the work presented 
in this thesis ensued. 
 
  1.6 Research problem 
Deaf people identify with the Deaf culture and use  South African Sign language 
(SASL) as their primary means to communicate (DeafSA,2011) . They also use 
modern mobile phone and computer technologies, including e-mail, short 
messaging service (SMS), Whatsapp® and Skype®, among others (Glaser & 
Tucker, 2004). While these technologies have proved useful in some contexts, 
limited text literacy hinders communication. Poor text literacy also renders 
medicine labels of little use. A medical communication exchange requires high 
levels of accuracy to avoid risk of incorrect diagnosis, treatment and correct 
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understanding of medicine administration. In Deaf persons, this risk can only be 
avoided using their ‘mother-tongue,’ sign language, to accurately and without 
ambiguity convey instructions in a manner that Deaf people can clearly understand.  
South African public healthcare facilities do not make provision for interpretive 
services for Deaf people; as a result they rely on the assistance of family and 
friends.  Deaf people have reported a desire for the same autonomy and 
confidentiality in medical issues that their hearing counterpart’s experience. This 
can only occur if the pharmacist is able to communicate with the Deaf person in 
sign language, which is unlikely to be the case.   
 
1.7 Research Approach  
To enable the research team to fully immerse ourselves within the Deaf culture and 
to elicit their communication needs, qualitative and participatory research 
approaches suited the inquiry process and theses strategies were employed 
throughout the stages of this research. Data collection was qualitative and data 
from each juncture of the study was incorporated into the subsequent phase, 
creating iterative cycles of research and subsequent design. A participatory action 
approach is well suited for innovation studies because it considers the requirements 
and input of the intended users of the product. Furthermore, participation and 
feedback at respective research sessions influenced subsequent design iterations of 
the mobile phone application. 
 
1.8 Overview of the research 
The iterative nature of the research necessitated a sequential pathway of events, 
outlined as research phases. The research team commenced work with a conceptual 
notion of a mobile phone application which would allow a pharmacist to 
communicate with a Deaf person in SASL. The concept was based on Looijestein’s 
(2009) computer model and Chininthorn’s (2011) work with a local Deaf 
community. Members from pharmacy, computer science and industrial design 
engineering backgrounds combined their expertise and agreed upon the design 
progression for the mobile phone application collectively, which in turn determined 
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the trajectory that my research would follow. Logically, research activities 
accommodated the design process in order to bring to fruition the overarching goal 
of a tangible, usable mobile phone application. Figure 1 outlines the sequence of 
research activities.  
Figure 1:  Sequence of research activities 
 
 
 
 
 
 
 
 
 
 
1.9 Thesis outline  
The iterative nature of this study calls for data to be reported on at each stage of the 
research. This dissertation is thus presented in narrative manner and deviates from 
the conventional manner in which thesis reports are structured. The first chapter 
has introduced the scope of research, the multi-disciplinary team members and 
their respective roles, my personal research background and the phases of this 
complex study. 
 
Chapter two sets the backdrop for the proposed mobile phone initiative within the 
local Deaf community and its applicability in pharmacies in the South African 
public health care system. Insights into the pharmacist’s crucial role in 
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medication 
dispensing 
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Design Prototype 
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communicating medicine related information substantiates the applicability of 
assistive devices in bridging communication gaps between pharmacists and 
vulnerable groups. A synopsis of health-related communication issues affecting 
Deaf persons portrays an immensely challenged community further subverted by a 
lack of resources and service facilities.  The chapter proceeds to report on and 
analyse published local and international policy and legislative documents looking 
toward elucidating the theoretical underpinnings for the development of assistive 
technologies in healthcare communication.  Furthermore, innovations in 
communication technology designed specifically for Deaf persons are explored, 
with a view to extract lessons of the successes and drawbacks of these technologies 
for incorporation into our own mobile phone application design.  
 
Chapter three elucidates from the literature the focal aspects that establish the 
rationale for the study and details the research objectives designed to fulfil the main 
aim and outcomes of the study.  
 
Chapter four (research design and methodology) presents the elucidation of the 
research plan and chosen methods, grounded in the underpinnings of the qualitative 
paradigm and of participatory action research. It further portrays the manner in 
which research theories are applied at each emerging phase of data collection and 
analysis.  This is followed by a discussion of the manner in which quality and 
rigour were addressed in every phase of the study. The chapter concludes with 
presenting and applying ethical issues particular to working with vulnerable 
groups.  
 
Chapter five presents the baseline study which comprises the first empirical 
processes of this dissertation. These processes, aimed at attaining the groundwork 
for the intervention described in this dissertation include a qualitative, explorative 
study with the Deaf community and a participatory action and qualitative study 
with senior pharmacy students. 
  
This thesis reaches its climax in Chapter six, which presents the conceptual 
processes toward a mobile phone application which facilitates communication 
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between a pharmacist and Deaf patient.  The application is presented as a pictorial 
series of screenshots of how it would appear on commercially available smart 
phones. 
 
Chapter seven serves to present usability studies of the mobile phone application, 
targeted at pharmacists and Deaf patients. A pilot study is described subsequent to 
which the pilot study is implemented in a real-world hospital setting.  
 
Chapter eight delivers a general discussion of the main themes emerging from this 
project, scholarly views of such themes and its implications on social redress for 
Deaf communities.  
 
Chapter nine brings this thesis to a close, delivering a distillation of the research 
findings, author opinions and recommendations for future work. 
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CHAPTER TWO 
LITERATURE REVIEW 
 
 
 
The literature review is separated into three sections and examines legislature, 
policy and published research pertinent to underpinning a theoretical  framework 
for the research. The opening section explores the concept of deafness and reviews 
definitions of deafness with a view to extract a single designation applicable to the 
research. I delve into the formal support structures for hearing-impaired 
communities both internationally and locally, and examine the constitutional rights 
of the Deaf community regarding health care provision and accessibility. The 
psychosocial and emotional impact of Deafness provides the landscape relating to 
the affective behaviour of Deaf people. The review further explores literature 
documenting the experiences of the Deaf community with healthcare 
communication, and specifically medicine instruction, thereby creating a case for 
the intended research. 
The second instalment explores global and national policy recommendations 
pertaining to the roles of pharmacists within the healthcare system, focusing 
specifically on characteristics of effective communication in service delivery. 
Literature focusing on the communication experiences of pharmacists with 
hearing-impaired patients is analyzed. 
The final segment reviews global trends in using assistive technologies to counter 
social problems experienced by the Deaf community, focusing on the area of 
information communication technology (ICT) for communication in healthcare. It 
reports on the foundational work done specifically in using assistive technology to 
assist the Deaf community in healthcare communication. The review culminates in 
lessons learnt from the literature that are central to this thesis. 
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2.1. UNDERSTANDING THE DEAF COMMUNITY 
 
Deaf people experience a unique and complex set of circumstances that extend far 
beyond their physical disability. Not merely people who have impaired hearing, 
they are a multifarious community characterized by cultural and societal intricacies 
which are essential to understand when working with them.  As a fairly  isolated 
and marginalized minority group, they have a strong sense of kinship and loyalty to 
other deaf people. This section explores the fascinating characteristics of Deaf 
people and how they function in a hearing society. 
 
2.1.1 Deafness and hearing loss 
 
The word ‘Deaf’ (adjective) is largely defined as: 
“Lacking the power of hearing or having impaired hearing” 
Notwithstanding its Germanic roots, related to Dutch ‘doof’ and German ‘taub’, 
(from an Indo-European root shared by Greek tuphlos ‘blind’), the term ‘deaf’ is 
Old-English in origin (Oxford University Press, n.d.). While the general definition 
is expansive encompassing everything from mild hearing loss to zero hearing 
ability, in reality the term is far more complex with multi-faceted connotations. 
 
In March 2015, the World Health Organization’s (WHO) media centre published 
updated indicators detailing key facts and statistics on the worldwide picture of 
deafness. Globally, 360 million people experience disabling hearing loss, the 
majority of who reside in low and middle-income countries (WHO, 2015). In the 
age group 65 years and older, 33 percent of people experience disabling hearing 
loss, the greatest prevalence occurring in Sub-Saharan Africa, South Asia and Asia 
Pacific (WHO, 2015). While Deaf prevalence in South Africa is contested, the 
statistics reflect numbers between 600 000 and 1.5 million people (DeafSA, 2011). 
Causes of hearing difficulties are either congenital or acquired. Congenital causes 
are present at or shortly subsequent to birth and include genetic factors, low birth 
weight of the infant, maternal rubella and birth asphyxia among others. Acquired 
causes  lead  to  hearing  loss  at  any  age  and  include  meningitis,  chronic      ear 
 
 
 
 
14  
infections, otitis media, ear or head trauma, ageing and exposure to excessive noise 
pollution (WHO, 2015). 
 
2.1.2 “Hearing loss” versus “Hard-of-hearing” versus “deafness” versus 
“Deafness” 
 
The degree of hearing impairment varies largely from one individual to the next; 
while one person may have zero ability to hear, another may experience only minor 
deficiency. For this reason, many different terms exist to describe hearing 
impairment (Middleton et al., 2010). These terms are often fluid, they are used 
interchangeably and vary across communities. While no single universally 
accepted definition for Deafness exists, I examine below the definitions presented 
by key organizations, with a view to elucidate therefrom a definition that applies to 
this study. 
According to the WHO (2015), the term ‘hearing loss’ applies to persons who 
experience hearing thresholds of 25 decibels (dB) or better in both ears. Hearing 
loss can be unilateral or bilateral and ranges from mild, through moderate and 
severe to profound. Persons who are hard-of-hearing are characterized by hearing 
loss spanning the range from mild (difficulty in hearing conversations in a noisy 
area or hearing whispering) to severe (begin to hear sound between 71- 85dB, i.e. 
equivalent to the sound of a lawnmower). They are able to communicate using 
spoken language, and are represented by a lower-case “d,” i.e. “deaf”. 
 
“Deaf” people denoted with an upper-case “D” experience profound hearing loss 
with very little or no hearing. They can only hear sound equivalent to or above 
95dB (WHO, 2015), for example a gunshot (140dB) (Cambridge University Press, 
2010). Instead of using spoken language, they use signed language to 
communicate. The WHO classification system of hearing impairment is based on 
objective clinical presentation (decibel count) and is classified in terms of 
presentation by the variables: mild, moderate, severe and profound. Conversely, the 
Cambridge University Press’s “Working with Deaf people: A handbook for 
healthcare   professionals,   (Middleton et al., 2010)”  defines   “deaf”  persons   as   
those   having  a 
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profound level of hearing loss and who use both signed language and spoken language 
in different contexts. 
 
Figure 2: WHO hearing- impairment classification scale 
 
 
 
 
The World Federation of the Deaf (WFD) serves as the international, non- 
governmental organisation for national associations of Deaf people and is 
recognized as the representing body for Deaf people who use sign language. While 
WFD does not classify varying degrees of hearing impairment, it embraces a 
concept of Deafness that mimics the WHO definition, with the common factor 
between the two being the usage of sign language (World Federation of the Deaf, 
n.d.). 
In their constitution the Deaf Federation of South Africa (DeafSA, 2008), defines 
Deaf (uppercase D), as “all persons with substantial hearing loss who may 
consider themselves Deaf” and includes persons who are hard-of-hearing, deaf- 
blind and deafened persons who affiliate themselves with the Deaf culture and the 
use of SASL.   The uppercase ‘D’ denotes adherence to a specific social    grouping 
i.e. the Deaf culture (DeafSA, 2008). 
 
Alternative constructs of the terms “deaf” and “Deaf” are based on the period of 
deafness in years, the individuals own perception of whether they are deaf , Deaf or 
hard-of-hearing, whether the person’s hearing impairment was congenital or 
acquired, and the literacy status and ability to communicate in the hearing world. 
For this research I have discarded these definitions due to the subjective nature of 
the variables. 
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2.1.3 Deaf community representation 
 
While hard-of-hearing and Deaf communities are often referred to as minority 
groups, substantial representation of deaf people by organized federations and 
societies is evident worldwide, with deaf community perspectives featuring in the 
work of the United Nations (UN) and WHO. 
The WFD is an international organization representing approximately 70 million 
Deaf people worldwide. Established in Rome in 1951, WFD comprises an existing 
membership of associations in 133 countries globally (World Federation of the 
Deaf, n.d.). It is estimated that more than 80 percent of these 70 million live in 
developing countries, where authorities are rarely familiar with their needs. WFD 
works closely with the UN and its various agencies in promoting the human rights 
of deaf people. This is in accordance with the principles and objectives of the UN 
Charter, the Universal Declaration of Human Rights and other general acts and 
recommendations of the UN and its specialized agencies globally  (World 
Federation of the Deaf, n.d.). WFD advocates for Deaf people in every country to 
have the right to preserve their own sign languages, organizations and cultural 
activities. Most important among WFD priorities are Deaf people in developing 
countries; the right to sign language; and equal opportunity in all spheres of life, 
including access to education and information. WFD’s philosophy is one of 
equality, human rights and respect for all people, regardless of race, nationality, 
religion, gender, sexual preference, age and all other differences. WFD supports 
and promotes in its work the many UN conventions on human rights, with a focus 
on the aim of solidarity and unity globally (World Federation of the Deaf, n.d.). 
 
The South African Disability Alliance (SADA) is a national board that comprises 
thirteen national organizations that represent various disabilities in South Africa, 
including Autism South Africa, Deaf-Blind South Africa and Down syndrome 
South Africa (SADA, n.d.). Serving as the voice of the disability sector in the 
country, SADA represents approximately 8% of the populace and advocate on 
behalf of disabled persons. The Deaf Federation of South Africa (DeafSA) is one 
of the thirteen members that constitute SADA. Formerly known as the South 
African National Council for the Deaf (SANCD), SANCD was founded in 1929 
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and in 1995 the former SANCD was transformed to a new democratically elected 
organization, DEAFSA. DEAFSA serves as the “national research, information and 
community action” association on behalf of an approximately 600 000 citizens that 
are culturally and linguistically Deaf (DeafSA, 2008). The vision of DEAFSA is “a 
fully functional Deaf community with equality in society, empowered to utilise 
opportunities in order to create and sustain a high quality of life  (DeafSA, 
2008).” 
DEAFSA comprises of and represents nine provincial Deaf federations. Among 
their national objectives, DEAFSA seeks to “formulate national policies regarding 
deafness, to promote the status of SASL, to initiate, develop, decentralize, co- 
ordinate and maintain structures and projects, to promote and assist standards of 
training of sign language interpreter services in South Africa, to be the official 
lobbying, representation and negotiation channel for the purpose of equalization of 
opportunities for Deaf people in South Africa and to co-operate with national, 
provincial and local authorities in all measures for the general well-being of Deaf 
people (DeafSA,2008).” 
 
2.1.4 Constitutional rights for Deaf persons 
 
Embedded within the Human Rights Charter and in accordance with its constitution 
and international conventions, South Africa is obliged to provide equal rights, 
opportunities and services for Deaf and hard-of hearing persons. The  constitution 
of South Africa advocates for equality for all people under Articles 9 (3), 10, 13 
which declare the right to privacy of communication, access to information and the 
right to practice culture, religion and language freely (Constitution of the Republic 
of South Africa, 1996). In addition, South Africa is a signatory nation to a number 
of global treaties and declarations relating to protection of human rights, protection 
of people with disabilities and matters of equality for all. It is indisputable that 
Deaf persons should have access to and equally enjoy the provisions and facilities 
provided to their hearing counterparts. This notion has been entrenched in 
international policy and resonates in South African policy which is fairly well- 
developed in establishing constitutional rights for disabled people. Policy  however 
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fails on an implementation level. South African legislation does not specify or 
obligate special services (for example sign-language interpretation) for Deaf people 
within healthcare facilities (Zulu, 2014). In addition, several circumstances  arise 
for Deaf people which compromise their constitutional rights. These are outlined 
later in this review. 
 
2.1.5 Epidemiology of Deafness in South Africa 
 
Population numbers detailing the prevalence of Deafness in South Africa are 
inconsistent across various sources. Community survey data 1997 report a 0.4% 
prevalence rate of Deafness in the country (Statistics South Africa, 2007) while 
DeafSA (2011) reports a prevalence figure of 3.7 percent. The DeafSA numbers are 
closer to the WHO estimate of 5 percent Deafness prevalence in the world 
populace. Census data 2011 reflect a total disability incidence of 7.1 percent 
(Statistics South Africa, 2013), of whom 20% are estimated to have a hearing 
disability. The discrepancies of Deaf prevalence data may be due to varying 
subjective classification systems of hard-of-hearing, deafness and Deafness. 
DeafSA reports an expansive range of users of South African Sign language, 
between 600 000 and 1.5 million users (DeafSA, 2011), the lower interval 
mimicking the WFD number of Deaf users. 
 
2.1.6 Deaf community profile in South Africa 
 
South Africa’s deaf community is well-established and experience strong 
s u p p o r t  in terms of national and provincial representative organizations and non-
profit organizations. The country’s history of inequity and social injustice has 
resulted in a high incidence of unemployment and limited literacy levels among the 
South African deaf community (Chininthorn, 2011). An estimated 600 000 South 
Africans communicate in SASL, this number coincides with the prevalence of 
profoundly Deaf people (DeafSA, 2011). Sign language is not universal; each 
country has its own unique form, with further dialectal differences from one Deaf 
community to the next. The same is true for sign language in South Africa. SASL 
is  a  visual,  natural  language  developed  through  its  use  by  the  local  Deaf 
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community (DeafSA, 2008). The language has a unique syntax and uses a series of 
signs to communicate a message, as opposed to the series of words used by hearing 
people. DeafSA hopes to officialize SASL as the country’s 12th official language in 
order to uphold the rights of the Deaf community (DeafSA, 2011). 
 
The deaf education system in the country is robust with more than forty dedicated 
schools for the deaf countrywide (Berke, 2014). Deaf colleges include the 
Worcester-based Deaf College South Africa, which trains deaf people to enter the 
job market, and the Gauteng-based Bible College for the Deaf which provides 
training to work in deaf ministry (Berke, 2014). About a third of all Deaf adults 
are functionally illiterate (Conrad, 1977). Functional illiteracy would mean that 
Deaf people requiring healthcare would most likely be dependent on sign-language 
interpreters or assistive audiology devices rather than traditional means of spoken 
and written information. If such resources are not available, the quality of care of 
Deaf people could be compromised. 
 
Sign-language interpreters in South Africa were recently in the spotlight when the 
authenticity of sign-language interpretation of the internationally broadcast former- 
president Nelson Mandela’s memorial service was questioned and derided  for 
using gestures meaning “rocking horse” and “prawns” in the bogus sign-language 
translation (Newling, 2013). While the fake interpreter’s presence and proximity to 
world leaders drew much attention in terms of breached security, it also highlighted 
the importance of authentic sign-language interpretation services for Deaf people 
and the fine line they experience between access to information and a lack thereof. 
 
Figures detailing the religious profile of the South African deaf community are not 
available. However, deaf Christians who prefer deaf churches are affiliated to one 
of 15 churches of fellowships associated with the Deaf Ecumenical Forum of South 
Africa (Smit, 2010). Several Deaf South Africans are Jehovah’s Witnesses and are 
members of Jehovah’s Witnesses sign language congregation, or are Muslims. Al- 
Waagah Institute for the Deaf is an Islamic institute providing services for the deaf 
community in Athlone, Cape Town (Smit, 2010). The South African deaf 
community enjoy a deaf-dedicated television series, Deaf TV which airs weekly on 
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the national broadcaster channel, SABC3. This privilege is one which is not 
ubiquitously available globally (Berke, 2014). 
 
2.1.7 The social and emotional handicap of Deafness 
 
Deafness is more than a physical disability. It is a physical, emotional, educational, 
social and psychological handicap (Arana et al., 1978; Ismail and Henderson, 2014; 
Mc Brien, 1982; Schlesinger, 1978), compounded by the reality that deafness is 
also an invisible handicap; often the general public do not recognize that a person 
is Deaf. 
 
Understanding the implications and full extent of the handicap of Deafness is an 
exhaustive task. Mc Brien (1982) found it best explained by sketching the 
developmental implications of Deafness in an infant who lost their hearing pre- 
lingually over the infant’s natural life span (from infancy into childhood, teenage 
years and adulthood). Mc Brien’s approach, although dated more than three 
decades ago, is a useful approach to understand the gravity of Deafness and how it 
impedes the natural development of human beings causing its extensive social, 
emotional and psychological implications. I have chosen to follow his approach in 
my own sketch of Deafness, extracted from various literature sources. 
 
Consider a comparison between a baby who is born profoundly Deaf or acquires 
Deafness in the first three years of life (before language acquisition) and a hearing 
baby who has normal auditory capability. Very early in life and in fact while still 
in the womb, a baby is able to hear its mother’s voice which impacts the baby’s 
brain development. Patricia Kuhl (Institute for Learning & Brain Sciences, 
University of Washington) reports that "the mother has first dibs on influencing the 
child's brain. The vowel sounds in her speech are the loudest units and the foetus 
locks onto them.” (Kuhl, 2013). Equally important, is the bonding between mother 
and infant that occurs when the mom talks and sings to the baby. Seconds after 
birth, a baby will turn its head toward voice and moves “in rhythm to his mother's 
voice” (Woodward, 2015). Babies particularly respond to human voices (McBrien, 
1982). Brain development and maternal bonding may be diminished for an infant 
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who is unable to hear. Very early in life, babies who are Deaf experience the 
mental, intellectual, psychological and emotional implications of deafness. 
McBrien (1982) reports that in the first year of life babies begin to experiment with 
sounds through “babbling and cooing,” and begins to learn language and the 
meanings of simple words. As the baby learns more words and the meanings 
thereof, he experiences encouragement from others and starts to understand the 
effects of his own words on others. Use of words in this way begins to impart to the 
toddler, some “control over his environment, and subsequently he becomes more 
secure, more independent of his parents and more socially integrated.” (Mc Brien, 
1982). However, in a deaf child, Schlesinger (1978) reports that mechanisms of 
internal control are not well-developed due to an inability to communicate feelings. 
Consequently, a deaf child struggles to stall or relinquish his desires, which 
manifests in impulsiveness and aggression (Schlesinger, 1978). Psychologists 
question whether a deaf child can connect normally to his parents in spite of the 
inability to communicate with them. The preclusion of normal bonding 
relationships with parents may impede the development emotional security and 
trustfulness. In addition, parents my further effect the child’s emotional security 
through denying or hiding the handicap, causing a delay in seeking appropriate 
help (Mc Brien, 1982). On the other hand parents may be unnecessarily over- 
protective (Kritzinger et al., 2014), causing the child to be “withdrawn, timid and 
accustomed to having his every whim indulged and cannot live with others as an 
equal” (McBrien, 1982). In early childhood, Deaf youth already experience social 
exclusion. 
In addition to poor impulse control and aggression, Deaf children also experience 
marked frustration due their inability to communicate. Such frustration may 
manifest as temper-tantrums and even violent behaviour, causing the deaf child to 
be considered as “disruptive or unmanageable.” McBrien reports that this may be 
owing to the fact that due to their inability to hear, Deaf children may not be 
warned about inappropriate behaviour, and when they do transgress, learning the 
consequences of their behaviour and receiving punishment for it may not be easy to 
achieve. Investigations with deaf children have indicated diminished levels of 
emotional   maturity   and   feelings   of   isolation   (Farrugia   and   Austin,  1980). 
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Furthermore, a deaf child may experience feelings of rejection with family 
members who approach them cautiously and may not be as openly warm as they 
are normally, and with other children who may mock or taunt them (Mc Brien, 
1982). 
With regards to education, further disparities emerge. Linguistic ability facilitates 
the process of abstract, theoretical, conceptual and figurative thinking 
tremendously. Deaf children, who often have poor linguistic capabilities, tend to 
think in “concrete,” literal terms more constantly than hearing children. 
Vocabulary, reading and writing skills are suboptimal owing to the inability to 
communicate effectively. At four years old, a hearing child knows approximately 
1500 words, while a Deaf child may only know one or two words (Mc Brien, 
1982). Memory and concentration is also impaired. 
 
As a result of all these obstacles, success in classes and examinations of traditional 
educational systems is so much more difficult to achieve, which in turn decreases 
the likelihood of advancing in education and securing well-paid employment. The 
inability to communicate manifests itself in the inability of the Deaf person to 
realize their full potential, which may negatively affect their confidence and sense 
of self-worth (McBrien, 1982), and often result in timid behaviour and insecurity 
(Kritzinger et al., 2014). 
 
In adolescent-hood and early adulthood, the teaching of what is socially 
appropriate and tactful is left unattended. The same applies with teaching 
appropriate “courting and sexual behaviour.” As a result, Deaf adults are seen as 
abrupt and too frank and candid in their behaviour, not conforming to the norms 
and intricacies of social decorum (Mc Brien, 1982). Deaf adults may face 
problems in finding a life-partner and subsequently starting a family. The same 
applies in finding work. Even when they overcome these problems, their actions as 
a partner, as a parent and as an employee are subject to scrutiny (Mc Brien, 1982). 
This is in addition to people who may taunt their disability. ‘Deafness paranoia’  is 
a term coined to describe the paranoid tendencies of Deaf people in  social 
situations (Bleckly, n.d) . Deaf people may erroneously assume that hearing people 
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are talking about them, scrutinizing their behaviour. “Deafness paranoia can be as 
mild as feeling embarrassment when you make a mistake believing everyone thinks 
you’re stupid, through to delusions of persecution…that everyone is out to get you, 
talking about you, judging you and laughing at you” (Bleckly, n.d.) In addition to 
Deafness paranoia, social exclusion, ostracizing, and a lack of self-worth are 
plausibly what results in the strong dependence of Deaf people on other Deaf 
people to interact and befriend, and the closeness of the Deaf community and their 
exclusion of the hearing society (McBrien, 1982). 
In summary, Deaf people experience marked difficulties in their ability to 
communicate, this impacts heavily on their emotional, social, psychological and 
intellectual development. As a result, Deaf people are characterized by emotional 
immaturity, poor impulse control, aggression, inappropriate social behaviour, lack 
of confidence, inability to realize their full potential and a struggle to form 
meaningful relationships socially and in the workplace. 
Unexpectedly, in comparison to hard-of hearing or deaf people, these findings are 
not unlikely, although the extent to which they occur may be lessened. Mc Brien 
(1982) reports that the distress of losing hearing later in life is comparative to being 
born deaf or losing hearing ability prelingually, with these individuals often 
becoming depressed and “paranoid” that they are being spoken about by other 
people. 
 
In offering healthcare to Deaf and deaf people, one would therefore need to be 
cognizant of minimizing the social and emotional barriers. In terms of 
pharmaceutical care, this would mean that the deaf/Deaf person’s accurate 
interpretation of medicine instructions would be essential to optimize therapeutic 
outcomes. The pharmacist’s understanding and ability to embrace Deaf people’s 
sensitivity to their communication barrier is crucial. 
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2.1.8 Deaf Culture 
 
Many definitions have been presented for Deaf culture, often varying with 
demographic profile and geographic location of the Deaf communities. For this 
reason, I circumvent the need to construct a single definition and instead seek to 
gain an understanding of what Deaf culture is and how it is experienced in the daily 
lives of Deaf people. 
 
Deaf culture is not unlike other cultural groupings in that it embraces its own 
unique social features, including social etiquette, recreation, entertainment, humour 
and arts (Barnett, 1999). Central to association with the Deaf culture is the use of 
sign language. In addition, Deaf culture is used in a positive perspective, signaling 
communal identity, pride and belonging, as opposed to terms such as hard-of 
hearing or deafness which to not imply belonging (Meador & Zazove, 2005; 
Barnett, 1999). 
 
Deaf people who adopt a culturally “Deaf” identity compare themselves to 
members of other ethnic communities. Within Deaf culture, social norms differ 
from those of non-deaf people (Meador & Zazove,  2005;  Barnett, 1999). For 
example, to get the attention of an individual or group, a Deaf person may 
repeatedly flick a light switch, stomp his/her foot, or bang on a table to 
communicate using vibration (Barnett, 1999). Touch is also acceptable; a Deaf 
person may tap on somebody’s arm or leg for attention. To the hearing world, all 
these means may appear rude or socially inappropriate belonging (Meador & 
Zazove, 2005; Barnett, 1999). 
 
The Deaf culture is one of a proud social identity. Historically, Deaf people have 
resisted efforts by oralists to minimise the use of sign language and mobilise Deaf 
people into the majority group (Hunt & Marshall, 2012). Deaf people still prefer to 
socialize with their own kind (Hunt & Marshall, 2012). The Deaf community’s 
self-determination and strong sense of maintaining their own identity is indicative 
of their independence and allegiance to other Deaf people. The self-determined and 
isolated nature of the Deaf community would mean that health care practitioners’ 
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ability to engage with sign-language interpreters would form a vital link  to 
optimize service delivery. Assistive interventions aimed at Deaf persons must thus 
embrace Deaf culture with all its nuances, including sign language and cultural 
norms. 
 
2.1.9 Deaf literacy 
 
The heterogeneity of Deafness extends into the facets of linguistic ability and 
literacy, with marked variances in these aspects between Deaf persons. Within 
these variances Barnett (1999) observed that persons who (i) became deaf in the 
pre-lingual stage (before three years of age ) and (ii) learnt sign language as their 
first language, are worse off in terms of literacy. For these members of the deaf 
community, written language is ineffectual. Onset of deafness before language is 
established occurs in 7 per 10 000 people (Fellinger et al., 2012). Furthermore, 
deficits in early auditory stimulation disturb neurocognitive processes including 
concentration and visual and aural memory, indicating that Deafness is more 
disabling than simply the inability to hear (Fellinger et al., 2012). Early exposure to 
linguistic and auditory stimuli is critical in the development of spoken language. 
People who experienced onset of deafness in early adulthood have better prospects 
in English proficiency than those who were born deaf or experienced pre-lingual 
onset of deafness (Marschark, 2001). In the ambit of healthcare service provision, 
this characteristic is of pronounced significance, especially where traditional means 
to convey messages rely on textual methods. This includes having to read and sign 
consent for treatment as well as receiving written directives on health advice or 
medicine instruction. 
 
While a literacy impediment seems to be more prominent in Deaf as opposed to 
deaf persons, Barnett (1999) reports that literacy impediments comparably affect 
deaf people. In the United States, the average literacy aptitude of a deaf high school 
graduate equates to that of a 4th or 5th grade leaner (McBrien, 1982, Barnett, 1999). 
Learning to read is an arduous task when you have a diminished ability to articulate 
sounds. This is causal to Deaf peoples’ struggle with comprehending any text– 
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based message. Further causes of low literacy have been presented by Barnett 
(1999) and are summarized in table 2 below. 
 
Table 2: Barnett’s multi-factorial causes of low literacy among Deaf people 
 
 
Multi-factorial causes of low literacy 
1.   Delayed  language  acquisition  by  deaf  children  who have hearing 
parents 
2.   English is a second language,  after  sign language 
3.   Lack of consistency in educational approaches of a deaf child 
4.   Lack of access to general information 
 
In light of their hearing and literacy difficulties, it is inevitable that Deaf people 
would become dependent on signed language interpretive services to engage 
meaningfully with the hearing worlds. 
 
2.1.10 Interpretive services 
 
Sign language interpreters are skilful professionals who are commonly registered 
with authorities that control their practice. Sign language does not depend on 
spoken word; it is a complex composite of gestures, inflections, facial expressions, 
attitude and body language (DeafSA, 2008). Unlike interpreters of other languages, 
sign language interpreters have the added responsibility of interpreting and 
decoding all these aspects, dissimilar to a linear transaction in which one language 
is translated directly to another. They must also be able to translate spoken 
language e.g. English into these complex gestures, in-so-doing ensuring that the 
Deaf person is able to fully understand the message intended by the sender. 
Interpreters immerse themselves in the Deaf culture and shift their social norms to 
those of a specific Deaf community. 
 
The World Association of Sign Language interpreters, WASLi, report a universal 
shortage of sign language interpreters (WASLi, 2015). The same is true for South 
Africa which experiences a critical shortage of the same. Interpretive services are 
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very costly (average cost per hospital visit per person of R 2074.80) and can rarely 
be afforded by the South African community (Zulu, 2014), of whom the majority 
are not educated at a tertiary level and thus eligible only for low-waged jobs 
(Chininthorn, 2011). 
 
 
2.1.11 Deaf people in relation to healthcare services 
 
Published works relating to the experiences of Deaf people in health care facilities 
are largely and characteristically anecdotal. Based on the subjective experiences of 
authors working within Deaf communities, these studies and are not generally 
representative of entire Deaf populations. Of the scanned literature, “hard- 
evidence” studies on the interactions of Deaf people in health facilities have 
emerged mostly from the United States and the United Kingdom (Reeves et 
al., 2002). The nature of sampling processes seem to be skewed toward 
opportunistic or convenience methods. While this may be a limitation in terms of 
producing data that is generalizable, it does provide depth and richness of 
description in reported findings. Furthermore, reports have produced congruent, 
consistent findings, augmenting the validity of assertions made (Reeves et al., 
2002). 
 
Deaf people report a number of difficulties in accessing healthcare services. These 
include sub-optimal quality of healthcare information (Steinberg et al., 2006; 
Kritzinger et al., 2014) lack of a clear understanding of where to proceed within 
facilities (Mathews et al., 2011; Reeves et al., 2002), the imposition of spoken and 
written instructions on treatment consent forms and in health-related 
information (Steinberg et al., 2006), and apprehension that they will miss 
treatment opportunities because they are not able to hear their names being 
called in waiting rooms (Reeves et al., 2002; Steinberg et al., 2006). Common 
adjectives describing the Deaf person’s experience emerge from several literature 
sources; these include fear, mistrust, disempowerment and frustration which is 
inevitably demonstrated through their aggressive facial and physical inflections 
(Mathews et al., 2011; Steinberg et al., 2006). 
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2.1.11.1 Communication with healthcare personnel 
 
It is indisputable that the inappropriateness of traditional communication methods 
(spoken and written language) used in healthcare facilities cause Deaf people to 
utilize health care facilities differently than the hearing community (Barnett, 1999). 
Steinberg et al (2006) report ubiquitous difficulties in the interactions between 
health care practitioners and Deaf persons. This finding is corroborated in 
publications by Ferguson and Shan (2015), Kritzinger et al., (2014) Mathews et al., 
(2011) and Barnett (1999). 
 
Speech, written messages and lip-reading (also called speech–reading) are the 
means most commonly relied on by healthcare personnel to communicate with 
Deaf people (Ferguson & Shan, 2015, Reeves et al., 2002). Speech cannot be 
relied on for effective communication because Deaf people, by definition, are 
profoundly deaf and unable to hear spoken messages (Steinberg et al., 2006). 
Furthermore, many Deaf people themselves have very limited to no intelligible 
speech (Reeves et al., 2002). 
 
Lip-reading poses a number of problems. Firstly, lip-reading is viewed by some 
Deaf cultures as inferior to signing and has the negative connotation of being forced 
to conform to the language of the hearing world, thereby creating a psychosocial 
barrier in addition to a communication barrier. Secondly, lip-reading is not 100% 
intelligible and this intelligibility is affected by a number of variables, including 
the physical differences in peoples’ lips (Steinberg et al., 2006), lighting in the 
area, word pronunciation and presence of a beard. The amount of speech 
understood by lip-reading is approximated by Steinberg et al., 2006 to be between 
30%  to 40 %. In a medical context this poses significant risks. 
 
Written communication is cited by Deaf people to be the most common method 
used by healthcare personnel to transfer a message to deaf people (Ebert, 1995). 
The main problem with written communication is the limited literacy levels of the 
Deaf community, particularly those who became Deaf pre-lingually (Barnett, 
1999). Speech and written communication are both dismissed by the Deaf 
community  as   inadequate.   Harmer   (1999)   reports   that   such communication 
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inadequacies may dampen the Deaf patients’ willingness to pose questions, and 
results in reduced confidence and suboptimal understanding of therapy Health- 
seeking behaviours are consequently compromised (Harmer, 1999) unless Deaf 
people are able to access the services of sign language interpreters. 
 
 
2.1.11.2 Sign-language interpretive services in healthcare 
 
Communication via certified interpreters is positively received by Deaf people. 
Steinberg et al’s (2006) USA-based study indicates that sign language interpreters 
effect superior communication in the healthcare ambit.  The presence of 
interpreters for medical interactions is valued by the Deaf community and is 
viewed as symbolic of the healthcare provider’s interest in their well-being 
(O’Hearn, 2006). Access to interpretive services may facilitate health care 
accessibility and receptivity to services as found in Pollard’s (1994) investigation. 
He reports that patients are more likely to select therapeutic plans involving sign- 
fluent personnel and sign-language interpreters. Interpreters however are scarcely 
available and there is no legal provision for the inclusion of sign language 
interpreters in healthcare facilities in South Africa (Zulu, 2014). 
 
In the absence of cost-estimate data on the use of sign-language interpreters in 
South African healthcare facilities, Zulu (2014) sought to estimate the costs of 
interpreter services at district health level. Cost estimates for the Cape Metro-pole 
district represented a range of 2.4-12.8% of the total budget for Western Cape 
district health services, indicating that the provision of interpretive  services in 
South Africa would require significant capital investment by government. 
 
Alternatives to using sign-language interpreters involve providing auxiliary aids for 
Deaf patients or using staff at the hospital to assist with interpretations. The 
monetary implications of providing auxiliary aids may be a significant obstacle. In 
addition, complexities arise when relying on healthcare staff to assist with 
interpretation. These may  include breaches in confidentially and autonomy for the 
Deaf patients, and their inexperience with medical terminology. Similar 
complexities arise when Deaf people rely on a family member or friend for 
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medical interpretation (Reeves et al., 2002). Building human resource  capacity 
and skills development in training medical staff to interpret sign language is an 
opportunity to be explored. This would require interest and willingness by staff 
and planning to accommodate for the extra workload in an already resource 
constrained environment. Unavailability of interpreters at health care facilities 
across South Africa inhibits Deaf patients from expressing themselves correctly 
and this limits the ability of health care workers to share relevant information 
(Kritzinger, 2011). 
 
 
2.1.11.3 Access to and assimilation of health information among Deaf people 
 
Limited literacy precludes Deaf persons from the opportunity to access health 
information because much of the information at health facilities is in a textual 
format, including pamphlets, posters, labels, charts and consent forms (Mathews et 
al., 2011 & Reeves et al., 2002). Health information is also regularly acquired  by  
the hearing community through radio, television, newspapers, magazines and the 
internet, all of which pose auditory or literacy obstacles for Deaf persons (Barnett, 
1999). In the context of health-related information, medical jargon and context- 
specific terminology require Deaf people to possess a level of literacy which is 
beyond their capacity (Zazove and Doukas, 1994, & Huntington et al., 1995). 
 
Highlighting their limited access to health-related information is Mohay & 
Kleinig’s finding that Deaf people have been shown to possess reduced knowledge 
on health-related topics than hearing people, knowing little about basic first-aid, 
sexually transmitted diseases and sexual activity and its associated risk of 
pregnancy (Mohay and Kleining, 1990; Miner, 1984, Chacko et al., 1987 & Van 
Biema 1994, cited in Reeves et al., 2002). Tamaskar et al (2000) report that Deaf 
people are less likely to believe the health benefits associated with reduced 
smoking, weight control and regular exercise. If the Deaf community is unable 
to take heed of health promotion information, then this would mean 
pharmaceutical care could pose an even greater challenge. Not only is the 
assimilation of health promotion information vital, but how health care 
professionals engage with the Deaf community is cornerstone to quality health 
care. 
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2.1.11.4 Attitudes of healthcare personnel toward Deaf patients 
 
Steinberg et al’s 2006 USA based study reveals perceptions of Deaf patients to be 
that they are treated unfairly in comparison to hearing patients. In the US, legal 
action has been sought by Deaf patients in filing a significant number of complaints 
of violation of rights and non-conformance to disability policy and legislation 
(Moore & Swabey 2007). Some hearing health care professionals display negative 
attitudes to Deaf persons, perceiving them to be obstinate and intellectually 
challenged (Meador and Zazove 2005; Scheieir 2009). This may impact on the 
willingness of Deaf individuals to seek healthcare. Abraham and Fiola (2006) have 
shown in a Canada-based study that healthcare professionals expect of patients that 
they either demonstrate fluency in the local language or have an interpreter present 
for the medical consultation. Such expectations may not be feasible in under- 
resourced countries such as South Africa. 
 
Deaf awareness describes the recognition that a person is Deaf and understanding 
the communication impediments experienced by Deaf people. Huntington e t  
a l . , (1995) and Lomas (1998) report that the Deaf community often complain 
about a lack of Deaf awareness by healthcare professionals. As a result they shout, 
fail to use plain English and often use medical jargon, do not mouth words 
clearly, speak very slowly and do not directly face the Deaf person during an  
interaction (Reeves, et al., 2002;  Moola, 2010). These behaviours all create further 
communication barr iers  for a Deaf individual. Not only does this pose a problem 
for over-burdened health professionals such a pharmacists, it also alienates the 
Deaf community from seeking health services (Herring and Hock, 2000). 
 
Kritzinger et al., 2014 describe the “pervasive disempowerment” attitude of 
deaf people, who may not want to think autonomously, but merely accept what they 
are told. In their article titled “I just answer “yes” to everything they say,” 
Kritzinger et al., (2014) report that even though deaf people may not 
understand what the healthcare professional is saying, they do not raise 
questions, and that from the healthcare professionals perspective, they may not 
realize that the deaf person does not know or understand unless the patient 
indicates a lack of understanding. 
 
 
 
 
32  
2.1.11.5 Deaf community experiences with medicine instructions 
 
In orthodox medical practice, the correct use of medicines is central to achieving 
optimal therapeutic outcomes. A good understanding of the purpose of the 
medicine and administration instructions is requisite to correct medicine use. A 
Manchester-based study (Reeves et al., 2002) depicts how the absence of such 
information from the healthcare professional diminishes the prospects of positive 
health outcomes. Within the study periphery, outcomes described that Deaf people 
were given inadequate information regarding prescriptions and that a number of 
Deaf people were of the opinion that they were given incorrect medicines for their 
ailment. Others expressed anxiety that their inability to communicate effectively 
may result in receiving wrong medicines. Deaf people also reported not being told 
the purpose of the medicines. Two patients suffered illness after drinking a 
medicine that was intended to be used externally (Reeves et al., 2002). 
 
In the South African milieu, Moola (2010) reported that pharmacists, when 
providing medicine related advice and counselling, often speak “louder, more 
slowly and their articulation is clearer”. Deaf patients who can lip-read understand 
the explanation from the pharmacist partially, but those who cannot do not 
understand the explanation well (Chininthorn, 2011). In addition, Deaf people have 
misconceptions about how to take their medicines. 
 
 
2.1.11.6 Health risks for Deaf patients in a health care setting 
 
Patient safety and risk minimization is a priority in modern health care systems. An 
adverse event is an unintended injury or complication caused in delivering clinical 
care (Bartlett et al, 2008). Patients with physical and sensory disabilities including 
Deafness and blindness face considerable barriers when communicating with health 
care professionals and are understandably at greater risk of healthcare-related errors 
including adverse events. Communication disorders are estimated to affect five to 
ten percent of the general population, and more than 155 of admissions  to 
university hospitals involved patients with one or more disabilities severe  enough 
to prevent any form of communication (Bartlett et al., 2008). In addition, patients 
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with communication disabilities are at increased risk for depression and other co- 
morbidities, and are three times more likely to experience a preventable adverse 
event than patients without such problems (Bartlett et al., 2008). 
 
Anecdotal evidence indicates that communication impediments render Deaf 
patients more likely to over-use emergency medical facilities for routine health 
problems (NAD, n.d). Correspondingly, effective communication may result in 
achieving better healthcare outcomes, shorter stays in hospitals and fewer 
readmissions, better treatment adherence and higher patient-satisfaction levels. 
Causal factors contributing to health disparities in public health care settings 
include inadequate health status information of the Deaf person, low literacy in 
Deaf adults, and healthcare deviations, impeding the Deaf person’s opportunity to 
attain the best possible healthcare (Barnett et al., 2011). 
 
Without interpretive services or auxiliary aids, healthcare personnel run the grave 
risk of misunderstanding patient symptoms, misdiagnosing illness and prescribing 
or administering inappropriate treatment. In light of limited access to interpretive 
services, accessibility to information and health-related advice is a significant 
concern. 
 
Notwithstanding the social, emotional, cultural and literacy challenges facing the 
Deaf community, their reliance on a health service that can accommodate their 
needs is unquestionable. The question for researchers to ask is: what potential 
avenue in the health services could be explored that would enable healthcare 
workers to work together with the Deaf community to address their health care 
needs? If a portal could be established at the point of pharmaceutical service 
delivery, then a window of opportunity could be created for  meaningful 
engagement with a vulnerable group of people who constantly remain on the 
periphery of the health care system. In the context of this study, the pharmacists’ 
role and their experiences with the Deaf community serve as the basis for further 
exploration. 
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2.2 PHARMACISTS’ ROLES IN HEALTHCARE PROVISION 
 
 
This section commences with a depiction of the situation in South Africa’s 
healthcare system, focusing on the practice of pharmacists within this role. I 
discuss the importance of communication by pharmacists during healthcare 
provision and critically analyze published literature on pharmacists’ interactions 
with Deaf patients. 
 
 
2.2.1 The healthcare system in South Africa 
 
The South African health system is well-known for its inequities. It is divided into 
two separate streams: a majority-serving, under-resourced, over-used public sector 
which provides for eighty percent of the population, and a smaller, well-resourced 
private sector which serves the remaining twenty percent (Ntuli & Day, 2004). The 
allocation of healthcare personnel is concentrated in the private sector and urban 
areas, leaving the majority of the population dependent on public healthcare which 
utilizes a substantially smaller workforce (George, Quinian amd Readon, 2009). 
Healthcare services are classified as either primary healthcare, secondary care or 
tertiary care (Haynes & Hall, 2002). 
 
Primary healthcare refers to a set of prescribed services which are generally either 
the first point of contact for patient care, or the provision of follow-up care. In the 
Western Cape, primary healthcare services are provided by the Provincial 
Government of the Western Cape (PGWC) and City Health. A Community Health 
Centre (CHC) is an example of a primary healthcare facility (Department of 
Health, 2006). Secondary care refers to services which are generally beyond the 
scope of primary care and requires the input of a registered specialist. The 
intervention of specialists in addition to general medical services is required 
(Department of Health, 2006). Tertiary care is beyond the normal scope of 
specialists and requires an even higher level of specialization. Both specialist and 
sub-specialist care is provided (Department of Health, 2006b). An academic 
hospital, such as Tygerberg hospital is an example of a tertiary hospital 
(Cummins, 2002). 
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A global paucity of human resources for healthcare poses a significant hurdle to 
achieving positive health outcomes. (World Health Report, 2006).  South Africa 
also faces a major crisis with regard to human resources for healthcare. There is a 
scarcity of healthcare professionals coupled with a skewed distribution to the 
private healthcare sector (Padarath, Ntuli, & Berthiaum, 2003/4). South Africa 
faces a considerable shortage of pharmacists, the number of pharmacists per 
population is 1: 3849, a ratio well below the WHO recommended norm of 1: 2300 
(SAPC, 2011). This may have negative consequences for pharmaceutical service 
delivery. Reports of exhaustingly long queues at public sector facility pharmacies 
are common with hundreds of people standing in line. In the Western Cape, patient 
waiting times for medicine were found to be up to 12 hours in some cases. (Ntuli, 
2007). In light of the human resource deficiencies and service-delivery 
inadequacies, people with special needs may be further disadvantaged through the 
system’s inability to handle their specific needs. 
 
Concerning healthcare services for special-needs patients, South African policy is 
fairly well developed, however this does not translate to specific legislation or 
implementation. For example, South African law does not necessitate sign 
language interpreters in health facilities, or the training of health professionals in 
sign language (Zulu, 2014). This is despite the well-documented inability of Deaf 
people to communicate using traditional methods. The critical need  is 
entrenchment of specific legislation for all disabled groups and the implementation 
of policy, especially in light of high disease burdens and major skills shortages. 
This then begs the questions: what is the quality of care offered to special-needs 
patients in the Western Cape? How are healthcare professionals addressing the 
health needs of the Deaf community in particular? In the context of this study, I 
discuss the role of the pharmacist in the health care system. 
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2.2.2 Pharmacist’s roles in the health care system 
 
Traditionally referred to as the ‘custodians of medicines,’ pharmacists are a group 
of registered professionals who are responsible for the medicine-related needs of 
society. They commit their efforts to ensuring the safe and effective use of 
medicines toward the goal of optimal therapeutic outcomes. Historically called 
apothecaries, (derived from Latin word apotheca, meaning storehouse), their main 
function was preparing and providing medicines (Sonnedecker, 1976).  The  onset 
of industrialization and globalization launched the small scale preparation of 
medicines into a global industry, manufacturing medicines in large scale in 
factories and distributing these medicines through international and local channels, 
a service which we make use of today. 
This advancement in medicine preparation called for transformation of the roles 
and practices of an apothecary into what we now know as the modern-day 
pharmacist (Anderson, 2007, Wiednmayer et al., 2006). The role of a pharmacist 
has expanded to currently include (among others) research, drug design and 
development, formulation and manufacture, selection and procurement, 
distribution, clinical pharmacy, dispensing, and monitoring the use of medicines 
(SAPC, 2010). 
Pharmacy is a highly regulated profession, with international and national 
authorities the world over prescribing roles, scopes of practice and professional 
codes for pharmacists and pharmacy support personnel. Two global edifices, the 
World Health Organisation (WHO) and the International  Pharmaceutical 
Federation (FIP) have been instrumental in establishing the roles and practices of 
modern-day pharmacists. Recognized by WHO for their unique skill set and 
credence in matters relating to medicine-related care, the most marked shift in 
practice from the apothecary to the pharmacist has been the shift in focus from the 
product to the patient. Based on the WHO premise that pharmacists serve in their 
greatest numbers within communities, their contribution can “have the most 
immediate effect in patient welfare” (WHO, 1994). 
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2.2.3 Global perspectives on the pharmacist’s role 
 
Since 1986, WHO and FIP have embarked on several initiatives to transform and 
influence the pharmacists’ role in developing, developed and newly industrialized 
nations. These ideologies have been accepted by governments worldwide and are 
entrenched in administrative policy and academic curricula. WHO advises that 
community pharmacists should “play a central role in the provision of advice and 
information to patients on the use of medicines” (WHO, 1994). Ensuing from the 
WHO Consultative Group meeting (New Delhi, 1988), Tokyo Meeting (1993); and 
subsequent WHO collaborations with FIP and other groups, the consultancy agreed 
that modern-day pharmacists must assume the role of effective healthcare team 
members who are able to fulfil various functions. Their practice must be 
underwritten by note-worthy knowledge, attitudes, skills and behaviours. These 
traits ought to be considered as rudimentary, essential and minimum expectations 
held of pharmacists (WHO 1994a; WHO 1994b, WHO 1994c, WHO 1996). From 
the WHO-FIP deliberations emerged WHO’s concept of the ‘seven-star 
pharmacist.’ 
The seven stars refer to the basic roles of a pharmacist and include caregiver, 
decision-maker, communicator, manager, life-long learner, leader and teacher. 
While WHO does not emphasize any of the seven-star attributes as being more or 
less important than the others, one could plausibly assert that all the features that 
comprise the seven-star are dependent on effective communication. This insinuates 
that communication is the central and most important feature since the remaining 
six features will be difficult to achieve without it. 
In addition to establishing communication as an important role of the pharmacist, 
FIP suggests standards for quality of services by pharmacists in their Good 
Pharmacy Practice guideline. This guideline requires that the “core of pharmacy 
activity is supply of medication and other health products of assured quality, 
appropriate information and advice for the patient and monitoring effects of use” 
(WHO, 1994a). Pharmacists are often the first port-of-call for persons requiring 
healthcare. In serving communities their roles involve identifying and interpreting 
the medicine-related needs of the patient, accurate and safe provision of medicines, 
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counselling patients at the time of dispensing and monitoring medicine usage, 
extemporaneous preparation of medicines, being a source of medicine and health- 
related information for health professionals and clients, responding to symptoms of 
minor ailments, health promotion activities and domiciliary services. (WHO, 
1994a) 
A common theme emerging from both the WHO and FIP perspectives of the 
pharmacist’s role, particularly in servicing the public, is the provision of advice and 
information to patients to ensure the safe and effective use of  medicine. This 
further signifies the importance of effective communication between a pharmacist 
and client. This review focuses on the role of the pharmacist in  providing 
medicines and medicine-related advice to the domestic sector, concentrating 
specifically on patient counselling during the medicine dispensing process. 
Effective communication is crucial within this role, but may be precluded for 
persons who are unable to communicate in the same way as pharmacists. 
 
 
2.2.4 Pharmacists’ roles in South Africa 
 
In line with national strategic goals, the professional practice of pharmacists in 
South Africa is rooted in the underpinnings of the White Paper for the 
Transformation of the Health System in South Africa (DOH, 1997) and the 
National Drug Policy (NDP) (DOH, 1996). The major thrust of the White Paper is 
to address the inadequacies in healthcare resultant from the apartheid regime 
through health reform by developing a “unified health system capable of delivering 
quality healthcare to all citizens efficiently and in a caring environment” (DOH, 
1997). The White Paper sets out to achieve this through meeting a set of goals and 
objectives. Among others, the objectives highlighted below include: 
 
• To promote equity, accessibility and utilization of health services 
• To  extend  the  availability  and    ensure appropriateness of health 
services 
• To foster community participation across the health sector 
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While the White Paper for health system transformation prioritizes redress and 
social reform, there is little mention of specific disabilities and even less 
consideration of targeted strategies entrenched in legislation to cater for the special 
needs of disabled people. 
 
The National Drug Policy (DOH, 1996) has as its overarching goal the ensuring of 
an adequate and reliable supply of safe, cost-effective drugs of acceptable quality 
to all citizens and the rational use of medicines by prescribers, dispensers and 
consumers. The NDP calls on pharmacists, in particular those who are practicing 
within communities to assume purposeful roles targeted at educating  and 
instructing patients in the community on appropriate use of medicines, entrenching 
and promoting in the community the notions of individual responsibility for health 
and informed decision making. Pharmacists must collaborate with other members 
of the healthcare team toward the objective of rational medicine use, and must be 
significant players in primary health care and preventive health services. The NDP 
however, does not make mention of skills that pharmacists need to gain to meet its 
mandate with disabled people. 
 
The South African Pharmacy Council (SAPC) is the regulatory and statutory body 
which controls the pharmacy profession and its functions in terms of the Pharmacy 
Act (Republic of South Africa, 1974), as amended. Pharmacists are registered with 
the SAPC who prescribe their scope of practice, code of conduct and other 
professional affairs (SAPC, 2010). The SAPC establishes the ethos of pharmacy as: 
“a dynamic, information driven, patient-orientated profession whereby the 
pharmacist, through his competence and skills is committed to meeting  the 
health care needs of the people of South Africa by being the: 
• custodian of medicines; 
• formulator, manufacturer, distributor and controller of safe, effective and 
quality medicine; 
• advisor on the safe, rational and appropriate use of medicine; 
• provider of essential clinical services including screening and referral 
services; 
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• provider of health care education and information; 
• provider of pharmaceutical care by taking responsibility for the outcome of 
therapy and by being actively involved in the design, implementation and 
monitoring of pharmaceutical plans; 
• provider of cost-effective and efficient pharmaceutical services” (SAPC , 
2010) 
 
The SAPC prescribes the roles and practice norms and standards for pharmacists 
through its publications the Good Pharmacy Practice (GPP) manual (SAPC, 2010). 
The GPP sets out professional norms and minimum standards for various practice 
scenarios and settings, including dispensing, therapeutic medicine monitoring, 
facilities and equipment and patient information and advice, among others. GPP 
rules and standards are obligatory as per Section 35Aof the Pharmacy Act 53 of 
1974 (Republic of South Africa, 1974). 
Additional practice guidelines for pharmacists set by the SAPC are the Code of 
Conduct (SAPC, n.d) and Ethical Rules (SAPC, n.d.) for pharmacists. The Ethical 
Rules advises acts or omissions which are deemed to be unethical or unprofessional 
behaviour by pharmacist, e.g. failure to furnish advice or information for the safe 
and effective use of medicines supplied by the pharmacist. The Code of Conduct 
for pharmacists functions as the standard of professional conduct and fundamental 
duties (SAPC n.d.). A breach in the code of conduct by registered persons could 
fuel disciplinary action against the registered person. Principles presented in the 
Code of Conduct include: (i) Wellbeing of the Patient, (ii) Confidentiality and (iii) 
Continuing Professional Development, among others. 
South Africa faces considerable shortage of pharmacists (SAPC), 2011. This 
shortage has a negative impact on pharmaceutical service delivery. Reports of 
exhaustingly long queues at public sector facility pharmacies are common, with 
hundreds of people standing in line. In the Western Cape, patient waiting times for 
medicine were found to be up to 12 hours in some cases (Ntuli, 2007). Inadequate 
pharmaceutical service delivery in the public sector has been the subject of media 
attention. Media reports have highlighted that long queues for medication cause 
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community frustration with long waiting times a seemingly insurmountable 
problem (Ryan & Peters, 2007). 
 
Pharmacists in South Africa conform to global trends in their areas and fields of 
practice. These include community pharmacy, hospital pharmacy, academia, 
pharmaceutical industry, regulatory pharmacy and clinical pharmacy. WHO (1998) 
reports that pharmacists serve in their greatest numbers within communities, where 
the role fulfilled by pharmacists is the safe and effective provision of medicine and 
they fulfil this role through adhering to the GPP minimum standards for dispensing 
of medicines. The medicine dispensing process, and particularly  patient 
information and advice, is the central context for this thesis and is discussed later in 
this chapter. I elucidate the importance of communication between the pharmacist 
and patient. 
 
 
 
2.2.5 Communication between pharmacists and patients 
 
Communication is the basis of all contact between human beings (Floyd, 2011) and 
consumes up to three-quarters of our daily activity. The etymology of 
“communication” implies that the word has its origins in Latin “communicare,” 
meaning “to share.” The benefits of effective communication in a social context are 
unlimited. It allows people to express themselves, to exchange important 
information, to establish relationships and achieve goals (Liu, Volcic & Gallois, 
2011). In a healthcare context the importance of effective  communication  is 
further amplified. The success of a healthcare system relies on effective 
communication between healthcare professionals and patrons, and inter-collegial 
communication among healthcare professionals (Schwarz et al., 2010). Ambient 
information in the general media (magazines, newspapers, internet etc.), in addition 
to healthcare professionals’ advice influences people’s decisions on what is 
considered to be ‘healthy’ (Schwarz et al., 2010). Inadequate communication is a 
common causal factor in inadvertent detriment to healthcare system patrons 
(Leaonard, Graham and Bonacum, 2004) 
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Communication is the transmission of information from one entity (person, data 
source) to be received by another. It is a process in which a message is generated, 
then directed toward and received and interpreted by another person. Various types 
of communication occur, including: (i) Interpersonal communication (transaction 
process between two or more persons in which both have a chance to speak), (ii) 
Impersonal communication ( based on a specific role, for example a sale, people 
are treated in a detached manner), (iii) Cross-cultural communication (between 
persons of different social and cultural backgrounds encompassing different 
communication styles) and (iv) Health communication (purpose-driven 
communication in a healthcare context) (Beebe et al, 2001; Wood, 2007; Dutta, 
2008; Duck & McMahan, 2010;  Dainton & Zelley, 2011, cited in Knoesen, 2014). 
 
 
 
Effective pharmacist-patient communication is cornerstone to appropriate medicine 
use and achieving optimal therapeutic outcomes (Beardlsey et al., 2008). Through 
successful transfer of medicine-related instructions and advice, pharmacists 
improve the use of medicines and patient adherence to therapy (Davis & 
Fallowfield, 1994). Since pharmacists rely on feedback from patients to assess 
whether they understand the medicine therapy and additional information, it is 
plausible to assert that pharmacist–patient communication should be interpersonal; 
rather than impersonal. This may be difficult to achieve in the context of a 
pharmacist providing medicine-related information to a Deaf person. Based  on 
their difficulties with spoken language and literacy, Deaf people are unlikely to be 
able to provide feedback, thus negating the inter-personal characteristic. 
Communication in this situation may be cross-cultural instead. Cross-cultural 
communication involves different styles and patterns (Kai, 2005); this may create a 
communication barrier which generates uncertainty in whether communicated 
messages are properly understood by the recipient. 
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2.2.6 Models of communication 
 
Numerous models exist for general communication. Shannon and Weaver’s (1964) 
Linear Model implies that messages are sent from one unit (sender) to another 
(receiver). Berlo (1960) expanded on the Linear Model by inserting into the centre 
of the model, two additional features: the Message and the Channel, so that the 
model appeared as Sender-Message-Channel-Receiver, also dubbed the SMCR 
Model (Lee, 1993). In a pharmacy interaction in which feedback from the patient to 
the pharmacist is crucial to assess whether the patient has understood the 
information given, both the Linear Model and Berlos’s expanded model are lacking 
as the one-way nature of these models do not acknowledge patient feedback and do 
not account for any interaction between persons or the transfer of messages to and 
from multiple persons involved in a communication process (Knoesen, 2014). 
Wilbur Schramms’s 1994 communication model introduces the element of 
interaction. Schramms recognizes that communication is not a one-way process, 
but instead encompasses feedback from the receiver (Croft, 2004; Floyd 2011, 
Johanson 2012). Such feedback is not simply passive listening, but rather active 
verbal and non-verbal reactions. Schramms further noted that the prime 
responsibility of the sender of a message is to convert the information (i.e. the 
message) that he/she wants to send into a words for the receiver to accept. This 
process is called ‘encoding.’ The prime responsibility of the receiver of the 
message is to understand what the sender is trying to say. This process is called 
‘decoding’. Encoding and decoding are vital processes of communication, and are 
influenced by the encoder and decoder’s personal experiences. For messages to be 
interpreted accurately, the encoder and decoder must share a commonality, for 
example the same language or culture (Croft, 2004; Floyd 2011, Johanson 2012). 
This highlights the potential difficulties that Deaf people face in communicating 
with pharmacists, with whom they do not share commonality in neither language 
nor culture. 
In 1970, Barnlund propositioned the Transactional Model of communication 
(Barnlund 2008), which implies the synchronized sending and receiving of 
messages in a reciprocal interaction.    Communication moves in multiple  manners 
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in a cyclical process. A further convoluted form, the model focuses on the manner 
in which an individual communicates, recognizing that this manner determines how 
the message will be interpreted. Communication occurs via a channel (e.g. air  in 
the case of a spoken face-to-face conversation) and in the presence of “noise”. The 
interaction has also described as an “ encode-transmit-receive-decode” 
interaction. It occurs in the presence of environmental noise and is influenced by 
personal factors including tradition, culture and gender. In summary, a person who 
wants to convey a message must first encode the message, (i.e. decide what it is 
he/she wants to say and how to say it) after which he/she then transmits the 
message by expressing it in words (or an alternative form). The message  is 
received by the intended recipient and then decoded (interpreted and understood). 
The entire process is influenced by personal factors of the encoder and decoder. 
 
This model is well suited to a dyadic communication context, dyadic referring to 
the inter-relationship between two individuals, as is the case of a pharmacist 
providing medicine information to a patient. Transaction communication models 
have been adopted by sectors of society for application in various contexts, 
particularly healthcare. Such models are well-suited to pharmacist-client 
interactions to achieve effective communication (Shah & Chewning, 2006). In 
summary transaction communication models comprise the following aspects which 
are ideally suited to pharmacist-patient interactions: 
1. A dyadic, reciprocal process 
2. A dynamic, cyclic process 
3. Encoding and decoding influenced by personal factors 
4. Environmental noise 
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Figure 3: A transactional communication model 
 
 
 
 
Interactions between pharmacists and patients have been termed ‘patient 
counselling’, and to a lesser extent ‘patient education’ and ‘pharmacist-patient 
communication’ (Shah& Chewning, 2006). Patient counselling commonly occurs 
during (but is not limited to) the process of dispensing medicines and the primary 
goal is health promotion. In line with this, communication must yield the necessary 
patient history (e.g. presence of allergies), purpose of the medication, dose and 
duration of therapy, therapeutic goals, medicine specific issues (e.g., side-effects) 
and how to deal therewith. These activities constitute both patient counselling and 
dispensing and are contextualized further in the next section. 
 
2.2.7 Medicine-related communication in pharmacy 
 
Transactional models have been widely accepted as appropriate for interactions 
between pharmacists and patients. Since pharmacists are the custodians of 
medicine, such interactions normally involve the transfer of information related to 
medicines. This section describes specific types of information and the context in 
which it is relayed. 
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WHO reports that pharmacists serve in their greatest numbers within communities, 
where the role fulfilled by pharmacists is the safe and effective provision of 
medicine. In South Africa, pharmacists fulfil this role through adhering to the GPP 
standards for dispensing of medicines. The medicine dispensing process, and 
particularly patient information and advice, is the central context for this thesis. 
 
 
2.2.7.1 Dispensing procedures 
 
The task of dispensing medicines is a central function of pharmacists. The Republic 
of South Africa’s Pharmacy Act  1974, as amended defines dispensing as: 
The interpretation and evaluation of a prescription, the selection, 
manipulation or compounding of the medicine, the labelling and 
supply of the medicine in an appropriate container according to the 
Medicines Act, and the provision of information and instructions by 
a pharmacist to ensure the safe and effective use of medicine by the 
patient . 
- (GNR 1158 of November 2000) – 
 
 
The GPP systematizes dispensing into  a 3-part procedure: 
PHASE 1: Interpretation and evaluation of the prescription. 
PHASE 2: Preparation and labelling of the prescribed medicine. 
PHASE 3: Instruction and information to the patient to ensure the    safe 
and effective use of medicines (SAPC, 2008). 
 
Phase 1 entails the acceptance of the prescription and assessing of the integrity 
thereof by verifying the authenticity of the prescriber, confirming the identity of the 
patient to whom the medicine is prescribed, assessing the legality of the 
prescription. The prescription is also reviewed for dosage suitability, drug 
interactions, contra-indications and therapeutic duplication. Phase 2 encompasses 
accurately picking, preparing and labelling the medicine. Phase 3 comprises direct 
interaction with the patient. At the interface with the patient, the pharmacist must 
supply information and advice to patient on how to safely and effectively use  their 
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medicines. This information must be personalized, taking into consideration the 
unique need of the individual patient. Accurate and individualized patient 
information is crucial to ensure the safety and efficacy of medicine therapy. 
(SAPC, 2010). 
 
The SAPC’s definition of the dispensing process mimics the omission of explicit 
and special solutions or skills to accommodate disabled people in healthcare 
provision. While the SAPC procedure for dispensing establishes the necessity to 
provide medicine–related information and advice and the responsibility of a 
pharmacist, it fails to elaborate on the importance of effective communication 
during dispensing and does not at all address the complexities of communication. 
The SAPC further fails to identify and mandate specific solutions for different 
disabled groups, including Deaf people. 
 
 
 
2.2.7.2 Contextual circumstances in dispensing 
 
In South Africa, dispensing of medicines to the general public occurs in two basic 
circumstances: (i) dispensing in accordance with a prescription from an authorised 
prescriber and (ii) dispensing medicines without a prescription which can legally 
and within limits, be supplied over-the counter (OTC) (Knoesen, 2014). These 
circumstances are hereafter referred to as prescription-only medicines and OTC 
medicines respectively. I differentiate between the two circumstances to highlight 
the differences in medicine-related information and advice between them. 
 
 
2.2.7.2.1 Prescription only medicines 
 
Patient-counselling in pharmacy typically follows a “sequence of instructions” 
including the provision of medicine-related information and advice (Rantucci, 
2007; Berger, 2009). According to Nigussie (2014) patients typically take their 
medicines in a way correlating to the way in which it was dispensed and the type of 
information received during the dispensing process. Dickinson and Raynor (2003) 
report   that,   with   regards   to   their   treatment,     patients   regularly  want more 
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information, and that the following medicine-related information is considered to 
be essential: instructions on how to use medicines, what it is used for, what it is 
intended to do, possible side effects and related warnings and recommendations 
(“do’s and don’ts”). Kreuger & Hermansen-Kobulnicky (2011) investigated 
community pharmacies in the USA over two years (2006-2008). The emphasis of 
their research was the type of information requested from patients with regards to 
new or repeat prescriptions. 
 
 
Table 3: the significance (%) of five types of information requested from 
patients with regards to new and repeat prescriptions 
(adapted from Kreuger &Hermansen-Kobuulnicky , 2011) 
 
  
NEW PRESCRIPTION 
  
REPEAT PRESCRITIPTION 
 
1. Basic instructions 33% No new information required 30% 
2. Indications for use 19% New facts(medicine-related) 15% 
3. Additional instructions 15% Review of medicine information 15% 
 
4. 
Side-effects and allergic 
reactions 
 
58% 
 
Number of repeat prescriptions 
 
24% 
5. Interactions 30% Concern for patient’s well-being 8% 
 
 
 
In a separate study on new prescriptions, Svarstad et al. (2004) cited in Knoesen 
(2014), focused on seven aspects of medicine-related information given to patients 
who visited 306 pharmacies in the USA. The patients were mystery shoppers to 
whom three medicines were dispensed; and antibiotic, an anti-inflammatory 
medicine and an anti-depressant. For each type of medicine, the  authors 
investigated the number of mystery shoppers who received verbal instructions on 
seven aspects of medicine related information. In table 4 below, I illustrate the 
number of mystery shoppers who received   the information in ranking order of 
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highest percentage to lowest percentage, expressed the average percentage over 
each the three medicine types. 
 
 
Table 4: Percentages of mystery shoppers receiving aspects of medicine- 
related information (adapted from Knoesen, 2014) 
 
  
 
Information type 
 
Average percentage of 
mystery shoppers who 
received verbal 
information 
1.  Directions for use 
 
56% 
2.  Name of the medicine 
 
55% 
3.  Purpose 
 
40% 
4.  Adverse effects 
 
28% 
5.  Duration of treatment 
 
26% 
6.  Other precautions 
 
23% 
7.  When  medicine  will start to have an effect 
 
7% 
 
 
 
Similarly, Berry et al (1997: 471) itemize medicine-related information to be 
covered in during dispensing as 16 information elements these 16 elements are 
ranked in order-of-importance as stated by patients and doctors. 
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Table 5: Patients’ and doctors’ ranking of importance   of medicine 
information aspects (adapted from Knoesen, 2014) 
 
 
Medicine-relation information aspect 
 
Patient’s 
ranking 
 
Doctor’s 
ranking 
 
Potential side-effects 
 
1 
 
10.5 
 
Action of the medicine 
 
2 
 
10.5 
 
Lifestyle modifications 
 
3 
 
3 
 
Questions regarding medicine use 
 
4 
 
2 
 
What the medicine is (e.g. active ingredient) 
 
5 
 
15 
 
Medicine interactions 
 
6 
 
1 
 
Action to take if symptoms do/do not change 
 
7 
 
10.5 
 
Effectiveness of treatment 
 
8 
 
14 
 
Alternative treatment 
 
9 
 
16 
 
Is it known to work 
 
10 
 
13 
 
Does medicine treat symptom  or cause 
 
11 
 
6.5 
 
Action to take when over-dosed  or dose was skipped 
 
12 
 
6.5 
 
Interactions with OTC medicines 
 
13 
 
4 
 
Consequences of not taking medicines 
 
14 
 
8 
 
Interactions with other prescribed medicines 
 
15 
 
5 
 
Signs that the medicine is having an effect 
 
16 
 
10.5 
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While the ranking order of importance differs between the studies, common 
elements of medicine-related information and advice are evident across all three 
studies. These are the basic directions for use, purpose of the medicine, side- 
effects, interactions, and additional information. Such studies have yet to be 
documented for dispensing to the Deaf community in South  Africa.  The 
dispensing process prescribed by the SAPC provides pharmacists with an 
opportunity to interact with patients/clients and provide the necessary medicine- 
related information. In the case of the Deaf community, salient medicine–related 
information could easily be overlooked or misinterpreted, compromising  the 
quality of pharmaceutical care. 
 
 
2.2.7.2.2 Over-the-counter medicines 
 
In South Africa, certain medicines may be supplied to the general public without a 
prescription. Commonly referred to as OTC medicines, they are typically supplied 
in a community retail pharmacy where a client walks in with a health-related 
problem, seeking advice from the pharmacist and in-so-doing, allows the client to 
“self-treat” minor health problems (Bakic-Miric 2009 :41) Technically, according 
to the SAPC three-step dispensing process, the supply of medicine’s on an OTC 
basis is not dispensing because there is no prescription to fulfil phase 1 of the 
process (phase 1: interpretation and evaluation of the prescription.) 
 
Bakic-Miric (2009:41) asserts that the following information must be provided to 
patrons to whom medicines are supplied on an OTC basis: 
• Generic/brand name of the medicine 
• Dosage form and route of administration 
• Dosage amount and frequency of administration 
• Storage instructions of the medicine 
• Potential interactions and therapeutic contra-indications 
• Techniques for self-monitoring therapy 
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In summary, the dispensing process requires mutual exchange of medicine-related 
information between the pharmacist and patient in order to optimize the patient’s 
therapeutic outcome. For a patient with auditory and  literacy  capabilities this 
occurs as a largely natural and ‘automatic’ interaction. However, for a Deaf patient, 
the dispensing process could be seen as a dead end, with little hope of making any 
sense of what the pharmacist is trying to communicate. 
 
2.2.8 Pharmaceutical care 
 
Along with dispensing, pharmaceutical care is a philosophy centered around 
pharmacist-patient communication. This  philosophy of practice has been embraced 
widely in the pharmacy profession (Burton, 2013) in line with its evolution from a 
product-focus to a patient-focus. It is a patient-centered, results- oriented 
ideology, aimed at improving the patient's health-related quality of life and 
attaining positive clinical outcomes. The philosophy has its roots in the work of 
Hepler and Strand, who advocate for “the responsible provision of drug therapy for 
the purpose of achieving definite outcomes that improve a patient’s quality of life.” 
Along with the profession, Hepler & Strand’s (1990) concept has also evolved 
from its emphasis on drug therapy to a stronger emphasis on the patient-
centered role of a pharmacist. Such a patient-centered approach establishes the 
responsibility of both the pharmacist and patient to optimize therapeutic 
outcomes. The joint responsibility implies open communication channels between 
a pharmacist and patient where mutual understanding is established to arrive at a 
common goal. In this regard, the pharmaceutical care process is especially relevant 
for marginalized communities who may require pronounced levels of care. 
Pharmaceutical care comprises a number of essential elements, tabulated below: 
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Table 6: Elements of Pharmaceutical Care (adapted from APhA, 1995) 
 
 
Pharmaceutical Care 
element 
Description 
 
Professional relationship 
between pharmacist and 
client/patient 
A pharmacist-patient relationship based upon 
compassion, open communication, trust and 
mutual decision making is established and 
maintained. The patient is forthcoming with 
personal information and provided input in the 
therapeutic plan. 
 
Patient-specific medical 
information is collated, 
organized and 
maintained 
Pharmacists must elicit from the patient 
information regarding his/her health and well- 
being, medical history, dietary and activity 
habits, history of medicines taken and current 
medicines being consumed, and social 
financial and information pertaining to the 
patient. 
Patient medical data 
must be assessed and a 
therapeutic plan jointly 
established with the 
patient. 
The pharmacist assesses the complete case, 
including social, psycho-social and medical 
aspects of the disease and together with the 
patient, designs the therapeutic plan. 
The pharmacist provides 
information and advice 
necessary to fulfil the 
therapeutic plan. 
The pharmacist shoulders responsibility for the 
therapeutic outcome, thus ensuring that the 
patient has all the necessary drug and non-drug 
therapy and understands the disease and the 
therapeutic plan. 
The pharmacist 
documents, reviews and 
amends the therapeutic 
plan with the patient and 
healthcare team. 
 
Patient progress recorded Patient feedback on 
progress, inter-collegial collaboration. helping 
assure continuity of care as the patient 
 
 
All the tabulated elements of pharmaceutical care above (establishing a 
relationship, collating patient information, assessing patient data, jointly 
establishing a therapeutic plan, providing information and advice and amending the 
therapeutic plan with the patient) involve effective communication between the 
pharmacist  and  patient.  Surprisingly,  the  importance  of  communication  is   not 
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addressed in the concept of pharmaceutical care (Knoesen, 2014). If 
communication is not possible, the ability of a pharmacist to provide 
pharmaceutical care may be undermined and the level of care obtained by the 
patient is likely to be sub-optimal. This is supported by Beardsley et al (2008), who 
establish communication as a requisite to achieve success of pharmaceutical care. 
In comparison with the SAPC’s recommended standards for dispensing, 
pharmaceutical care is more complex and encompasses elements of mutual 
responsibility, the establishment of a relationship with the patients and social 
competency. Conversely, dispensing according to the SAPC is a one-way process 
by the pharmacist, and is largely product-focused. While various definitions of 
pharmaceutical care include an emphasis on medicine-related i n f o r m a t i o n  
(“ensures safe and rational drug use”, “responsible provision of drug therapy” etc.), 
it also includes a patient-focus, joint responsibility for therapeutic outcomes and 
patient-centered care. 
For marginalized populations who are often already disadvantaged, the lack of 
pharmaceutical care is potentially detrimental. To overcome this problem, 
pharmacists must obtain the skills required to provide services and care to people 
from different social backgrounds and with different social skill levels and 
communication abilities. 
 
2.2.9 Cultural competency for pharmacists 
 
Cultural competency describes the relationship of health professionals to diverse 
members of their community and, in relation to healthcare has been defined as “the 
ability...to provide care to patients with diverse values, beliefs, and behaviours, 
including tailoring delivery to meet patient’s social, cultural and linguistic needs.” 
(Betancourt et al., 2002) In its aim to enhance service quality and improve health 
outcomes, the notion of cultural competency echoes the philosophy of 
pharmaceutical care. Cultural competency may thus be asserted as a necessary skill 
set for pharmacists to have. 
Camphina-Bacote (2002) is the developer of the Volcano model for cultural 
competency that can provide healthcare professionals with a blueprint to attain   the 
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skills to practice within multicultural communities. The volcano is depicted to 
illustrate a process involving five steps. The procedural nature of  the  model 
reflects Camphina-Bacote’s assertion that cultural competency is an attribute to be 
developed through a course of progression, i.e. one “becomes”  culturally 
competent rather than “being” culturally competent. The foundation of the 
m o d e l  or the base of the “volcano” is the aspiration of the healthcare worker 
to develop cultural awareness and is the launching pad from which a pharmacist 
can progressively develop cultural competency. Figure 4 below illustrates the 
Camphina-Bacote Volcano model. 
 
 
 
Figure 4: Volcano model for cultural competency (Camphina Bacote) 
 
 
 
 
 
 
 
 
Apart from cultural desire, the model illustrates that the characteristics of cultural 
skill, cultural awareness, cultural knowledge and cultural encounters emerge from a 
developmental progression that comprises the process of becoming culturally 
competent. According to Camphina–Bacote (2002), cultural awareness is the 
healthcare professional’s self-awareness of their own cultural background and their 
biases to other different cultures. Cultural skill is the ability to juxtapose a patient’s 
cultural profile against his/her presenting medical problem on order to address 
his/her health problem.  Cultural knowledge is the understanding of and familiarity 
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with different cultures and their unique beliefs and outlooks. Cultural-encounter  is 
a construct which encourages healthcare professionals to participate in cross- 
cultural interactions with people of different cultural backgrounds in order to expel 
biases and identify and dismiss stereotypical views of that culture. 
Cultural competency education has been entrenched in many pharmacy curricula 
worldwide. The American Colleges of Pharmacy Education  (ACPE)  has 
committed to cultural competency training through establishing accreditation 
standards that pave the way for schools of pharmacy to include  cultural 
competency within their curricula (Smith et al., 2011) . However, disability is not 
normally included as a component of cultural competency education, and disabled 
groups are generally under-represented. This may result in the inequities 
experiences by disabled people. (Smith et al., 2011) 
The Volcano model is ideally suited to the unique South African milieu, 
distinguished by its rich heritage of numerous cultures and languages and extreme 
socio-economic differences. With eleven official languages and an even greater 
level of cultural diversity, the limitations in linguistic ability and literacy of a large 
numbers of South Africans may present a barrier to accessing medicine 
information. 
Further compounding this problem is the reality that many pharmacists in South 
Africa are unable to speak African languages (Mansoor & Dowse, 2004). 
Consequently, patients use medication inappropriately, which results in failure of 
therapy and untoward effects. Pharmacy cases that have been observed include oral 
administration of suppositories, failure to complete antibiotic regimens and 
inability to use insulin pens (Parker & McCrae, 2008). Such situations may be 
even more magnified when pharmacists are required to dispense medicines to Deaf 
patients who are able to communicate only in sign-language, and may compromise 
their rights of access to information and medical care. In this regard, the constructs 
of the Volcano model are essential skills for pharmacists to develop and are 
important in the provision of pharmaceutical care to patients with diverse social 
and cultural backgrounds. 
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2.2.10 Traditional set-up of dispensaries in South Africa 
 
Typically a South African pharmacy contains a dispensary from which pharmacists 
dispense medicines and provide patient counselling and medicine-related 
information. The SAPC prescribes Good Pharmacy Practice requirements for 
dispensaries and other pharmacy facilities. The size of the dispensary must allow a 
“safe and efficient workflow,” allow for adequate supervision of tasks by a 
pharmacist and reflect the number of prescriptions dispensed (SAPC, 2010). 
Factors to consider in dispensary size are prescription volume, workload  and 
overall space allocation in the pharmacy. For each pharmacist, a space of 90cm x 
1m must be allocated in the dispensary (SAPC, 2010). As a minimum standard 
where medicines are supplied to the public, there must be a “reasonably private” 
area where background noise is minimal for provision of information and advice. 
In addition, the area must have a professional appearance and sufficient space to 
promote counselling (SAPC, 2010). Other types of areas include a private area and 
a semi-private area. According to the SAPC, among the main concerns are the 
security of medicines and scheduled substances and ensuring patient confidentiality 
through allowing levels of privacy. To this effect, glass windows with an open 
hatch at the bottom through which medicines are dispensed are commonplace, 
especially in hospital pharmacies. While the window serves as a security barrier, it 
also isolates the pharmacy staff from patients whose needs require s p e c i a l  
attention. 
Dispensary guidelines do not explicitly consider or account for disabled people 
including Deaf persons. The prescribed features of privacy and security in the form 
of glass windows may form further barriers for Deaf people who pay close 
attention to facial expressions and gestures and lip-read need an up-close face-to- 
face interaction to understand a message. In addition, public sector hospital 
pharmacies initiate contact with patients in the waiting area via a microphone 
system which serves no purpose for a Deaf patient. 
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2.2.11 Pharmacists and communication with deaf persons 
 
Pharmacists are ethically and professionally duty-bound to communicate medicine 
instructions and health-related information relative to the particular needs of an 
individual patient. The profession has embraced the notion of a patient-
centered philosophy of practice which further supports the provision of 
individualized care. To bring this notion to fruition, it is crucial that pharmacists 
become culturally sensitive and capable in their interaction with diverse 
communities, especially marginalized communities such as minority language 
groups who are often disadvantaged in healthcare provision. On communication in 
health promotion, South Africa’s White Paper for Transformation of the Health 
system asserts that historically, “communication strategies for health promotion 
have been restrictive and have favored target audiences that are literate, urban 
based and who have easy access to print and audio-visual media.” This health 
disparity f u r t h e r  validates the necessity for socially competent healthcare 
practitioners in South Africa. 
 
Available literature on the pharmacist-deaf patient interaction is limited (Ferguson 
& Lui, 2015),  with more studies having focused on the physician-deaf patient 
interaction. In both situations, study efforts are skewed toward how the healthcare 
professional experiences communication with the deaf person, with fewer studies 
focusing on how the deaf patient experiences communication with a healthcare 
professional. Even fewer studies are available on how Deaf people experience 
communication with pharmacists, with no published research thereof in the US 
existing in 2014 (Ferguson & Lui, 2015). Below I analyze pharmacist-perspective 
studies, while the deaf-perspective studies were appraised in the previous segment 
of this review. 
A cross-sectional, survey-based study in Southern Illinois (Ferguson & Shan, 2015) 
surveyed pharmacists who practice in communities with a high prevalence of deaf 
patients. The study sought to probe pharmacists’ experiences in communicating 
with the deaf community. Findings suggest that pharmacists generally experience 
discomfort and primarily use written material as the main methods to convey 
medicine and health related information.   A separate study surveying published 
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research on the experience of deaf persons with their physicians corroborated this 
finding, with deaf persons indicating that writing back and forth is the  most 
frequent mode of communication (Chaveiro et al., 2009). The South Illinois study 
further found that speaking in a manner that the Deaf person can read ones lips was 
the second most adopted manner of communication followed by relying on the 
assistance of a family member or friend. All three scenarios present problems 
specific for the Deaf community. These problems are explored in the subsequent 
section of this review. 
In their “Introduction to Diversity” course, Wegman School of Pharmacy (New 
York), in collaboration with the National Centre for Deaf Health Research offer 
pharmacy students an exercise dubbed “Deaf Strong Hospital (DSH).” Adapted 
from the University of Rochester’s School of Medicine and Dentistry program, 
Deaf Strong Hospital is a role-reversal exercise in which pharmacy students are 
asked to assume the role of a patient at a hospital (Mathews et al., 2011). At this 
hospital, all healthcare personnel are deaf and can communicate only in sign 
language. Aimed at raising student awareness of communication barriers in 
healthcare, the program uses an atrium, classrooms and study rooms to simulate a 
hospital setting. Personnel at the hospital are volunteers who are able to 
communicate in American Sign Language. Students must attend the hospital as 
hearing patients, but are not allowed to talk because the personnel are all deaf. 
Students receive instructions in sign language, similar to the way in which a deaf 
person would normally be given instructions in spoken language. Two days 
prior to their experience at DSH, students are given instructions on how to finger-
spell the alphabet, some basic signs in American Sign Language and reading 
material on Deaf culture. On the day of the exercise, students are not allowed 
to use their voices in any way, but are encouraged to use alternative methods o f  
communication (e.g. pantomiming). Students must navigate the waiting area, 
doctor’s office, emergency room and pharmacy during the exercise. In the waiting 
room, they must wait for their name to be “called” using fingerspelling, mimicking 
the situation a Deaf-person would experience when a hearing person calls their 
name in spoken language. Students are instructed to communicate their symptoms 
including nausea, headache etc. without speaking. A volunteer, acting as a   doctor, 
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would explain the diagnosis in American Sign Language. At the pharmacy, 
medicine containers are filled with different colour candies to mimic a real-world 
situation in which a patient would receive different medicines. Again, the students 
are not allowed to utilize their voice. As part of the hospital experience, students 
are also asked to complete a treatment consent form, except that the form is drafted 
in a language which they are unfamiliar with, to represent the textual language 
barriers encountered by deaf persons when they are asked to sign consent in 
English, while their mother-tongue is sign language. The exercise was designed 
to elicit feelings of frustration and disempowerment in students, in-so-doing 
instilling the value of cultural competency. Subsequent to the exercise, students 
participated in a panel discussion and debriefing session to allow them to reflect on 
the experience. Student reflections pointed to a number of problems experienced 
by deaf people in the provision of health services at a typical health center 
(Mathews et al., 2011). 
Many students found the waiting room procedure to be unclear and frustrating. 
Several students reported that they feared missing their name being called and that 
would be left in the waiting area to be ignored (Mathews et al., 2011). Since 
students only had limited exposure to fingerspelling, many missed their doctor’s 
appointment because they were unable to identify their name being “called.” 
Further problems identified by the students were that they needed clarity in 
navigating stations as they were unclear of where to proceed to next. They also 
lacked clarity on the extent of their health problem, or the symptoms they reported 
were understood by the healthcare practitioner. In addition, students struggled to 
ask the pharmacist questions or highlight concerns. Students found communicating 
via an interpreter challenging, expressing difficulty in interacting with and focusing 
on the deaf healthcare provider as if the interpreter was not there. The consent from 
presented a language barrier, rendering students to be functionally i l l i t e r a t e . 
Several students signed consent, not understanding what they were signing for 
(Mathews et al., 2011). 
Although this study did not survey the experience of pharmacists communication 
with deaf patients, the ‘pharmacy-student-as-patient taking instruction from deaf 
healthcare provider’ design delivers a fascinating insight into the    pharmacist-deaf 
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patient interaction. It provides a realistic account of challenges experienced by the 
Deaf community. As adjectives to describe the experience, pharmacy students used 
the words “frustrating, eye-opening, thought-provoking and interesting” and 
several expressed an interest in taking a sign language course. Study findings 
highlight a need for pharmacists to be more proficient in interactions with Deaf 
people. 
In another study, an analysis of the experiences of medical interpreters in 
interpreting interactions between nurse and deaf patient revealed inaccuracies in 
terms of perception, performance, memory and meaning (Cokely, 1982). 
A non-systematic review of computer-databases spanning a decade was aimed at 
analysing aspects of interactions between physicians and deaf persons. The review 
found that physicians are generally underprepared to care for deaf persons as 
academic curricula preclude the skills-set needed to meet this minority group. 
(Chaveiro, 2009). A lack of awareness by healthcare workers about deaf people is 
one of the most significant factors that impact quality of care. This finding is 
corroborated for pharmacists by Moola (2010), who reports that pharmacists 
mistakenly assume that all deaf people can lip-read and prefer it as a means of 
communication, resulting in pharmacists talking in a slower and louder manner, 
taking care to pronounce words clearly for articulation by a Deaf person. 
Published work indicates that when communicating with Deaf  patients, 
pharmacists are challenged to provide individualized, patient-centred care. Their 
regular methods of communication are not always suitable due to their inability to 
communicate effectively in a manner that can be understood by the Deaf patient. 
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2.3 WORK RELATED TO THIS THESIS 
 
A major outcome of the research is to collaboratively create an assistive device to 
facilitate communication between a Deaf person and a pharmacist. Expertise from a 
computer programmer and industrial designer is to be intricately linked to arrive at 
a mobile phone application. This final section of the review seeks to critically 
appraise technological interventions aimed at assisting Deaf people  to 
communicate with healthcare professionals. While I had no part in the technical 
aspects of this collaboration (programming and construction of the technical 
architecture), I include this critical appraisal as a backdrop and further motivation 
for the mobile phone intervention. 
The proliferation of technological advancements has caused a global ever- 
expanding impetus toward using technology to neutralize social problems. The 
world of communication has been transformed by the mushrooming networks and 
applications that allow for real-time relay of access to information. Society at large 
is employing technologies as a means of social and economic expansion. Its  use 
has also been seen in marginalized communities and minority groups with the aim 
of social upliftment. Several interventions have been created for use specifically by 
the Deaf community. These interventions differ on the basis of the delivery 
medium, network requisite, inclusion of avatar versus actual interpreter, and use of 
text versus video (Motlhabi, 2014). The intervention envisaged as the outcome of 
this research would be a mix of the above variables that are suited to the unique 
needs of the South African Deaf community. 
 
 
 
2.3.1 Information Communication Technology for deaf people 
 
A telephone type-writer (TTY) is an apparatus with a QWERTY keyboard and a 
small screen that allows for communication transfer from voice to text with the use 
of an interpreter (Motlhabi, 2014). A speaking caller gives a message to an 
interpreter, who in turn types the message on the keyboard, for transfer to a Deaf 
person on the other end of the line. The Deaf person can respond in text to the 
interpreter, who voices the message to the hearing person. There are two major 
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shortcomings in this system: (i) it is text-based and (ii) it requires the services of a 
sign-language interpreter (Motlhabi, 2014). Text-based formats are not suitable for 
most of the Deaf community in light of their literacy problems (Zafrulla, 2008); 
and in South Africa, the monetary impact and scarcity of interpretive services pose 
an operative barrier for the TTY system to work. 
Video-Relay Service (VRS) systems are naturally preferred to the TTY by the 
Deaf community as this system allows for transfer of messages in sign language. It 
works by sending a sign language video over a cellular phone network and requires 
broadband internet connectivity (Motlhabi, 2014). While VRS is superior to TTY 
in terms of communication applicability for Deaf people, it poses significant 
limitations in that it requires high-definition cameras, high speed internet 
connectivity and expensive devices. For Deaf communities outside first-world 
countries, VRS systems are inaccessible in terms of affordability (Motlhabi, 2014). 
Mobile ASL is an American Sign Language based venture that solves many of the 
problems of TTY and VSR (Motlhabi, 2014). It enables Deaf people to use easily 
available mid-range mobile devices to send sign language videos over a mobile 
phone network, negating the need for specialized equipment and high-end devices. 
Video compression techniques are used to condense videos in order to reduce the 
cost of sending them over the network. The drawback with video messages lies in 
the perspective of the service provider of the mobile network. Service providers 
prioritize voice and text rather than video (Motlhabi, 2014). In-so-doing, service 
providers alter the bit-rates and frame-rates of transmitted videos at the nearest 
base-station. Altering videos in this manner almost always results in a diminished 
video quality, which may render sign language videos unintelligible and unusable 
for sign language communication. The Mobile ASL team have surpassed this 
drawback by pre-processing the video before it is sent over the network. Deaf 
people have been enthusiastic and receptive toward Mobile ASL, but poor video- 
handling infrastructure set up by providers to handle video requests remains an 
obstacle (Motlhabi, 2014). 
Artificial Intelligence Techniques have also been applied in the attempt to 
translate spoken language into sign language. The Automatic Speech Recognition 
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and Augmented Reality (ASRAR) system uses a human signing avatar to alter 
voice messages sent by a hearing person into sign language, and sign languages 
messages sent by a Deaf person into text (Motlhabi, 2014). In computing, an 
avatar is a cartoon-like image that represents a person. The instrumentation of 
ASRAR means that the avatar communicates programmed signs that it recognizes 
from text, thereby negating the use of a sign language interpreter. Artificial 
intelligence techniques usually require infrastructure that is already included in 
many commercially available phones, and they have the added benefit of allowing 
Deaf persons to autonomously communicate with hearing persons without the need 
of an interpreter. The constraint of this system lies in the cost implication of 
creating the avatar. For the avatar to recognize sign language, highly sophisticated, 
intricate mechanics using sensors in headgear, gloves and a body-vest to record 
body motion and facial expression are  required  (Motlhabi, 2014).  Furthermore, 
the specific language used medicine instruction and the accuracy required in 
conveying medicine-related information makes artificial intelligence methods 
unsuitable in communicating medicine instructions. 
Automated Dispensing Systems (ADS) include the Baxter Dispensing System® 
and Pyxis Medstation® among others. The advantages of automated dispensing is 
that these systems often do the manual tasks of assimilating dosage units into 
patient-ready quantity packages, and seal and label the packages with printed 
instruction. In this way, most of the manual process-centred tasks are completed for 
the pharmacist without large human-resource demands (Motlhabi, 2014). 
Drawbacks of ADS are that the instructions are text-based, and therefore not 
appropriate for persons who have limited text literacy (Motlhabi, 2014). 
Furthermore, instructions are pre-programmed and finite, they cannot be altered 
based on the individual needs of the patient and preclude caring and empathy 
which is cornerstone to the pharmaceutical care philosophy. 
Shared Speech Interface is a system designed to facilitate  communication 
between a deaf person and their consulting physician. It involves a multi-touch 
table top display with speech recognition to facilitate medical conversations 
between doctor and patient, a standard keyboard and a microphone headset 
(Motlhabi, 2014). The system works by having the doctor and patient sit opposite 
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one another, on either side of a table with a large multi-modal touch screen 
interface. Messages are fed into the system in one of two ways: (i) text input or (ii) 
audio input. The doctor or patient is also able to add visual information, such as x- 
rays, and scans and these can be “discussed” collaboratively, by creating text-boxes 
or speech–bubbles of the input of either user that appears on the screen, to be seen 
by both users. The strengths of this system include the face-to-face orientation of 
the patient and doctor, allowing the communication of body language, facial 
gestures and non-verbal cues, and the size of the table top screen which allows the 
sharing of information on a platform that can be viewed by both users 
simultaneously (Motlhabi, 2014). The system was also designed using a 
participatory action approach with deaf persons and hearing persons who 
frequently interact with the deaf community. The drawback of this system is the 
reliability of transcription of natural language into text, which is problematic. Due 
to its heavy reliance on text, the researchers have also found this system to be of 
value only in certain sub-populations: deaf persons who are comfortable using 
English and those who are hard-of hearing, thereby precluding Deaf people. 
 
2.3.2 Supporting Work 
 
The intervention described in this dissertation was based on the conceptualisation 
and prior work of Looijestein (2009) and Chininthorn (2011), industrial-design 
engineering students from Delft University of Technology (TU Delft), and 
Mutemwa (2011), a computer science student from the University of the Western 
Cape. 
Looijesteijn (2009) designed the first prototype which is the base-model for this 
work: a model of a mobile phone on a personal computer that enabled the 
transmission of messages between a Deaf person and a doctor using pre-recorded 
SASL videos. The program was set-up to question a Deaf person on medical issues 
in SASL. The Deaf person answered the questions in SASL, subsequent to which 
the answers were accessible to the doctor in English text. The doctor was able to 
read a symptom summary and respond; this response was translated into a. SASL 
video to be watched by the Deaf patient. Looijestein dubbed his application 
“SignSupport.” 
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Mutemwa (2009) then implemented Looijestein’s SignSupport on a  Symbian 
phone and engaged web pages with an arrangement of both SASL videos and 
English text. Once again, the Deaf patient was able to communicate to the doctor 
their symptoms and duration of the symptoms. In a sequential series of patient 
medical history type questions presented in SASL, the Deaf patient’s answers are 
translated in English indicating to the doctor how the patient is feeling. The real- 
world application of Looijestein and Mutemwa’s collective work  however 
presented a significant problem: in order for SignSupport to work, all possible 
aspects of the doctor-patient interaction had to be pre-recorded in SASL to enable 
the phone to translate messages entered by the doctor. This included all the 
imaginable symptoms, ailments and illnesses which presented an endless number 
of possibilities. The domain of the communication was simply too large to be 
video-recorded and stored on a commercially available phone. 
 
Chininthorn (2011) recognized that the pharmacy context is more restricted than 
the doctor-consultation context and re-oriented Mutewmwa’s SignSupport 
prototype toward pharmacy. She commenced by investigating the manner in which 
Deaf people use cellular phones in their daily lives to communicate with both 
hearing and Deaf people. Since the pharmacist-patient exchange is more limited 
than the doctor-patient exchange, it is more viable to pre-record and store a 
restricted communication flow on a mobile phone. With input from a local Deaf 
community, Chininthorn (2011) set in motion a plan to craft a context-specific 
solution to be implemented on a mobile phone. She recognized that for this to come 
to fruition, the involvement of pharmacist and computer programmer was 
necessary. This marked the birth of this collaborative project which aimed to 
recreate SignSupport for use in a pharmacy. 
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2.4 LESSONS LEARNT FROM THE LITERATURE 
 
 
Below I provide a synopsis of the lessons that have emerged from the literature 
review. These are mainly issues that affect a pharmacist-Deaf patient interaction 
and are further summarized comparatively in Table 1. 
Global and national influences have endorsed patient-centered care in 
pharmacy practice activities and recognize the significance of effective 
communication in achieving optimal health outcomes. While human rights, health 
policy and disability policy are well developed, they fail to advocate for key 
elements which are essential for the Deaf community. No provision is made 
for SASL interpretive services at healthcare facilities. Similarly, international and 
national pharmacy practice guidelines establish communication as a key 
characteristic and important skill for pharmacists, but communication skills 
specific for the needs of the Deaf community are not prescribed. While global and 
local disability charters have been established to protect Deaf people, who are 
also affiliated to organized structures which advocate for equal rights and 
accessibility, the literature has revealed that in reality the Deaf community often do 
not enjoy the same level of healthcare service provision as hearing people. 
Although the literature on pharmacist-deaf patient interaction is scant, all reviewed 
studies point toward communication complexities and impediments which 
potentially hinder patient adherence and understanding of therapy. Pharmacists use 
spoken and written language to interact with patients, but Deaf people 
communicate in sign-language and likely do not understand written or spoken 
language. In addition, transactional models of communication have widely been 
accepted for pharmacist-patient interactions, but such models are not appropriate 
for a Deaf person who is unable to formulate a response in written or spoken 
language. The ability to respond is an essential feature of transactional 
communication models; Deaf people are thus only able to experience linear 
communication when interacting with a pharmacist. 
The applicability of the term ‘Deaf’ is not fixed but its most common associations 
include the use of sign-language and an affiliation with Deaf culture. Deaf people 
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experience a strong sense of culture. The nuances of Deaf culture are unique; 
affiliation to the culture not only implies pride and communal identity, but also a 
set of social norms which differ vastly to those of non-Deaf people. Furthermore, 
the cultural norms of one Deaf community may differ to that of the next, with 
dialectal variances in sign language and behavioural differences in social customs. 
Pharmacists, similar to other healthcare professionals have shown a lack of Deaf 
awareness, failing to realize that Deaf people may have limited literacy and prefer 
to not lip-read. Pharmacists are likely to be unaware of other Deaf-specific 
issues including difficulties in cognitive processes such as memory and attention. 
Public healthcare facilities in South Africa face human resource shortages and high 
workloads. Pharmacies have come under scrutiny for long patient queues and 
extended waiting times. Such circumstances may be even more magnified for the 
Deaf community, who, in light of staff shortages may not receive the 
specialized attention they require. Furthermore, they are not able to voice their 
queries or concerns to staff about their prescriptions or appointments and are often 
left to keep waiting to be called in patient-waiting areas. In conforming to GPP 
requirements of security and privacy, the traditional set-up of pharmacies and 
dispensaries in South Africa may create a physical communication barrier for Deaf 
patients who struggle to see intricate facial gestures and lip movements (in lip-
reading) over a dispensary counter and through a glass window. 
Pharmaceutical care requires the establishment of a mutual relationship in which 
the patient is jointly responsible with the pharmacists to  achieve optimal 
therapeutic outcome. There is a dependence on mutual interaction between a 
pharmacist and a patient. Deaf persons are not able to communicate effectively 
without a SASL interpreter. This may preclude the provision of pharmaceutical 
care to Deaf patients. 
Several technological innovations have been created for the Deaf people. These 
interventions all differ substantially and have shown benefits to Deaf communities 
abroad. A critical analysis of a number of these interventions has revealed various 
incompatibilities with the local Deaf community. These incompatibilities are based 
on affordability, network access, network-provider infrastructure and suitability   to 
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literacy deficits. In order to create a technological innovation appropriate for the 
local Deaf community we must extract from these prior innovations elements 
which are appropriate for them and exclude those which are not. Furthermore, such 
an innovation must accommodate Deaf culture, literacy capacity and South African 
Sign Language, in a manner that does not require large monetary investments, 
high-end devices or sophisticated network requirements. Pharmacy-related 
innovations have all been text-based and are thus inappropriate for Deaf persons 
due to the afore-mentioned reason of limited literacy. 
 
Table 7: Summary of lessons elicited from the literature 
 
 PHARMACIST DEAF PERSON 
 
Health policy 
Access to information 
Access to medical care 
No provision for sign-language 
interpreters at  health facilities 
Pharmacy practice 
guidelines 
Communication as a 
central role and 
responsibility 
No mention of communication 
for Deaf persons 
Communication medium Spoken e.g. English SASL 
Communication theory Transactional Linear (receiver) 
Deaf definition Lack of awareness Strong sense of culture 
Medicine–
related 
 
Verbal and 
Written instructions 
SASL 
Limited literacy 
 
Pharmacy unit 
Staff shortages 
High workload 
Minimal time 
Special needs, requiring 
additional attention 
Dispensary set-up Conformance to GPP 
Physical communication 
barrier 
Pharmaceutical care 
Joint responsibility 
Reciprocal relationships 
Unable to communicate 
effectively 
Available technology Text-based 
Not appropriate for limited- 
literacy persons 
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In conclusion, the literature review has emphasized several problems pertaining to 
the interaction between pharmacists and Deaf patients. It has also shown how 
technology designed for Deaf patients are inappropriate for the unique South 
African Deaf-community backdrop. These problems influence my thesis 
tremendously through highlighting key concerns and lessons to consider in ensuing 
research activities. 
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CHAPTER THREE 
STUDY RATIONALE 
 
 
 
The literature review highlighted a labyrinth of interconnecting problems pertinent 
to medicine use in the Deaf community. A systematic summation of the 
dominating issues examined in the literature provides the causal factors and 
theoretical underpinnings of the study. Furthermore, lessons emerge from a 
dissection of similar and related work. These lessons pave the way forward and 
culminate in the over-arching study goal and specific research aims and objectives 
set out to achieve the goal. This is highlighted to bring lucidity to all ensuing study 
endeavours. 
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3.1 DEVELOPMENT OF RESEARCH QUESTIONS 
 
 
In this chapter I provide an overview of obstacles to effective pharmacist-Deaf 
patient interaction to contextualize the research problems. I categorize these 
problems as: 
(i) Barriers to effective interaction; 
(ii) Health policy disparities; 
(iii) Perceptions of Deaf community 
(iv) Nonconformity to professional practice recommendations 
(v) Available technology 
These problems are pertinent to conceiving more specific research questions and 
are systematically synopsized below. Following collective synopses, the research 
questions are elucidated through further refinement of the problems. Refined 
problems and subsequent research questions are provided in shaded and bordered 
text. 
 
3.1.1 Barriers to effective interaction 
 
The literature highlights a complex set of barriers to effective interaction between a 
pharmacist and Deaf patient. These can be categorized as physical barriers, 
physiological barriers, and psychosocial barriers and emotional barriers and 
emphasize the need for an intervention to bridge communication gaps during the 
medicine dispensing process. 
 
1. Physiological barriers: Lack of auditory ability 
Limited cognitive ability and memory 
2. Physical barriers: Dispensary counters 
  Dispensary window Pharmacist 
proximity      to      patient           
Lack of human resources 
3. Psycho-social barriers: Language barriers 
  Limited literacy 
Deaf cultural unawareness by pharmacists 
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Lack of independence in seeking healthcare 
Lack of confidentiality in accessing care 
 
4.   Emotional barriers: Frustration, mistrust in the system 
Fear of not receiving service 
Anxiety associated with hospital visits 
 
3.1.2 Health policy disparities 
 
While human rights, health policy and disability policy are well developed, they 
fail at an implementation level resulting in circumstances which compromise the 
fundamental human rights of Deaf people. These circumstances include a lack of 
access to information in a medium that is suitable for their unique needs, a lack of 
awareness by healthcare professionals of their disability, a lack of privacy and 
confidentiality in medical interactions due to reliance on interpretation or assistance 
and the potential risks associated with not understanding medical communication. 
Policy also fails to specify and legislate essential services for the Deaf community. 
No provision is made for SASL interpretive services at healthcare facilities, 
compounding the communication barrier faced by Deaf people with health care 
providers. 
 
3.1.3 Perceptions of Deafness 
 
The literature review has emphasized that health professionals are unaware of the 
specific characteristics of the Deaf community and how these characteristics differ 
within each community from one Deaf person to the next. There seems to be a 
flawed perception that all Deaf people are the same: they are unable to hear, but 
can read and lip-read. Deafness however, is heterogeneous. Deaf people differ in 
terms of their physical degree of deafness, literacy, lip-reading ability, level of 
education, dialect, and culture and sub-groups of are different to ‘deaf’ people who 
experience reduced levels of deafness and higher levels of literacy. The WHO, 
WFD and DEAFSA each have separate, unique definitions of ‘Deafness.’ The 
coinciding element of all three definitions however, is the use of sign language. For 
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this reason, and for the purpose of this study, I have constructed the following 
definitions of  ‘deafness’ and ‘Deafness.’ 
 
 
 
 
 
 
Deaf people have limited linguistic skills including literacy. Medicine instructions 
are traditionally given verbally and in a text format, neither of which are suitable 
for Deaf people. They prefer to communicate via an interpreter rather than receive 
instructions in a format that they do not understand, but interpretive services are 
inaccessible due to the cost implication and scarcity of interpreters. Interpretative 
services pose problems for a Deaf person who wants to communicate in privacy, 
and for a pharmacist who must interact via an interpreter, since the presence of an 
interpreter precludes patient confidentiality as prescribed in the pharmacists’ code 
of practice. 
Defining Deafness 
 
‘deaf’ (lower-case ‘d’) refer to individuals who experience hearing loss 
from moderate to severe, and use mainly spoken language to 
communicate. 
 
‘Deaf’ (uppercase ‘D’) refer to those individuals who experience profound 
hearing loss and use South African Sign Language as their main means of 
communication. They identify with Deaf culture. 
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3.1.4 Nonconformity to professional practice recommendations 
 
Pharmacists have a professional and ethical responsibility toward maintaining 
levels of social competency in their interaction with patients. The philosophy of 
pharmaceutical care calls on pharmacists to assume mutual responsibility with 
patients to achieve optimal therapeutic outcomes; this is supported world-wide in 
codes of practice. In order for pharmacists to adopt these roles, effective 
communication with their patients is crucial. The literature reveals that pharmacists 
experience difficulties in communicating with Deaf people. This has been shown to 
undermine the patient counselling process, with anecdotal evidence of Deaf 
patients not understanding instructions by pharmacists resulting in incorrect use of 
medicines. 
 
The SAPC organizes the process of dispensing medicines into three sequential 
phases and prescribes the responsibilities of pharmacists within each phase. 
According to the SAPC classification, direct interaction and communication with a 
patient mostly occurs during Phase 3 of the dispensing process, during which a 
pharmacist  must  provide  instructions,  information  and  advice  to  the  patient to 
We  are  politically  and  socially  obliged  to  uphold  rights  for  Deaf  people  but 
significant barriers to meeting this obligation are evident. This is particularly the 
case with regard to the right to accessibility of health-related information. Failure 
to  implement  policy,  lack  of  Deaf  awareness  and  the  absence  of  sign-language 
interpretive services all create circumstances which negate Deaf peoples’ rights to 
access  healthcare  information.  Deaf  communities  require  solutions  which  can 
accommodate their unique and heterogeneous needs and characteristics. 
What  are  the  experiences  of  the  local  Deaf  community  with  regard  to 
medicine use and their interactions with pharmacists? 
What are their specific challenges during their interactions with pharmacists 
and what would they like to experience during such an interaction? 
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ensure the safe and effective use of medicines (SAPC, 2008). However, in terms of 
pharmaceutical care, the SAPC definition is flawed as it implies a one-way process 
of giving information and advice, whereas pharmaceutical care philosophy focuses 
on mutual interaction and responsibility between pharmacists and patients. For this 
reason I have chosen to use the term patient-counselling to represent phase 3 
dispensing which is the professional context of the research, and use the two terms 
interchangeably throughout this dissertation. Equating these terms and using them 
interchangeably is supported in the literature. 
 
 
 
 
 
Unless a pharmacist is sign-fluent or can ensure the assistance of a sign–language 
interpreter, they are not able to properly conduct patient counselling with patients 
who experience profound Deafness. Deaf people generally experience superior 
communication with the presence of a sign-language interpreter.  SASL 
interpretive services however are inaccessible to the majority of Deaf South 
Africans. Pharmacists do not have the skills or sign-language interpretive facilities 
to communicate effectively with Deaf people. The traditional setup of dispensaries 
in South Africa may further impede their interactions with pharmacists, who 
operate behind a counter that offers a semi-private counselling area (a requisite for 
counselling prescribed by the SAPC). While such a semi-private counselling area 
Equating ‘Dispensing Phase 3’  to  ‘Patient counselling’ 
Dispensing Phase 3  is defined by the SAPC as: 
“Provision of information and instructions to the patient to ensure safe and 
effective use of medicines.” 
Patient counselling is defined as: 
“A one -to-one interaction between a pharmacist and a patient and/or 
caregiver. It is interactive in nature. It should include an assessment of 
whether or not the information was received as intended and that the 
patient understands how to use the information to improve the probability 
of positive therapeutic outcomes.” (Beardsley, 1997) 
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fulfils the SAPC’s requirement, it hinders efforts to communicate with Deaf people 
who rely on close-up, clear, face-to-face interactions to be able to understand the 
message being conveyed. 
 
Digital technology may offer an alternative option to interpretive services suited to 
the needs of Deaf people. Such a technological intervention in dispensing could 
eliminate the breaching of patient confidentiality which is expounded through the 
presence of a sign-language interpreter. By introducing technology to facilitate the 
pharmacist-Deaf patient counselling process, it is essential that professional 
practice codes would have to be followed. 
 
 
 
 
In a real-world setting, a pharmacist needs a sign language interpreter to 
effectively conduct patient-counselling with a Deaf person.in the absence of 
sign-language interpretation, pharmacists are unable to sufficiently provide 
patient counselling and should find ways to replace interpreter services. 
Technology may be a plausible opportunity to explore. Such technology 
would need to accommodate all the obligatory features of the patient- 
counselling process and conform to professional practice stipulations. 
What are the typical and obligatory features of the patient counselling 
process? What do pharmacists ‘say’ during this process, and what 
information is necessary to obtain from a patient to ensure the safe and 
effective use of medicines? 
What are the specific pharmacy practice guidelines that a technological 
intervention must comply with in bridging the gaps in pharmacist-Deaf 
patient communication? 
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3.1.5 Available technology 
 
In the previous chapter I have discussed several technologies created to overcome 
communication barriers for Deaf people. I have discussed reasons why these 
technologies are not suitable for the South African Deaf community. They may 
require sophisticated, high-end equipment or high speed data connections. Neither 
of these requisites is affordable for the South African Deaf community. A number 
of the technologies are text-dependent, precluding limited-literacy populations. 
Mobile phone technology which is ubiquitous in service sectors is yet to be 
introduced into the South African pharmaceutical services. A mobile phone 
application could be explored as an assistive device during pharmacist-Deaf patient 
counselling. 
 
 
 
 
 
Looijestein and Mutemwa developed a prototype for interaction between a doctor 
and Deaf patient during a medical consultation. This prototype, called SignSupport, 
demonstrated positive outcomes in using sign-language translation videos on a 
mobile phone for communicating with Deaf people. On the contrary,  their 
prototype was not successful in the doctor-consultation context because the domain 
of possible communication between doctor and patient was too large to pre-record 
and store all possible interactions 
The South African Deaf community experience a unique socio-economic climate 
and demographic circumstances etched by historical injustice. Technology designed 
for their use would need to accommodate their unique characteristics including 
financial status, literacy level and level of education. 
Are Deaf persons receptive to using a mobile phone technology in their 
inter1a. ctions with pharmacists? Can such technology accommodate their unique 
needs? 
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The Looijestein-Mutemwa SignSupport prototype was not suitable for medical 
doctors because it was not physically and technically possible to record and store 
sign-language videos corresponding to all the terminology (symptoms, signs, 
illnesses and other medical terms) that doctors may require to effectively 
communicate with a patient, onto commercially available phones. Hence it did not 
suit their professional context or conform to their practice norms and was not able 
to communicate all the aspects that they wanted to say to the patient. While Deaf 
patients were enthusiastic about the prospect of communicating with their doctor 
through sign-language videos on SignSupport, it was ultimately not ideally suited 
because SignSupport’s inability to capture all the doctor’s messages would lead to 
Deaf patients receiving incomplete information. SignSupport could be an option to 
facilitate counselling on medicine use between a pharmacist and a Deaf  patient. 
The use of such an assistive device would have to conform to both their needs in 
terms acceptability. 
The Looijestein-Mutemwa SignSupport prototype was successful in using sign- 
language translation videos in a doctor-consultation context but was unable to 
contain the expansive scope of the doctor-patient interaction. In comparison, the 
pharmacist-patient interaction is more confined.  The research team therefore 
hypothesized that re-orienting SignSupport to a pharmacy context may result in 
better outcomes. 
Are sign-language translation videos able to accurately and effectively 
translate medicine instructions to a Deaf patient in a way that is 
understandable for the patient? 
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The questions elicited above leads to the overarching research questions: What 
pharmacy-related information aspects can be incorporated into digital technology? 
How can t e c h n o l o g y - b a s e d  pharmacy i n t e r a c t i o n s  be designed for use 
by pharmacists and Deaf patients during the patient counselling process? 
If pharmacists were to use SignSupport to aid their interaction with a patient, it  
would need to (i) conform to their practice contexts and (ii) be acceptable to 
pharmacists in terms of their ability to communicate what they want to say. 
Pharmacists would also need to have confidence that there are no gaps in the Deaf 
patient’s understanding of his/her medicine regimen when they conclude the 
patient counselling process. 
Would pharmacists be keen to interact via SignSupport, and is SignSupport 
able to accommodate the features of the patient-counselling that pharmacists 
deem necessary? 
Are Deaf patients able to better understand medicine instructions when 
using SignSupport as opposed to their regular interaction without 
SignSupport? 
Will Deaf people incorporate SignSupport into their daily medicine-taking 
routines? 
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3.2 AIM AND OBJECTIVES 
 
In an attempt to answer research questions presented in the shaded boxes above, the 
following aim and objectives were elucidated: 
 
3.2.1 Overall Aim 
• To provide dispensing-related pharmacy expertise in the design and 
implementation of SignSupport: a mobile phone application to facilitate 
communication between a pharmacist and a Deaf patient. 
 
3.2.2 Objectives 
 
1. To qualitatively evaluate the experiences and challenges of the Deaf 
community regarding their experiences of the medicine dispensing process 
and using their medicines. 
 
2. To extract a dialogue pattern representing the communication flow that 
would typically occur between a pharmacist and a patient during 
medication counselling, and to express this pattern as a series of ordered 
sentences. 
 
3. To compile databases containing the standard medicine-related information 
features captured during the patient counselling process: 
(i) Medicines and Symptoms/Illnesses database and  
(ii) Prescription instruction database 
 
4. To verify that recorded SASL videos which translate to medicine-related 
information features from text into SASL videos incorporated into 
SignSupport communicate the medicine-related information correctly and 
accurately. 
 
5. To iteratively test SignSupport with Deaf persons and pharmacists to assess 
their acceptability and usability thereof. 
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CHAPTER FOUR 
RESEARCH METHODOLOGY and DESIGN 
__________________________________________________________________ 
 
In the preceding chapter, research questions were elucidated and cast as research 
aims. In light of these aims, I sketch a framework that led to the selection of the 
study methods and design strategies. The following parameters influenced my 
selection: research methodologies employed in previous Deaf community studies 
reviewed in the literature; the unique cultural value system of the Deaf 
community; pharmacist availability; methodological homogeny with members in 
the multidisciplinary research team and restrictions faced in communicating via a 
sign-language interpreter.   
This chapter serves to present the theoretical underpinnings of all the research 
techniques employed in this dissertation. Only a brief description is included of 
how they were applied in the study, with further details of the procedural 
application presented in the ensuing chapters (five, six and seven) which deliver 
the empirical processes of this thesis. Presented as two main sections, the first 
section reflects on the motivation for the chosen research paradigms and includes 
conceptualization of relevant study theories, data collection and data analysis 
methods, a description of how quality and rigour of findings were attained and 
ethical considerations. 
The second instalment of this chapter details how the identified research strategies 
were applied in successive study phases by illustrating this application in a series 
of diagrammatic illustrations (the research design).  This section culminates in a 
description of how findings are structured in the ensuing thesis chapters.  
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SECTION A:   RESEARCH METHODOLOGY 
In this section I provide an overview of the SignSupport prototype design 
requirements to establish motives for the selected research strategies.  In 
developing SignSupport, qualitative and participatory research strategies were 
followed, both of which are discussed in this chapter.  I describe a general 
overview of the research theories pertaining to these strategies and discuss the 
specific methods used and how they were applied to obtain data that would 
influence the development of SignSupport. In evaluating SignSupport, qualitative 
methods were used to assess the acceptability and usability of the intervention and 
participatory action methods were used to influence subsequent prototype 
iterations. Data analysis techniques are discussed followed by an explanation of 
how the validity and reliability of study findings was ensured. This section 
concludes with a description of the ethical considerations that were applied in the 
research.  
 
 4.1.1 Overview of SignSupport development requirements 
SignSupport was conceptualized to transcend the communication barriers that 
exist between pharmacists and Deaf patients during patient counselling. The 
underlying hypothesis was that a collaboratively designed prototype would assist 
Deaf people to better understand their medicine instructions and empower 
pharmacists to communicate medicine–related information effectively to Deaf 
patients. Logically, SignSupport had to be developed in order for the hypothesis to 
be proven. The iterative development of SignSupport necessitated the following 
pre-requisites previously alluded to in chapters one and two: 
1. Multi-disciplinary collaboration to converge different expertise to develop 
SignSupport 
2. Participation from Deaf community and pharmacists to influence design 
features 
3. SASL interpretive services for interactions between the  Deaf community 
and the research team  
 
 
 
 
84 
 
4. An in-depth insight into the experiences of Deaf people with regards to the 
patient counselling process and medicine usage. These insights would 
inform the design of the Deaf-user interface of SignSupport.  
5. Naturalistic behavioural patterns of pharmacists when providing medicine 
instructions. This would lead the design of the pharmacy interface. 
6. Sign-language videos translating medicine instructions from text into 
SASL  
 
Figure 5a  illustrates the overall content requisites needed to build SignSupport. 
These requisites led to the selection of study methods and design strategies.  
Figure 5b, which follows on from Figure 5a, illustrates how the content requisites 
were interconnected to realise SignSupport.  
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In addition to SignSupport requisites, several considerations influenced selection of 
the study methods. These include (i) working within a multi-disciplinary team, (ii) 
conducting research with Deaf people (iii) conducting research with pharmacists 
and (iv) suitability of research paradigms. These considerations are discussed 
below. 
 
 4.1.2 Multi-disciplinary collaboration 
A multi-disciplinary collaboration between various stakeholders was central to 
developing SignSupport. The specific duties and contribution of stakeholders 
comprising the multi-disciplinary team are the following:   
1. Pharmacist: to construct the pharmacy dialogue pattern, to ensure accuracy 
and safety of medicine instructions, to ensure completeness of medicine-
related information, to fulfil pharmacist’s code of practice by respecting 
patient dignity and confidentiality. 
2. Computer programmer: technical expertise to program the application 
onto a mobile phone interface in a manner that was usable and functional. 
3. Industrial designer: to design icons for SignSupport and a system flow in 
a manner that would be cognitively acceptable for the Deaf community. 
4. Deaf community and interpreters: The Deaf community were the drivers 
of the design; they dictated the features of SignSupport to be suitable for 
them. Interpreters bridged the communication gap between the researchers 
and Deaf community at every step of the research. 
 
In addition, senior pharmacy students were employed as research assistants. As part 
of their fourth year curriculum requirement to engage in research, pharmacy 
students are invited to state their preference from one of four disciplines 
(pharmaceutical chemistry, pharmacology, pharmaceutics and pharmacy-practice). 
Students who had opted to undertake pharmacy-practice based research were 
randomly assigned to one of three staff members within the discipline. Three 
student groups (one group per year) consisting of five or six students per group 
were involved in this research for 2012, 2013 and 2015 (Appendix A). 
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In light of the research objectives of this thesis, the study techniques selected had to 
accommodate the participation of multiple members of the multi-disciplinary team, 
the inter-dependence of expertise and the dynamic interplay between team 
members required to develop SignSupport.   The participatory nature of the 
collaboration led to the consideration of Participatory Action Research (PAR) as a 
methodological choice. PAR is explored later in this chapter.  Particular research 
tasks were conducted collaboratively while others were done independently. 
Appendix A provides details of team members and Appendix B provides an outline 
of the scope of work and individual and group responsibilities mutually agreed on 
by all stakeholders in the multi-disciplinary team. 
 
4.1.3 Deaf community research considerations 
The literature review revealed that the preponderance of studies with Deaf 
communities is anecdotal rather than statistical, owing to the nature of the data that 
researchers were aiming to achieve. For SignSupport development we wanted to 
assess experiences, behaviours and attitudes of Deaf people. In order to accomplish 
this, the following was necessary for interactions with the Deaf community: 
1. Availing SASL interpretation services 
2. An understanding of the nuances of Deaf culture 
3. Accommodating Deaf-specific needs ( e.g. limited literacy) 
4. Recognizing and planning for the heterogeneity between participants and 
different Deaf communities  
 
Researchers needed to immerse themselves within the Deaf community to 
establish familiarity with participants and understanding of their cultural value 
system. Only once this was sufficiently achieved did research commence.   
Owing to the strong sense of cultural connectedness within Deaf communities, 
we aimed to recruit SASL interpreters with which the Deaf community already 
had an existing relationship and level of comfort.  This was essential to 
establish a harmonious working relationship to initiate the research inquiry 
process. Other specific cultural considerations included Deaf participants’ 
preference to sign-language, their impartiality to lip-reading and 
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accommodation of their socio-economic circumstances. For example, at the 
first contact session with the Deaf community, their main concern was how 
they would afford the transport cost to research sites.  As a result, all transport 
needs of Deaf participants were pre-arranged and paid for by the researchers. In 
addition, meals were provided during research sessions to negate the 
participants having to prepare or buy meals on research days. With regard to 
Deaf community’s cultural nuances, researchers were cautioned by staff at the 
Deaf community centre not to push participants by insisting that they respond 
to questions. Staff advised us that certain issues were very sensitive and that 
probing excessively on these topics would upset the Deaf community and even 
alienate them which would hinder research activities.  Sensitive topics were not 
pre-known or predictable and researchers had to pre-empt our course of action 
should an issue arise that would cause distress to the Deaf community.  
Foreseeably, Deaf people prefer to communicate in sign-language. In addition 
to sourcing interpretive services, researchers ensured that study materials 
accommodated sign-language translation (not excessively wordy or verbose) 
and allowed responses in sign language (for example participant consent was 
video-recorded as a show of hands). Their limited literacy meant that at no 
point would we require Deaf people to fill out forms, read text or cause them to 
feel that spoken language was imposed on them.  Lastly, it was imperative that 
researchers recognised that what would work with and for one Deaf participant 
may be unacceptable for the next due their heterogeneity in language, literacy 
and culture. This required researchers to be dynamic and pre-empt study 
adaptations during data collection activities to ensure the success of the study.  
 
4.1.4 Research considerations with pharmacists and pharmacy students 
SignSupport development required pharmacists’ input to obtain their user 
requirements and assess their acceptability and usability of the prototype.  In order 
to obtain this requirement, key considerations in working with pharmacists were: 
1. To minimise and be efficient with regards to the time required from them. 
2. To accommodate their peak workload times 
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3. To obtain permission from their managers when research activities occurred 
within working hours. 
 
Senior pharmacy students were used as a sub-sample in the initial study phases to 
represent practicing pharmacists in the required study phases.  The reasons for 
using pharmacy students were: (i) senior pharmacy students would provide a 
freshly trained and updated insight into best-practice behaviours by pharmacists as 
they had been newly groomed at university as opposed to practicing pharmacists 
who may have inherited suboptimal practices, and (ii) due the shortage of 
pharmacists and their immense workloads, access to pharmacists at their workplace 
is limited. Senior pharmacy students were an appropriate and useful sub-sample to 
represent pharmacists.  In the later research phases practicing pharmacists were 
recruited because they had protracted and more intense experiences in patient 
counselling. Cognisance was taken of their peak workload times and research 
activities were not scheduled during these times. The same applied to pharmacy 
students who also have busy academic schedules. With both groups, researchers 
avoided wasting time in dawdling and doing unnecessary tasks or tasks that could 
be done prior to the data collection session.  All research with pharmacists was 
permitted by their manager and the pharmacy director.  
 
 4.1.5 Research methodology considerations 
In the early stages of the research, quantitative methodology was considered as a 
strategy to achieve the aforementioned requisites for SignSupport. Quantitative 
research produces data which is objective, numerical and statistically significant, 
generating procedures which are likely to produce quantified and possibly 
generalizable conclusions (Bell, 1993). Quantitative data measures facts and 
focuses on variables (Neuman, 2003), and can be statistically analysed to test 
hypotheses (Armstrong, Calnan & Grace, 1990). For the purposes of this study, 
quantitative research approaches were rejected for the following reasons: 
1. Quantitative inquiry produces objective data. For programming 
SignSupport, we required (i) in-depth insights into the experiences of Deaf 
people and (ii) natural behavioural patterns of pharmacists during 
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dispensing. Research of experiences and behavioural patterns require 
subjective, rather than objective data. 
2. The literature reviewed on Deaf communities is anecdotal rather than 
statistical. This is attributed to the heterogeneity in culture and social norms 
from one Deaf community to the next. Such heterogeneity implies that it is 
unreasonable to expect generalizable results between different deaf 
communities whose social behaviours are dissimilar and unpredictable. 
Quantitative data is applied when generalizable results are sought. 
3. Instead of generalizability of findings, the researchers aimed for 
transferability of findings to subsequent research phases and in SignSupport 
iterations. Further negating the requirement for quantitative inquiry.  
4. Active participation of the target groups (Deaf community and pharmacists) 
was cornerstone to development of SignSupport. Such participation 
involved intense workshop sessions of small numbers of participants in 
order gauge their attitudes and preferences toward SignSupport. Smaller 
sample numbers and the investigation of attitudes, preferences and 
authentic experiences is difficult to achieve through quantitative inquiry. 
 
The afore-mentioned reasons precluded the application of quantitative strategies in 
the research and led to deliberations on alternative methodological influences 
which are explored below.   
 
4.2 METHODOLOGIAL INFLUENCES 
Dominant influences in selecting appropriate methods for this work emerged from 
the literature review, a newly-acquired familiarity with Deaf culture and the 
exclusion of quantitative methodology as an appropriate research strategy for this 
thesis. On commencing the literature review, I expected to find predominantly 
quantitative studies. Instead, previous work was largely anecdotal with rich 
descriptions and insights into the Deaf world. It was through this process that I 
realized that such insights could not be achieved through quantitative investigation 
and saw the value of qualitative inquiry for the research. This was the first major 
methodological decision which determined the trajectory of the ensuing research 
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progression. Further cementing the decision was my continued interactions with 
Deaf persons. As my understanding of their unique and fascinating cultural 
nuances evolved, it was evident that a one size-fits-all statistical inference based 
approach would not do justice to the overarching goal of crafting a solution for 
their communication difficulties at the pharmacy.   
 
Crafting the afore-mentioned solution required collaborative action to bring to 
fruition a tangible prototype that could potentially achieve the research goal. The 
process of innovation and design depended not only on the collaboration of the 
professionals involved but substantially on the input and contribution of the Deaf 
community themselves. This reality lent itself to the second major methodological 
decision:  the employment of a Participatory Action Research (PAR) approach. In 
PAR, data collection, action and reflection are aimed at reducing health inequities 
and improving health outcomes through the involvement of people who, through 
the research process take actions to improve their own health (Baum et al., 2006). 
Both qualitative doctrine and the notion of PAR resonated with the intent of this 
work and are presented below as research theory, research features and 
rationalization for the relevant methodological choice. This is illustrated in Figure 
6: 
 
Figure 6:  Methodological influences for SignSupport research and 
development 
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4.2.1 Qualitative research theory 
There is broad consensus among experts that research is typified by three 
major taxonomies: Positivism, Interpretivism and Critical Theory (Merriam, 2009). 
Qualitative methodologies are grounded in the philosophy of interpretivism which 
is typical of social science research.  Interpretive ontology and epistemology adopts 
the notion of multiple realities owing to the subjective nature of knowledge 
(Creswell, 2013).  Merriam (2009) describes this notion in the following quotation:  
“There is not a single observable reality…rather multiple realities, or 
interpretations of a single event. Researchers do not find knowledge. They 
construct it (Merriam, 2009, p. 9).” 
 
Hence, interpretivism is also known as constructivism, (Mouton, 2001), and differs 
to positivism which assumes that reality is steady and is best observed through an 
objective understanding.  
 
4.2.1.1 Features of qualitative research 
The scope of qualitative research is broad and expansive. Straus and Corbin (1990) 
provide an inclusive definition of qualitative research as ‘any kind of research 
which produces findings that is not arrived at by means of statistical procedures.’ 
Merriam (2009) provides a different, narrower perspective: “qualitative 
researchers are interested in…how people make sense of their world and the 
experiences they have in the world.” (Merriam, 2009, p. 13) 
 
Qualitative research seeks to find and express the subjective understandings of 
participants about the study subject and how they experience it. It provides detailed 
descriptions of occurrences and the functions of collecting, analysing and 
interpreting data is done by observing what people do and say (Neuman, 2000). 
“Qualitative data is asserted, it can provide rich insight into human behaviour.” 
(Guba & Lincoln, 1994, p. 106), Merriam (2009) describes four major 
characteristics of qualitative research as: 
1. Process-, understanding- and meaning-directed research  
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2. The researcher is the prime instrument of data collection and analysis 
3. The  research process is emergent 
4. The outcome is richly descriptive 
 
The researcher aims to understand the experience from the participants’ point of 
view by gaining an insider’s perspective. Pauly (1991) describes qualitative 
research as a five-step procedure: defining a topic; constructing the research 
question; collecting evidence; interpreting the evidence and expressing the 
researcher’s story. Direct observation, recorded speech or behaviour, video or 
audio tapes and interviews are qualitative research procedures. Data emerging from 
a qualitative inquiry include full field notes, interview and focus group transcripts, 
the researcher’s jotted records, field journals and video recordings. (Pope et al., 
2000).  In this regard, qualitative research seemed to be an appropriate study option 
to meet SignSupport development requisites alluded to in Figure 5a.  
 
4.2.1.2 Rationalization for qualitative research inquiry 
Lessons emerging from the literature review and subsequent process of research 
question elucidation have lent itself to the qualitative, interpretivist characteristics 
of human inquiry described by Merriam (2009) in the following ways: 
• The research sought to explore (i) experiences of the Deaf community with 
pharmacists during the patient counselling process and (ii) their typical use 
of medicines, thus drawing on the participants’ perspective to understand 
these occurrences. 
• Similarly, the research identified as an outcome a pattern of typical 
medicine dispensing dialogues extracted from the normal dispensing 
behaviour of pharmacists. Once again, there is a dependence on the 
participants’ perspective to understand the subject. This research activity 
was also emergent in that the dialogue was central to subsequent research 
activities. 
• Data appeared in the form of transcripts, video recordings, field notes and 
interview notes.  The researcher was thus involved in “constructing 
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meanings” to the participants’ experiences in the form of words (Creswell, 
2007, p. 38). The researcher is therefore the primary instrument of data 
collection and analysis. 
 
4.2.2 Theory of Participatory Action Research  
One of the many approaches in collaborative research investigations is 
participatory action research (PAR). It is a progressive research process which is 
gaining popularity in a wide variety of healthcare settings and has been shown to 
be ideally suited in innovation aimed at improving healthcare and developing new 
professional skills and roles.  PAR is apportioned to the broader genus of action 
research modalities (Reason & Bradbury, 2008). Action research seeks to pursue 
action outcomes and research outcomes simultaneously and has components which 
resemble both field inquiry and change interventions. It differs from most research 
approaches which conventionally focus on “acquiring knowledge” (Reason, 2006; 
Waterman et al., 2007).  In addition it is unlike quantitative deductive research or 
qualitative interpretive techniques in that it is underpinned by a “moral dimension,” 
focusing on societal improvement through “engaging people in dealing with issues 
in their lives” (Greenwood & Levin, 1999; Reason, 2006). Meyer (2001: 173) 
describes this notion in the following quote: “Essentially action research is 
concerned with generating knowledge about a social system, while, at the same 
time, attempting to change it”. Most action researchers hold the view that their 
primary goal is the service to their participants (Dick, 2009). 
 
No single established definition exists for PAR, instead many research experts 
agree on a number of common features: (i) participation, (ii) a cyclic process (iii) 
the emergent nature of the engagement and (iv) reflection (Reason & Bradbury, 
2008).  Other researchers have contested this standpoint, instead favouring the term 
“collaborative action research‟ (Kemmis & McTaggart, 2003). Hughes, (2008) 
describes PAR as including three elements:  “systematic inquiry, a professional 
practice intervention and participation in decision making by key stakeholder” 
(Hughes, 2008: 385).  He represents these elements as an interconnected web of 
overlapping features: 
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Figure 7: Hughes’s concept of Participatory Action Research  
 
 
 
 
 
 
 
 
 
For this research I have adopted Hughes’s concept of PAR for research endeavours  
With the Deaf community and pharmacists. Hughes’s model encompasses all the 
essential features required for the inquiry process  to achieve the envisioned 
prototype.  
4.2.2.1 Features of Participatory Action Research 
Aforementioned features of PAR include: (i) participation, (ii) a cyclic process (iii) 
the emergent nature of the engagement and (iv) reflection (Reason and Bradbury, 
2008).   Below I discuss each feature in relation to this study. 
Participation is central to a PAR approach. Fals-Borda and Rahman’s (1991) work 
(cited in De Koning & Martin, 1996) emphasized the rights of people to contribute 
to decisions which affect them and is underpinned by liberation theology and the 
neo-Marxist approach to community development (De Koning & Martin, 1996).  
Some researchers connect such contribution by the people with 
democratic/egalitarian values. Interestingly, South Africa’s disability movement 
adopts a slogan which aptly represents such democracy-inclined community 
participation:  
Participatory 
Action Research 
Research 
Action Participation 
Action research Participative research 
Participative action 
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“Nothing about us, Without us.” 
In PAR, participation can occur in all or certain stages of the research process 
spanning from the stages of exploring the research emphasis to utilising the study 
results. Varying degrees of participation have been endorsed by some researchers 
who hold a pragmatic view that participation should be included in the most 
relevant research areas, not necessarily in all stages (Reason, 2006; Laws et al. 
2003). Others are of the view that participation by researchers and participants 
must be evident across all stages of proper PAR. 
A high level of participation was needed throughout this study. At each stage, from 
conceptualization to implementation, the input of Deaf persons, pharmacists and 
research partners was crucial. The very idea for SignSupport was sketched out by 
the Deaf community, whilst all pharmaceutical elements were contributed through 
research with pharmacists. Subsequent to initial conceptualization and development 
of version 1 of SignSupport (incorporating the pharmacists’ contributions), the 
prototype was evaluated by both Deaf participants and pharmacists. Their feedback 
was incorporated into the first iteration, resulting in SignSupport version 2. The 
process was repeated, again with both participant groups to inform the second 
iteration: SignSupport version 3. 
The cyclical process is another characteristic typical of PAR. The cyclical process 
can be explained as cycles of research activities which converge to form a 
continuum of cycles of reflection. Overlapping of circles occur when findings from 
the reflections of one research cycle are incorporated into the subsequent cycle. 
Each cycle may comprise interventions or changes in understanding or behaviours 
(Waterman et al, 2007). The idea of a cyclical process resonated with the iterative 
design cycles of SignSupport. Data emerging from initial research cycles was 
incorporated into SignSupport as a component or design feature. The completed 
prototype was then evaluated by participants in the second iterative cycle, and 
adjusted according to their feedback, which in turn shaped the second iterative 
cycle.  
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Reason (2006) describes the third characteristic of PAR: the emergent process of 
engagement. It begins with situational knowledge and develops with the process of 
inquiry:  
“Good PAR emerges over time in an evolutionary and developmental 
process, as individuals learn skills of inquiry, as communities of inquiry 
develop, as understanding of the issues deepens and as practice grows and 
shifts change over time.”     -Reason, 2006- 
Reason’s stance illustrates emergence which refers to possible modifications in 
research questions, approaches and the purpose of research due to the generation of 
knowledge during the inquiry.  This feature of PAR was particularly appropriate in 
a context where the researchers did not know much about medicine instruction in 
the Deaf community, owing to a scarcity of published literature. In addition, the 
researchers had limited experience with the nuances of conducting research with 
the Deaf community.    
Reflection is a cornerstone feature of action research and was central to the 
research-related and SignSupport design-related study objectives. The value of 
reflection has been noted in assisting professionals in complex health systems 
where there is a need to solve multifaceted problems. The literature on reflection is 
immense; the concept has been dissected by many scholars. Overall, it is 
considered as a process of learning from experience; that which is learnt is then 
used to develop practices (Loughran, 1996, Leitch & Day, 2000). In the literature, 
reflection is predominantly associated with the cognitive processes involved in 
conceiving and solving a problem.  Loughran (1996), defines reflection as ‘the 
deliberate and purposeful act of thinking which centres on ways of responding to 
problem situations.’ In the context of this study, the complex problem situation is 
the communication barriers between pharmacists and Deaf patients. It is complex 
in the sense that neither has the skills or ability to communicate with the other and 
the well-being of the Deaf patient is dependent on how the pharmacist engages 
meaningfully with the patient. The cognitive processes involved in arriving at a 
practical solution comprised the collaborative creative efforts of the primary 
researchers and participants, each contributing to the design aspects and 
SignSupport refinement in each successive iteration.  
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4.2.2.2 Rationalization for participatory action research 
The characteristics of PAR have been explored in detail earlier in this chapter. 
Within the discussion of each characteristic, I provided a description of how that 
specific characteristic was applied in the study.  This is summarised below: 
• The development of the pharmacy version of SignSupport depended hugely 
on the specific naturalistic behaviours of both Deaf persons and 
pharmacists. These behaviours were noted and contributed by the 
participants themselves. Participation was key; without it this research 
would be a futile exercise.  
• Action was evident in each stage of the research: action to solve the 
problem motivated the creation of SignSupport, and each step in the 
fabrication of SignSupport was accomplished with the researchers and 
participants.  
• Actions were reflected upon; these reflections formed the data sets which 
was, in turn, the launching pad for subsequent modifications and iterations.  
• The research and SignSupport design processes were cyclic rather than 
linear. Research activities were often repeated with the intent of learning 
from one cycle lessons to apply in the next cycle.  
• The emergent process of engagement was necessary in  a context where not 
much was known by the researchers about the specifics of medicine 
instruction in the  Deaf community  or how to conduct research with Deaf 
people 
The choices of research paradigm (interpretivism) and methodology (qualitative 
research and PAR) formed the foundation of the study and paved the way for 
selection of specific methods and techniques which comprise the research 
framework.   
 
4.3 RESEARCH FRAMEWORK 
The research framework illustrates how the dominant research influences were 
applied in the study. In Figure 8, a pyramid representing the framework illustrates 
how the interpretivist approach shapes the foundation for this research, which in 
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•Reflexivity 
•Thematic analysis  
Data  
analyisis 
•Video observations 
•Field Observations 
•Interviews 
•Surveys 
Data collection 
methods 
•Qualitative research 
•Participatory Action 
Research 
Methodology 
•Interpretivism Paradigm 
turn determined research approaches and the chosen methods of data collection and 
analysis. Methods based on interpretivist methodology included video recording of 
role-plays and user tests to construct elements of SignSupport and usability ideas 
and recommendations thereof. To ensure sound validity, a reflexive framework 
(Srivastava & Hopwood, 2009) for interpretation was combined with thematic 
analysis of data in the form of transcribed verbatim. Specific data collection 
methods and data analysis techniques are explored later in this chapter.  
Figure 8:  Research framework 
 
 
 
 
 
 
 
 
 
4.4 DESCRIPTION OF THE TARGET POPULI  
 
SignSupport is intended for 2 user groups: Deaf persons and pharmacists. More 
specifically, target groups for this study were Deaf people and pharmacists from 
the Western Cape Province who were acquainted with the medicine dispensing 
process at a public hospital pharmacy. Study samples were not chosen to be 
representative of the larger samples for either target group (600000 -1.5 million 
Deaf persons and 11000 pharmacists) and findings are not intended to be 
generalizable. Instead, findings were intended to be transferable, i.e. to feed into 
the successive design cycles of SignSupport with a view to realize it as a mobile 
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phone application that can bridge the communication gap between the 2 target 
groups.  
The Deaf sample numbers differed throughout the various phases of the research 
and the total samples for each phase is described in detail in the forthcoming 
chapters (five, six and seven)  which present the empirical activities of this thesis.  
The Deaf samples were small due to a number of reasons: 
• Deaf sample size was influenced by the literature review which revealed 
that the preponderance of Deaf study findings are anecdotal in nature and 
have a qualitative underpinning. Qualitative studies seek a rich 
understanding of the subject being studied, rather than results representative 
of large numbers.  
• Secondly, each Deaf community is unique and complex; tenets within one 
Deaf community may differ from the next, which in turn may produce 
different study results, making it unreasonable to expect results that are 
generalizable.  
• The nature of the data we were hoping to extract necessitated in-depth, 
intense examination of the thoughts, impressions and attitudes of 
participants, further cementing the requisite for qualitative inquiry.  
• The complexity of ensuing research undertakings via a sign language 
interpreter limited research time and as a result, sample size.  
• Participants numbers were determined by the number of Deaf people who 
were affiliated with the communities which we were studying: DCCT and 
DeafSA PAARL.   
• Lastly a significant component of this work is design-oriented (designing 
features of SignSupport). This was done in line with the tenets of PAR and 
community-based co-design, both of which closely mimic the qualitative 
paradigm in that they produce results that reflect an understanding of 
peoples’ needs, how they interact and what they perceive and experience.   
Albeit small, the Deaf participant sample size is not viewed as a limitation but is 
instead seen as an opportunity to gain an in-depth insight required in qualitative 
investigation.  
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The sample size of the pharmacist participants (also detailed in the forthcoming 
thesis chapters five, six and seven) mirrored that of the Deaf sample. Once, more 
this was in part due to the qualitative and PAR study orientation. While the reasons 
of cultural uniqueness and interpreter-assisted communication do not apply to the 
pharmacist group, the sample size was dictated by the Deaf participant sample size. 
This is because majority of the research activities involve an interaction between a 
Deaf person and a pharmacist to assess the communication between them assisted 
by SignSupport. In essence, if we were studying 5 Deaf persons, we needed 5 
pharmacists.  More pharmacists would be of no use unless we also had the Deaf 
numbers to match them. Furthermore, pharmacists in South Africa are scarce-skill 
professionals and public healthcare facilities are fraught with human-resource 
constraints. In light of staff shortages, pharmacists and their managers are reluctant 
to make the time for research-based activities. The study was designed with the 
intent of placing minimum demands on the time required from pharmacists.  
Senior (final year) pharmacy students from the UWC School of Pharmacy were 
used as a sub-sample in the initial study phases to represent practicing pharmacists. 
As a pre-requisite, that had to have experience in dispensing at a public hospital 
pharmacy. The reason for using pharmacy students is bi-fold: (i) senior pharmacy 
students would serve as exemplars for dispensing practice needed in Phase 1 of the 
study to construct dispensing dialogues because they have been freshly groomed at 
university as opposed to practicing pharmacists who may have inherited 
suboptimal practices over time and (ii) due the shortage of pharmacists and their 
immense workloads, access to pharmacists at their workplace is limited. 
 
4.4.1 Sampling and Recruitment strategies 
Non-random sampling methods are applied in this qualitative, iterative study which 
sought data that is transferrable as opposed to data that is generalizable. Three non-
random methods were used: (i) Purposive sampling for Deaf community, Purposive 
Expert sampling for key informants and (ii) Convenience sampling for pharmacy 
students and pharmacists. 
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4.4.1.1 Purposive sampling for Deaf participants 
Purposive sampling (alternatively called selective or subjective sampling) draws on 
the judgement of the investigator to select study participants. The sample being 
investigated is typically small and the aim is not to randomly choose participants 
from a population to create a sample with the intent of making statistical 
conclusions from that sample to the larger population (Purposive sampling, Laerd 
Disseration, n.d.). The goal is instead to focus on particular characteristics of a 
target group which will best enable one to answer research questions (Merriam, 
2009). For researchers pursuing qualitative research inquiry this is not considered 
to be a weakness. Literature reveals up to fourteen different purposive sampling 
strategies, each differing with the nature of the researcher’s intent. I applied 
different types of purposive sampling techniques to the successive study phases. 
These are outlined below. For some study groups I found that 2 different strategies 
were applicable.  
In Homogeneous sampling, participants are selected on the pre-requisite that they 
have similar characteristics which are of certain interest to the researcher. A 
homogeneous sample is often chosen when the research question that is being 
addressed is specific to the characteristics of a particular sample. The homogenous 
characteristics in our Deaf sample are the following: 
(i) All participants are Deaf and  
(ii) All participants became Deaf pre-lingually and  
(iii) They were affiliated to DCCT (Cape Town) and DeafSA (Paarl)  
where research activities took place 
In phase 1, a study objective was to evaluate the experiences and challenges of the 
Deaf community regarding the medicine dispensing process and using medicines. 
In this regard, their characteristic of probable impaired literacy due to pre-lingual 
Deafness onset was of interest since it would affect the level of comprehension 
during the medicine dispensing process.   Affiliation with DeafSA in Cape Town 
was of interest because later in the study, I aimed  to compare an urban-based 
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group with a rural-based group on the basis of their comfort with the mobile phone 
technology.  
In Typical case sampling, the researcher is interested in the typicality of 
participants (i.e. their normal behaviour). The interest in typicality is not to infer 
generalization but rather investigate such typicality in terms of its comparison with 
other similar samples (Purposive sampling/Leard Dissertation, 2012). In this study 
I tested SignSupport with one group of urban-based participants and tested it a 
second-time with a rural-based group. Typical case sampling can be used 
exclusively, or as I have done, used with another type of purposive sampling 
technique which can help in exploratory inquiry. 
Maximum variation sampling is a sampling practice used to enable an 
investigation of a wide range of viewpoints relating to the study subject. 
Participants may exhibit a wide range of characteristics, behaviours, experiences 
etc. The idea of maximum variation sampling is to gain deeper comprehension of 
an occurrence by observing at it from different angles. This can help in the 
thematic identification of findings which are evident across samples (Purposive 
sampling/Leard Dissertation, 2012).  In the final segment of the research, I digress 
from the Deaf community with whom I conducted the initial research phases, to a 
community in a rural town with a different mother-tongue and schooling system, 
with a view to investigating whether they would experience and use SignSupport 
differently to those in an urban-based area that is predominantly English speaking. 
Purposive sampling strategies are useful in instances where qualitative study 
comprises multiple phases as it allows for a wide range of non-probability 
sampling techniques to be used in successive phases.  Such sampling techniques 
that draw on researcher judgment and subjectivity can be prone to researcher bias.  
(Purposive sampling/Leard Dissertation, 2012). This bias is however only a 
significant drawback where judgements have not been based on well-defined 
criteria. Such criteria may appear as a theoretical framework, expert elicitation, or 
some other accepted criteria. It can be difficult to defend the representativeness of a 
sample based on purposive methods, but that is not of major concern in this study 
as I am not aiming for generalization of findings.  
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Participants were recruited based on their affiliation with DCCT and DeafSA, and 
were accessed via telephone calls to their community representatives, who assisted 
in selecting samples based on the afore-mentioned criteria. Community 
representatives also introduced us to sign-language interpreters who were 
appropriate for the purposes of the study. Most study activities occurred within the 
Deaf community centres on days that were convenient for the Deaf community, for 
example if they were present at the centre for some other reason such as a class. 
Deaf participants were only studied outside of their community centres on the trial 
experiment and hospital experiment days. On these days, researchers fetched and 
escorted participants to study sites. All data collection was via a DeafSA-affiliated 
and certified interpreter.  
 
4.4.1.2 Sampling strategies for pharmacy students and pharmacists 
Expert sampling is a purposive technique used to glean understanding from 
persons that have particular expertise, the ‘expertise’ in this case being (i) deafness 
or Deafness, (ii) familiarity with dispensing services to the Deaf community. 
Expert sampling was used in the initial phase of this study when I sourced key 
informants who were able to give insight on both being Deaf and being a 
pharmacist (ideally, somebody who had both characteristics). DeafSA staff 
members who provide healthcare services to Deaf people or accompany them to 
health facilities were also considered in key informant selection.  
As is the case in this study, such expertise may be required during the exploratory 
phase of qualitative research; the particular expertise being explored may shape the 
foundations of the study or influence the study design. Expert sampling is 
particularly useful where there is a lack of empirical evidence and high levels of 
uncertainty in a research area.  
Convenience sampling is another non-probability sampling method that draws on 
the judgement of the researcher to select study participants.  As the name implies, a 
convenience sample is one where the participants who are chosen for inclusion in 
the sample are convenient and simple to access. Logically, findings do not imply 
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generalization. Convenience sampling is however a suitable method to use when a 
researcher encounters obstacles in accessing participants and requires easier access 
to qualitative data. Convenience sampling was applied to this study with 
pharmacists, who were difficult to access due to their work commitments and time 
limitations, and pharmacy students for similar reasons. Advantages of convenience 
sampling methods are the ease of sample collection and the possibility of extracting 
useful findings that may not have been possible using probability methods which 
require more strict access to populations. The disadvantage of these techniques is 
the possibility of bias and the risk of under-representation or over-representation of 
specific groups within the sample. The sample is also unlikely to be representative 
of the larger population being studied.  
Key informants were accessed through telephonic appointments and met at their 
places of employment for research activities. Pharmacy students were accessed at 
UWC School of Pharmacy and research activities took place during their recess 
period over lunch hour.  Access to pharmacists at a public hospital pharmacy was 
granted via their director and deputy director. Research activities took place at in 
the pharmacy boardroom and dispensary at their place of employment.  
 
 
4.5 DATA COLLECTION METHODS 
 
This section delivers the theoretical underpinnings of the specific data collection 
techniques employed in this study to obtain the data sets required for SignSupport 
development. Only the theoretical aspects are described, while a detailed 
application thereof in the empirical processes of this study is delivered in the 
ensuing thesis chapters (five, six and seven).  
 
4.5.1 Theory of data collection 
The process of data collection is undertaken to secure sound, reliable information 
that will assist in answering research questions and achieving research objectives. 
Creswell (2007) distinguishes the functions of data collection as site identification, 
securing site access and establishing relationships, recruiting a sample, recording 
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information, collating and storing data and overcoming field issues.  Data is the 
chief outcome of data collection activities, and is described by Merriam (2009): 
“Data is nothing more than ordinary bits of information found in the environment. 
They can be concrete and measurable, as in class attendance, or invisible and 
difficult to measure, as in feelings.”  
There are several methods of data collection. Creswell (2007) classifies these 
methods into 4 groups: (i) observations, (ii) interviews, (iii) audio-visual materials 
and (iv) documents.  All four categories were used in this study in the following 
order ranking highest use to lowest use: 
• Observations and audio-visual materials 
• Interviews 
• Documents 
Deaf people rely largely on gestures, inflections and the presence of a sign-
language interpreter to communicate; as such written or spoken data sets are not 
realistic outcomes in conducting research with Deaf people.  This being the case, 
one would expect mostly audio–visuals material as data sets. In the list above, 
observations and audio-visual materials are ranked together at the highest position 
of use because they were the most frequently obtained forms of data and because 
all observations were video-recorded. Interviews were used to a lesser extent, and 
applied to key-informants and focus-group attempts with the Deaf participants via a 
sign-language interpreter.   
The focus group method was later abandoned due to non-feasibility; the sign-
language interpreter was unable to manage multiple responses and questions 
simultaneously. 
Lastly we used simply structured surveys (documents) with both participant groups 
(Deaf participants and pharmacists). This was not done to achieve generalizability; 
the sample groups remained small and generalizability was not a study objective. 
Instead, surveys were used as a means to allow participants to highlight issues or 
problems they had with SignSupport that they were not easily able to articulate 
(especially the Deaf participants). With Deaf participants, a SASL interpreter 
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signed the questions; they marked their responses as crosses or ticks with the SASL 
interpreter’s assistance.  
 
4.5.2 Observations and audio-visual materials 
Observation is an orderly way of viewing and listening to people’s actions and 
interactions, and the recording, analysing, and interpreting of their behaviours 
(Gray, 2004). Types of observation include participant observation and non-
participant observation. In participant observation the researcher becomes part of 
group being studied, participating in the same activities as the members of the 
culture under study in an attempt to experience the view and perspective of a 
participant rather than an outsider. This produces narrative accounts as data 
(Mertler, 2005). In non-participant observation the researcher assumes a non-
active, on-looker type role and does not get involved in the activities of the group. 
(Patton, 2002). 
 
Observation is either overt or covert. In overt observation, participants are 
cognisant of the reality that they are being observed (Gray, 2004). A shortcoming 
of this method, known as the Hawthorne effect, is the possibility of a change in the 
behaviour of participants owing to awareness that they are being observed (Kumar, 
2005). This may result in inaccurate data; what is observed may not mimic typical 
behaviour. On the contrary, in covert observation participants are not aware that 
they are being observed. The data produced should provide a naturalistic, real 
reflection of the phenomenon under study. (Gray, 2004). Covert observation may 
be a useful technique to assess the receptivity of an intervention. 
 
Observations were used to extract the pharmacy dialogue patterns in a role-play 
enactment of a pharmacy student acting as if they were dispensing medicines to a 
(simulated) client in a ‘role-play room’ which imitates a public hospital pharmacy 
setting. The interactions and dialogues were observed via live video in another 
room which had a screen connecting to a camera in the role-play room by research 
team members. The reason for this was that we wanted to construct a pattern of 
typical, naturalistic dialogues that a pharmacist would have with a patient. We did 
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not feel confident that we would get this natural communication by observing as a 
third party in the same vicinity where the role-play was taking place. Instead we 
wanted to observe covertly, hence the use of video cameras.  
The simulated client approach is an internationally accepted tool for gauging 
outcomes in pharmacy practice research (Watson et al., 2006). This approach was 
used to simulate clients that hand prescriptions to pharmacists at public sector 
pharmacies. In the role-play, prescriptions were given to final year pharmacy 
students (representing pharmacists) in the role-play room. Pharmacy students 
dispensed medication from a prescription to a simulated client. Their dispensing 
dialogue and communication flow was observed and structured as dispensing 
dialogue patterns.  
 
All data banks with the Deaf community comprise video recordings which yielded 
the outcome of video observation notes made with the assistance of a SASL 
interpreter who translated all interactions during research sessions. In addition, 
comprehensive field notes were taken regularly. This allowed the researchers to 
observe body language, gestures and other non-verbal cues.  Field notes are the 
‘backbone of collecting and analyzing field data’ (Bailey, 1996, p.80). Gray (2004) 
recommends that field notes be written up instantaneously after the observation. 
Field notes are the fundamental data from which the analysis will surface and 
comprises everything the fieldworker believes to be important (Lofland, & 
Lofland, 1984). 
 
4.5.3 Interviews 
Two types of interviews were employed in the research: key informant interviews 
and focus group interviews. Key-informant interviews were conducted as per 
structured interview guideline. They comprised face-to-face interactions with 
participants who were able to share specialized insight on medicine use by Deaf 
persons, and were audio-recorded. The guideline was adapted as required during 
the interview session.  
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A focus group is an exploratory approach in which an assembly of participants is 
selected to discuss a subject being researched (Miller & Brewer, 2003). A typical 
feature of focus groups is the interaction between research participants. In this 
interaction, the sharing of views, stories and experiences between the respondents 
is what produces the ‘rich, insightful data’ (Miller & Brewer, 2003). 
 
4.5.4 Questionnaires 
Questionnaires are among the most prevalent methods for data collection in 
research. Questionnaires may be filled out either with or without supervision by the 
researcher (Bourque & Fielder, 2002). Supervised administration involves face-to-
face interviews where the participant is in a one-to-one position with the surveyor. 
The surveyor is able to answer any questions that the participant may need to ask. 
In unsupervised administration the researcher is not with the participant whilst 
he/she completes the questionnaire (Bourque & Fielder, 2002), which may be 
directed via traditional mail, e-mail, the internet (online) or by the drop-and-collect 
system. Wording and structure are important elements of a questionnaire as they 
affect the data obtained.  
 
The questions which make up a questionnaire may be asked as either open-ended  
(a possible response is not provided, participants write an answer in their own 
words) or closed-ended (possible answers are provided in the questionnaire 
(Kumar, 2005). The respondent selects one answer from a set of given answers, for 
example Yes-No or True-False type answers (Gray, 2004). An attitudinal scale is 
another manner of posing questions, it useful for the researcher who wants to gauge 
the participant’s attitude about a topic (Kumar, 2005). A Likert scale is a type of 
attitudinal scale which allows the participant to select a category which best 
describes their attitude toward a statement (Kumar, 2005). For example, 
participants may be required to select one of the following responses: agree, neutral 
or disagree, to express their attitude toward a particular statement (Miller & 
Brewer, 2003). Likert scales show the strength of one respondent’s attitude in 
relation to another (Kumar, 2005). All survey instruments used in this study 
included Likert scales. This was done for ease of selecting a response to a question 
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which was posed in SASL and to avoid requiring the Deaf participants to write 
wordy responses.  
4.6 DATA ANALYSIS  
Data extraction from research in which the data was largely in sign-language and 
appeared as gestures, body language and other non-verbal cues was challenging. 
The researchers initially intended to transfer all data into transcripts for analysis, 
but found that direct transcripts of what was signed in SASL excluded crucial non-
verbally communicated data. Instead, we depended on raw data (videos) and video 
observation notes detailing the videos for analysis. Where applicable in data 
collection with pharmacists, direct transcription yielded data sets. The two main 
methods of data analysis were (i) Thematic analysis and (ii) Reflexive analysis.  
 
4.6.1 Thematic analysis 
Thematic analysis is a suitable method for exploratory research that produces 
copious amounts of data where rigorous, methodical analysis is required. Plentiful 
data requires thoughtful reduction to extract "big ideas" from the data (Ayres, 
2008). Thematic analysis has been defined  as "a systematic approach to the 
analysis of qualitative data that involves identifying themes or patterns of cultural 
meaning, coding and classifying data (usually textual) according to themes and 
interpreting the resulting thematic structures by seeking commonalities, 
relationships, overarching patterns, theoretical constructs or explanatory 
principals.” (Lapadat, 2010, p. 926). Essentially, it is the extraction of common 
themes emerging from data sets. 
Thematic analysis includes analysis of both discernible, apparent data and 
underlying obscured data and allows for condensation of qualitative data though 
separation, classification, summation and subsequent restructuring to represent the 
most important concepts embedded in the data. Thematic analysis is beneficial in 
sketching a narrative of the data and finding patterns whilst maintaining contextual 
perspectives. (Ayres, 2008). Boyatzis (1998) states five purposes for using thematic 
analysis: it allows one to see data patterns; uncover relationships; analyse data; 
systematically observe a situation and measure qualitative findings. Additional 
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advantages of thematic analysis is that it serves as a means to focus data 
interpretation,  reduce large volumes of data without losing the context and it 
allows the researcher to immerse oneself in the data. (Lapadat, 2010, p. 926).  
The pattern-finding feature of thematic analysis was used in the objective of a 
constructing a dialogue pattern of typical pharmacist-patient counselling 
interactions in the role-play scenarios. It also was useful in analysing data on 
experiences of the Deaf community with medicine use.  Thematic analyses were 
later applied in usability tests for the emerging versions of SignSupport. Responses 
from focus groups, observation of pharmacists and Deaf participants and survey 
responses were classified as being positive, negative or neutral responses. This 
helped to identify significant themes and patterns that emerged from the analysed 
data. 
 
4.6.2 Reflexive analysis 
Reflexive analysis is an outcome of reflexivity-orientated methodology. In 
qualitative inquiry, it is not possible to remain independent of the subject matter; 
the researcher’s presence inevitably has some effect on the study subjects and 
subsequent data. Reflexive research methodology emphasizes the researcher’s 
involvement as a major operative factor. In reflexivity, the researcher’s awareness 
of the effect of his/her presence on the progression and products of the research 
resonates with Steedman’s (1991) view that ‘knowledge cannot be separated from 
the knower.’ A clearly articulated research design is crucial to establish balance 
and the researcher’s awareness that while the he/she may be closely involved in 
subject matter and co-constructing meaning, he/she must remain conscientious and 
uphold a level of professional detachment (Johnson and Duberley, 2000). 
Furthermore, the researcher must be clear about his/her perspective and 
epistemological and ontological views in to order to attain truly reflexive research.  
Srivasta’s  (Srivasta & Hopwood, 2009) framework for reflexive analysis 
comprises three questions to ask in the data analysis process: 
1. What is the data telling me? 
2. What is it that I want to know? 
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3. What is the relationship between what the data is telling and what 
we want to know? 
Srivatsa’s reflexive analysis framework (Srivasta & Hopwood, 2009) was applied 
throughout the research process which required a high level of subjective 
interpretation. Reflexive questions were applied in data collection activities and 
were used to shape the final discussion and develop study recommendations.  
 
4.7 VALIDITY AND RELIABILITY 
 Literature puts forward several different terms for research validity including 
credibility, authenticity, trustworthiness and quality (Herr & Anderson, 2005,  
Marti and Villasante, 2009). Reasons for introducing different terms are owing to 
the dissimilar nature of research paradigms. Qualitative research is aimed at 
acquiring an understanding; hence what makes it “valid” will differ from that of 
quantitative study (Nieuwenhuis, 2010).  As such, positivists generally prefer the 
notion of validity, while “trustworthiness” is adopted by naturalistic researchers. 
Both terms have been contested in action research as they do not take into account 
participation and action. Since this study is influenced by qualitative and PAR 
methodologies, and generalizability or statistical significance of findings is not a 
research aim, I have chosen to discard the term “validity” and instead use the term 
“quality”, favoured by a number of experts (Reason et al., 2001, 2006 and Marti 
and Villasante, 2009). Reliability refers to the consistency of data obtained if the 
same study were repeated under very similar conditions (Neuman, 2003). Several 
researchers have recommended criteria for ensuring quality in research. I have 
selected a targeted set of criteria which applies to this study.   
 
4.7.1 Criteria applied to ensure quality 
Several criteria were applied to enhance quality in the research. These include 
perspective, doing-what-is-right, repetition, member checks, triangulation, 
redundancy, critical reflexivity and transferability.  
 
Perspective is a criterion I developed to help me ensure that I kept my personal 
opinion and stance separate from that of the participants, with the intention of 
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accurately and truthfully depicting their feelings, opinions experiences and points 
of view. Throughout the research, I was cognisant of keeping my perspective 
separate from their perspective.  This was grounded in the interpretivist view of 
multiple realities: “there is not a single observable reality. Rather multiple 
realities, or interpretations, of a single event.” Researchers do not find knowledge, 
they construct it.” The purpose of applying “perspective” as a research criterion 
was to ensure that I consistently represented the participants’ view instead of my 
own. This was achieved through direct transcription of data and using raw data in 
the form of video recordings to extract themes and draw conclusions.  
 
The second criterion applied by the researchers was a composite of Herr and 
Anderson’s (2005) “democratic” validity and Reason’s (2006) criteria of 
“democracy and participation” and “pursuing worthwhile purposes.” For this study, 
we adopted these criteria as “doing what is right.” This meant many different 
things: it meant social responsiveness; it meant confining our design outcomes to 
what was needed and requested by the Deaf community and pharmacists and it 
meant basing our work on best practices and human rights recommendations of 
policy frameworks and good practice advices. It also meant insisting on a high 
level of collaborative participation to ensure entrenchment of participant 
contribution in all study endeavours, producing work that is applicable to and for 
the context in which we were working, and not in any manner inconveniencing 
participants or breaching confidentiality. This criterion was applied through always 
achieving consent and input from participants, being transparent in all research 
undertakings, caring for participants’ needs during research activities (meals, 
intervals, transport etc.) and establishing and maintaining a relationship with 
participants through feedback on findings and regular contact.  
 
Repetition and Member checks: Repetition was applied by repeating research 
activities to gauge whether outcomes were similar when studies were duplicated, 
and also through posing the same questions in different data collection activities 
(e.g. focus groups and questionnaires). Findings were always directed back to 
participants and co-researchers so that they could verify it. Feedback was easy to 
achieve since most activities were conducted in a work-shop style, negating the 
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need for participants to write or e-mail back verification and member-check 
responses.  
 
Triangulation of methods means to employ different methods for the same aim 
with a view to achieving a comprehensive understanding the research topic 
(Creswell, Fetters & Ivankova, 2004). Looking at an object of research from 
multiple perspectives provides researchers and theorists with more comprehensive 
understanding about the object of study (Silverman, 1997).  Methodological 
triangulation is used to exploit the strengths of qualitative and quantitative 
approaches (Miller & Brewer, 2003) and has the advantage of producing 
understanding of the topic under investigation in ways that cannot be realized by 
use of a single method (Bernard, 1994). Triangulation was achieved by using 
multiple data collection methods and multiple researchers to answer research 
questions.  
Redundancy was a criterion agreed upon by all research members regarding the 
aspects of the study which was aimed at testing the usability of SignSupport. We 
aimed to repeat usability tests and iterations until the point of saturation or 
redundancy when the findings of one set of experimentation resembled the results 
of the previous experiment. The disadvantage of this was that we did not know how 
long it would take to achieve redundancy; it could be two or twenty experiments. 
Redundancy was also applied by comparing findings from one researcher to that of 
the next in the multi-disciplinary collaboration. Whilst I do not report on the 
findings of the other members of the multi-disciplinary team, I do refer to them in 
the discussion of my results and conclusions.  
Critical reflexivity is the practice in which the researcher acknowledges the biases 
of his/own perspectives in the subject matter and critically reflects on these biases 
throughout the research process. I maintained this criterion in the research through 
application of Srivastava’s three question framework when analysing all data and 
shaping the “big ideas” and conclusions from study findings. 
Transferability: As afore-mentioned, results were not intended to produce 
generalizability, instead I aimed for transferability of data. Such transferability was 
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applied in the sense that data emerging from the initial study stages was 
incorporated into, or “transferred” to the design aspects of SignSupport and 
validated in the usability experiments. For example, the first SignSupport prototype 
incorporated aspects given by both pharmacists and Deaf participants. The 
prototype was then tested with both sets of users. If it incorporated their aspects 
incorrectly, or not at all, their dissatisfaction would surface in usability 
experimentation where participants were afforded the opportunity to verify that 
their suggestions were incorporated and to comment on the overall acceptability of 
the prototype. In addition, data from usability experiments were expressed as 
modifications to subsequent iterations on the prototype.   
 
4.7.2 Criteria applied to ensure reliability 
Reliability is a termed used to describe the extent of reproducibility of the study 
findings under identical experimental conditions (Merriam, 2009). While this 
concept is widely accepted in positivist research, it is contested in studies with 
human beings as participants because human behaviour cannot be definite. Instead 
the terms “consistency” or dependability have been used in qualitative inquiry.  
Rather than reproducibility of findings, the question is “are results reflected 
consistent with data collected” (Lincoln and Guba, 1985 in Merriam, 2009). To this 
effect, we have used member checking and an audit trail. I kept an audit trail by 
maintaining consistently a research log of all undertakings and recording analysing 
and organizing data in research iterations.  
 
4.8 ETHICAL CONSIDERATIONS 
Ethics approval was applied for from UWC Senate Research Ethics Committee and 
was approved as per registration numbers 12/2/15 and 15/3/37. Further approval 
was attained from the director of DeafSA Western Cape, the manager of DCCT 
and the principal pharmacist at Tygerberg hospital pharmacy.  Participants were 
informed of the voluntary nature of this investigation prior to the commencement 
and that they may leave the study at any point should they feel the need to do so. 
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The ethical principles of non-maleficence, beneficence, respect for autonomy and 
justice and principles promoted by the MRC (Guidelines on Ethics for Medical 
Research, 4th edition 2001) were applied consistently throughout research 
proceedings. Deaf individuals are a vulnerable group and particular care was taken 
to uphold ethical principles. Participant information sheets (Appendix C) and 
consent forms (Appendix D) were applied with all study participants, the details of 
which is described in the study procedure of each empirical activity of this thesis, 
presented in the forthcoming chapters (five, six and seven). Informed consent 
implies that participants know what they are involving themselves in, the risks and 
benefits of their involvement, and what is expected of them. The same informed 
consent was applied to the sign language interpreters. The researchers ensured that 
no harm came to the participants and their wellbeing was the dominant 
consideration in making decisions pertaining to the study. This was established 
through carefully considering and respecting participants’ time, providing meals 
and transport, frequent checks with participants during research activities that they 
were comfortable, and efforts to meet any participant needs that arose during 
research activities.  In addition, researchers were cognisant of the nuances of Deaf 
culture and made efforts to appreciate and respect their culture at all times. 
Furthermore, participants were communicated with in a language with which they 
felt comfortable. All Deaf interactions were via a certified SASL interpreter with 
whom the Deaf community had an existing relationship and understanding. Deaf 
participants were at no point forced to read or write, participant information was 
signed to them in SASL, they indicated their informed consent through raising their 
hands (this was video-recorded) instead of signing forms.    
The researchers did not identify any foreseeable risks as the study was conducted 
using mock prescriptions and involved role-plays between Deaf participants and 
pharmacists. Usability questionnaires and videos were recorded, analysed and kept 
confidential as per the participant-information and informed-consent documents. 
Each participant was assigned a random research code only known to the primary 
investigators involved. All other personal information used to identify participants 
was assigned a separate code and kept separately from the other data. The data 
obtained for the investigation was entered into a research database and is 
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identifiable only by the research codes. Researchers of the multi-disciplinary team 
and research assistants reached mutual agreement on roles and responsibilities of 
different stakeholders: 
Responsibilities of the research session leader, investigators and facilitators 
• To keep the data collected confidential 
• To review scientific literature to ensure that research guidelines are 
consistent with current research practices and do not place participants at 
unnecessary risk; 
• To respect fellow investigators, participants and supervisors 
• To maintain professionalism at all times during study research 
• To adhere to the ethical obligation, i.e. honesty, loyalty 
• To keep the data as true and accurate as possible  
 
Confidentiality 
Data collected and recorded was of a visual nature in the form of videos containing 
the observations. These were protected in the following way:  videos are stored on 
a password protected computer system known only to the investigators involved in 
the research. Upon completion of this study, all information emerging from the 
study was locked away with access allowed only to the primary investigators.  
Risk and benefit 
No threat or risk was involved due to the role-play nature of the study. The main 
concerns involved with this research were confidentiality of the participants and the 
special regard for the Deaf participants. Information obtained was captured via 
electronic (videos) means and was password protected and the written material kept 
safe in a locked cabinet. All symptoms or diseases mentioned in the play are 
simulated and are not the real conditions which Deaf participants have. Thus 
SignSupport will not cause any confusion or misconceptions to a participant who is 
on concomitant treatment. The experiments were conducted under controlled 
conditions. This was beneficial since the researcher and other stakeholders were 
able to observe how a Deaf patient experiences interaction with pharmacists.  
Another benefit is that, due to the participatory nature of the study, participants are 
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able to give valuable input to the researcher as the researcher learns from the 
experience of the participant.   
The use of an interpreter 
Study purposes necessitated the use of certified SASL interpreters to communicate 
between the investigators and the Deaf participants. The interpreter had to be 
adequately proficient in signing in SASL to the Deaf participants and also be fluent 
in English to communicate to the investigators. Furthermore, we aimed to use 
interpreters who had an established relationship with the Deaf community we were 
surveying to ensure a level of comfort. Interpreters assisted in notifying Deaf 
participants of all the study-related information and signed as witness of the Deaf 
participants’ consent to research proceedings. 
 
SECTION B: RESEARCH DESIGN 
 
4.9 RESEARCH PLAN  
In this section I provide a series of schematic representations to illustrate how 
research theories discussed in the previous section are implemented in a logical and 
sequential manner to establish the research design.  Furthermore, I outline the 
experimental sites and timeline.  
Three main subject matters were studied to present this thesis. These are 
represented as three study domains: Pharmacists, Deaf community and 
SignSupport.  Pharmacists and the Deaf community were studied to reveal user 
elements that would inform the design of SignSupport. SignSupport was then 
studied as an intervention in terms of how it would impact on the medicine 
dispensing process experiences of both pharmacists and Deaf participants. This is 
illustrated in further detail in Figure 9 below: 
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Figure 9:  Domains to be evaluated in this study 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Data collection occurred prior to, during and after implementation of SignSupport. 
The data collected prior to designing SignSupport formed the baseline data of this 
inquiry and was done to obtain: (i) a dialogue pattern typical of a pharmacist-
patient interaction during patient counselling, (ii) pharmacist’s experiences and (iii) 
Deaf patients’ experiences with the medicine dispensing process and medicine use.  
These aspects were incorporated into stage 2 in which all aspects were collated to 
program SignSupport, which was tested with pharmacists and Deaf persons 
iteratively in stage 3. Figure 10 further illustrates the study design. 
 
SIGNSUPPORT DEAF COMMUNITY PHARMACY 
Pharmacists, 
students and Deaf 
participants 
 
Deaf participants Pharmacists and 
pharmacy students 
• Experiences with 
medicine instruction 
• Requirements for 
SignSupport 
 
• Dispensing dialogue 
pattern 
• Social competency: 
knowledge, practices 
with Deaf persons 
• Experiences with Deaf  
patients 
 
• Acceptability  
• Receptivity 
• Usability 
• Real-life 
application 
 
DOMAIN 
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Figure 10: Outline of study design and research methods used 
 
4.10 RESARCH SITES 
The following locations represent study sites in chronological order and correspond 
to research phases: 
 
Stage 1 : Pre-intervention/ Baseline Study 
Objectives: 
1. To extract a dialogue pattern representing pharmacist-patient communication   
2. To evaluate Deaf community experiences/challenges regarding the medicine  
use and the dispensing process  
 
Research Method             Pharmacists                                         Deaf community  
 
Qualitative and PAR      Participant observation                          Focus groups 
 
 
    Stage 2: Collation of elements needed to program SignSupport 
Objectives: 
3. To compile the databases of medicine information aspects 
4. To verify  recorded SASL videos on SignSupport  
 
Research Method             Pharmacists                                         Deaf community 
 
PAR, Qualitative               Practice guidelines, literature                          - 
 
PAR                                -                                                            Participant observation                                                                                                                             
 
 
Stage 3: Post-intervention Study 
Objectives: 
5. To obtain user data on  and acceptability and usability of SignSupport  
6. To modify /iterate SignSupport based on user feedback 
 
Research Method             Pharmacists                                         Deaf community 
 
 PAR                             Participant observation                           Participant observation 
Qualitative                     Questionnaire                                       Questionnaire 
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2012 
• Literature review 
• Pharmacy dialogues 
• Deaf user input 
2013 
• Pharmaceutical 
Databases 
• Video recording 
• Video verification 
• User test 
• 1st iteration 
2015 
• Final test 
• 2nd iteration 
• Thesis writing 
1. UWC School of Pharmacy 
2. Deaf Community of Cape Town (DCCT), Claremont 
3. Deaf Community of Cape Town (DCCT), Heathfield 
4. UWC School of Pharmacy 
5. Deaf Community of Cape Town (DCCT), Heathfield 
6. UWC School of Pharmacy- Pharmacy Practice laboratory  
7. Tygerberg Hopsital Pharmacy 
 
 
4.11 RESEARCH TIMELINE 
 
This study was registered and approved by April 2012. Research activities 
commenced immediately with pharmacy students, with subsequent research 
activities ensuing thereafter. In 2012 the exploratory phases were completed.  In 
2013, the pharmaceutical aspects and design features were prioritized. 
Corresponding video translations in SASL were recorded, after which the first fully 
functional version of SignSupport was realized.  The year 2013 closed with the first 
SignSupport user experiment and subsequent first iteration.  The New Year (2014) 
saw no research activity due to personal reasons that necessitated my withdrawal 
from the research field.  January 2015 commenced with a proposal submission for 
permission to conduct studies at a public hospital, after which ensued the second 
user experiment and subsequent iteration.  This timeline corresponds to the 
research phases in chronological order.  
Figure 11: Research timeline 
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Phase 1: 
 
● Constructed  
dispensing dialogue 
patterns 
 
 ● Collated Deaf user 
input 
Phase 2: 
 
● Compiled 
pharmaceutcal databases 
 
● Compiled  prescription 
instructions 
 
● Recorded matching  
SASL videos, verified 
the videos 
Phase 3:  
 
● Pilot tested 
SignSupport  in 
simulated dispensary 
 
●Iteration 
 
● Hospital 
experimentation 
4.12 REPORTING THE FINDINGS AND STRUCTURING THE THESIS 
 
Until this I have presented this dissertation in a manner that follows typical thesis 
protocol. The ensuing chapters deviate from the conventional format in that I have 
chosen to represent the findings form each research phase in a narrative style as 
isolated chapters.  Within each chapter I deliver actual sample size(s), research 
site(s), method(s), data collection instrument(s), results, discussion and a 
conclusion. I have chosen this arrangement because the research trajectory was 
such that one set of results was fed into the subsequent research phase, making it 
more logical to present as a chronicle. The upcoming three chapters are presented 
according to the research phases illustrated in the phase progression diagram 
below: 
 
Figure 12: Research phase progression 
 
 
 
:  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Chapter five presents and discusses findings from the pre-intervention/baseline 
study. A description of how the dispensing dialogues were constructed is given 
together with findings from Deaf community focus groups and key informant 
interviews.  
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This baseline data was used to inform research processes in Chapter six, which 
presents the intermediate phase in which SignSupport was completed. During this 
phase, pharmaceutical databases of medicine names, diseases and prescription 
instructions were collated to export into SignSupport’s program. Thereafter, the 
process of recording videos in SASL to match the pharmaceutical elements was 
recorded using a SASL interpreter to sign. For example, if we loaded a disease or 
symptom that a pharmacist would say (e.g. headache), we had to record an 
interpreter “saying” headache in sign language, in order to achieve the text-to-sign 
capability we were aiming for. The videos were then incorporated into SignSupport 
and tested for accuracy. This culminated in a complete prototype (SignSupport 
Version 1) that was ready for user testing. 
 
Chapter seven presents the post-intervention stage in which SignSupport is tested 
iteratively with Deaf users and pharmacists, first in a simulated dispensary and 
thereafter in a real-world hospital pharmacy.  
 
Chapter eight delivers a general discussion of the main themes emerging from this 
project, scholarly views of such themes and its implications on social redress for 
Deaf communities.  
 
Chapter nine brings this thesis to a close, delivering a distillation of the research 
findings, author opinions and recommendations for future work. 
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CHAPTER FIVE 
 
 
RESULTS AND DISCUSSION: BASELINE STUDY 
 
 
 
 
 
 
This chapter presents findings from research phase one, the baseline investigation, 
which was conducted to yield data to inform the design of SignSupport. Two main 
study undertakings were conducted and are presented as Section A and Section B 
respectively. In Section A I deliver the findings of a qualitative investigation with 
the Deaf community to learn about their experiences of the medicine dispensing 
process at hospitals. This data was important in the development of SignSupport 
because it was intended that the application improve the medicine dispensing 
process for Deaf persons. 
 
 
In Section B I present the findings of an empirical investigation with senior 
pharmacy students who were asked to role-play a dispensing interaction with a 
simulated client to their best ability. The objective was to observe their interaction 
in order to extract a dialogue pattern of what pharmacists say and ask during the 
dispensing process. This dialogue pattern was necessary for incorporation in 
SignSupport programming architecture, since the application aims to facilitate the 
communication between a pharmacist and Deaf patient.  The chapter culminates in 
a compilation of data from the baseline phase that will be incorporated in the 
imminent intervention phase. 
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Introduction 
 
 
The exploratory baseline study was conducted to meet research objectives 1 and 2 
presented earlier in chapter three: 
 
1. To qualitatively evaluate the experiences of the Deaf community 
regarding the medicine dispensing process and the use of such 
medicines. 
2. To extract a dialogue pattern representing the communication  that 
would typically occur between a pharmacist and a patient during patient 
counselling, and to express this pattern as a series of ordered sentences. 
Separate research activities were conducted to fulfil the two research objectives. 
These are presented separately as Section A and Section B to represent objectives 1 
and 2 respectively. Each section is described in detail under the following sub- 
headings: 
1. Linkage to research objective 
2. Actual sample and study site 
3. Methodology 
4. Materials 
5. Study procedure 
6. Results and discussion of findings. 
The chapter concludes with the extraction of relevant data that will be used in the 
design of SignSupport. 
 
SECTION A: DEAF COMMUNITY EXPERIENCES WITH THE 
MEDICINE DISPENSING PROCESS 
 
5.1.1 Qualitative evaluations with the Deaf community 
 
An insight into Deaf community’s experiences with medicine instruction was an 
important consideration for SignSupport because the researchers intended to design 
the prototype with input from the users. To gain this insight I led two empirical 
activities: 
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i. Focus group sessions with Deaf participants 
ii. Key informant interviews with individuals who had expertise in the 
area of medicine use in the Deaf community. 
 
The focus groups and key informant interviews were linked to the same objective 
and since both are qualitative techniques that were undertaken to meet the same 
objectives, they produced similar data. As such, it was logical to analyse the data 
sets emerging from these research activities together. For this reason, and to avoid 
repetition, I have chosen to present the focus groups and key informant interviews 
together under each of the afore-mentioned subheadings. 
 
5.1.2 Research objective linkage 
 
Focus groups and key informant interviews were conducted in order to achieve the 
first research objective: 
• To qualitatively evaluate the experiences and challenges of the Deaf 
community regarding the medicine dispensing process and using medicines. 
 
Specific research questions connected to this objective are: 
1. What are the experiences of Deaf people when they collect their 
prescription medicines at a public sector pharmacy? 
2. How do staff members at the facility and at the pharmacy communicate 
with Deaf people? 
3. How do Deaf people perceive their interactions with pharmacy staff and 
other healthcare workers? 
4. Are there any challenges they experience? If so, what are these 
challenges and what can we do to overcome these challenges? 
5. What are their experiences of the patient counselling process and of using 
medicines? 
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5.1.3 Study site and participants 
 
 
Focus groups 
Focus groups were directed to the Deaf community and staff at DCCT, Heathfield. 
All participants were informed about the study and all its criteria and that 
participation was voluntary. They had the opportunity to withdraw from the focus 
group at any time. Deaf participants were informed via a SASL interpreter who 
also communicated to them the informed consent procedures. Homogenous 
purposive sampling and typical case purposive sampling was used to target 
participant samples for focus groups. Focus group participants (n=16) were split 
over two focus group sessions, both of which were held at the DCCT on separate 
days. Inclusion criteria were that the participants should be Deaf, have a connection 
with the DCCT and must have used/are using medication. The exclusion criterion 
was hearing participants and those with no connection to the DCCT. 
 
All focus group participants were long-standing residents of previously 
disadvantaged areas in the Cape Town metro-pole, with most residing in the Cape 
Flats, a lower socio-economic housing plain in Cape Town. The majority of 
participants were in their senior years, older than 60 year of age, with 81% of the 
total sample having a pre-lingual onset of Deafness (i.e. born deaf or before age of 
3), implying that they are Deaf and  thus may experience problems in literacy. This 
is reflected in their level of schooling, with most participants not having 
entered secondary schooling (grade 7-12). Figure.14 reflects the number of 
participants using the public and private sectors for healthcare. The graph shows 
that only 1 participant used private healthcare services, with the rest using 
public healthcare services. 
Demographic profile of focus group participants 
 
GENDER AGE GROUP ONSET OF DEAFNESS (age) 
 
Male 
 
Female 
 
30-59 
 
60-69 
 
70-79 Born Deaf 
Pre- 
lingua
l (<3) 
 
4-6 
 
>18 
4 12 5 6 5 10 3 2 1 
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Figure 13: Highest completed educational level of participants 
 
 
 
 
 
 
 
Key informant interviews 
 
Four interviews were conducted, three at the DCCT and the fourth at Groote 
Schuur hospital. All key informant interview sessions lasted 1 hour. Expert 
purposive sampling was used to select participants (n=4) for key informant 
interviews. Inclusion criteria were that key informants should have specialized 
knowledge and insight of medicine use within the Deaf community, with the 
exclusion criteria being those with no such knowledge or insight. 
All key informants were female. One was a pharmacist who is deaf and had done 
prior research with the deaf community. The other three participants were deaf staff 
members who are community workers, working with the Deaf community  at 
DCCT and have particular experience in healthcare service delivery to Deaf people. 
Figure 14:  Use of public versus private healthcare services 
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Demographic profile of key informant interview participants 
 
 
GENDER AGE GROUP 
Male Female 20-35 36-50 
0 4 2 2 
 
 
 
5.1.4 Methodology 
 
Qualitative methods (focus group interviews and key informant interviews) were 
used to explore the experiences of Deaf people at public sector pharmacies when 
they collect their medicines. For both methods, participants were informed about 
the study by way of participant information sheets and informed consent 
documents (Appendices C and D). They were asked to sign consent forms 
(Appendix D) to indicate their voluntary participation. In cases where they were 
unable to sign, they indicated their informed consent with a cross (X). Focus group 
interviews and key informant interviews were conducted according to structured 
protocols which comprised a list of questions which guided the discussion 
(Appendices F and G). 
 
Since the researchers did not have any experience in conducting research with 
Deaf people, and particular via a sign-language interpreter, the only considerations 
in the development of the focus group and key-informant protocols were (i) the 
research questions and (ii) lessons about Deaf culture and social behaviour that was 
gleaned from the literature review. Data collection activities were recorded and 
transcribed verbatim, then double checked for accuracy with co-researchers. 
 
5.1.5 Materials and resources 
 
 
The materials and resources used in executing the afore-mentioned study tasks are 
tabulated below: 
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FOCUS GROUPS (n=2) 
 
KEY INFORMANT INTERVIEWS (n=4) 
 
Focus group protocol 
 
Key informant interview protocol 
 
Video recorders 
 
Audio and video recorders 
 
SASL interpreter 
 
SASL interpreter (where appropriate) 
 
Notepads and pens 
 
Notepads and pens 
 
5.1.6 Study procedure 
 
Focus groups 
 
In preparation for the focus groups, the researchers requested permission from 
DCCT to conduct the study at their premises and with the staff members. On the 
first visit to DCCT we were introduced to the staff and familiarised ourselves with 
the facility with a view to present the proposed study and to recruit participants. On 
the second visit a preliminary information session was held to present the proposed 
study and obtain study approval. The participant information was explained to the 
study participants in order to elaborate the purpose of this study. Participants were 
asked to indicate informed consent as proof of voluntary participation in this study. 
This was done by raising their hands to indicate their consent (this was video- 
recorded), or writing a cross (X) on the document, whichever method they 
preferred. In addition we recruited a certified interpreter proficient in SASL and 
known to the DCCT community. Both focus groups were conducted at the DCCT: 
the first with 5 Deaf participants lasted for 1 hour and the second with 11 senior 
(age) Deaf participants for an hour and forty minutes. The focus groups were video-
recorded, transcribed verbatim and double-checked for accuracy by member- 
checks with the SASL interpreter and co-researchers. All communication was via a 
certified SASL interpreter. Focus groups were conducted according to  a focus 
group protocol (Appendix F). Responses were coded together with key informant 
responses for thematic and reflexive analysis. 
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Key Informant interviews 
 
Key informants were selected based on their specialized expertise in the study area. 
Key informant interview participants and timeslots were secured through 
telephonic appointments. Three key informants were staff members at DCCT who 
had direct experiences in healthcare service to the Deaf community. On the first 
visit we were introduced to the staff and familiarized ourselves with the facility 
with a view to recruiting key informants. At the following visit, a preliminary 
information session was held to present the proposed study and obtain study 
approval. The participant information sheet was explained to the study participants 
in order to elaborate the purpose of this study. Participants signed an informed 
consent document as proof of voluntary participation in this study. The interviews 
followed a structured key informant guide and lasted one hour per interview and 
took place in a private, enclosed environment. The interviews were conducted via a 
sign-language interpreter, who signed a modified version of the informed consent. 
The interviews were recorded, transcribed verbatim and double-checked for 
accuracy. The fourth key informant was a deaf pharmacist who was working at a 
public hospital in Cape Town. She had prior experience in conducting research 
with deaf people. A telephonic appointment as made with her and the interview 
was conducted at her workplace during her break. The interview lasted fifty-five 
minutes. Responses were combined with focus group responses, then coded and 
analyzed thematically and according to Srivatsa’s three question framework. 
 
5.1.7 Overall impression of data collection activities 
Focus groups 
At first, the participants were noticeably uncomfortable and apprehensive about the 
focus group procedure. The researchers asked whether they would prefer to abort 
the intended procedure but participants indicated, albeit reluctantly, that they would 
go ahead. In this first interaction with the Deaf community, we were privy to their 
social connectedness with and loyalty to other Deaf people and realized that this 
may obstruct research procedures. In addition, the circumstance of having to 
conduct the focus group via a SASL interpreter appeared as a further impediment 
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to the process. The researchers approached the focus group questions cautiously 
and at a slow pace, hoping to establish rapport. At first, participants were reluctant 
to share their opinions and views but as the discussion progressed they became 
more relaxed and were more open to sharing their experiences. Although all 
participants were involved in the discussion some were more willing to speak their 
mind while others remained reserved throughout the session. Some questions were 
not answered well and at other times, participants refused to answer treatment- 
related questions as they felt that it was personal information. Nevertheless, the 
focus group discussion served as a platform for Deaf participants to express 
themselves as they responded to the pre-arranged topics in the focus  group 
protocol, and the researchers were able to glean an understanding of the 
experiences of Deaf people at public sector pharmacies. 
 
Key Informant interviews 
 
Key informants were more open to sharing their views as they were more informed 
and interact with hearing individuals on a regular basis. They were forthcoming in 
sharing their experiences and openly offered advice and recommendations for 
working with Deaf communities. They also provided insights into the challenges 
faced by the deaf patients with medicine usage and their knowledge and 
behaviours. 
 
 
5.1.8 Data analysis 
 
 
Early on in the data analysis process, it became apparent that it was more logical to 
analyze focus group data and key-informant interview data together since common 
themes were emerging across the two data sets. As a result thematic analysis and 
Srivasta’s reflexive framework was applied to both data sets collectively to achieve 
a composite analysis. Prior to analysis, each interview was transcribed (with the 
assistance of the SASL interpreter where applicable) and additional points of 
interest (burning issues) was noted. After transcripts were generated, they were 
read with the intention of assigning codes to common responses. Codes appeared in 
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the form of a short descriptive phase summarizing the gist of what the code 
represented. When a code became apparent during the focus group or key- 
informant interviews, it was mentioned to the participant(s) as a theme during the 
interview with a view to apply member-checks, reflexivity and elicit further 
responses. Data analysis occurred after each focus group and key informant 
interview in two stages: 
(i) Thematic analysis 
(ii) Application of Srivasta’s reflexive question framework. 
 
 
5.1.8.1 Steps of analysis 
 
Data analysis occurred in a step-wise format which comprised a sequence of 
analysis tasks for each set of data. Figure 15 below illustrates the stepwise data 
analysis process. Individual sets of data (e.g. a focus group record) converge with 
other data sets in the ‘categorization-of-coding’ step. During this step, codes are 
refined through either grouping sub-codes into a bigger code or minimizing a 
code through its dissolution into a related/similar code. 
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Figure 15: Steps in the data analysis process for focus groups and key 
informant interviews 
 
 
 
 
 
 
 
 
 
 
 
 
 
STEP 6: Application of Srivasta's framework 
 
• A: What is the data telling me? 
• B: What is it that I want to know? 
• C: What is the relationship between A and B? 
 
STEP 5: Clarifying codes  to represent themes 
 
• Thematic analysis 
 
STEP 4: Categorization of codes 
 
• Grouping  subcodes together to form larger codes where applicable 
 
STEP 3: Focused coding 
 
• Re-reading the transcript to modify codes appropriately 
• Altering code linkages where necessary 
 
STEP 2: Preliminary coding 
 
• Tagging similar/related responses with colour-coded  markers 
• Representing each group of same colour responses with a short-phrase 
code name to represent a code 
 
STEP 1:  Truth-of-transcript 
 
• Verbatim transcription of focus groups and interviews 
• Accuracy and authenticity  are key considerations 
• Member-checks with participants and co-researchers 
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5.1.8.2 An example of coding to illustrate coding process 
 
 
In the text-box below I illustrate the coding process with an example of how I 
coded a participant’s quotation from the raw data (transcript) into a preliminary 
code, focused code and theme (adapted from Theunissen, 2014). To illustrate 
reflexivity, I also provide a link to the relevant research question. 
 
 
Transcript quotation: “You  know  I  get  cross  after  a  while 
and then I’m rude and I grab my bag 
and then I leave. Then I go home and 
cry. And I’m asked by my family why 
I’m    crying    and    then    I    explain, 
because,  you  know,  I’m  stressed,  I 
cannot    communicate    at    the    day 
hospital,  I’m  sick,  I  don’t  know  what 
to buy at the pharmacy for myself even 
if  I  have  to  self-medicate…  that’s  a 
big stress in my life.” 
Preliminary code applied: Failure of the healthcare system to 
provide services to Deaf people 
Focused code applied: Dissatisfaction with healthcare service 
delivery 
Theme applied: Pharmaceutical services experienced 
by Deaf patients 
Sub-theme applied: Dissatisfaction with pharmacy 
services 
Research question link: What   are   the   experiences   of   Deaf 
people when they collect their 
prescription   medicines   at   a   public 
sector pharmacy? 
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5.1.9 Results and Discussion 
 
5.1.9.1 Thematic analysis of focus groups and key informant interviews 
 
Themes representing similar responses were extracted across two focus groups 
with Deaf participants groups (n=5) and (n=11) and four key informant interviews 
(n=4). In total, six themes were elucidated according to the afore-mentioned coding 
procedure. These themes are represented below: 
 
 
Table 8: List of major themes and subthemes from focus groups and key 
informant interviews 
THEMES SUB-THEMES 
Communication challenges 
during healthcare service 
delivery 
• Lack of effective communication 
• Attitudinal barriers of healthcare personnel 
• Infrastructural challenges 
• Comparisons with hearing patrons 
 
Pharmaceutical services 
experienced by Deaf patients 
 
• Dissatisfaction with pharmacy services 
• Suggestions for improvement 
 
 
Strained relationship between 
Deaf patients and pharmacists 
 
• Inadequate pharmaceutical care 
• Lack of Deaf awareness 
• Request for increased levels of social 
competency by pharmacists 
Communication methods 
employed by pharmacists with 
Deaf patients 
 
• Common methods employed 
 
Limitations in knowledge and 
purpose of medicines 
• Misconceptions regarding medicine use 
• Insufficient information regarding medicine 
use 
• Challenges in using medicines 
Need for autonomy in 
healthcare 
• The need to be independent or self-reliant 
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A total of six broad themes with sub-themes (14) have been represented in Table 1. 
Reflexive questions allowed the sub-themes to be categorized in relation to 
research questions. Below I present each elicited theme and expand on the theme 
and subthemes (presented within the main theme in bold text) through 
substantiation with raw data quotations (italics) and a juxtaposition of these study 
findings with related findings in published literature. Quotations are from key 
informant interview participants (K1–K4) and focus group participants (F1-F16). 
 
5.1.9.1.1 THEME 1: Communication challenges during healthcare 
service delivery 
 
A plethora of healthcare policy exists which advocate for quality in healthcare 
service delivery and equal rights to access and care for all citizens. However, 
participant responses indicate that this is not upheld for Deaf persons in local 
healthcare facilities. This finding is supported extensively in the literature. 
Haricharan et al. (2012) and Kritzinger’s (2011) investigations in the Western 
Cape province of South Africa have shown multifarious complexities in accessing 
the right to healthcare, a finding echoed in studies worldwide (Steinberg et al 2006; 
Moore & Swabey, 2007; Abraham & Fiola, 2006; Reeves et al., 2002). In the USA, 
Deaf patients have sought legal action by filing a significant number of complaints 
of violation of rights and non-conformance to disability policy and legislation 
(Moore & Swabey, 2007). One of the main problems identified was the lack of 
effective communication with Deaf patrons, who often feel excluded and despair 
that will not be seen to, which results in them having to return again the next day. 
This inconvenience is represented by the quotations below. 
FG 12: “It’s a very difficult situation…showing people I can’t hear, I can’t 
speak and then they just smile at you and then they’ll ask for your 
name and I’ll write down my name on a piece of paper and then 
they just say “Tomorrow, tomorrow.” So even though I’m very sick, 
I go back home and come back the next day…and the same thing 
happens.” 
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FG 4: “You know I get cross after a while and then I’m rude and I grab my 
bag and then I leave. Then I go home and cry. And I’m asked by my 
family why I’m crying and then I explain, because, you know, I’m 
stressed, I cannot communicate at the day hospital, I’m sick, I don’t 
know what to buy at the pharmacy for myself even if I have to self- 
medicate… that’s a big stress in my life.” 
FG 7: “nobody is interested (in me)…and I can’t go the next  day  again 
and the next day again.” 
KI 3:  “The health department must remember that there are people  who 
are Deaf. There is a shortage of interpreters in Cape Town. It would 
be preferable if there are pharmacists who can sign.” 
FG 4: “When I go to the clinic, I’ll be meeting the doctor…there are 
communication problems. I don’t understand the doctor. It’s very 
hard to explain.” 
The finding ‘lack of effective communication’ with Deaf patrons in healthcare 
facilities is well supported in local and international research. In a case-study based 
investigation of a Deaf patient in Cape town, Haricharan et al. (2012)  illustrate 
how the healthcare rights of a deaf person is compromised through a lack of 
“informational access”, the cause of which is the inability of a Deaf person to 
access health-related information in sign-language. As a result, their right to 
healthcare is violated. Bat-Chava et al., (2005) assert that communication and 
language are the main barriers experienced by deaf people in accessing healthcare 
information. This is corroborated by Kritzinger (2011) who found that 
communication barriers are the most significant barrier to healthcare services and 
information. Comparable findings are reported by Iezonni et al., (2004),  Law et 
al., (2005) and Steinberg et al., (2006). The implications of a lack of effective 
communication in a healthcare setting are substantial. Haricharan et al., (2012) 
argue that deaf people suffer tremendous detrimental consequences due to a lack of 
effective communication. These consequences include “misdiagnosis, 
incorrect/inappropriate treatment or a lack of treatment, problems with treatment 
adherence,  missed  appointments,”  and  ultimately,  a  violation  of  their  right  to 
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healthcare. Draioni et al., (2006) identify a lack of effective communication 
between disabled people and health care providers as a structural barrier faced in 
the healthcare system. From a pharmacy perspective, such a lack of 
communication may cause patients to take their medicines incorrectly or not at all. 
Providing medicines is the last link in the chain of healthcare service delivery and 
appropriate treatment with medicines is often the outcome of a series of efforts 
expended in diagnosis and medical consultations. Medicines not taken properly 
due to a lack of understanding negates the effort, time and cost incurred in medical 
consultations and diagnostic procedures and puts the patient at risk of not receiving 
treatment essential to solving their health-related problems. For marginalized and 
disabled people who often require increased levels of medical attention, this is 
unacceptable. Pharmacy professionals must learn to bridge communication gaps 
with patients to ensure that people know how to take their medicines and receive 
the appropriate care from health care facilities. 
 
Attitudinal barriers of healthcare personnel emerged as  a  second subtheme. 
Two main issues arose: the taunting of Deaf patrons by healthcare personnel and 
their lack of Deaf awareness resulting in indifference to their special needs. These 
are illustrated in the quotations below: 
FG 8: “They (staff members) will be like “aah, I can’t sign,” and do a 
negative gesture to kind of make a joke about it which really makes 
me cry…because like really nobody is interested in interpreting for 
me. Plus you’ll find the hospital staff are kind of making fun of the 
fact that I cannot speak and cannot hear…” 
KI 2: “Greet the person, be respectful, do not show that you do not want 
to help the Deaf patient or that you are put off by helping them. 
Work on the facial expressions.” 
FG 4: “I don’t like that the staff call me ‘deaf and dumb’. I don’t like that 
word. I am Deaf, I am not stupid, I am just Deaf.” 
KI 1: “If the pharmacist uses spoken language, Deaf people are treated as 
being stupid. They are shouted at or spoken down to.” 
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Poor attitudes of healthcare personnel and a lack of Deaf awareness are also seen in 
the literature. Kritzinger reported that healthcare workers “misuse” deaf people and 
are afraid of them. Furthermore, healthcare workers find it simpler to ignore deaf 
people and do not provide all their treatment and diagnosis-related information or 
pay attention to their concerns. This is corroborated by Steinberg et al., (2006),  
whose study reveals that Deaf patients feel that healthcare workers have an 
aversion to working with deaf people. Health care providers may show 
“insensitivity or a lack of respect” to disabled people, and people with disabilities 
believe that healthcare workers treat them as if they are unworthy of receiving 
optimal, high quality care (Draioni et al., 2006). The following quotations from a 
deaf patient in Haricharan et al’s case-study further corroborate these findings: 
“I did not receive any counselling…I did not have a chance to ask 
questions when I tested (for HIV)” 
“They (clinic staff) scolded me…I explained the situation. They scolded 
me.” 
Some hearing health care professionals display negative attitudes to Deaf persons, 
perceiving them to be obstinate and intellectually challenged (Meador & Zazove 
2005, Scheier, 2009). While the perception of negative attitudes of healthcare 
professionals toward deaf people is a common finding in the literature, it is 
important to note that this perception is based on the Deaf patient’s reality. Deaf 
people cannot hear what is happening around them, they are only able to see. As a 
result, they may perceive situations to be negative toward them while this may not 
actually be the case. For example, if a pharmacist is frowning or has a discouraging 
expression, it may be due to a number of reasons; perhaps an error on prescription, 
unclear handwriting, by the prescriber, missing information etc. The pharmacist 
cannot communicate this to the Deaf person, who erroneously assumes that the 
pharmacist is frowning at them or because of them. Deafness paranoia was 
described in the literature review as a deluded view of persecution by a Deaf 
person; that people are gossiping about them and have an intention to “get” them 
(Bleckly, n.d.) This is in addition to their existing social exclusion and lack of self- 
worth. Deafness paranoia and a perception of a bad attitude on the part on 
healthcare professionals may result in a further psychological barrier to treatment 
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and care. Deaf people are unlikely to accept care form a person whom they believe 
acts negatively toward them. Healthcare professionals must be made aware of this 
situation and be taught the skills to be self-aware and cognizant of their behaviour 
toward Deaf people to minimize the possibility of bad perceptions. 
 
Abraham & Fiola (2006) have shown in a Canada-based study that healthcare 
professionals expect patients to have fluency in the local language or have an 
interpreter present for the medical consultation. Such expectations may not be 
feasible in under-resourced countries such as South Africa. Deaf awareness 
describes the recognition that a person is Deaf and understanding the 
communication impediments experienced by Deaf people. Huntington (1995) and 
Lomas (1998) report that the Deaf community often complain about a lack of Deaf 
awareness by healthcare professionals. As a result they shout, fail to use plain 
English and often use medical jargon, do not mouth words clearly, speak very 
slowly and do not directly face the Deaf person during an interaction. These 
behaviours all create further communication barriers for a Deaf individual.  Not 
only does this pose a problem for over-burdened health professionals such as 
pharmacists, it also alienates the Deaf community from seeking health services. 
KI 1: “if a deaf person is not recognized (acknowledged) then they won’t 
take you seriously because you were neglecting them in the first 
place.” 
FG 7: “…I’m getting help (only) because I’m the last one there (at the day 
hospital). Didn’t they realize that this person is Deaf…we’ve missed 
this person down the queue. Sometimes they say come back 
tomorrow because we closed already. Major thing, major thing.” 
KI 1: “I was in the hospital, the nurse used to come at night…and she 
would ask me to give her my hand but I could not hear her…then 
she got angry because she did not know I was deaf.” 
The lack of Deaf awareness points to an absence of training on Deaf culture in 
healthcare and pharmacy curricula. It is unreasonable to expect healthcare 
professionals to  be sensitive to  specific nuances  of a small  marginalized  society 
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when they have no knowledge or understanding of that society. Schools of 
medicine and pharmacy should incorporate training of Deaf culture in their 
curricula to prevent a lack of Deaf awareness. 
Infrastructural challenges were described by participants. The most common 
barrier was not being able to hear when their name was called for their doctor’s 
consultation or collect their medicines. Public healthcare services rely on patients 
being able to hear their name or card number being called while they sit in the 
waiting room so that they know when it is their turn to be seen to. In this type of 
setting where patients and healthcare providers rely strongly on hearing and their 
voices, it is very difficult for the Deaf patient to function optimally. Most Deaf 
patients find waiting rooms to be particularly stressful and frustrating. They are 
anxious while they wait for their number/name to be called as they are fearful that 
they will not hear their name, which leads to missing their appointments and an 
opportunity for receiving treatment. This appears to be a problem  with waiting 
areas in general, including pharmacies and doctor’s rooms. The following quotes 
illustrate this: 
FG 8: “It is a major struggle to know when it’s your turn, they will call 
you because you’re there, but you’re not going because you don’t 
know that you have to go and then they think you’re not there.” 
FG 7: “…I’m getting help (only) because I’m the last one there (at the day 
hospital). Didn’t they realise that this person is Deaf…we’ve missed 
this person down the queue…” 
FG 2 “I always show someone (in the waiting room) my patient card and 
ask them if they heard my name being called.” 
FG 16: “Once I sit with patients I ask them to tell me when they hear my 
name.” 
FG 7:  “If somebody is a new mother and you‘ve got to take your baby to 
the day hospital to be weighed etc. and there are problems, one does 
not know what is happening with your own child because you 
cannot communicate. You will not know, people (staff) will just 
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write things down and move on to the next person. I have had that 
problem myself and many others in the community have the same 
problem. When you have to take your new-born baby, that first 
couple of years to the clinic…a lot of communication is missed 
there, a lot of information is missed. 
The problem of missed appointments due to not being able to hear their name being 
called is a common finding in the literature. In a role-reversal exercise where 
pharmacy students are asked to assume the role of a patient at a hospital where all 
the workers are deaf and can communicate only in sign language (including calling 
patients for their appointments), hearing “patients” missed their appointments 
because they did not realize when they were being called in sign-language. Further 
findings by Reeves et al., (2002), Iezzoni et al., (2004), Ubido et al., (2002) 
and Kritizinger et al., (2014) all point to the afore-mentioned problem of missing 
appointments or treatment opportunities for the lack of hearing their name being 
called. Valios and Vale (2004) provide a quotation similar to those presented in the 
finding of this thesis to illustrate the waiting room situation of a deaf patient: 
“You’re sitting in your GP’s surgery and your name is called over the 
tannoy system. Unaware, you continue flicking through a magazine, after 
waiting for some time; you approach the receptionist to ask whether the 
doctor is running late, only to be told that you’ve missed your appointment 
as your name was called 15 minutes earlier. The receptionist had forgotten 
that you were deaf…(pg 30) 
Not receiving treatment simply because of the inability to hear one’s name being 
called out is attributed to poor institutional planning, alienating the Deaf 
community from seeking care in the public sector. Healthcare institutions must 
establish technological solutions for Deaf people. Simple attention in recognizing 
that the person is Deaf and may not hear their name when being called  for 
treatment is not unreasonable to expect from healthcare providers, however it does 
not occur. 
Deaf people often compare healthcare services provided to themselves with those 
provided to the hearing community. Such comparison with hearing people is 
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largely negative and negates the promotion of equality and non-discrimination of 
persons who have disabilities. This is corroborated in Steinberg et al’s 2006 USA 
based study which reveals that the perceptions of Deaf patients are that they are 
treated unfairly in comparison to hearing patients. It is also a plausible reason for 
the significant number of complaints of violation of rights and non-conformance to 
legislation (Moore & Swabey, 2007). The following quotes illustrate how study 
participants viewed their services compared to those provided to hearing people: 
FG 13:“I also have problems getting assistance, but I can speak a little, so 
that gets me through at the end of the day, a little bit…but I’m still 
not getting the full service that the other people are getting.” 
FG 1: “I go to the hospital early, as early as possible in the morning and I 
see Hearing people next to me who came later than me, going home 
and getting help.” 
FG 7 : “…I’m getting help (only) because I’m the last one there (at the day 
hospital) Didn’t they realise that this person is Deaf…we’ve missed 
this person down the queue. Sometimes they say come back 
tomorrow because we closed already. Major thing, major thing.” 
Literature pertaining to health service provision to Deaf people yields similar 
findings of inferior service provision to Deaf people. Ralston et al., (1996) in an 
investigation with 165 doctors, found that all the doctors were lacking in their 
knowledge of their professional obligations to deaf patients.  Shapiro  (1993) 
reports that many deaf people complain that health care workers fail to see them as 
people; instead they see the disability and may even have difficulties  in dealing 
with patients’ health problems unrelated to that disability. In addition, Harmer 
(1999) asserts that healthcare providers may experience “disincentives” in deciding 
to provide care to deaf people. These disincentives include the need to spend more 
time with deaf peoples who may in turn result in negative financial implications for 
institutions and the possibility of having to incur costs for sign  language 
interpretive services adds a strain to the health system. Furthermore, healthcare 
professionals may experience psychological barriers when suddenly having to work 
with deaf peoples. They feel a level of uneasiness that may cause ineffective help 
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to the deaf patient (Schlesinger & Meadow, 1972, cited in Harmer, 1999). 
Solutions should be explored to empower healthcare professionals to feel less 
uneasy and more confident in providing services to Deaf people. These solutions 
may lie in the inclusion of Deaf awareness in healthcare curricula, or alternatively 
in exploring technological solutions which can facilitate communication to Deaf 
people and diminished the reluctance and uneasiness of healthcare workers to 
interact with Deaf peoples. 
 
 
5.1.9.1.2 THEME 2: Pharmaceutical services experienced by Deaf patients 
 
There is very little literature reporting on Deaf peoples’ experiences at a pharmacy. 
Only one study (Ferguson et al., 2015) exists regarding Deaf patient’s experience 
with pharmacists in the USA. In South Africa, no studies exist apart from the 
research done within the context of SignSupport development. Instead, studies 
have focused on the use of medicines by Deaf people. The findings of this study 
regarding deaf people’s experiences at pharmacies echo the literature on their 
experiences at healthcare facilities in general, with communication barriers and a 
lack of deaf awareness constituting the main findings. 
Deaf peoples’ dissatisfaction with pharmacy services 
Hearing patients have many complaints when it comes to the waiting time to 
receive their medicines at the pharmacy. This is a predictable finding as waiting 
times at public sector pharmacies in South Africa are known to be problematic. 
Reports of tiresomely long queues at public sector facility pharmacies are 
commonplace. Queues are considered to be outrageous with hundreds of people 
standing in line. In the Western Cape, Ntuli (2003/4) reports that patient waiting 
time for medicine were found to be up to 12 hours. Ferguson & Liu (2015) report 
that Deaf people perceive that pharmacists are always rushed and impatient, which 
may imply high workloads and limited time. Deaf patients often experience even 
longer waiting times as they are not identified as being Deaf by healthcare 
providers, owing to a lack of Deaf awareness. Therefore Deaf patients are often 
overlooked in
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the waiting room. This leads to Deaf patient dissatisfaction with public healthcare. The 
following quote illustrates this: 
FG7: “We are living in a hearing world; pharmacists only seem to worry 
about the hearing patients, so when it comes to the deaf there is a 
struggle.” 
FG 1: “I go to the hospital early, as early as possible in the morning and I 
see hearing people next to me who came later than me, going home 
and getting help.” 
FG 7: “…I’m getting help (only) because I’m the last one there (at the day 
hospital). Didn’t they realize that this person is Deaf…we’ve missed 
this person down the queue. Sometimes they say come back 
tomorrow because we closed already. Major thing, major thing.” 
 
 
Another issue identified in this study is the way the Deaf community perceives the 
attitude of pharmacists. Deaf people believe that pharmacists are frustrated in 
working with them and as a result are not patient and caring, instead in a rush to do 
the minimum that is required of them. The rushed and impatient behavior of 
pharmacists was also a finding in Ferguson & Liu (2015) study. Shapiro reports 
that many deaf people complain that health care workers fail to see them as 
people; instead they see the disability and may even have difficulties in dealing 
with a patient’s health problems unrelated to that disability. In addition, Harmer 
(1999) asserts that healthcare providers may experience “disincentives” in deciding 
to provide care to deaf people. These disincentives include the need to spend more 
time with deaf people who may in turn result in negative financial implications and 
the possibility of having to incur costs for sign language interpretive services. 
Furthermore, healthcare professionals may experience psychological barriers when 
suddenly having to work with deaf people, causing a level of uneasiness that may 
cause ineffective help to the deaf patient (Schlesinger & Meadow, 1972, cited in 
Harmer, 1999). The following quotations from study transcripts illustrate Deaf 
patient’s perceptions of pharmacists: 
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KI 4: “The majority of the pharmacist just focuses on giving the medicine, 
they do not focus on the needs of the deaf patient, the 
communication needs, they focus on the quantity and not the quality 
of information and only want to get done, they do not think the deaf 
patient cannot understand, that is why they need to make time for 
the deaf. They must ensure that when the person leaves they fully 
understand and know what to do. Most pharmacist talk even though 
they know you are deaf, hence no, there is no relationship.” 
FG 15:“It seems that they are always pressured for time or they always ask 
you to bring a hearing person, always frustration.” 
 
A very prominent finding of this study is that Deaf people want pharmacists to 
understand them and learn to use sign-language. This is their most common 
suggestion for improvement in pharmacy services. This suggestion is not 
surprising. The literature indicates that Deaf people prefer to use sign-language 
over any other form of communication, and in fact that they find lip-reading and all 
other methods to inferior to sign-language. Furthermore, they dislike the imposition 
of spoken and written language by healthcare professionals. In spite of the 
importance that Deaf people assign to pharmacists being able to communicate in 
sign–language, this is probably an unrealistic expectation. In reality, pharmacists 
already have immense workloads and face human resource shortages, it is unlikely 
that they can and will be trained to be fluent in a new language.  Instead 
pharmacists should look toward other ways to provide sign-language services, 
perhaps through interpretive services at healthcare facilities or through drawing on 
technological innovation solutions that are able to provide sign language translation 
services. The following quotations represent participants preference to and need for 
sign-language communication from the pharmacist: 
KI 2: “The pharmacist must learn the deaf culture. This will put the deaf 
patient at ease as this is something he can relate to.” 
FG 12:“Also, why can’t the pharmacist learn sign language, it would be 
easier and instil more confidence for the deaf patients on the 
pharmacist.” 
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FG 16: “The pharmacist needs to understand that the deaf people are not 
children; they need to learn to communicate with them. 
FG 3: “Also, why can’t the pharmacist learn sign language, it would be 
easier and instil more confidence for the deaf patients on the 
pharmacist.” 
FG 8: They must learn how to communicate with us so they can sign back 
to us. 
 
 
5.1.9.1.3 THEME 3: Strained relationship between Deaf patients and 
pharmacists 
Pharmacists often feel uncomfortable when having to deal with a patient who is 
disabled to such an extent that it affects their ability to communicate with that 
patient effectively (Ferguson & Shan, 2015). This does not only affect the 
communication from the pharmacist to the patient, but is reciprocal. The Deaf 
patient can easily pick up from the providers’ expression and body language that 
they are uncomfortable or irritated with the fact that they cannot communicate 
effectively (Harmer, 1999). Consequently, not only does the pharmacist feel 
uncomfortable, but the Deaf patient may feel even worse. Due to their inability to 
communicate with Deaf patients, pharmacists may not establish relationships with 
them, precluding the provision of adequate pharmaceutical care. In 
pharmaceutical care, establishing relationships with patients enables the joint 
responsibility to achieve optimal therapeutic outcomes. Understandably, if there is 
no relationship, pharmaceutical care is impossible to achieve. The health care 
system is failing in its mandate to serve Deaf patients, especially on their 
pharmaceutical needs. The following quotes illustrate the lack of relationships of 
Deaf patients with pharmacists: 
KI 3: “There is no relationship” (between a deaf patient and pharmacist) 
KI 4: “There is a void” (with regard to a relationship with their 
pharmacist) 
KI 1: “it should be more caring…more, more caring…because a deaf 
person they look at your face. If it’s sour then they won’t take note 
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because a deaf person goes according to emotion, facial 
expressions, so if you have a sour face they won’t take notice of you 
because they’re afraid to ask anything. That’s why your facial 
expression should be like a smiley face and you should just. be 
approachable 
FG 12: “The majority of the pharmacist just focuses on giving the medicine, 
they do not focus on the needs of the deaf patient, the 
communication needs, and they focus on the quantity and not the 
quality of information and only want to get done. They need to make 
time for the deaf.” 
Deaf people requested increased levels of social competency by pharmacists. 
Apart from wanting pharmacists to learn sign-language, they expressed a need for 
awareness of the challenges experienced by Deaf people, and that pharmacists must 
exercise patience in their interactions with them. This alludes to the lack of Deaf 
awareness similarly allotted to healthcare workers in general by Huntington et al., 
(1995), Lomas (1998) and Haricharan et al., (2012). Many schools of pharmacy 
have included cultural competency in their curricula (Smith et al., 2010). However, 
disability is not normally included as a component of cultural competency 
education, and disabled groups are generally under-represented. This may result in 
the health inequities experienced by disabled people in pharmacies (Smith et al, 
2010). Improving the skills capacity of pharmacists to work with disabled people, 
including Deaf persons can limit the health inequities they experience (Smith et al., 
2010). The gaps in social competency by pharmacists emphasized in study findings 
include a frustration when working with Deaf people, a lack of patience and a lack 
of awareness about the inability of deaf people to read and write. These are 
illustrated in the following quotations: 
KI 2: “There is frustration from the pharmacist’s side when working with 
a deaf patient.” 
KI 4: “Pharmacists do not know that the deaf patients might not know 
how to read their instructions, and take it for granted that all deaf 
or people can read.” 
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KI 3: “Pharmacists themselves think it’s easier to write to a deaf patient 
or think that deaf people can lip read, but when the deaf person goes 
home, they do not know exactly what that is all about, there are       
a lot of misunderstanding.” 
FG 3: “They do not think the deaf patient cannot understand, that is why 
they need to make time for the deaf. They must ensure that when 
they leave they fully understand and know what to do. Most 
pharmacists talk even though they know you are deaf.” 
 
 
 
5.1.9.1.4 THEME 4: Communication methods employed by pharmacists 
 
Communication problems are a certainty for Deaf patients in a pharmacy setting 
(Iezonnio et al., 2004; Law et al., 2005 ; Steinberg et al., 2006; Kritzinger, 2011; 
Bat-Chava et al., 2005). This has resulted in pharmacists using alternative forms of 
communication. The most commonly used alternative forms found in this study are 
writing and lip reading. 
 
This is likewise a common finding in the literature (Ferguson & Shan, 2015; 
Iezonni et al., 2004; Reeves et al., 2002; Steinberg et al., 2006; Huntington et 
al., 1995). There is a misconception amongst pharmacists that all Deaf patients are 
able to read instructions. Limited literacy however, negates their ability to read, and 
even Deaf people who have some literacy capability, find the complex words used 
by pharmacists difficult to understand (Ferguson & Liu, 2015). There is a 
general assumption that all Deaf people are able to lip-read, which likely stems 
from a lack of Deaf awareness. Lip-reading is an acquired skill which is made more 
difficult by the fact that many similar words appear the same on a person’s lips 
(Reeves et al., 2002; Kritzinger, 2011). Despite its wide-spread use by 
pharmacists, relying on lip-reading and written communication have both found to 
be inadequate for the Deaf community (Steinberg et al., 2006, NAD, n.d. ; 
Ferguson & Liu, 2015). Deaf people prefer to have the pharmacist sign back to 
them instead of written or verbal instructions. All sixteen participants mentioned 
signing as their first preferred method for medicine instruction. This was followed 
by six participants mentioning that
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they preferred written instructions second to sign language for the reason of having a 
record that they could ask somebody to read it to them should they forget how to use 
the medicines. Only two participants preferred lip-reading second to signing. The 
strong preference for health-related information in sign language is supported in the 
literature, with most patient preferring sign-language interpretive services and 
experiencing higher levels of patient-satisfaction with the presence of a sign- 
language interpreter (Reeves et al., 2002; Steinberg et al., 2006). However, in under- 
resourced settings, technology may be deemed an alternative assistive service for 
Deaf patients. 
 
5.1.9.1.5 THEME 5: Limitations of medicine knowledge and its purpose 
 
A sub-theme that emerged from this theme is ‘misconceptions regarding 
medicine use.’ Spoken language (requiring a Deaf patient to lip-read) and written 
instructions are the most commonly used methods of instruction used by 
pharmacists in their interactions with Deaf patients. However these are 
inadequate methods of instruction as very few Deaf people have sufficient literacy 
and can effectively lip- read. They rely strongly on visual instruction rather than 
spoken or written instruction, preferring sign-language over other method. Deaf 
participants in this study felt that medicine instructions are often very vague, not 
specific and clear as they need it to be. This ambiguity leads to uncertainty 
about the medication and Deaf patients feel that they would rather abstain from 
taking the medication than being unsure about its indication and dosage. The 
majority of the participants complained that when providers supplied them with 
medication, they were not adequately counselled and therefore they were unable to 
use their medication in an optimal manner. Participants would not take medicine 
at all if they did not know what its purpose was. The following quote illustrates 
this: 
FG 9: “I couldn’t understand what the medication was about so I had to 
take it. My reading levels are not great. Which lead me to a point 
where I was not going to take the medication and be sick for  a 
while, but I’d rather be sick than not knowing what medication I’m 
taking.” 
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FG 5: “…words (as instructions) are difficult for me and I do not want 
what I don’t know” 
This finding is established in the literature. In a case-study based approach with a 
Deaf woman in Cape Town, Haricharan et al., (2012) also found that Deaf 
patients may not take their prescribed medicine if they do not know or understand 
its purpose. A quotation from Haricharan et al’s publication is very similar to the 
quotations by FG 9 and FG 5 above: 
“I threw the tablets away when I came back home because I did not know what 
they were for and I did not feel sick…I did not know what I had. If I had known, I 
would have taken them.” 
The context of this quotation illustrates the gravity of not understanding the 
purpose of medicines. In this case, the Deaf patient was raped and the medicines 
were for post-exposure prophylaxis of HIV/ AIDS. This patient subsequently 
contracted HIV, although the authors cannot definitively prove that contraction of 
the disease was from the rape incident. Patients’ non-adherence to pharmaceutical 
therapy due to a lack of understanding the purpose of the medicine is a problem 
that requires urgent attention. Non-adherence to therapy can have detrimental 
consequences and pharmacists must make very attempt possible to communicate to 
a Deaf patient the purpose of their medicine. 
 
Understandably so, Deaf patients are likely to vehemently refrain from taking 
medicines for which they have no understanding of the clinical indications. Such a 
situation clearly calls for imminent communication strategies to address the needs 
of the Deaf community which is often overlooked at health care facilities. As a 
start, concerted efforts are needed from role-players to introduce visual 
communication alternatives since it is the Deaf community’s most preferred mode 
when trying to engage with hearing society. 
 
Additional misconceptions and confusion regarding medicine use is illustrated in 
the quotations below: 
KI 3 “...when the deaf person goes home, they do not know exactly   what 
is that all about, there are a lot of misunderstanding.” 
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KI 4: “When its three times a day, they think you  take  3  tablets  not 
necessarily morning, midday and afternoon. This is very confusing 
for the deaf.” 
KI 2:   “Some deaf people are confused with before meals and after  meals, 
there is misconception with that.” 
KI 1:       “The thing is in the deaf community, they rely more on  instructions. 
If they see on TV or read that Panado® is taken two tablets, three 
times a day, they’ll only take two tablets, three time a day and they 
won’t recognise that it’s only for pain, unless somebody tells you 
“Listen, Panado® is only for pain,” you have to explain that to 
them properly in order for them to use it that way.” 
Again, analogous verdicts appear in the literature. Ferguson & Liu’s (2015) 
p a p e r  implied similar findings, with study participants requiring more clarity in 
medicine instructions, and commenting on their lack of understanding of the 
instructions. A number of participants in Ferguson & Liu’s (2015) study 
experienced an adverse effect as a result of the lack of understanding. One 
participant took two tablets at once, when they should have taken 1 tablet twice 
a day, while another drove after taking a medicine that causes dizziness but he 
was unaware thereof. Another participant took aspirin which interacted with 
treatment for a common cold and got ill as a result (Ferguson & Liu, 2015). 
Reeves et al., 2002, describe how Deaf people were given inadequate information 
regarding prescriptions and that a number of Deaf people were of the opinion 
that they were given incorrect medicines for their ailment. Others expressed 
anxiety that they were not told the purpose of the medicines. Two patients suffered 
illness after drinking a medicine that was intended to be used externally. Deaf 
participants in this study also experienced the following challenges when using 
medicines. These were based specifically on (i) the colour of the medicines and (ii) 
the medicine name: 
KI 1: “Deaf people do not look at the name of the medicine, they look at 
the colour e.g. Red tablet, when the person ask what medicine they 
use, they would say the Red tablet, and not the name, hence the 
person would not know the tablet.” 
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FG 14: “I don’t know green and yellow pill, what does that mean? It’s 
confusing because I don’t know what it is for but I take it anyway 
because the doctor said I should but I couldn’t understand him. I 
don’t know what green and yellow means; I know what the vitamins 
are and the pain tablets. 
FG 7: “Different names are confusing” 
 
FG 3: “small names and words are easy but big words are difficult. E.g. 
flu is easy.” 
 
 
The problems with the names of the medicine are easily understandable. Deaf 
people experience limited literacy and medicine names are often long, complicated 
and often chemistry based. For example, flucloxacillin is a common antibiotic, and 
is likely to be a difficult name to read for an individual who has limited literacy. 
Similar findings are reported by Ferguson & Liu (2015), with words being “too 
big, too complicated” and “words are specific and I don’t understand”. With 
regards to colours of medicines, some participants preferred to identify medicines 
using colour, while others did not. One participant was very frustrated with being 
told to use the green and yellow tablet, stating he/she does not know colours. This 
was not found in the literature, but may be explained by the fact that some 
Deaf people have a corresponding sight disability and commonly known as being 
deaf-blind, which may compromise their ability to see colour, For SignSupport 
design purposes, the problems with medicine names and colours are a significant 
finding which was noted by the researchers as important consideration in designing 
SignSupport. 
 
5.1.9.1.6 THEME 6: Need for autonomy in healthcare 
 
 
Deaf participants in this study showed a strong need to be self-reliant and do not 
want to be a burden on friends and family members to help them communicate in a 
hearing world. The Deaf participants indicated that being independent means that 
the feeling of being an invalid and incapable of functioning in society falls away 
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and enables them all to feel free to make their own decisions regarding their 
health. It also eliminates the negative connotation surrounding being “disabled.” 
Confidentiality regarding their treatment was also a significant issue. This was 
similarly found in the focus group, during which many participants refused to 
answer specific –treatment related questions, saying that “it is personal.” The 
following quotes illustrate the need to be independent or self-reliant and the 
need for confidentiality: 
KI 3: “The pharmacist needs to understand that the deaf people 
are not children; they need to learn to communicate with 
them, why should they always bring someone with them? 
Where is the confidentiality? Deaf people are very worried 
about their confidentiality.” 
FG 12: “There must be someone for us to communicate through. I 
am tired of asking other people to help me to communicate.” 
FG 9: “There must be someone that  is able to help us to 
communicate with us…there must be…I don’t like to ask 
other people at the clinic for help…I am tired of asking other 
people.” 
FG 7: “The major and most common issue for us is that we don’t 
like to ask other people to help.” 
FG 16: “ When there is  no signing there is no privacy, 
confidentiality is an issue as pharmacist tends to shout 
instructions’, e.g. getting ARVs, the pharmacist will shout 
“ARVs” and other people will hear. 
According to the literature, a lack of confidentiality is also a problem that the Deaf 
people find with the use of sign-language interpreters in healthcare interactions, 
and would prefer to avoid having their medical information known by an 
interpreter. Harmer (1999) suggests that healthcare providers resist using sign- 
language interpreters to avoid violation of a patient’s privacy. The same is true   for 
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Deaf patients who choose not to use interpreters for reasons of privacy and 
confidentiality (Glickman, 2003). 
 
 
5.1.9.1.7 Summary of focus group and key informant interview results 
 
There were no anomalies in the findings of the baseline study. Even though there is 
marked paucity in the available literature on pharmacist-Deaf patient interactions, 
all study findings were confirmed in published research focusing largely on 
doctors’ or health-workers’ interactions with Deaf people. I have extensively 
presented the literature findings alongside my findings within the text. 
Shortfalls in the provision of effective health-related information and medicine 
instruction are evident. Pharmacists mostly use spoken language and written 
instructions to communicate, both of which are inadequate for Deaf  people. 
Among the challenges in using medicines are uncertainty about the purpose of the 
medicine, the inability to identify lengthy generic names, poor understanding of 
verbose instructions and problems in identifying medicines based on the colour of 
the tablets or capsules. Consequently, Deaf people have used medicines incorrectly, 
thus experiencing untoward effects, or have not taken medicines at all, implying 
non-adherence to prescribed therapy. 
In addition, Deaf people experience negative attitudes from healthcare 
professionals, including pharmacists and believe that they are not given an equal 
level of care as hearing patrons. Participants have requested increased levels of 
social competency from pharmacists in interacting with Deaf people. This is a 
finding that needs to be considered in pharmacy curricula. When asked to suggest 
strategies of improvement to counter these problems, all participants advocated for 
pharmacists to communicate with them in sign-language, but this is understandably 
an unreasonable expectation. It would require pharmacists to become fluent in 
another language, mastery for which, in light of their high workloads, they are 
unlikely to have the time. Lastly, Deaf people are concerned about their 
confidentiality when  relying on  family or  a  sign-language  interpreter  for health- 
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related problems. The lack of privacy may affect their health-seeking behaviour, 
precluding essential treatment. 
In our attempt to consider a design for a potential technological intervention which 
aimed to bridge the communication gap between a pharmacist and Deaf patient, it 
was incumbent for the research team to consider the challenges and suggestions 
emergent from the focus groups and key informant interviews. This information is 
presented as challenges below, accompanied by proposed suggestions to resolve 
these challenges: 
Challenges emergent from the qualitative study with the Deaf community: 
 
• Deaf people must be communicated with in sign-language. For them, it is 
not an option; it is their language, and the only means they have to 
communicate in the world. 
• There is significant lack of Deaf awareness from healthcare professionals 
including pharmacists. 
• Waiting rooms are a particular problem for Deaf people, often resulting in 
missed opportunities for treatment. 
• Specific challenges in medicine instruction are the use of words  and 
colours. If possible, these would need to be avoided in using SignSupport. 
• Deaf people are concerned about their confidentiality in healthcare 
interactions. They resist the assistance of a third person during the 
interaction for a fear of violation of their privacy. If possible, SignSupport 
needs to be an intervention that offers Deaf people independence. 
 
 
In addition, we need to take cognizance of the context in which pharmaceutical care 
is offered at facilities. It is inevitable that capturing common pharmaceutical 
phrases that are shared routinely during a pharmacist-patient interaction would 
serve as a framework for the next logical step, which is the extraction of a dialogue 
pattern that could be translated into sign language. 
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SECTION B: DIALOGUE PATTERNS FOR DISPENSING 
 
Pharmacists are intended to be significant users of SignSupport. They will dispense 
medicines to Deaf people using the prototype to ‘say’ that which they would 
normally say during patient counselling (for example, take one tablet three times a 
day). Instead of using words, the ‘saying’ would occur by selecting the medicine 
instructions on SignSupport which are subsequently converted into a corresponding 
sign-language video that can be watched and interpreted by a Deaf patient. 
 
Understandably, for pharmacists to be receptive to using SignSupport, it would 
need to be set up in such a manner that it could be intuitively and instinctively used 
by pharmacists. It can reasonably be asserted that intuition and instinctiveness 
during a process comes from continuous and protracted experience of the process. 
For example, if pharmacists typically habitually day after day say “take 1 tablet 
three times a day after meals,” then the words and the word order are intuitively 
spoken; he/she does not have to think about what words to use or which order to 
use the words in. An analogy of such intuitivism is seen in the process of driving a 
motor vehicle. Drivers steer the wheel, apply the brakes, accelerate and decelerate 
etc. instinctively and without having to pause and think about what to do. In the 
same way, we aimed that the communication flow on SignSupport be intuitive for 
pharmacists. To achieve this, the researchers wanted to design the patient 
counselling dialogue structure in such a manner that it mimics as closely  as 
possible the dialogue which pharmacists would typically say and the order in which 
they say it. 
 
5.2.1 Research objective linkage 
 
This component of the study was conducted to achieve the second research 
objective: 
• To extract a dialogue pattern representing the communication tha t  
would typically occur between a pharmacist and a patient during patient 
counselling, and to express this pattern as a series of ordered sentences. 
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Specific research questions connected to this objective are: 
 
1. What are the sentences that pharmacists typically speak during the 
patient counselling process? 
2. What is the sequential order of these sentences? 
3. If pharmacists ask questions, what are the possible answers that they are 
trying to elicit? 
 
5.2.2 Study site and participants 
 
Final year pharmacy students were invited (convenience sampling) to participate in 
the study as a substitute for pharmacists. The benefits of using students to 
investigate the dialogue patterns are (i) that students were freshly trained in patient 
counselling at university as opposed to practicing pharmacists who may have 
inherited suboptimal practices over time, and (ii)  that  accessing  students was 
easier than the limited access to pharmacists at their workplace (due to shortage of 
pharmacists and high patient loads). The study occurred at UWC School of 
Pharmacy to ensure convenience for and close proximity to the participants (n=9). 
All the participants were English speaking and in the age group twenty to thirty 
years. The majority were female (n=7) and two participants were male. Participants 
were informed about the study in person and via participant information sheets. 
They were asked to sign consent forms to indicate their voluntary participation. 
 
 
5.2.3 Methodology 
 
Dialogue patterns were investigated qualitatively through covert observation and 
role-play techniques. The objective was to study the typical dialogue that occurs 
between a patient and a pharmacist during patient counselling. To accomplish this 
objective, the pharmacist is represented by the pharmacy student and a patient is a 
simulated-patient actor. A role-play room was set-up to resemble a dispensary 
located in a hospital pharmacy, typically resembling a scenario where Deaf people 
normally collect medicines. A mock patient identification card, pseudo 
prescriptions   for   acute   and   chronic   treatment   (influenza,   and  hypertension 
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respectively) and the medicines for treatment of these conditions were prepared. 
The simulated patient was given the mock patient identification card and the 
prescription and was briefed to act as a patient presenting the prescription to the 
pharmacist at the dispensary. The pharmacy students were given only  the 
medicines and were asked to dispense the medicines to the simulated patient during 
the role-play in the best way that they could (i.e. adhering to professional 
requirements). The reason for having both acute and chronic  treatment 
prescriptions was to investigate dialogues that would adequately represent patient 
counselling for both short-term and long-term medicine use. The role-plays were 
observed covertly through video transmission via an adjacent room setup with 
television screens. 
 
 
5.2.4 Materials 
 
The following materials were used in executing the afore-mentioned study tasks: 
• Video-relay system (video cameras and television screens) 
• Mock patient identification card 
• Pseudo prescriptions for treatment of influenza and hypertension 
• Medicines to dispense from the prescription (amoxicillin, enalapril, 
hydrochlorothiazide and paracetamol) 
• Medicine counting tray and spatula 
• Brief for the simulated patient 
• Stopwatch 
 
 
5.2.5 Study procedure 
 
Each pharmacy student was asked to dispense two prescriptions in total, one each 
at separate patient counselling sessions. One prescription was for influenza and the 
other, for hypertension. The study procedure occurred as the following successive 
steps: 
1. A pharmacy student entered the role-pay room, stood at the ‘dispensary’ (to 
represent a pharmacist) and was approached by the simulated patient who 
handed over a prescription to the pharmacy student. 
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2. After handing over the prescription, the simulated patient sat down in the 
waiting area (as per the briefing instructions). 
3. The student evaluated and interpreted the prescription and selected and 
prepared the medicines. 
4. The student called the simulated patient to receive the medicine. 
5. The student dispensed the medicines on the prescription. 
6. The student concluded the interaction and both the student and simulated 
client exited the role-play room. 
7. Steps 1-6 were repeated eighteen times, each student (n=9) completed 1 
session for acute treatment and another for chronic treatment. 
 
The interaction was observed covertly through video transmission to an adjacent 
room setup with television screens. Researchers recorded the dispensing time per 
prescription, sentences which were spoken, questions asked by the pharmacist and 
the chronological order of the sentences and questions. 
 
 
5.2.6 Data analysis 
 
Srivasta’s 3-question framework was used as the main method of analysis. It was 
applied in the process of constructing and interpreting an OSCE (Objective 
Structured Counselling Evaluation) checklist which was used as a data analysis 
instrument. An OSCE is a widely accepted training tool that is utilised to teach and 
assess the competency of students in the practice of patient counselling. It is used 
to evaluate whether students have the skills to practice professional counselling and 
comprises a series of patient counselling parameters as checklist points. The 
checklist points are grouped into consecutive steps that make up a counselling 
session. While OSCEs are not formally known to be a data analysis tool, the 
researchers found it to be a useful instrument for analysis because it resembles a 
communication flow that occurs during patient counselling. In addition, it 
comprises all the compulsory medicine information parameters required to be 
covered during the course of such counselling. An example of an OSCE used at 
UWC School of Pharmacy is illustrated below: 
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Figure 16: Example of an OSCE 
 
STEP 1: Clarification of the presenting problem  √ 
STEP 2: General history 
2 Age √ 
3 Physiological  status( e.g. pregnant) √ 
4 Previous allergies and reactions to drugs √ 
5 Previous and Current illness √ 
6 Current medication √ 
STEP 3: History of present illness 
7 Onset of Symptoms (duration?) √ 
8 Accompanying symptoms to current condition √ 
 
To suit study purposes, the researchers modified an OSCE from the undergraduate 
curriculum at UWC School of Pharmacy. The modified OSCE (Appendix H) was 
used as a data collection and analysis instrument and allowed us to tick off 
checklist points representing the parameters of patient counselling that the 
pharmacy student did/did not cover. Adjacent to each checklist point that the 
student communicated, researchers wrote the associated sentence (verbatim) that 
was spoken by the pharmacy student. 
 
5.2.7 Results and Discussion 
 
The modified OSCE is a consecutive checklist of patient counselling parameters 
that a pharmacist is obligated to cover during the medicine dispensing process. 
Nine pharmacy students were each asked to dispense two prescriptions (one each 
for acute and chronic treatment) to a simulated patient. This generated a total of 
eighteen dispensing sessions. 
 
Participants did not always conform to the same order of the checklist points for 
each of the 18 sessions. The researchers however, noted that for 13 of the 18 
sessions, the same order of checklist points was followed. From this majority 
incidence (72 %) the sentence order was subsequently adopted as the dialogue 
pattern. The literature supports the sequential order of medicine instructions. 
Rantucci (2001) and Berger (2009) refer to a common “sequence of instructions” 
followed during the provision of medicine-related information to patients. 
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Researchers collated the sentences which were spoken by participants during their 
interaction with the simulated client. These sentences were not identical for all the 
students but the differences between them were negligible as they were all 
essentially communicating the same aspect of patient counselling. For  example, 
one student would say “this is your medicine, panado,” while another would say 
“doctor prescribed the medicine, panado, for your problem.” It became evident to 
the researchers that, more important than the exact words in the sentences, was the 
content it represented and the order in which the sentences were spoken. 
 
The complete dialogue pattern and sentences are represented in Figure 17 as study 
results. Adjacent to each sentence and allocated in brackets is the frequency (total 
number of times the sentence was spoken) expressed as a total number out of 18 
(the total number of dispensing sessions). Note that the sentences reflected in 
Figure 16 are not a verbatim reflection of what the student said, instead each 
sentence represents a group of similar equivalent responses that were expressed in 
different ways. For example, in all 18 sessions the students greeted by saying 
“hello,” or “hi” or “good-day” or “good afternoon.” These are represented 
collectively in the results by using a generic term, “hello” as it communicates the 
same patient-counselling parameter. Figure 17 below presents the frequency scores 
of similar sentences or phrases used during the role-play session between the 
pharmacy students and simulated patient. 
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Figure 17: Frequency scores of similar sentences/phrases spoken during the 
role-play session between the pharmacy students (n=18, 100%) 
and simulated patient 
 
 
 
 
 
 
 
 
 
 
 
 
Feedback and closing 
 
•Do you understand? 
•Can you tell me how to use your medicines? 
•Do you have any questions? 
•Thank you/ Bye 
(n=14) 
(n=4) 
(n=14) 
(n=18) 
Medicine decision-making 
 
•This is (medicine name) and it is for your (illness/symptom name) (n=18) 
• Medicine instructions (dose and frequency) (n=18) 
• [e.g. You must take (n) tablets    times a day   meals] 
•Recommendations (n=18) 
[e.g. take it only when necessary/ take it everyday at the same 
time/complete the treatment] 
•Warnings 
• 
• 
Reduce smoking and alcohol when you take the medcine (n = 18) 
If you experience side effects call your doctor (n = 14) 
Clinical reasoning 
 
•Advice about medical problem (causes and lifestyle considerations)  (n=10) 
General history 
 
•Where do you live? 
•Do you have allergies to food or any medicine? 
•Are you using  any medicines currently? 
•Have you used medicines in the past 6 months? 
•Do you have clean water and acess to three daily meals? 
•Do you smoke or use alcohol? 
•What is your weight? 
•What do you do for a living? 
(n=4) 
(n=14) 
(n=14) 
(n=14) 
(n=12) 
(n=10) 
(n=8) 
(n=4) 
Patient Identification 
 
•What is your name? 
•Show me your identification card or date of birth 
(n=16) 
(n=11) 
Patient Greeting 
•Hello 
•How are you? 
•I am (name), the pharmacist for today 
(n=18) 
(n=15) 
(n=12) 
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Pharmacy students commenced all eighteen sessions by greeting. They asked the 
patients “how are you?” in fifteen sessions and introduced themselves as the 
pharmacist in twelve sessions. Since these sentences were used in the majority of 
sessions, they were considered important in the pharmacist-Deaf  patient 
interaction. Sentences were grouped as “patient greeting” and constructed for 
SignSupport as: 
• ‘Hello, I am the pharmacist (…name……). How are you?” 
 
 
Students asked the patient for their name (n=16) and requested to see an 
identification card eleven times. Once again, due to the frequency that these 
questions were asked, they were considered important to use in SignSupport, and 
was constructed as: 
• “Could you state your name please, and may I see your patient card? 
Interestingly, none of the studies reviewed in the literature reported  that 
establishing a patients’ identification is an important part of medicine-related 
information. This may be due to the fact that asking for a patient’s identification is 
a function specific to the context of hospital/institutional pharmacy. 
 
During all the sessions, students asked questions about the patient’s general 
medical history. However, all eight questions regarding general history reflected in 
Figure 17 were only asked in ten of the eighteen sessions. In addition, the order of 
these sentences varied largely between sessions. Only two sessions included an 
enquiry into where the patient resides. This was asked to ascertain living 
circumstances, for example an urban or rural area which would indicate access to 
water, sanitation etc. In a country such as South Africa where poverty levels are 
high and it is common for people to live in informal settlements where basic water 
and sanitation services are often compromised, this is important information for 
pharmacists to elicit. 
 
The experience of allergies was enquired about in sixteen of the eighteen sessions 
(89 %). This was possibly due to the presence of an antibiotic on some of the 
prescriptions. Pharmacy students are trained to be sensitive to the possibility of 
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allergic reactions when dispensing medicines. This finding is corroborated in the 
literature, with allergic reactions and side effects receiving the highest significance 
(58 %) with regards to information requested from patients for medicines in 
accordance with a new prescription. Furthermore, in Berry et al’s (1997) study of 
the ranking of sixteen information types by patients and doctors, patients ranked 
adverse effects (including allergic reactions) to be the most important (ranking 
number 1). 
 
Fourteen sessions included questioning of current and past medicine use while 
twelve sessions incorporated questioning of access to clean water and  regular 
meals. Meals and water are important considerations to pharmacists who often 
advise patients to take medicines with, before or after meals to ensure the safety 
and efficacy of medicines and are even more important in South Africa where the 
high levels of poverty often preclude people’s access to meals and clean water. 
Questioning of meals and water is not seen in the literature, perhaps because the 
reviewed studies were not done in resource constrained countries. 
 
For similar reasons of safety and efficacy, the patient was asked about whether he 
smokes and uses alcohol, which interacts negatively with some medicines causing 
untoward effects or negating the efficacy of the medicine. Patients were asked 
about their weight during eight sessions. This is supported in Berry et als’s (1997) 
ranking study where patients ranked lifestyle modifications as the third most 
important aspect of patient counselling. Most of the questions posed on general 
medical history were asked in majority of the sessions and thus seem to be an 
important part of the dialogue. For incorporation into SignSupport, these questions 
were constructed as the following: 
• Do you have allergies to food or any medicine? 
• Are you using any medicines currently? 
• Have you used medicines in the past 6 months? 
• Do you have clean water and access to three daily meals? 
• Do you smoke or use alcohol? 
• What is your weight? 
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The afore-mentioned questions posed a significant challenge for the research team. 
These are crucial questions to ask in a pharmacy context, but from a SignSupport 
programming perspective, and taking into consideration that Sign  Support 
translates text (input by the pharmacist) to sign-language for the Deaf patient, it is 
not able to translate sign-language from the patient into text for the pharmacist. We 
identified a problem in that we would need to preclude aspects of the dialogue 
which would require the Deaf person to formulate lengthy answers. Alternatively, 
researchers would have to find a way to incorporate these questions into 
SignSupport in another, less problematic manner. 
 
‘Clinical reasoning’ was the next section of the dialogue pattern and involved the 
pharmacy student providing advice to the patient about the medical condition that 
the prescription was intended to treat. This advice included causes of the medical 
condition and lifestyle behaviour modifications to improve the condition. Clinical 
reasoning is another important feature of the dialogue pattern, but does not feature 
prominently in any of the reviewed studies on medicine information. This may be 
due to the fact that pharmacist and patients concentrate on information directly 
linked to the medicine, and not the medical condition it is intended to treat. The 
dialogue that emerged from the ‘clinical reasoning’ section was reminiscent of the 
reasons why the Looijestein-Mutemwa SignSupport prototype was unsuccessful. It 
would be impossible to record sign language videos to translate the causes and 
lifestyle modifications regarding every possible symptom and illness, and store 
these on commercially available phones which simply do not have the storage 
capacity to handle multiple, large videos. As a result, no dialogue was constructed 
for SignSupport featuring illness/symptom specific clinical reasoning. 
 
Medicine-specific instructions followed the ‘medical issues’ section. The findings 
from this section differ to those previously presented in that four of the five 
sentences were said by all the pharmacy students. In addition, the sequence of 
sentences was identical for the eighteen sessions. The strength of the findings for 
this section is indicative of the medicine-specific biases of the pharmacy students. 
Pharmacists are seen as the custodian of medicines and it is their duty to advise 
patients about how to use medicines. This finding is supported in the literature with 
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basic medicine instructions featuring prominently in the lists of medicine 
information that must be communicated. It also features as a pharmacist’s 
responsibility in the SAPC definition if dispensing: “Provision of information and 
instructions to the patient to ensure safe and effective use of medicines.” 
The strength of the results in this section also indicated to the researchers that this 
section was crucial to pharmacists and that if SignSupport failed to present the 
intended dialogue pattern properly, pharmacists may not be receptive to using the 
prototype. We expressed these sentences in the following manner for incorporation 
into SignSupport: 
 
1. This is your medicine, … (name) 
2. You have to take … (number) tablet(s)/capsule(s) ... (number) times 
per day. 
3. That means take it in (the morning and/or afternoon and/or evening. 
4. Take it (in relation to meals) ….. before meals/with meals/after meals. 
5. Recommendations 
a. Take this medicine only when necessary 
b. Take this medicine  every day at the same time 
c. Complete the treatment 
6. Warnings 
a. Reduce smoking and alcohol when you take the medicine 
b. If you experience side effects call your doctor 
c. This medicine may cause drowsiness. Avoid driving or 
operating machinery 
 
 
 
In closing the session, majority of the pharmacy students asked participants 
whether they understood what was said and students allowed the participant to 
ask question multiple times until they were satisfied that the participant understood 
sufficiently. Conversely, the participant asked to explain the instructions they 
were given back to the pharmacist only during four sessions. The dialogue in this 
circumstance was “would  you  please tell  me how  you  will take this medicine” 
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(holding up a particular medicine container). Interestingly, feedback and 
questioning do not feature on any of the reviewed studies regarding medicine 
instructions, even though joint interaction is cornerstone to pharmaceutical care. 
At the end of all the sessions, the pharmacy student handed over the medicine with 
general greeting dialogues (bye, thank you, have a good day etc.). Since 
SignSupport is intended to largely allow a one-way communication flow, we 
excluded questions from the closing sessions of dialogue and constructed the 
sentence as: 
Thank you, goodbye. 
 
 
The sentences elucidated from the role-plays and reconstructed for SignSupport 
appear in bold, italicized font above. These sentences were collated and formed the 
dialogue pattern for incorporation into SignSupport. The complete communication 
structure is presented in Table 9 below: 
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Table 9: Communication script for SignSupport 
 
 
ORDER 
 
DIALOGUE 
1. Hello, I am the pharmacist (…name…). 
2. How are you? 
3. Could you state your name please, and may I see your patient card? 
4. Do you have allergies to food or any medicine? 
5. Are you using any medicines currently? 
6. Have you used medicines in the past 6 months? 
7. Do you have clean water and access to three daily meals? 
8. Do you smoke or use alcohol? 
9. What is your weight? 
10. Doctor has prescribed  medicine for your ….(illness/symptom) 
(Here include a complete list of all possible symptoms and illnesses) 
11. This is your medicine, … (name) 
(Here include a complete list of all possible medicine names.) 
12. You have to take … (number) tablet(s)/capsule(s) ... (number) times per day. 
(Here include all possible dosage forms (e.g. tablets, syrups etc.) and dose 
units (milliliter, spray, puff, pump etc.) 
13. That means take it in … (the morning and /or afternoon and/or evening). 
14. Take it … (in relation to meals)…before meals /with meals /after meals. 
15. Recommendations 
16. • Take this medicine only when necessary 
17. • Take this medicine every day at the same 
18. • Complete the treatment 
19. Warnings 
20. • Avoid smoking and alcohol intake while using this medicine 
21. • If you experience side effects call your doctor 
22. • This medicine may cause drowsiness. Avoid driving or operating 
machinery 
23. Thank you, goodbye 
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5.3 CONCLUSION: BASELINE STUDY 
 
The research objectives outlined for the baseline investigation were successfully 
achieved. Findings from the focus group discussion and key informant interviews 
offered in depth insight into the Deaf community’s experiences at healthcare 
facilities and delivered valuable information to be incorporated in the design and 
development of SignSupport. 
The dialogue pattern elucidated from role-pay sessions between a simulated patient 
and pharmacy student generated a communication structure that will be used as the 
foundation of the programming architecture for pharmacist-patient interaction via 
SignSupport. 
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CHAPTER SIX 
RESULTS AND DISCUSSION: INNOVATION PHASE 
_______________________________________________________________ 
 
This chapter presents the second and most intensive research phase which 
comprises development of key components needed to build SignSupport. It is 
divided into two main sections, the first of which describes the theoretical 
underpinnings influencing the design of SignSupport, and incorporates three 
conceptual processes and one empirical activity (Section A). The conceptual 
processes include the compilation of prescription instructions, a database of 
symptoms/illnesses and a comprehensive list of medicine names. The empirical 
process involves video verification testing to evaluate the accuracy and correctness 
of the sign-language translation videos used in SignSupport.   
The thesis reaches its apex with Section B which presents the first completed 
version of SignSupport incorporating the dialogues, user input, databases and 
verified videos. A description of how a pharmacist would use SignSupport is 
provided with an annotated pictorial illustration of the application.  
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SECTION A: SIGNSUPPORT DESIGN DETERMINANTS 
The previous chapter concluded with a communication script for SignSupport and 
Deaf user experiences which influence the design of SignSupport. The logical 
forward progression is to collate the other components needed in SignSupport’s 
programming, these components include (i) databases of medicine names and 
disease/symptom names and (ii) sign language videos which accurately translate 
the instructions and symptom/diseases from English text into SASL.  
 
This section details the innovation of SignSupport. Firstly, the theoretical 
foundations on which SignSupport are grounded are described.  Thereafter, the 
development of specific components required to build SignSupport is explained. 
During such development, a conflict arose which caused the research team to 
suspend our efforts and re-strategize before the project could continue.  This 
conflict and the resolution thereof are also described in this section. 
 
6.1 Theoretical underpinnings for design of SignSupport 
A significant part of this dissertation is aimed at research, and an equally 
significant part is innovation. Chapter four detailed the theoretical paradigms for 
the research aspect. Below I discuss the selected paradigms (Human-centred design 
and Community-based co-design) for the innovation of SignSupport.  
 
6.1.1 Human Centred Design 
Human-centred design (HCD) has been placed alongside Technology-driven 
design and Environmentally-sustainable design as one of the three major discourses 
for design and innovation (Giacomin, 2012). With origins in semi-scientific arenas 
including computer science, artificial intelligence and ergonomics, HCD focuses on 
incorporating human factors, usability knowledge and techniques in design and 
innovation. It is essentially design for the human user, taking into account human 
factors and based on pre-determined user aspects.  International standard ISO 
9241-210 presents six features of HCD (Giacomin, 2012): 
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1. The adoption of multi-disciplinary skills and perspectives 
2. Explicit understanding of users, tasks and environments 
3. User-centred evaluation driven and refined design 
4. Consideration of the whole user experience 
5. Involvement of users throughout design and development 
6. Iterative process of development  
 
Many experts have written on the benefits of HCD as elevating the usability of an 
innovation since design is centred on user aspects. All six of the above 
characteristics were design intentions among the multi-disciplinary team and were 
applied in the design process of SignSupport. HCD has however also been 
criticised. The main basis of such criticism is that HCD leads to design that is 
skewed toward one or more predetermined user patterns, thereby presenting 
limitations in levels of interactivity and exploration (Giacomin, 2012).  Experts 
who are critical of HCD have suggested elevated levels of design:  designers 
should aim to determine design requirements based on what they know about the 
people involved and the environment in which they interact. Furthermore, 
designers must consider their users’ emotional engagement and identify what the 
product means to and for intended users. Krippendorf (1989, 2004) cited  in 
Giacomin, (2012) describes this as: “…the use of artefacts is inseparable from how 
users conceive them and engage with them in their world….humans do not respond 
to the physical qualities of things but to what they mean to them.” It was apparent 
that if we wanted to achieve noteworthy benefits for the Deaf community in using 
SignSupport, we had to extend our view beyond the notion of design for humans 
(HCD), and elevate it to include “emotional” and meaningful elements.  
 
6.1.2 Community-based co-design 
Community-based co-design is a multifactorial approach developed by Blake et al., 
(2011) and integrates “action research, industrial design approaches, education and 
other societal elements”. Blake et al., (2011) describes community-based co-design 
as: 
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“a way of exploring a design space in a way that alleviates the restrictions of the 
designer's own viewpoint and bias. In a cyclical fashion the designers develop 
according to their skills and learning and according to the users' expressed 
requirements and their learning. The researchers and the users end up being the 
design team.” 
Blake et al., (2011) who conceptualized community based-co-design, are our 
predecessors in research with the Cape Town Deaf community and much of this 
work was based on their prior work with, and input from joint meetings with the 
Deaf community. Furthermore, Blake et al. were also pioneers of SignSupport with 
their involvement in conceptualization of Mutemwa’s (2011) doctor-Deaf patient 
prototype on a Symbian phone.  
 
By making users significant players in the design process, community-based co-
design extends beyond the boundaries of human-centred design in that it 
establishes design with human users, rather than for human users. I incorporated all 
the elements of human-centred design in the medicine-information communication 
elements and also entrenched the concept of community-centred design as the 
principal theoretical inclination for my contribution in this multi-disciplinary 
venture.  
 
6.2 A recap of SignSupport design requirements 
The iterative development of SignSupport necessitated the following pre-requisites 
previously alluded to in preceding chapters: 
1. A multi-disciplinary collaboration to contribute different areas of expertise. 
2. An in-depth insight into the experiences of Deaf people with regards to the 
patient counselling process and medicines usage. These insights would 
inform the design of the Deaf-user interface of SignSupport.  
3. Naturalistic behavioural patterns of pharmacists when offering medicine 
instructions. This would lead the design of the pharmacy interface. 
4. Sign-language videos which translate medicine instructions from text into 
SASL.  
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6.3 Development of components for SignSupport 
The following list of items was needed to build SignSupport: 
1. A pharmaco-therapeutic communication script (dispensing dialogue 
patterns) 
2. Information regarding Deaf user experiences at the pharmacy 
3. Medicine information databases 
a. Symptoms and illnesses database 
b. Database of medicine names 
4. Recorded and verified SASL videos to translate items 1 and 3above  into 
sign language. 
 
6.3.1 Conflicting perspectives 
In the previous chapter, empirical activities which yielded the pharmaco-
therapeutic communication script and information regarding Deaf user experiences 
at the pharmacy (items 1 and 2 on the list above) were presented. These were 
intended to be the first building blocks in the architecture of SignSupport. 
However, the research team immediately encountered technical problems which 
altered the course of SignSupport’s design. These technical problems involved a 
conflict between that which was considered to be essential from the pharmacist’s 
perspective, and that which was possible, from the computer programmer’s 
perspective. What was ‘possible’ related to the coding limitations of commercially 
available mobile phones, For example, in the pharmacists’ dialogue pattern, the 
first item is “Hello, how are you?.” Pharmacists greet the patients to establish 
rapport and as a matter of courtesy. Furthermore, a key feature of the dispensing 
process is that a patient is able not only to receive messages, but also to encode a 
response, which is usually feedback on their understanding or questions they may 
have with regard to their medicine. The pharmacist was of the opinion that without 
an opportunity for the patient to pose questions or provide feedback, the patient 
counselling session was not truly fulfilled.  
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 The computer programmer however, was of the opinion that greetings and other 
courtesies, including feedback and questioning, were unnecessary to incorporate 
into SignSupport for two reasons: (i) a Deaf patient is unlikely to answer the 
question of how they are, and (ii) the words “Hello, how are you?” would need to 
have a corresponding SASL video to be translated to the Deaf patient. Since a code 
(computing) needed to be written for all the communication elements on 
SignSupport,   the ‘unnecessary’ script and videos would also require coding. 
Furthermore, with regard to the feedback and questioning, SignSupport would need 
to be able to translate sign-language (‘spoken’ by the Deaf patient) into text for the 
pharmacist, in order to enable such functions. This would require highly 
sophisticated and expensive equipment, including hand- and facial sensors and 
intricate connectivity to be possible. This was simply not feasible due to the cost 
implications thereof.   
 
Moreover, the computer programmer felt that only elements of the dialogue that 
was absolutely crucial should be included. If this was not done, the unnecessary 
script elements would complicate the coding process and may introduce avoidable 
glitches in the programming architecture. In addition, the extra space required by 
the additional videos files, which are typically large and occupy significant 
capacity, may cause a delay in uploading and playing of the videos (i.e. it would 
take considerably longer for the videos to be viewed). The computer programmer 
was of the opinion that glitches in the system and a possible delay in playing videos 
would cause Deaf people to not use SignSupport, while the pharmacist felt that it 
was necessary to include all professionally required aspects of the interaction in 
SignSupport. The led to an impasse, causing design operations to cease until 
members of the collaborative team resolved this conflict. The conflict resolution is 
described in the next section. 
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6.3.2 SignSupport practical limitations and resolutions 
In an effort to find resolutions for the afore-mentioned conflict, members of the 
collaborative team called a strategizing meeting to state their perspectives and the 
importance thereof.  The perspectives of the team-members are elaborated on 
below: 
Pharmacist:  was unwilling to compromise the pharmacist’s code 
of practice. All professional and legally required 
items needed to be included in SignSupport to ensure 
my continued involvement in the project. 
Computer-programmer: asserted that it was unreasonable and impractical for 
SignSupport to include unnecessary items. He was of 
a pragmatic view that the research team had limited 
time and funds and that our efforts and time should 
be expended only on what was essential and would 
allow Deaf person to understand medicine 
instructions. He was of the opinion that “they (Deaf 
people) do not need a hello to understand how to use 
their medicines.” More importantly, he explained 
that SignSupport is a “limited communication 
domain” system. Limited in the sense that it contains 
preloaded communication elements, thus the system 
is only able to translate into sign-language that which 
has been programmed into the system. As such, fluid 
communication in the case of questions and 
feedback, which may include words or phrases that 
are not within the limited communication domain, 
would not be possible.   
Industrial designer: was in Netherlands at the time, but advised that the 
members above mutually decide on how to build 
SignSupport in a way that was practical, meets 
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professional stipulations and most importantly, 
would accommodate Deaf community needs. 
Further input from the computer science study promoter was the following:  
“We are building a prototype, not a market-ready system (yet). We eventually will 
get it to be commercially ready, but for now, we must design a prototype, a system 
that can carry a medicine interaction from start to finish that will has the 
capability to cause the Deaf patient to leave the pharmacy knowing clearly how to 
use their medicines because they were given instructions in sign-language by 
SignSupport”. We must get the communication flow right on a prototype, once we 
get it right it is then easy to populate the program with additional features.”   
-William Tucker, study promoter (UWC, Bellville, Cape Town, 2012)- 
 
As a result of the study promoter’s position and the strategizing meeting, the 
collaborative team took the decision to build SignSupport as a prototype. A 
prototype, by definition is “a first, typical or preliminary model of something, 
especially a machine, from which other forms are developed”(CourseHero, n.d.) 
The decision to build SignSupport as a prototype had significant implications: that 
we would design a complete (start-to-finish) communication flow for a pharmacist-
patient interaction, with a view that once it is designed and functioning in an 
acceptable and usable manner for Deaf people and pharmacists, that it could then 
be easily populated with additional aspects. This was a major decision in the 
trajectory of SignSupport’s design, and resulted in the following mutually agreed 
practical limitations of the prototype version: 
 
1. SignSupport would only include what was absolutely necessary in line with 
legal and professional requirements for a pharmacist-patient interaction. If 
during usability tests a burning issue arose that required another aspect to 
be added, the team would do so accordingly. This meant that we needed to 
revise the communication script elicited in the previous chapter, by 
selecting from that communication script only sentences which are 
absolutely essential.  
 
 
 
 
181 
 
 
2. SignSupport would be a ‘limited communication domain system.’ As 
such, only communication elements agreed on by the team would be pre-
loaded into the system, precluding the possibility of feedback and questions 
from the deaf patient.  The prototype would be designed to facilitate 
medicine instructions from the pharmacist to the Deaf patient with no 
option for the patient to reply. Communication via SignSupport would not 
be dyadic, but one-directional.  
 
3. At this stage in the design of SignSupport, we would structure the prototype 
to contain all the medicines possible for only one dosage form (*see note 
below); the selected dosage form would be the most commonly used by 
adults). For the reasons that it is the “most common type of dosage form in 
contemporary use” (Aulton, 2007) and frequently used by adults, we chose 
to design SignSupport for tablets/capsules, with the view that once we get 
the system operating smoothly for the selected dosage form, it would be an 
easy task add the additional dosage forms.  
• *A dosage form refers to “the physical manifestation of a drug as a 
solid, liquid and can be used in a particular way. Examples of 
dosage forms include tablets, capsules, creams, ointments, 
solutions, injections, and aerosols.” 
 
4. As much information as the phone’s storage capacity would allow, would 
be translated into SASL videos for the patient to watch, interpret and 
understand. It was not enough to merely record the videos. We would 
independently verify the content of each sign-language video for 
correctness (i.e. does it say what it is intended to say).  The team agreed that 
we would not take any risks in medicine instruction; we needed to verify 
the videos to be certain that they would communicate the correct 
information to a Deaf patient.  
 
5. The computer programmer would, if possible, add a Skype®-call feature 
onto the prototype. Skype®-call would allow a Deaf person to call an 
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interpreter during the patient counselling process should any critical issues 
arise during the interaction which necessitated SASL interpretive services. 
 
6.3.3 The way forward 
In light of the afore-mentioned resolutions and SignSupport requirements, the 
developmental progression of SignSupport changed. Along with these planning 
changes, the communication structure elicited in the previous chapter had to be 
modified to accommodate the resolutions. Once this was completed, the ensuing 
design functions could be executed. Design functions were executed in the 
following sequential order:  
1. Modify communication structure elucidated in  the previous chapter (five) 
2. Compile medicine information databases:  
a. Symptoms and illnesses database 
b. Database of medicine names 
3. Record SASL videos  to translate 1 and 2a above into sign language 
a. Independently verify recorded videos 
4. Collate 1-3 above into SignSupport and finalize SignSupport version 1 
 
6.4 Modifying the communication script  
In Chapter five, results of role-plays simulating interactions between pharmacists 
and patients to elicit the naturalistic dialogues of pharmacists were presented. 
These dialogues were organised in a pattern reflecting the sequence in which 
pharmacist participants spoke. This sequential order of sentences was accepted as a 
generic pharmacists’ communication script for SignSupport. However, in light of 
the previously discussed resolution to only include what was absolutely necessary 
in line with legal and professional requirements for a pharmacist-patient 
interaction, this communication script had to be altered. Table 10 below illustrates 
how the initial communication script was modified. Communication points 1-3 and 
23, highlighted in red, were completely removed from SignSupport because, while 
they help to establish rapport, they are not absolutely necessary or a legal 
requirement. It was also felt that these points could be replaced by the pharmacist 
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acknowledging the patients presence. Communication points 4-9, which are 
questions to the patient about his/her general medical history, were also removed, 
but not completely. Instead they were kept in SignSupport but transferred to 
another programming location and would still be sufficiently addressed. This is 
discussed later in the chapter. Table 10 below illustrates how the communication 
script was modified by presenting the communication points which were removed 
in red font. This is followed by Table 11, which presents the finalized 
communication script, after the modifications were effected.  
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Table 10: Modifying the original communication script 
ORDER DIALOGUE 
1.  Hello, I am the pharmacist (…name…).  
2.  How are you? 
3.  Could you state your name please, and may I see your patient card? 
4.  Do you have allergies to food or any medicine? 
5.  Are you using any medicines currently? 
6.  Have you used medicines in the past 6 months? 
7.  Do you have clean water and access to three daily meals? 
8.  Do you smoke or use alcohol? 
9.  What is your weight? 
10.  Doctor has prescribed  medicine for your ….(illness/symptom) 
(Here include a complete list of all possible symptoms and illnesses) 
11.  This is your medicine, … (name) 
(Here include a complete list of all possible medicine names.) 
12.  You have to take … (number) tablet(s)/capsule(s) ... (number) times 
per day. 
(Here include all possible dosage forms (e.g. tablets, syrups etc) and 
dose units (millilitre, spray, puff, pump etc) 
13.  That means take it in …(the morning and /or afternoon and/or 
evening). 
14.  Take it … (in relation to meals)…before meals /with meals /after 
meals. 
15.  Recommendations 
16.  Take  this medicine only when necessary 
17.  Take this medicine  every day at the same  time 
18.  Complete the treatment 
19.  Warnings 
20.  Avoid smoking and alcohol intake while using this medicine 
21.  If you experience side effects call your doctor  
22.  This medicine may cause drowsiness. Avoid driving/ operating 
machinery 
23.  Thank you, goodbye 
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Table 11 below represents the newly adapted communication script that was used 
for SignSupport. It was modified from the original script by removing 
communication points 1, 2 and 23, replacing communication point 3 and relocating 
communication points 4-9.  
Table 11: SignSupport communication script 
ORDER DIALOGUE 
1.  May I see your patient card? 
2.  Doctor has prescribed  medicine for your ….(illness/symptom) 
(Here include a complete list of all possible symptoms and illnesses) 
3.  This is your medicine, … ( medicine name) 
(Here include a complete list of all possible medicine names.) 
4.  You have to take … (number) tablet(s)/capsule(s) ... (number) times 
per day. 
(Here include all possible dosage forms (e.g. tablets, syrups etc.) and 
dose units (millilitre, spray, puff, pump etc.) 
5.  That means take it in … (the morning and /or afternoon and/or 
evening). 
6.  Take it … (in relation to meals)…before meals /with meals /after 
meals. 
7.  Recommendations 
8.  Take  this medicine only when necessary 
9.  Take this medicine  every day at the same  
10.  Complete the treatment 
11.  Warnings 
12.  Avoid smoking and alcohol intake while using this medicine 
13.  If you experience side effects call your doctor  
14.  This medicine may cause drowsiness. Avoid driving or operating 
machinery 
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6.4.1 Relocating communication points 4-9: General medical history questions 
The general medical history questions elicited from the dialogue patterns were: 
• Do you have allergies to food or any medicine?     
• Are you using any medicines currently?     
• Have you used medicines in the past 6 months?    
• Do you have clean water and access to three daily meals?   
• Do you smoke or use alcohol?      
• What is your weight?  
 
These questions were removed from the pharmacists’ conversation script in 
SignSupport for two reasons (i) they were questions (SignSupport facilitates the 
communication of medicine instructions from the pharmacist to the patient, it is not 
set up for questions because it converts text to sign-language not vice-versa as 
would be the case when the patient asks questions in sign-language, and (ii) the 
researchers felt that it was background information that could be recorded and 
stored by the Deaf patient prior to their interaction with the pharmacist. Instead of 
appearing as part of the dialogue, these general medical history questions were to 
be included on the phone as a section where Deaf patients are taught to upload their 
medical history based on a series of questions asked to them on a SASL translation 
video. This was called the ‘Patient profile’ section, and is one of the initial screens 
a pharmacist would encounter in their interaction with a Deaf patient while using 
SignSupport. The screen shows the presence of allergies, concurrent medicines, 
patient weight, whether they smoke or drink alcohol, and whether they have clean 
water and three meals daily. As a result, the pharmacist would still have this 
important information without having to ask the patient for it. Instead, it would 
appear on SignSupport.  
At this juncture in the study, and in relation to SignSupport design requirements, 
we have finalized the modified communication script and questions regarding a 
patient’s general medical history. Items 3-6 in Table 12 below will be addressed as 
this chapter progresses under the forthcoming subheadings.  
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Table 12: Progressive development of SignSupport components 
1. Modified communication script √ 
2. Patient general medical history questions √ 
3. Incorporate Deaf user experiences  
4. Compile medicine information databases: 
a. Symptoms and illnesses database 
b. Database of medicine names 
 
 
5. Independently verified SASL videos  to translate 1, 3 and 4 
above into sign language 
 
 
6.5 Incorporating Deaf user experiences 
From focus group interviews with Deaf people and key informant interviews with 
persons who had both Deaf knowledge/experience and pharmacy 
knowledge/experience (Chapter five),  specific information was elicited regarding 
the Deaf community that we would use to inform the design of SignSupport. The 
following information (1-3) was specifically addressed by solutions A-C below, 
respectively.  
1. Deaf people must be communicated with in sign-language only. For them 
sign-language is not an option; it is how they communicate in the world.   
 
2. Specific challenges for Deaf people in medicine instructions include the use 
of verbose, complex words and colours. If possible, these would need to be 
avoided in using SignSupport.  
 
3. Deaf people are concerned about their confidentiality in healthcare 
interactions. They resist assistance from a third person during the 
interaction for a fear of violation of their privacy. If possible, SignSupport 
needs to be an independent system.  
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A. All communication on SignSupport aimed at the Deaf user appears as sign-
language videos. This was done through the use of icons (designed with 
the Deaf community and by the industrial design engineer) and SASL 
translation videos recorded with an interpreter. At no point on the 
application does a Deaf patient encounter text. This includes the section in 
which he/she is required to upload information pertaining to their general 
medical history (i.e. the patient profile section).   
 
B. No words or colours are used to communicate medicine related 
information to the Deaf patient. Instead, a photograph of the medicine 
(taken by the pharmacist) appears as an image on the sign-language 
translation video to indicate to the patient which medicine to take. This 
will be explained more clearly in the second section which presents 
SignSupport. 
 
C. To maintain privacy and patient confidentiality, SignSupport will be set up 
as far as possible to preclude the use of an interpreter or any other third 
party to assist with medicine or health-related information. 
At this juncture in the study, and in addition to the modified communication script 
and questions regarding a patient’s general medical history, we have incorporated 
Deaf user experiences. Table 12 below demonstrates the progress thus far.  
Table 12: Progressive development of SignSupport components 
1. Modified communication script √ 
2. Patient general medical history questions √ 
3. Incorporate Deaf user experiences √ 
4. Compile medicine information databases: 
a. Symptoms and illnesses database 
b. Database of Medicine names 
 
 
5. Independently verified SASL videos  to translate 1, 3 and 
4 above into sign language 
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6.6 Compiling medicine information databases 
Following on from Table 12 above, the next requirement for SignSupport is 
compilation of a database including all possible symptoms or illnesses which a 
pharmacist could communicate to a patient in order to indicate the purpose of the 
medication. This is required to be included in point 2 on the conversation script 
presented earlier:  
“Doctor has prescribed medicine for your …. (Illness/symptom)” 
(Here include a complete list of all possible symptoms and illnesses) 
 
6.6.1 Database of symptom/illness names 
A pharmacist is required to include the symptom/illness name in their selection on 
SignSupport, and their selected symptom/illness name will be converted into a 
SASL translation video. For this to be realized, it was necessary to compile a 
database of symptoms and illnesses. In my approach to this, my first instinct was to 
be as inclusive as possible and be cognisant not to exclude any symptom or illness 
name. As a result, the Merck Manual of Diagnosis and Therapy (1992) was used 
to extract all possible symptoms/illness disease names. Commonly referred to the 
Merck Manual, the first edition was published in 1899 and it has since been used 
extensively by medical doctors, pharmacists and healthcare faculty as a reference to 
reach clinical and medical information. “Within the confines of a single 
publication, the Merck Manual remains unparalleled in its scope and detail” (de 
Korte, 1992). The strategy to achieve a full and comprehensive list of all 
conceivable symptoms/illnesses was to thoroughly elucidate it from the Merck 
Manual. Simultaneously, the computer programmer would contract a sign-language 
interpreter to provide SASL translations of each itemized symptom and illnesses in 
the database. The SASL translation would be video-recorded and added to 
SignSupport.  The practical implications would be that pharmacist would select on 
SignSupport the text equivalent of “This medicine is for your…(Illness/symptom 
name),” which would then be translated into a SASL video for a Deaf patient to 
watch and interpret.  
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When the computer programmer commenced the process of recording sign 
language videos, a significant setback was encountered. Most of the medical 
symptoms/illnesses extracted from the Merck Manual to indicate to the patient the 
purpose of the medicine, could not be translated in SASL because a sign-language 
translation equivalent ‘word’ for many symptoms/illnesses simply does not exist. 
For example, if the pharmacist would select on SignSupport to say to a patient “this 
is for your auto-immune disease, multiple sclerosis,” a sign-language equivalent for 
the word ‘auto-immune disease’ or for the word “multiple sclerosis” could not be 
recorded because these words simply do not exist in SASL vocabulary. The SASL 
interpreter who was contracted to translate the symptoms/illnesses advised that we 
adhere to simple symptoms and illnesses that Deaf patients could easily identify 
with. As a result, the strategy to use the Merck Manual to elicit symptom and 
illness names was aborted. 
 
 The next strategy was to use the Standard Treatment Guidelines (STG) for primary 
healthcare South Africa (2012). The STG is targeted at doctors and pharmacists 
who use it as an information resource of the standardised treatment approaches for 
illnesses and ailments. The STG contains a section “Index of Disease conditions.” 
This was the primary resource for the list of symptoms/illnesses for SignSupport. I 
compiled the list through consultation with the SASL interpreter who advised us of 
the symptoms/illnesses for which there was an equivalent SASL translation, or in 
which cases an alternative could be used. For example, there is no SASL sign for 
‘peptic ulcer’, the interpreter advised we use the word ‘heartburn’ instead, which 
she could easily sign to be understood by Deaf people.  Table 13 below contains 
the list of symptoms/illnesses which comprises the database transferred to 
SignSupport. These are all words which can be translated into SASL to be 
understood by a Deaf patient. 
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Table 13:  Symptoms and illnesses list for SignSupport 
SYMPTOMS AND ILLNESSES 
Arthritis  Kidney problems  Ringworm 
Bleeding Lice, head 
Rubella (German 
measles) 
Common cold Lice, pubic Scabies 
Cough Malaria Shock 
Diabetes Measles Snakebite 
Dental problem Meningitis Strains and sprains 
Ear infections Mood disorders Sinusitis 
Eye problem Mumps STI  
Fever Nappy rash Tonsillitis and 
pharyngitis 
Heartburn  Nausea and vomiting Tuberculosis 
Heart problems Nose bleeds Ulcers, mouth 
HIV prophylaxis 
(PEP) 
Pain Bladder infection 
HIV/AIDS Pneumonia Vitamin deficiency 
Hormone 
replacement therapy 
Prophylaxis in adults Worm infestation 
Hypertension Prophylaxis in children   
Insomnia  Psychosis  
Itching Poisoning  
Jaundice 
 Prevent child 
transmission of HIV  
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6.6.2 Database of medicine names 
Findings from the baseline study indicated that Deaf patients have an aversion to 
complex words including medicine names. Nevertheless, medicine names needed 
to be included in SignSupport for 2 reasons: (i) for pharmacists to identify which 
medicines to link their instructions with and (ii) it is both a professional obligation 
and a healthcare right of the patient to know which treatment they are taking for a 
particular condition or symptom.  
Despite inclusion of medicine names in the prototype, patients would not be put in 
a position in which they need to identify a medicine by name, which we know they 
are uncomfortable to do. Instead, the research team overcame this by inserting a 
feature on SignSupport which requires the pharmacist to take a photograph of each 
medicine dose unit (for example tablet/capsule). This picture appears immediately 
prior to the sign language video which instructs the patient on how to use the 
medicine.  
Three considerations were pertinent to compiling the database of medicine names: 
1. Use of generic medicine name versus brand name 
2. Which medicine names to include 
3. Translation of medicine names to SASL 
 
Regarding the decision to use generic or trade (brand) medicine names on the 
prototype, I decided to use generic names only and exclude brand names. A generic 
name refers to the active ingredient within a medicine and is typically a universally 
used name, while trade/brand names are specific to the pharmaceutical 
manufacturer who is licensed to produce a certain brand of medicine.  There are 
several reasons for the decision to use generic names.  
Firstly, SignSupport was intended for use in a public sector pharmacy, where 
medicines are dispensed using generic names instead of the trade name. To adhere 
with the norms at public facilities, generic names were selected. Secondly, multiple 
trade names exist for one generic name, based on how many pharmaceutical 
manufacturers produce different brands of the same medicine. To simplify the 
process in which a pharmacist would have to select medicine name, it can logically 
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be asserted that is it simpler to select an option of one name instead of multiple 
options.  In addition new brands may be manufactured every year, implying that 
SignSupport would need to be updated continuously. In addition, pharmacists may 
not be familiar with brand names and would have better familiarity with trade 
names. 
Once a decision was made to use generic names only, a question arose of which 
medicines would be included on SignSupport. Public sector healthcare facilities 
procure medicines based on provincial code lists which include all the medicines 
that may be used in a facility. The first consideration was to include all medicines 
on the provincial (Western Cape) code list. Problems with this decision were that 
the code list excludes many medicines which may be added at a later stage, 
implying that SignSupport would need to be updated. Another issue was that 
SignSupport was not being developed for the Western Cape Province exclusively; 
if we chose only medicines on Western Cape code lists then the widespread 
usability of the prototype would be limited. As a result, I chose to include all 
medicines, based on generic names that are registered in South Africa by the 
Medicines Control Council (MCC) of South Africa.  
Since medicine names would not be translated to SASL, the problems encountered 
with sign-language translation of symptoms/illnesses are not applicable. This 
allowed the researchers to incorporate the MCC list of all generic medicine names. 
The list was copied directly from the MCC list (Republic of South Africa, 1965) 
into a Microsoft Excel® and imported into SignSupport. The use of the entire 
medicines list implies that the application is as inclusive as possible of all 
medicines that a pharmacist can possibly dispense to a patient in South Africa. As 
new medicines are added to the MCC list, they will be incorporated into 
SignSupport as well. Apart from excluding some items from the list (usually 
chemical entities), there were no alterations in the MCC list. The author has chosen 
not to include the medicines register in this thesis as it is an exhaustive list, instead 
it is included as a reference. The list was extracted from the MCC’s Consolidated 
Schedules document. (MCC, 2015). 
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At this juncture in the study we have added to SignSupport a symptoms/illnesses 
database and a database of medicine names. Item 5 in the table below is the only 
component remaining for SignSupport to be complete and is addressed in the next 
section.  
Table 12: Progressive development of SignSupport components 
1. Modified communication script √ 
2. Patient general medical history questions √ 
3. Incorporate Deaf user experiences √ 
4. Compile medicine information databases: 
a. Symptoms and illnesses database 
b. Database of Medicine names 
 
√√ 
5. Independently verified SASL videos  to translate 1, 3 and 4 
above into sign language 
 
 
6.7 SASL videos for SignSupport 
In order to record sign-language videos which translate all the afore-mentioned 
components into SASL, the computer programmer converted the communication 
script and symptoms/illnesses database collated by the pharmacist into a series of 
corresponding sentences which he used as a script for a SASL interpret. Below I 
provide an example of how a sentence from the pharmacy communication script 
was converted into a corresponding sentence:  
 Example of sentence conversion for SignSupport: 
Sentence in pharmacy conversation 
script: 
May I see your patient card? 
Corresponding sentence for SASL 
video: 
The pharmacist would like to see your 
hospital card. Please show it to 
him/her. 
 
The interpreter read each corresponding sentence in the script, and then signed the 
equivalent sentence in SASL. The computer programmer recorded (video) a SASL 
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translation for each sentence. As a result, each sentence has an equivalent sign-
language video which was then programmed into SignSupport. The author’s role 
during this process was to advise whether the script made sense, whether it was 
presented in an acceptable order and adequately reflected the communication script 
elucidated from the dialogue patterns. This led to the next empirical activity which 
involved testing the videos for correctness and accuracy. We called this activity 
‘video verification testing,’ and it was conducted by the computer programmer and 
me, the author of this dissertation. I present the study below. 
 
6.7.1 Video verification testing 
SignSupport is a system which is intended to convey medicine instructions to a 
Deaf patient in sign-language videos. To ensure safety and efficacy, medicine 
instructions require a hundred percent level of accuracy with no compromises. If 
the sign-language videos were not accurate, or did not communicate what we 
expected it to communicate, a patient would receive incorrect information which 
may have potentially dangerous consequences. To avoid this risk, it was important 
to verify that the videos articulate that which we expect of them. The computer 
programmer and myself, the pharmacist, had different perspectives in testing the 
videos. As a result, during the process of testing the videos, they investigated 
different parameters.  The different approaches of the pharmacist and computer 
programmer to video verification testing are presented below: 
Pharmacist:  Do the SASL videos articulate what we expect them 
to say in terms of medicine instructions? 
Are they sufficiently accurate for medicine 
instructions? 
 
Computer programmer:  Are all the videos contained in the SignSupport 
system? 
Are the videos in the correct place on the 
application? 
Do the SASL videos match the script? 
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The collaborative aim of video verification testing is to ensure that SignSupport 
provides accurate information to the Deaf patient. The pharmacist’s and computer 
programmer’s perspectives to address the above will uncover any errors on 
SignSupport with regard to translation of the medicine instructions from text 
format into SASL.  
 
 6.7.1.1 Research objective linkage 
Video verification testing was conducted in order to achieve the research objective 
4 presented in chapter 3: 
• To verify that recorded SASL videos incorporated into SignSupport 
communicate the medicine-related information correctly and accurately. 
 
A specific research question relating to the aforementioned objective is:  
• Are sign-language translation videos able to accurately and effectively 
translate medicine instructions to a Deaf patient in a way that is 
understandable for the patient? 
6.7.1.2 Study site and participant 
Video verification testing was conducted at the DCCT, Heathfield in Cape Town. 
The only participant was a certified SASL interpreter affiliated to DCCT. Since she 
was not the same interpreter who was initially contracted to record the SASL 
translations and had no prior involvement in the study, video verification was thus 
conducted independently.  The researchers were the pharmacist and computer 
programmer members of the multi-disciplinary team.  As is often the case with 
qualitative research, the researchers were also participants in the empirical 
activities.  
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6.7.1.3 Methodology 
Video verification testing was both qualitative (observations of the SASL 
interpreter and role-plays) and PAR (contribution of the SASL interpreter with 
regards to the best way to express sentences in the dialogue in sign-language). 
Video verification testing occurred in three separate ways; all tested the same 
afore-mentioned parameters of accuracy, correctness, and position on the 
prototype.  
The first manner of testing involved basic playing of SASL videos, which the 
SASL interpreter translated into English. The second and third testing activities 
involved role-plays to simulate how a Deaf patient and pharmacist would use 
SignSupport in a real-world context. The testing procedures are described in the 
‘study procedure’ section.  
 
6.7.1.4 Materials and resources 
The following were essential to the video verification testing experiment: 
1. A computer (laptop) 
2. Computer screens (x 2) 
3. Pre-recorded SASL videos 
4. A mobile phone (Android smartphone) on which SignSupport is 
installed 
5. A video recorder 
6. A conversation script (from the computer programmer) 
7. Mock prescriptions 
8. A certified South African sign-language (SASL) interpreter 
 
6.7.1.5 Study procedure 
The main purpose of this study task was to run the SASL videos on SignSupport 
for an interpreter and have her translate the SASL videos into English. This was 
achieved by conducting the following three video-verification tests: 
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i. SASL interpreter translates played SASL videos into English 
ii. Role-play: the SASL interpreter assumes the role of  a Deaf patient 
attempting to retrieve medicine instructions on SignSupport and translates 
the videos she encounters into English 
iii. Role-play: dispensing role-play during which a pharmacist enters mock 
prescriptions presented by the patient (played by the SASL interpreter) into 
SignSupport.  The patient (SASL interpreter) retrieves the instructions and  
translates it into SASL, comparing it to the instructions on the mock 
prescription 
All testing was conducted in the course of one day.  The procedure for each video 
verification process is described below. 
 
The first test involved playing the videos for the interpreter who voiced the content 
of the video in English. The researchers recorded whether the video was accurate 
by passing or failing the video based on its comparison to the English script.  The 
procedure followed is described in steps 1-7 below: 
Step 1:  All SignSupport SASL videos are uploaded onto a computer which 
is situated on desk. The computer screen is connected to a second 
screen on the opposite side of the desk for the interpreter to watch.  
Step 2: The SASL videos are played for the interpreter to watch on the 
opposite screen. 
Step 3:  The interpreter verbally translates the SASL video content into 
English for the researchers. 
Step 4:  While the interpreter voices the English translation, the researchers 
look at the corresponding English sentence on the script in order to 
compare what the interpreter is saying to what we want her to say.  
Step 5:  If a match is found in step four we ‘pass’ the video;  if the 
interpretation does not match we ‘fail’ the video. The result for each 
video is recorded on a checklist.   
Step 6:  We also document comments from the interpreter on how some of 
the content could have been expressed in sign language in a better 
manner.  
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Step 7:  We repeat Step 3 to Step 6 till we have viewed and ticked off all the 
videos that are on the system. 
 
The second video verification procedure comprised a role-play exercise. In this 
role-play, the interpreter was asked to assume the role of a Deaf person who 
retrieves medicine instructions from SignSupport. The researchers navigated the 
SignSupport screens together with the interpreter. Each time a SASL video was 
encountered, the interpreter provided the corresponding English translation for the 
video and we confirmed that the video content is accurate and appears in the 
correct order. The procedure followed is described in steps 1-4 below: 
Step 1:  A SASL interpreter is asked to simulate a Deaf patient who is 
viewing instructions for his/her medicines on SignSupport. 
Step 2:  The interpreter is required to navigate through the SignSupport 
screens in the same way a Deaf patient would when receiving 
instructions from a pharmacist.  
Step 3:  The interpreter provides the English translation of each video.  
Step 4:  The researchers confirm the correctness and accuracy of the video 
by passing or failing the video on a checklist.  
 
The third video verification procedure was conducted to simulate the real-world 
application of SignSupport in which a Deaf person collects medicines at the 
pharmacy and the pharmacist provides medicine instructions for the dispensed 
medicines using SignSupport.   For use during the role-play, I prepared mock 
prescriptions that cover all the possible medicine instructions on SignSupport and 
permutations of these instructions. Prescriptions were selected randomly. The 
pharmacist entered the medicine instructions corresponding to the selected 
prescription. The SASL interpreter was asked to view the corresponding SASL 
videos on SignSupport and interpret it in English. In this experiment, researchers 
were testing whether the English text selections made by the pharmacist are 
consistent with the medicine instructions being given on the videos (researchers 
also referred to the conversation script for confirmation). The procedure followed 
is described in steps 1-7 below: 
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Step 1: Prepare mock prescriptions which cover all possible prescription 
permutations on SignSupport. 
Step 2:  Select prescriptions randomly. 
Step 3:  A pharmacist enters medicine instructions on a mobile phone 
containing SignSupport software. 
Step 4:  The pharmacist hands the phone to the SASL interpreter to view 
and interpret the medicine instructions selected by the pharmacist. 
Step 5:   The SASL interpreter translates the selected medicine instructions in 
English. 
Step 6: The researchers compare the English translation to instructions on 
the prescription. If a match is found we ‘pass’ the video; if the 
interpretation does not match we ‘fail’ the video. The result for each 
video is recorded on a checklist.   
Step 7:  Repeat Step 3 to Step 6 for each selected prescription.  
 
6.7.1.6 Data analysis 
Data was input into a Microsoft Excel® spread sheet and frequency scores 
frequency scores were tallied for videos that passed the video-verification 
procedures and videos which were considered unusable for SignSupport (failed the 
verification procedures).  The failed videos were classified as being ambiguous, 
unclear or unsuitable.  
 
6.7.1.7 Results and Discussion 
During the video verification procedure, 180 videos were recorded in total. Of the 
180 videos, 35 videos were found to be unsuitable and were rejected for use in 
SignSupport. Reasons for rejection of videos included ambiguity, poor video 
clarity or incorrectness. These videos were subsequently re-recorded and tested in 
the same video verification procedure. 
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 Videos that were of poor clarity were unclear due to lighting or that one could not 
clearly see the sign-language hand signals. Videos that were incorrect means that 
the translated English meaning did not match the meaning intended on the 
conversation script. For example, the illness of ‘worm infestation’ was translated 
by the interpreter as ‘an acidic stomach’. Of the total number of videos, 47 were 
videos explaining the medical condition/symptom that the medicine was intended 
for.  Of these 47 videos, nine were incorrect as a consequence of the limited 
medical vocabulary in sign-language. Many illnesses simply do not have a SASL 
equivalent ‘word.’ The SASL interpreter suggested that more time be spent to 
explain the condition in a way that a Deaf person could understand. This implied 
longer videos, which in turn implied more storage capacity on the phone. At this 
stage, the researchers were unsure of the feasibility of this suggestion.  
Videos that were classified as ambiguous were mostly those that dealt with the 
frequency of taking medicines. For example, the instruction to “take 1 tablet 6 
hourly after meals” was interpreted as “Take 1 tablet after meals after that every 6 
hours and after that 6 hours and after that 6 hours and after that 6 hours.” Similarly, 
the instruction to “take one tablet once a day after a meal every 24 hours” was 
translated as “take 1 tablet every morning after meals and after 24 hours and after 
24 hours and after 24 hours”.   The repeated hourly instruction is due to the way 
that Deaf people indicate time, using a motion that involves moving their forearms 
and hands (from the elbow to the fingertips) in a clockwise fashion to represent 
time on a clock, This was found to be problematic for the 6 hourly and 24 hourly 
instructions but not for any other time connotation.  
All 35 videos that were incorrect were discarded and subsequently re-recorded. 
Medicines instructions require a high level of accuracy and risks of a patient 
misunderstanding the instructions must be eliminated. The 145 remaining videos 
“passed” all of the three verification tests and were assessed by the computer 
programmer to appear in the correct place on SignSupport. These videos were 
consistent with the communication script and were used in SignSupport.  
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6.7.1.8 Conclusion  
Although the task of modifying the original communication script arose from a 
conflict situation, the altered script suited the technological and communication 
features of SignSupport well. Apart from discarding non-essential sentences, the 
relocation of the patient’s background information to a section where Deaf people 
are personally responsible for uploading their past medical information may 
empower them to feel more in control of their own healthcare. In addition, the 
researchers were able to include Deaf user experiences gleaned from the focus 
groups and key informant interviews and incorporate it into SignSupport in a 
manner that is potentially meaningful for Deaf patients.  
Professional requisites for pharmacists including databases of symptoms/illnesses 
and medicine names were elicited in a way that is suitable for Deaf patients by 
avoiding medical jargon and the use of colour identification of medicines. In the 
compilation of both databases, researchers were cognisant to be as inclusive as 
possible, of both Deaf community needs and professional pharmacy stipulations.  
Video verification testing concluded that most of the SASL videos were correct 
and ready to be used in SignSupport. The majority of videos were understood 
immediately and without hesitation.  Those that were not understood immediately 
were rejected, re-recorded and tested in the same manner. The outcome was a 
complete set of videos to be incorporated in SignSupport. 
Table 12: Progressive development of SignSupport components 
1. Modified communication script √ 
2. Patient general medical history questions √ 
3. Incorporate Deaf user experiences √ 
4. Compile medicine information databases: 
a. Symptoms and illnesses database 
b. Database of Medicine names 
 
√√ 
5. Independently verified SASL videos  to translate 1, 3 and 4 
above into sign language 
√ 
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At this stage in the thesis, I have presented all the components that were required to 
develop SignSupport.  These components, itemised above in Table 12 culminate in 
the final collation and programming of SignSupport which I present in the next 
section.  
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SECTION B: PRESENTING SIGNSUPPORT 
In this section SignSupport is presented as an assistive technological device which 
can potentially bridge the communication gaps between Deaf patients and 
pharmacists during patient counselling. I commence by providing a brief recap of 
SignSupport specifications alluded to in preceding chapters. The format of 
SignSupport including how it is structured specifically to suit the needs of each 
user group (Deaf persons and pharmacists) is described together with a synopsis of 
the contents of SignSupport.  A chronological and pictographic illustration of 
SignSupport with screenshot pictures of how the application appears on a mobile 
smartphone closes this chapter.     
 
6.8 Recap of SignSupport specifications 
In building SignSupport, the researchers agreed upon a number of specifications 
which defined the format and style of SignSupport. These include: 
1. SignSupport comprises a text-based English format for pharmacists, and 
an exclusively SASL format for Deaf people.  
2. The mobile phone onto which SignSupport is installed as and application, 
is intended to belong to the Deaf patient, who takes it along to the 
pharmacy on the day they that they collect medicines.  
3. SignSupport has been developed for the circumstance in which medicine 
is dispensed in accordance with a prescription from an authorised 
prescriber at an institutional pharmacy. It has not been developed for 
medicines dispensed on an OTC basis or for in-patient hospital use. 
4. SignSupport has been built on an Android smartphone with touch-screen 
capability, and is compatible with most smartphone technology. During 
the research we have used Samsung Galaxy S2®, Samsung Galaxy S4®, 
Samsung Galaxy S5® and Huawei P7® phones.   
5. SignSupport will include a  Skype®-call feature which will be activated in 
the event of a critical communication situation of communication 
breakdown during the pharmacist-Deaf patient interaction. This feature is 
wholly the responsibility of the computer-science team member.  
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6.9 Description of SignSupport 
SignSupport comprises three main sections; (i) Background (patient profile), (ii) 
Pharmacist’s interface and (iii) Deaf patient interface. Collectively, these three 
sections contain all the previously elicited components of SignSupport.  Below is a 
description of the three sections.  
 
6.9.1 Background setup (Patient profile) 
This section is for the Deaf patient and contains 18 short sign language videos 
which function to elicit general medical history from a Deaf user.  Earlier, during 
compilation of the communication script for SignSupport, the general medical 
history questions extracted from the dialogue patterns were removed and relocated 
to the ‘patient profile setup’ position on SignSupport. This allows a Deaf patient to 
upload and update their medical history before approaching the dispensary counter. 
Since all the questions are presented as SASL videos, the Deaf patients are capable 
of entering the information according to sign-language prompts. Consequently, the 
pharmacist is able to see the weight, whether the patient has a food or medicine 
allergy, is using any concomitant medicine therapy, or smokes and uses alcohol at 
the dispensing point and before providing medicine instructions.  
 
6.9.2 Pharmacist user interface 
The pharmacists’ user interface contains only English text and is seen and used 
solely by a pharmacist to select medicine instructions from a touch screen menu 
which is structured to resemble a logical dispensing sequence. The screens 
encountered by the pharmacist in chronological order include:  
a. A general menu screen which contains an icon for the pharmacist and a 
separate icon for a Deaf patient. To access their interface, pharmacists 
would touch on the icon which represents a pharmacist. 
b. A password screen, using the pharmacist’s registration number with the 
SAPC as the password. This was done to ensure that non-pharmacists 
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could not enter medicine instructions, thereby ensuring a level of patient 
security and safety. 
c. An introduction screen which directs the pharmacist to commence the 
interaction with the Deaf patient.   
d. A screen prompting the pharmacist to establish that the patient’s 
identification card matches the patient’s details on the prescription.  
e. A screen entitled ‘Get ready to dispense.’ This screen prompts the 
pharmacist to check where the prescription contains ‘conflict,’ the 
conflict being a drug-interaction, a contra-indication, insufficient 
information on the prescription or  any other situation which would 
cause the pharmacist to not dispense the medication. In the event that a 
conflict is found, the pharmacist selects ‘X’ on the screen, which plays a 
SASL video directing the patient to either  (i) wait at the counter while 
the pharmacist resolves the issue; (ii) go back to being seated in the 
waiting room or (iii) return to the doctor to rectify the error. 
Alternatively, the pharmacist does not find a conflict and selects ‘√’ on 
the screen. This allows the pharmacist to proceed to the next screen for 
dispensing.  
f. A ‘Patient Background’ screen where the pharmacist can view the 
patient’s profile including general medical history.  
g. A screen prompting the pharmacist to select the symptom /medical 
condition corresponding to the medicine being dispensed. 
h. A screen prompting the pharmacist to select whether the treatment is 
acute or chronic.  
i. A screen prompting the pharmacist to select the medicine name from a 
pre-loaded drop-down tab. 
j. A screen prompting the pharmacist to take a photograph of the dose unit 
(tablet/capsule) and medicine package for the patient to identify when 
taking the medicine.  
k. A series of screens pertaining to medicine instructions (dose, frequency, 
time of administration and duration of treatment).   
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l.  Screens prompting the pharmacist to select pre-loaded warnings (e.g. 
do not use alcohol while taking this medicine and recommendations 
(e.g. take the medicine at the same time every day.) 
m. A menu screen which presents options to (i) review the selected 
instructions; (ii) dispense another medicine, or (iii) close and save the 
selected instructions. 
n. On the afore-mentioned review screen, the pharmacist is given a 
summary of all the selected instructions and is able to view in text,   that 
which will be communicated to the patient in sign-language. 
o. The final screen prompts the pharmacist to hand the phone back to the 
Deaf patient, who is able to view all the selected instructions on a sign-
language video.  
 
6.9.3 Deaf user interface 
This section contains a total of 170 sign-language videos, permutations of which 
match the medicine instructions selected by the pharmacist. In addition, a 
photograph of the medicine is stored for the Deaf patient to view together with the 
instructions corresponding to the medicine in the photograph. In addition, Deaf 
patients are able to protect the confidentiality of their information through setting a 
password, and are able to program reminders on the phone that correspond to 
medicine administration times.  
 
6.9.4 Real-world application of SignSupport 
As previously mentioned, SignSupport was developed to facilitate medicine 
instructions between a pharmacist and a Deaf patient in accordance with a 
prescription from a public sector institutional pharmacy. SignSupport is installed 
onto the Deaf patient’s phone, who, when called to collect their medicines, 
approaches the pharmacist with the phone in hand. The phone is handed to the 
pharmacist in order to commence the patient counselling process. Figure 18 below 
provides a pictorial illustration of how SignSupport will be used by a Deaf person 
and a pharmacist at an institutional public sector pharmacy. 
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Figure 19 depicts be a stepwise annotated pictorial illustration of the pharmacist 
interface on SignSupport. I have not included the Deaf interface for two reasons (i) 
the scope of this thesis was to provide pharmacy perspectives in the development 
of SignSupport; the Deaf interface was the scope of the industrial design engineer 
and computer programmer, and (ii) the Deaf interface comprises a series of SASL 
videos; a reader would not be able to interpret these pictures and would thus be 
redundant in this dissertation. I do however; include examples of the Deaf interface 
where appropriate. In addition, green arrows are used in the illustration to depict a 
forward progression on SignSupport, while red arrows indicate that the pharmacist 
stops navigating the application. Multiple coloured arrows are used to indicate 
several selections from one screen. 
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Figure 18: Application of SignSupport in an institutional pharmacy 
Smart-phone with 
SignSupport 
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Figure 19: SignSupport communication flow: Pharmacist interface 
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This screen appears 
when pharmacist 
selects ‘Review 
selection’ 
This screen appears 
when pharmacist 
selects ‘Dispense next’ 
These screens appear when 
pharmacist selects “Save 
and finish’ 
This is the end of the pharmacist 
interface. Videos are now 
available to be viewed and 
interpreted by the Deaf patient. 
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CHAPTER SEVEN 
 
RESULTS AND DISCUSSION: POST-INTERVENTION STUDY 
 
__________________________________________________________________ 
 
The preceding chapter presented the first complete version of SignSupport. This 
chapter presents the evaluation of SignSupport in terms of participant experiences 
of the usability and acceptability to pharmacists and the Deaf community in a 
dispensing context. This was achieved by way of two experimental procedures, 
presented within the chapter as Section A (Pilot study) and Section B (Hospital 
study) respectively.  
 
In the pilot study, SignSupport was tested in a simulated dispensary where a 
pharmacist dispensed medicines to a Deaf patient using SignSupport to 
communicate medicine instructions. During and after the pilot experiment, 
participants were asked to assess how they had experienced SignSupport and 
whether they had any suggestions for improvement of the application. This data 
culminated in the first design iteration which modified SignSupport by 
incorporating feedback and suggestions from the pharmacist and Deaf patients.   
 
The hospital study implemented the pilot study in a public hospital pharmacy in 
Cape Town, where pharmacists employed at the pharmacy dispensed medicines to 
Deaf patients using SignSupport. In line with the iterative process, data was once 
again collected to ascertain how users experience SignSupport and whether they 
had suggestions for improvement. This data culminated in the second design 
iteration. Each experiment is described in terms of actual sample, study site, 
materials and methodology, study procedure, results and discussion of findings. 
The chapter brings to close the empirical activities of this thesis. 
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SECTION A:  SIGNSUPPORT EVALUATION: PILOT STUDY 
At this stage of its developmental trajectory, SignSupport is a fully operational 
prototype which has the capability to facilitate the communication of medicine 
instructions (for oral solid dosage forms) from a pharmacist to a Deaf patient. 
Logically, the next step would be to introduce the prototype to pharmacists and 
Deaf persons and evaluate it in the context for which it is designed. This would 
allow the researchers to assess how users experience SignSupport and whether they 
are receptive to using it. User feedback is crucial for the iterative process as 
subsequent modifications to SignSupport would be based on such feedback.  
 
The research team unanimously agreed that SignSupport was ready to be tested 
with pharmacists and Deaf people. It was thus decided to conduct a preliminary 
evaluation in a simulated dispensary in order to learn an appropriate experimental 
procedure for testing the prototype. This preliminary testing would constitute the 
pilot usability experiment. If the pilot study was found to be feasible in terms of 
experimental procedure, the same experiment would be applied in a real-world 
hospital dispensary. Subsequent to each experiment, SignSupport would be 
modified by incorporating user feedback from the experiment. Such iteration would 
establish the next version of SignSupport which would subsequently be subjected 
to the same experimental conditions. The iterative process for evaluating 
SignSupport is represented in Figure 20 below: 
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Figure 20: Iterative process for evaluation of SignSupport  
 
 
 
 
 
 
 
 
 
 
 
 
This chapter presents two usability evaluations of SignSupport: (i) a pilot study in a 
simulated dispensary and (ii) a hospital study in a real-world hospital pharmacy.  
The hospital study was based on the pilot study; thus the experimental procedures 
were reasonably similar. The two evaluations differed however, in terms of study 
sites and participant profile. Below I discuss the pilot study in terms of research 
objective linkage, study site and participants, methodology, materials, study 
procedure and results and discussion. Subsequently, the hospital study is described 
in the same succession.  
 
7.1 Usability evaluation 1: Pilot study in a simulated dispensary 
The pilot study was conducted for two reasons: (i) to determine an appropriate 
experimental procedure for testing SignSupport with Deaf people and pharmacists 
in a dispensary context and (ii) to obtain preliminary results with regard to how the 
users (pharmacists and Deaf patients) experience SignSupport. Pilot testing 
required two research phases. The first phase involved a demonstration workshop 
each for pharmacists (participant group ‘X’) and Deaf persons (participant group 
‘Y’) to introduce and demonstrate SignSupport. The aim of the demonstration 
workshops for pharmacists and Deaf participants was to present SignSupport to 
Pilot testing in a 
simulated 
dispensary with 
pharmacy students 
and Deaf patients 
Actual testing in a 
real-world 
hospital 
dispensary with 
pharmacists and 
Deaf patients 
● Review testing methodology 
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smart phone (Android) 
Reflections for further 
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PHASE 2      
Pilot  test: 
simulated 
dispensary with  
'X' and 'Y' 
PHASE 1 
Demonstration 
workshop:   
Pharmacists 'X' 
PHASE 1 
Demonstration  
workshop:                 
Deaf persons 'Y' 
both groups and allow them to ‘play’ with the application in order to establish 
familiarity therewith. A level of familiarity was necessary for the second phase, 
during which the same pharmacists and Deaf persons who participated in the 
workshops would also participate in the usability experiment. If participant 
familiarity with SignSupport was not established, it could reasonably be expected 
that participants would fumble and hesitate during the experiment because it would 
be the first time they would have seen the application. This could potentially 
influence usability results.  I led the demonstration workshop with pharmacist and 
this is discussed in this chapter. The computer programmer led the  workshop for 
Deaf participants which occurred parallel to the pharmacists’ workshop. In this 
thesis the Deaf participant workshop alluded to but not discussed in terms of results 
as it is not within the scope of this research (my focus was the pharmacist’s 
perspective). These workshops ran parallel to one another and culminated in phase 
2,  which entailed testing SignSupport in a simulated dispensary with the same 
participants (‘X’ and ‘Y’)  from phase 1.  Figure 21 below illustrates the study 
design. 
 
Figure 21: Study design for usability evaluation 1 
 
 
 
 
 
 
 
 
 
 
 
 
 
Phase 2, which comprised the experimental phase was set up in a simulated 
dispensary and involved a role-play exercise to replicate the scenario in which a 
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Deaf patient collects medicine from a hospital pharmacy, except that in the role-
play, the pharmacist would use SignSupport to communicate medicine instructions 
to the Deaf patient. This experiment was conducted subsequent to and in the same 
week as the demonstration workshops. The reason for doing so was that the 
literature review revealed that Deaf persons may have problems with memory and 
recall. In order to ensure the afore-mentioned familiarity of Deaf participants with 
the application it was essential to conduct the experiment in a close time-proximity 
to the demonstration workshops. Both research phases of the pilot experiment are 
described below.  
 
7.1.1 Research objective linkage 
The pilot user experimentation was conducted in order to achieve research 
objective 5 presented in chapter three: 
• To iteratively test SignSupport with Deaf persons and pharmacists to assess 
their acceptability and usability thereof. 
 
The following aims were necessary in order to achieve this objective: 
1. To design a Microsoft PowerPoint® presentation for use in the 
demonstration workshop for pharmacists. 
2. To conduct a pilot demonstration workshop with pharmacist 
participants. 
3. To conduct a pilot experiment with pharmacist participants and Deaf 
patients in a simulated functional dispensary. 
4. To qualitatively assess the usability of application for pharmacists and 
Deaf users. 
5. To evaluate feedback from the pharmacists on the use of the mobile 
application. 
 
7.1.2 Study site and participants 
The study involved two participant groups; (i) senior pharmacy students (n=8) to 
represent pharmacists and selected on the basis of a convenience sampling strategy, 
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and  (ii) Deaf persons (n=8) who are familiar with the medicine dispensing process 
at public health facilities in Cape Town and selected on the basis of a purposive 
sampling strategy. Inclusion criteria for the pharmacy students include: 
a. That participants  are final year pharmacy students 
b. That participants have experience in dispensing in a public hospital 
pharmacy environment 
c. That participants are unable to communicate in SASL 
 
Inclusion criteria for Deaf participants include: 
a. That  participants are Deaf in terms of the definition presented in chapter 3 
b. That participants are  affiliated with the DCCT from which consent was 
obtained  to access the Deaf community 
c. That participants must all have had experience in  using medicines 
 
Participation in the study was voluntary and all participants were informed of study 
details and expectations via participant information documents (Appendices I, J, K, 
L). Participants were asked to indicate their informed consent (Appendices J and 
L). A registered SASL interpreter was used to translate the participant information 
and consent documents into sign language for the Deaf participants who indicated 
informed consent by raising their hands. This indication of agreed participation was 
video recorded. 
 
The demonstration workshop for pharmacy students and the pilot experiment both 
occurred at UWC’s School of Pharmacy. The workshop occurred in the school’s 
seminar facility and the pilot experiment occurred in the pharmacy practice 
laboratory which was set up to simulate a hospital pharmacy dispensary. This 
included setting up a computer with dispensing software, placing health-promotion 
posters in the ‘pharmacy’ area, and positioning pharmacy-related paraphernalia on 
the ‘dispensary’ counters (tablet counters, typical reference books kept in a 
pharmacy). In addition, a patient waiting area was set up in close proximity to the 
dispensary to mimic a waiting area at a hospital pharmacy. Figure 22 below 
illustrates the simulated dispensary that was created for the pilot study. 
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Figure 22: Simulated dispensary for the pilot study 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
7.1.3 Methodology 
Pilot evaluation of SignSupport employed both qualitative and PAR 
methodologies.  Qualitative techniques included demonstration workshops, role-
play exercises and video observations of pharmacy students and Deaf participants 
during the role-plays in which pharmacy students were asked to dispense 
prescription medicines to Deaf patients using SignSupport. PAR methods 
comprised contributions of the pharmacy students, Deaf participants and SASL 
interpreters with regard to their input for conducting the experiment and 
suggestions for modifying SignSupport. Both methods were incorporated in a 
community-based co-design strategy which facilitates the participation of multiple 
groups toward crafting a solution that suits their varying needs. The first research 
activity comprised the demonstration workshop for pharmacists followed by the 
second research activity which was the user experiment in a simulated dispensary.  
 
 
 
 
 
223 
 
7.1.4 Materials and resources 
The following materials/resources were used in the two research activities: 
demonstration workshop and pilot experiment respectively: 
 
 
7.1.5 Study procedures 
Separate procedures are described for the demonstration workshop and pilot 
experiment.  
 
7.1.5.1 SignSupport demonstration workshop for pharmacists 
To conduct the demonstration workshop, I created a Microsoft PowerPoint® 
presentation (Appendix O) which incorporated screenshots from the SignSupport 
application as they were presented in the preceding chapter. Screenshots refer to 
images of the application on the phone in the same way that it would appear to the 
user when they are working with the application. The screenshots were placed in a 
step-by-step format to illustrate how the application should be used.  
DEMONSTRATION WORKSHOP PILOT EXPERIMENT 
1 laptop computer A simulated dispensary 
Microsoft PowerPoint® software Video cameras on tripod stands x 4 
SignSupport demonstration presentation  Mock prescriptions 
8 Samsung® Galaxy SII phones on which 
SignSupport is installed 
Medicines: amoxicillin, 
paracetamol, indomethacin 
A digital projector Mock patient folders 
 Chairs for the patient waiting area 
 SASL interpreters x 2 
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The demonstration workshop was conducted over a three-hour session. During the 
first forty-five minutes, the PowerPoint® slides were presented, after which 
students navigated through the screens on SignSupport in a stepwise process (the 
next forty-five minutes). Thereafter, the students were asked to pair with a partner 
and practice in a role-play format by using SignSupport to communicate medicine 
instructions (one hour). During the role-plays, each pharmacy student took a turn to 
act as both the pharmacist and the Deaf patient. Feedback regarding the interface, 
usability and functionality of the application was taken both by covert observation 
and in a group feedback session (thirty minutes) which concluded the workshop. 
Recommendations from the pharmacy students for future modification were also 
noted.  Steps 1 – 13 below describe the sequential process pertaining to the 
demonstration workshop for pharmacists. 
 
 
Step 1:  Create a Microsoft PowerPoint® presentation incorporating 
SignSupport screen shots in a sequential stepwise fashion to 
demonstrate the application 
Step 2:  Schedule a three-hour session with pharmacy students during 
which to conduct the demonstration workshop  
Step 3:   On the workshop day, seat all participants in a venue with a 
laptop and digital projector 
Step 4:  Project the afore-mentioned PowerPoint® presentation to 
conduct the demonstration presentation. 
Step 5:  Hand each pharmacy student participant one Samsung® 
Galaxy phone on which SignSupport is installed. 
Step 6:  Allow participants time to ‘play’ with the application on the 
phone.  
Step 7:  Once participants have indicated that they have had enough 
time to explore the application, ask them to partner with 
another participant to form a pair. 
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Step 8: Ask the participants to role-play by pretending that one 
participant is a pharmacist and another is a Deaf patient to 
whom the pharmacist is dispensing medicines. 
Step 9:  The ‘pharmacist’ pretends to dispense medicines to the 
‘patient’ using SignSupport. 
Step 10:  The pharmacist and patient switch roles and repeat step 9. 
Step 11:  Repeat steps 8-10 at least three times. 
Step 12:  Conduct a group feedback session and record participants 
perceptions of their experience in using SignSupport, 
feedback and suggestions for modification/improvement.  
Step 13:  Conclude the demonstration workshop by thanking 
participants for their time. 
 
Subsequent to the demonstration workshop and within the same week, the 
computer programmer conducted a similar demonstration workshop with the Deaf 
community. Two days thereafter the pilot experiment ensued. The study procedure 
for the experiment is described in the next instalment.  
 
7.1.5.2 Pilot experiment: SignSupport usability 
The pilot experiment occurred three days after the demonstration workshop for 
pharmacists. To conduct the pilot experiment, a simulated dispensary was set up 
using various pharmacy-related items to mimic a real-world dispensary setting. The 
simulated pharmacy included a patient-waiting area, dispensary counter, a 
computer with dispensing software and several typical pharmacy paraphernalia. 
Each pharmacy student dispensed one mock prescription to a Deaf patient by using 
the SignSupport application as demonstrated in workshop.  
 
Video cameras recorded the dispensing interaction between the pharmacy student 
and Deaf patient from various angles, positioned to capture closely the hand-co-
ordination of the pharmacist-user with the application, and the facial gestures of the 
Deaf patient to indicate acceptability and understanding of instructions given. After 
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all participants had completed their duties a short group interview was held 
between the pharmacy students, Deaf participants, study project members and 
interpreters in order to obtain feedback on the experience with regard to the usage 
of SignSupport . Thereafter, pharmacy students and Deaf participants were each 
asked to complete a short questionnaire (Appendices M and N) regarding their 
opinion of SignSupport. Deaf participants completed their questionnaires with 
assistance from the SASL interpreters. Steps 1-13 below describe the sequential 
process pertaining to the pilot usability experiment. 
 
 
Step 1:  Set up a simulated dispensary and patient waiting area to 
resemble a pharmacy and patient waiting area at a public 
hospital pharmacy 
Step 2:  Schedule an experiment day with Deaf persons and 
pharmacy students. 
Step 3:   Prepare mock prescriptions and mock patient identity cards. 
Place the mock prescriptions on the dispensary counter ready 
to be dispensed by the pharmacy students. Collate the 
medicines corresponding to the prescriptions and place it in 
the mock dispensary. 
Step 4:  On the experiment day, ask Deaf participants to be seated in 
the patient waiting area and hand each participant a mock 
patient identity card and one Samsung® Galaxy smart-phone 
on which SignSupport is installed. 
Step 5:  Ask Deaf participants to input their general medical history 
on the background information screen as they have been 
demonstrated to do by the computer programmer during 
their demonstration workshop. 
Step 6:  Direct pharmacy students to take a turn to, one at a time, 
behind the dispensary counter, at the computer to get ready 
to dispense one of the prescriptions placed on the 
prescription counter.  
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Step 8:  Each pharmacy student processes a prescription and selects 
and labels medicines corresponding to the prescription. 
Step 7: Once the medicines have been prepared, the pharmacy 
student calls out the patient name on the prescription. 
Step 8: A SASL interpreter communicates to the Deaf patient whose 
name was called, that their medicine is ready and they can 
now proceed to the dispensary counter with their patient 
identity card and phone in hand. When they reach the 
dispensary, the phone is handed over to the pharmacy 
student. 
Step 9: The pharmacy student is asked to dispense the medicines to 
the Deaf patient using SignSupport. 
Step 10:  When the pharmacist concludes the interaction, the Deaf 
patient is directed by the interpreter to return to his/her seat 
in the waiting room. 
Step 11: Steps 7-10 is repeated 8 times, one time with each pharmacy 
student and a different patient. 
Step 12: The entire process is recorded on video by placing video 
cameras in strategic positions to record the participants’ 
hands on the mobile phone to assess how they navigate 
through SignSupport screens. 
Step 13:  A group interview (via a SASL interpreter) is held with the 
Deaf participants to assess their opinions on the dispensing 
experience and SignSupport. In addition, they are asked to 
complete a questionnaire on SignSupport. 
 
Data emerging from the demonstration workshop for pharmacists and pilot 
usability experiment included group discussion transcripts, video-recordings and 
questionnaire responses. 
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7.1.6 Data analysis 
Data analysis occurred separately for each data set emerging from the research 
activities. The demonstration workshop activity yielded workshop field notes as a 
data set, while the usability experiment activity yielded three data sets: (i) video 
logs, (ii) group discussion notes and (iii) usability questionnaire responses for both 
pharmacy students and Deaf participants.  Figure 23 below illustrates the data sets 
generated by each research activity.  
 
Figure 23: Data sets generated by usability evaluation activities 
 
 
  
 
 
 
 
 
  
 
 
 
 
Field notes, video logs and group discussion notes from the demonstration 
workshop and usability experiment were analysed in terms of Srivasta’s (2009) 
three question framework. Furthermore, the author noted common themes 
emerging from these data sets. Questionnaire data was input into Microsoft Excel® 
to obtain frequency scores for responses that indicate positivity, negativity and 
uncertainty/neutrality toward SignSupport.  
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7.1.7 Results 
Results are presented separately for each data set emerging from the demonstration 
workshop (which yielded field notes) and pilot user experimentation (which 
generated video logs, group discussion notes and questionnaires).  
 
7.1.7.1 Demonstration workshops: pharmacists 
The Microsoft PowerPoint® presentation used in the demonstration workshop was 
understood and well-received by all the pharmacy student participants. No 
confusion or hesitation was evident and questions raised were minimal. All 
students were enthusiastic about the technological approach, with one student 
suggesting that the application be modified to apply to situations to breach 
communication gaps existing between pharmacists and patients who only 
understand other indigenous spoken languages. When asked to ‘play’ with the 
application and role-play in pairs, all the pharmacy students (n=8) found 
SignSupport easy to use and commented that the procedure on the application 
mimics a logical dispensing sequence with which they could easily identify. All the 
participants were able to navigate from the start to the end with minimal hesitation. 
Uncertainty arose in three areas: 
 
a. Omitted medical conditions.  Students (n=3) recognized that several 
medical conditions (symptoms/illnesses) were excluded on the application. 
When attempting to select a medical condition pertaining to the purpose of 
medicine therapy, pharmacy students encountered a situation in which the 
medical condition they were attempting to type was not available in the 
preloaded menu of symptoms/illnesses on SignSupport, and they could not 
proceed to subsequent screens. Several medical conditions do not appear in 
SignSupport for the reason that no SASL equivalent exists for the word 
representing that condition (e.g. for peptic ulcer, SignSupport uses the word 
‘heartburn’ since the SASL interpreter was unable to sign the phase ‘peptic 
ulcer’. Refer to the previous chapter (five) which elicits symptoms/illnesses 
database). While sound reasons exist for not including several medical 
 
 
 
 
230 
 
conditions in SignSupport,   one cannot reasonably expect pharmacist to 
predict those which are/are not in the application since they would not 
know which terms have equivalent SASL ‘words.’ This creates a practical 
bottleneck of the application for which the research team needed to find a 
solution.   
 
b. Erroneous spelling of the medicine names and medical conditions. 
Students (n=4) identified incorrect spelling of medicine names and 
therefore could not find certain medicines in SignSupport. It could be 
expected that medicine names would be spelt incorrectly since the computer 
programmer, who has no pharmaceutical background and had not 
encountered these names before, was responsible for typing the names into 
SignSupport program. Each name was typed from the medicine database 
that was provided by the pharmacist into the SignSupport program. 
Medicine names are often long and complex and within the exhaustive 
medicines list, it can reasonably be expected that the computer programmer 
would incur spelling errors in typing such complex medicine names. This 
was a problem which could be resolved in the first iteration of SignSupport.  
 
c.   Not receiving any feedback.  A chief concern identified by majority of 
the pharmacy students (n=6) was the aspect of concluding their interaction 
with the patient and not receiving feedback on whether they understood the 
instructions or had any additional questions. SignSupport does not enable a 
dyadic communication process and hence does not facilitate the provision 
of pharmaceutical care. Pharmacy students are taught to establish joint 
relationships with patients and dyadic interactions are cornerstone to 
achieving these relationships. While it can reasonably be expected that this 
would be a professional issue for pharmacist participants, it remains nearly 
impossible to establish a two-way conversation with a patient who cannot 
speak or understand the same language as a pharmacist. Although 
SignSupport cannot facilitate mutual interaction and joint relationships, it 
can facilitate the communication of medicine instructions which is a 
component of pharmaceutical care.  
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All the pharmacy students indicated that the PowerPoint® presentation was an 
appropriate manner to demonstrate SignSupport and that the presentation was 
informative, useful and sufficient to lead them into the role-playing exercises.  
Seven of the eight students said that they would not be confident to use 
SignSupport in an experiment had they not attended the demonstration workshop. 
This implies that, in a real-world context, practicing pharmacists would need 
similar introduction and orientation to the application if they would be required to 
use it in their workplaces.  
Four days after the demonstration workshop the pilot experiment ensued. Findings 
obtained from this experiment are described in the next instalment.  
 
7.1.7.2 Pilot experimentation 
Data from the pilot experiment included video logs of the experiment, a group 
interview transcript and questionnaire data from Deaf participants and pharmacists. 
Results emerging from each data set are discussed separately below.  
 
Video logs   
On the video footage of the pilot experiment, all pharmacy student participants 
appeared confident when dispensing to the Deaf patients using SignSupport and 
navigated the application easily. Hand-to-screen co-ordination with the phones 
proceeded smoothly and with minimal hesitation for pharmacists and Deaf persons. 
Facial expression and hand-co-ordination indicated confidence and assurance when 
navigating SignSupport. The transition from the paper prescription to selecting 
instructions on SignSupport occurred effortlessly and without indecision.  Students 
(n=4) hesitated briefly when encountering the screen on which they are asked to 
take a photograph of the medicine, but soon  and without intervention realized what 
they needed to do and proceeded to subsequent screens. A possible explanation for 
their hesitation at this point is that taking a photograph of the medicine being 
dispensed is not a typical feature of the dispensing process and would not normally 
be done by a pharmacist. It thus would not occur intuitively to the pharmacy 
student as would the other features on SignSupport which are all typical dispensing 
procedures.  
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The average dispensing patient-interaction time using SignSupport was 4 minutes 
34 seconds. This is expectedly longer than published dispensing time for patient 
counselling during normal dispensing without SignSupport, which was estimated in 
South Africa to be 1 minute, 14 seconds (Lubbe and Steyn, 2010). All the 
pharmacy students indicated that the time taken to dispense on SignSupport was 
reasonable and would be feasible in a pharmacy practice setting as it was only a 
few minutes longer than regular dispensing.  Table 14  below depicts the 
dispensing time per medicine and total prescription dispensing time using 
SignSupport.  
 
Table 14: SignSupport dispensing time per item and per prescription 
 
On the video footage, all pharmacy student participants appeared enthusiastic with 
regard to using the application to communicate with Deaf patients and closed the 
patient counselling session with a stance of self-assurance. Deaf participants also 
seemed enthusiastic and appeared to understand the SASL videos on their phones 
pertaining to instructions for their medicines. This positivity toward SignSupport 
was also evident from the group discussion during which all participants were 
given the opportunity to express their opinions of and experience with 
SignSupport. 
Pharmacy student 
participant (code name)  
Time taken to dispense (minutes: seconds) 
1st item 2nd item Total 
Ph A 02:27 01:43 04:10 
Ph B 02:38 02:01 04:39 
Ph C 02:16 01:45 04:01 
Ph D 03:04 02:32 05:36 
Ph E 02:26 01:53 04:19 
Ph F 02:55 02.12 05:07 
Ph G 02.41 02.06 04:47 
Ph I 02.17 01.43 04:00 
Average dispensing 
time 02:35 01:59 04:34 
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Group discussion 
A short group discussion was held between all participants, interpreters and 
researchers subsequent to the pilot experiment to glean an overall impression of 
their experience of the dispensing interaction using SignSupport. All the students 
(n=8)  reported that the dispensing process using SignSupport was easy; however 
none of the students had prior experience with dispensing to Deaf patients and were 
thus not able to draw a comparison between dispensing interactions with a Deaf 
patient with and without SignSupport. Pharmacy students (n=8) commented that 
the communication flow was easy to follow and made sense to them in terms of 
dispensing.  
They  indicated that they particularly appreciated the patient background 
information screen (n=7),  commenting that they often do not  know whether  a 
patient has a medicine allergy or is on concomitant treatment, and that the screen 
serves as a reminder to follow up on the allergy condition or drug interaction 
possibilities with other medicines being taken by the patient. All the students (n=8) 
commented that the review screen was necessary as it provided a summary of all 
the instructions they had selected on the screens. All students agreed that they 
would rather dispense to Deaf patients using SignSupport than not having any other 
means of communication with the Deaf community. Students identified two areas 
of concern with regard to the dispensing process using SignSupport:  
 
a. Not receiving any feedback: The previously mentioned concern with 
regard to not receiving any feedback on whether the patient understood the 
instructions or had any questions was raised once again. The only way to 
alleviate this problem on SignSupport would be via the Skype®-call 
function alluded to in the previous chapter, which would allow the Deaf 
patient to video-call an interpreter who would translate the signed question 
into English for the pharmacist, and the pharmacist’s response into SASL 
for the patient. At this stage in development, the Skype® feature was not 
yet programmed into SignSupport.   
b. The “awkward silence.” Students (n=5) found that the “awkward silence” 
during the dispensing interaction using SignSupport with a Deaf patient 
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made them feel uncomfortable as they are accustomed to engaging mutually 
with a patient during the patient counselling process.  
 
All Deaf participants (n=8) reported that they understood the instructions on the 
SASL videos and that the videos would diminish uncertainty with regard to when 
and how to use medicines. All Deaf participants also indicted that the experimental 
procedure was a success and hence they had no suggestions for improvement.   
Deaf participants (n=2) commented that the SASL video should be brighter or 
appear in color, rather than the black and white format. Even though the Deaf 
participant’s feedback regarding SignSupport was largely positive and optimistic in 
terms of whether it could facilitate the communication of medicine instructions, 
there was an evident aloofness seen in facial expression and body language of the 
Deaf participants. Further probing by the researchers as to the reason for this 
resulted in a dead end, as the Deaf participants continued to report the same afore-
mentioned positive opinions of SignSupport. Consequently, the researcher decided 
to conclude the session by asking all the participants whether they had any further 
questions or comments. When none were raised, participants were thanked for their 
time. 
 
After the session I engaged with the SASL interpreter to enquire whether she knew 
the reason for the detached stance of the Deaf participants. She replied that she was 
not aware that they had any problems with SignSupport or the study, but that she 
would enquire whether they were experiencing any issues. After a short closed 
session with the Deaf participants (approximately 7-10 minutes) the SASL 
interpreter reported that the Deaf community felt that even though SignSupport 
works well and can communicate to them how to use their medicines, it does not 
help them in a primary care situation where they need to approach a pharmacist in a 
community pharmacy seeking assistance for a minor ailment. Furthermore, the 
application does not provide health information which they often need. Deaf 
participants also indicated  that they have been taking medicines prior to 
SignSupport in a way that was told to them by fellow Deaf people, and often the 
advice was generic for all different medicines and seemed to work for them. An 
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example is the notion that all medicines should be taken at night after a meal. They 
felt conflicted that SignSupport instructs them differently.  
 
 The implications of these problems for SignSupport are minimal, as neither are 
directly related to the operational functionality of SignSupport. It does however 
highlight significant problems experienced by Deaf people which are not within the 
scope of SignSupport. These problems include a lack of access to general 
healthcare information and the lack of primary healthcare services as a result of 
their communication difficulties.  In addition, it highlights the cultural 
misconceptions Deaf people experience with regard to medicine instructions. The 
reluctance of the Deaf participants to share the finding in the open group discussion 
is indicative of their cultural connectedness; even with probing the researchers 
were not able to establish the reasons for their aloofness which they only shared 
with the SASL interpreter. This highlights yet another issue; that data may not be 
credible and a true reflection of the Deaf community’s experience of SignSupport 
unless the researchers immerse themselves within the community and become a 
member of the Deaf culture.  
 
Another implication is that misinterpretation or lack of health information could 
lead to deeply ingrained medicine use practices and beliefs which could result in 
untoward effects. Pharmacy practitioners and pharmacy faculty should engage 
meaningfully with marginalized communities about their medicine use patterns to 
alleviate such misconceptions.  After the group interview session, pharmacy 
student participants and Deaf participants were each asked to complete a short 
usability questionnaire about their opinion of SignSupport.  
 
Questionnaire results 
All the participants completed usability questionnaires which were based on Likert-
scale type closed-ended questions which measured positive (yes), negative (no) or 
uncertain/neutral (unsure) responses to questions related to SignSupport. Separate 
questionnaires were created for the pharmacy student participant group and the 
Deaf participant group. The questions were structured in a simplistic manner to 
allow the participants to concisely and confidentially articulate their perception of 
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SignSupport to compensate for the possibility that they may not want to have 
shared this perception in the group discussion.  
 
Pharmacy student questionnaire responses 
All the pharmacy students (n=8) indicated that SignSupport was a useful 
intervention in dispensing to Deaf patients, that the application made it easier to 
assist Deaf patients and that they will recommend the application to their 
colleagues. Seven out of eight pharmacy senior students felt that SignSupport 
would improve patient adherence and all eight agreed that it will facilitate the 
communication between the pharmacist and the eaf patient. Overall, there were no 
neutral responses and only one negative response across a total of forty questions 
(from all five questions posed in eight questionnaires), indicating that the pharmacy 
students were positive about using SignSupport and would likely be willing to use 
it in their professional practice in the future. The overwhelmingly positive response 
is encouraging as this was the first evaluation of the practical usability of 
SignSupport. Table 15 below depicts questionnaire results from the pharmacy 
students; this is followed by a graphical presentation illustrating a comparative 
analysis between positive, negative and neutral questionnaire responses.  
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Table 15: Usability questionnaire responses: Pharmacy students 
 
 
Figure 24:  Graphical representation of positive, negative and neutral 
responses: pharmacist questionnaire 
 
 
 
 
 
 
 
 
 
  
 
Questions 
Pharmacy student 
responses (n=8) 
YES NO 
  n 
    
% 
   n   % 
1 
Do you find SignSupport useful for dispensing to Deaf 
patients? 
  8 100  0    0 
2 
Do you feel that SignSupport would make it easier when 
dealing with Deaf patients in the future? 
  8 100  0    0 
3 
 Do you think that SignSupport would facilitate and 
improve patient adherence? 
  7 87.5  1   2.5 
4 
Would you say that the way which SignSupport works is an 
effective way to facilitate communication between the 
pharmacist and the Deaf patient? 
  8 100  0    0 
5 Would you recommend SignSupport to your colleagues?   8 100  0    0 
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Deaf participant questionnaire responses 
All eight (100%) Deaf participants agreed that the usability of SignSupport was 
acceptable, found the application easy to understand and indicated that it could 
assist with their adherence by making it easier to receive information. Seven out of 
the eight Deaf participants felt that their confidentiality was being protected, that 
SignSupport was useful and that the experimental session was successful. As was 
the case with the pharmacy students, opinions of the Deaf participants were largely 
positive, indicating no uncertain/neutral responses and 4 negative responses across 
all ten questions posed to all eight participants (total of eighty responses). Table 16 
below presents questionnaire results from the Deaf participants followed by a 
graphical presentation illustrating a comparative analysis between positive, 
negative and neutral questionnaire responses.  
 
Table 16: Usability questionnaire responses: Deaf participants 
 
 
Questions 
Pilot experiment 
Deaf   user 
responses (n=8) 
YES NO 
n % n % 
1. Do you like SignSupport? 8 100 0    0 
2. Do you feel that your confidentiality is being protected when using 
SignSupport? 
7 87.5 1 12.5 
3.  Do you think SignSupport® will make it easier for you to 
understand how to take your medication? 
7 87.5 1 12.5 
4. Do you feel that the application was easy to understand? 8 100 0    0 
5. Will this application help assist your adherence to your medication? 8 100 0    0 
6. Do you feel that it was easier to receive information with the use of 
SignSupport? 
8 100 0    0 
7. Do you feel this session was a success? 7 87.5 1 12.5 
8. Will you tell others about this application and research study?   8 100 0    0 
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9. Did you enjoy this application?   8 100 0     0 
10 Did you find SignSupport useful?   7 87.5 1 12.5 
 
 
Figure 25:  Graphical representation of positive, negative and neutral 
responses: Deaf participant questionnaire 
 
  
 
 
 
 
 
 
 
 
 
 
7.1.8 Discussion  
The usability evaluation commenced with separate demonstration workshops 
targeted at pharmacy student participants and Deaf participants, followed by a pilot 
usability experiment during which the two participant groups merged in a role-play 
simulation exercise to test SignSupport in a simulated dispensary.  The 
demonstration workshop for the pharmacy students was successful and well 
received by all participants, who commented that the stepwise Microsoft 
PowerPoint® presentation incorporating screenshots of SignSupport was easy to 
follow and provided the necessary orientation to the application. The strategy to 
conduct the presentation before allowing participants the freedom to explore the 
application and role-play dispensing scenarios of their choice was appropriate and 
positively handled by the participants. Due to the positive response of pharmacy 
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students to the demonstration workshop process, a decision was taken that the same 
PowerPoint® presentation and same procedure would be followed in all subsequent 
demonstration workshops for pharmacists in subsequent usability evaluations.  
 
At this preliminary session students recognized that not all symptoms/illnesses 
were loaded onto SignSupport and commented that it would create a problem in a 
real-world context if a pharmacist was attempting to use SignSupport but was not 
able to find the medical condition  pertaining to the purpose of the medicines. In 
addition, incorrect spelling of certain terms on SignSupport was observed by the 
students. These errors are accounted for due to lack of familiarity of the computer 
programmer (who entered the medicine names into the application) with long and 
complex medicine names.  
 
The pilot usability experiment was conducted in a simulated dispensary which was 
set up to resemble a public hospital pharmacy. The experiment comprised a 
simulation exercise in which participants were briefed to role-play a situation in 
which Deaf patients would present a prescription at the pharmacy and wait for their 
name to be called before their medicine was dispensed by a pharmacist working at 
the pharmacy. The only difference to this role-play was that a practicing pharmacist 
would be using SignSupport to communicate the medicine instructions to the 
patient.  Both pharmacy student participants and Deaf participants commented that 
the simulation exercise method was successful and had no suggestions for 
improvement of the experimental session. There were no significant hurdles 
encountered during the session; consequently the researchers agreed that the same 
experimental procedure would apply to subsequent usability experiments of 
SignSupport. 
 
Video logs and the group discussion notes indicated that pharmacy students and 
Deaf participants experienced a positive dispensing interaction using SignSupport. 
Pharmacy students felt that the time take to dispense using SignSupport was not 
unreasonable and would be acceptable in a real-world context. All students 
indicated that they would prefer to dispense to a Deaf patient with the SignSupport 
rather than without. Pharmacy students once again noted spelling errors on the 
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application with regard to medicine names, and the omission of certain symptoms 
and medical conditions. These were noted by the researchers who planned to 
rectify these problems in the first design iteration of the application.  
 
Students mentioned their discomfort with the awkward silence that occurred during 
their interaction, as normally they would be speaking the medicine instructions to 
patient if the patient was Deaf. Pharmacy students were taught to interact with 
patients while counselling to building patient relationship. Models of 
communication relevant to pharmacist-patient interactions are dyadic in nature and 
include the features of sender, receiver, message, feedback and interference. If one 
juxtaposes SignSupport in the context of a communication model for a pharmacist-
patient interaction, the ‘sender’ in the model relates to the pharmacist who inputs 
information into SignSupport and the ‘receiver’ relates to the Deaf patient who 
receives the  information entered by the pharmacist in the form of SASL videos. 
The message refers to the SASL videos which are compiled on the application 
containing the relevant instructions. The missing element is the feedback which is 
not obtained since the Deaf patient is not able to ask any other queries which they 
may have. Pharmacy students were not comfortable that the patient did not have an 
opportunity to pose questions or indicate that they understood the instructions. This 
implies that while SignSupport can deliver medicine instructions, it is not able to 
facilitate pharmaceutical care in which the establishment of a joint relationship 
between patient and pharmacist is crucial in achieving optimal therapeutic 
outcomes.  This inability of SignSupport to offer pharmaceutical care is discussed 
further in the following chapter of this dissertation.  
 
All Deaf participants indicated that SignSupport was easy to understand, that it 
facilitated their understanding of how to use their medicines and that it would assist 
them to adhere to their medicine regimens. They appreciated the sign language 
format and did not experience any problems specific to the medicine administration 
instructions. Furthermore, they were able to input their medical history questions 
without difficulty.  Concerns were raised by the Deaf participants with regard to the 
color of the SASL videos. The addition of color videos on any mobile application 
software requires more software storage space than those appearing in a black and 
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white format due to an increase in pixels required for color images, the computer 
programmer was tasked to assess the feasibility of changing the videos to a color 
format.  Further concerns expressed by Deaf participants were not directly related 
to SignSupport. These concerns include the lack of access to general healthcare 
information and restricted access to primary health series as a result of  the 
communication barriers they face in attempting to seek primary healthcare services.  
 
Overall, pilot user evaluation results indicate that the communication of medicine 
instructions, confidentiality and autonomy of the Deaf community can be improved 
with the utilization of SignSupport. The application is able to bridge 
communication gaps that exist during the medicine dispensing process and enables 
a pharmacist to provide stipulated information regarding medication usage.  The 
application is not able to facilitate the provision of pharmaceutical care as it does 
not allow for a two-way communication process which incorporates questions and 
feedback by the patient.  
 
7.1.9 First design iteration 
Findings from the pilot user evaluation generated the following recommendations 
to the research team for modification to SignSupport: 
• Rectify medicine spelling errors by comparing the medicines list in 
SignSupport to the Medicines Control Council list of scheduled medicines.   
• Expand the list of symptoms/medical conditions to include additional 
common symptoms/illnesses.  
• At the section in SignSupport where a pharmacist is required to enter the 
name of the medication, provide an indication that pharmacists should enter 
the generic medicine name.   
• When a medicine needs to be taken only when required, include an option 
to avoid the reminder, currently this is not possible. 
• Enhance video clarity and assess the feasibility of full-color SASL videos. 
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7.1.10 Conclusion 
All study objectives articulated for the pilot usability evaluation of SignSupport 
were achieved.  Presentation materials for the purpose of demonstrating 
SignSupport for pharmacists was designed appropriately and was found to be 
useful and easy to understand.  A simulated dispensary was created for pilot testing 
and was appropriate for the purpose of the experimental procedure. Pharmacy 
students and Deaf patients were able to effectively and efficiently operate 
SignSupport on the Samsung Galaxy SII mobile phones when they were required to 
partake in a simulated dispensing interaction. The usability of SignSupport from the 
pharmacy students’ and Deaf participants’ perspectives were evaluated and 
generated largely positive results. Data generated from the pilot usability 
evaluation informed the first design iteration of SignSupport.  
 
The forward progression is to implement the pilot usability evaluation in an actual 
hospital pharmacy with practicing pharmacists and Deaf patients to assess the 
applicability and usability of SignSupport in a real-world context i.e. the hospital 
study.   
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SECTION B: SIGNSUPPORT EVALUATION: HOSPITAL STUDY 
The hospital study aimed to investigate the applicability of SignSupport in a real-
world context at the interface between practicing pharmacists and Deaf patients 
who collect their medicines from a public hospital pharmacy. In particular their 
first-hand impressions and experiences of using SignSupport were evaluated. The 
research design was based on the pilot study and was thus conducted in a similar 
fashion. However, this study differed from the pilot experiment in terms of study 
site and participant profile.  
 
7.2 Hospital study 
As was the case in the pilot study, the hospital study comprised two phases; (i) 
demonstration workshops and (ii) a usability experiment. During the first phase, 
demonstration workshops were conducted separately for pharmacists and Deaf 
participants.  Neither of the participants groups had seen the completed version 
SignSupport prior to the demonstration workshops. The aim of these workshops 
was to introduce SignSupport to both groups and allow them to ‘play’ with the 
application in order to establish familiarity therewith. During the pilot phase, I led 
the demonstration workshop for pharmacists, while the computer programmer led 
the workshop for the Deaf participants. For the hospital study however, I conducted 
the workshops for both pharmacists and Deaf persons, presented in this section.  
For the hospital study, a group (n=5) of final year pharmacy students (Appendix A) 
who selected pharmacy practice as a research area for their mandatory research 
projects, acted as my research assistants. They were especially helpful in handling 
the many logistical issues associated with simultaneously managing research 
protocol with pharmacists and Deaf persons, and in light of the fact that I was the 
only member of the multi-disciplinary research team involved in the hospital study.  
 
Phase two, the usability experiment, was conducted subsequent to and in the same 
week as the demonstration workshops to ensure a close time-proximity between the 
two phases, which was necessary to ensure that SignSupport was fresh and familiar 
in the minds of the participants.  During the experiment, a pharmacist was asked to 
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dispense medicines to a Deaf patient using SignSupport. This dispensing 
interaction was recorded by video cameras which were strategically positioned to 
capture the hand-screen co-ordination of the participants with the mobile phones. 
Figure 26 below illustrates the general study design for the hospital evaluation and 
incorporated both demonstration workshops and the usability experiment. 
 
Figure 26: Study design for hospital usability evaluation 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
The demonstration workshops for pharmacists and Deaf participants and the 
hospital experiment are described below under the following subsections: research 
objective linkage, study site and participants, methodology, materials, study 
procedure and results and discussion 
 
 
PHASE 1: Demonstration workshop: 
Pharmacists 
PHASE 1:  Demonstration workshop:  
     Deaf participants 
PHASE 2: Hospital experiment: Pharmacists dispense 
medicines to Deaf persons using SignSupport 
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7.2.1 Research objective linkage 
The hospital usability evaluation was conducted in order to achieve research 
objective 5 of this thesis: 
• To iteratively test SignSupport with Deaf persons and pharmacists to assess 
their acceptability and usability thereof.  
 
The following aims set out in order to achieve the afore-mentioned objective: 
1. To recruit a sample of pharmacists practicing in a hospital pharmacy 
setting. 
2. To recruit a Deaf participant sample from a rural town on the outskirts 
of Cape Town which had a different linguistic demographic than the 
Deaf participant sample in the pilot usability experiment 
3. To conduct demonstration workshops with the Deaf participant sample 
and the pharmacist sample 
4. To conduct a usability experiment including both participant samples in 
an actual hospital pharmacy 
5. To qualitatively assess the usability of application for pharmacists and 
Deaf users 
6. To evaluate feedback from the pharmacists and Deaf participants on the 
use of the mobile application 
7. To use the results obtained from the hospital usability evaluation to 
iteratively modify SignSupport 
 
7.2.2 Study sites and participants 
The study was directed to two participant groups:  (i) pharmacists working at a 
public healthcare facility dispensary (n=5) and selecting on the basis of a 
convenience sampling strategy and (ii) Deaf participants who are familiar with the 
medicine dispensing process at public health facilities in Cape Town and are 
selected on the basis of a purposive sampling strategy. 
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For the pilot study, senior pharmacy students were substituted for pharmacists due 
to the non-availability of pharmacists. In this experiment I aimed to include 
practicing pharmacists who have extensive experience in working at a public 
hospital facility. This would allow insight into whether SignSupport can 
accommodate specific pharmacy practice requirements and whether it would be 
acceptable to practicing pharmacists. Inclusion criteria for the pharmacists include: 
• that participants are employed  at a public hospital pharmacy in Cape Town 
• that participants are unable to communicate in SASL 
 
The sample population was a total of 5 pharmacists.  This sample was considerably 
smaller than what I had aimed for. However, as the primary researcher for the 
pharmacy component, I was dependent on the hospital pharmacy’s director to allow 
as many pharmacy staff as she could afford to partake in the study during working 
hours and to use the facilities of the hospital pharmacy. Furthermore, Nielsen 
(1994) reports that a number of five users is sufficient to uncover 85% of the 
problems of a system. Pharmacists were recruited to attend the demonstration 
workshop where they were introduced to SignSupport. The same pharmacists were 
used to dispense medication to the Deaf in the hospital experiment. 
 
The second group of participants for the study comprised Deaf individuals (n=6) 
and one SASL interpreter from DeafSA Paarl. A maximum variation sampling 
strategy was used to recruit this sample; ‘maximum variation’ in that this was a 
rural based community whose linguistic demographic was Afrikaans, compared to 
the pilot study group from a mixed-language based urban community. Urban 
versus rural was a significant variable in that the use of smart-phone technology 
may not have strongly infiltrated a rural based group as it would an urban group.  I 
aimed to test SignSupport in groups who were both familiar with technology and 
those who were not.  The language was a significant variable because the linguistic 
demographic in which a Deaf community is resident may affect the dialect of 
SASL specific to that community. Furthermore, Deaf people who are able to lip-
read different languages may have varying understanding of the SASL videos on 
SignSupport. Testing the application with a Deaf community from different 
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linguistic backgrounds would allow the researcher to test this possibility.  Inclusion 
criteria for Deaf participants included: 
• that  participants were Deaf in terms of the definition presented in chapter 3 
• that participants are  affiliated with the DCCT from which consent was 
obtained  to have access to the Deaf community 
• that participants must all have had experience in using medicines 
 
Participation in the study was voluntary and participants were informed of study 
details and expectations on participant information and informed consent 
documents (Appendix I-L). A registered sign language interpreter facilitated 
communication between the Deaf participants, myself and the pharmacists. 
Informed consent was obtained from the Deaf participants via the interpreter who 
signed the participant information and informed consent documents to the 
participants. Participants agreed and indicated informed consent by raising their 
hands in a closed consent session. This indication of agreed participation was video 
recorded.  
 
The study comprised three research activities:  
i. Demonstration workshop for pharmacists 
ii. Demonstration workshop for Deaf participants 
iii. Hospital experiment 
The demonstration workshop for pharmacists took place in the pharmacy 
boardroom at their place of employment, Tygerberg hospital pharmacy. A venue 
that was located as closely as possible to the hospital pharmacy was deemed most 
appropriate to minimize the duration of time which the pharmacist was needed to 
attend study activities. For Deaf participants, the demonstration workshop occurred 
in the boardroom at the DeafSA offices in Paarl, Western Cape. The usability 
experiment was conducted at Tygerberg hospital pharmacy where the participants 
occupied one semi-private dispensing area in the pharmacy. Permission to utilize 
each of the venues was obtained from the respective authorities, namely the 
pharmacy director and DeafSA manager.  
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Figure 27 below illustrates the experimental procedure occurring between a 
pharmacist (dressed in a white coat) and Deaf patient at a semi-private counselling 
area at Tygerberg hospital pharmacy.  In addition, Deaf participants occupied a 
section of the pharmacy waiting room while they were waiting for their names to 
be called for collection of their medicines by the pharmacy participants, who 
occupied a section within the pharmacy.  
 
Figure 27:  Experimental procedure: dispensing interaction between a 
pharmacist and Deaf patient at Tygerberg hospital pharmacy  
 
 
 
 
 
 
 
 
 
 
 
 
 
7.2.3 Methodology 
Hospital usability experimentation employed both qualitative methods 
(demonstration workshops, role-plays and video observations) and PAR techniques 
(contributions of the pharmacists, Deaf participants and SASL interpreter with 
regard to suggestions for improving SignSupport). Although the experiment tested 
SignSupport in a real-world context, role-plays were used to mimic a scenario in 
which a Deaf person collects medicines from the pharmacist. The medicines were 
not on actual prescriptions that belonged to the Deaf patient for medicines that they 
would actually use. At this stage SignSupport was still in the process of being 
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evaluated. To forego risks associated with Deaf patients taking medicines as 
instructed on a device that was still in a testing phase, I chose to conduct the 
experiment on a role-play basis even though it was in a real-world context. The 
hospital usability experiment occurred in line with a community-based co-design 
strategy which facilitates the participation of multiple groups toward creating a 
solution that suits their needs.  
 
The first research activity comprised a demonstration workshop for pharmacists, 
followed by a demonstration workshop for Deaf participants. The final research 
activity entailed the usability experiment at Tygerberg hospital pharmacy.  
 
7.2.4 Materials and resources 
The following materials were used in the two research activities: demonstration 
workshop and hospital pharmacy experiment respectively: 
 
 
 
Demonstration workshops 
Pharmacists Deaf community 
1 laptop computer 6 laptop computers 
Microsoft PowerPoint® software Microsoft PowerPoint® software 
SignSupport demonstration 
presentation for pharmacists 
SignSupport demonstration presentation 
for Deaf people 
5 Samsung® Galaxy SII phones on 
which SignSupport is installed 
6 Samsung® Galaxy SII phones on which 
SignSupport is installed 
A digital projector SASL interpretive services 
1 video camera on a tripod stand 1 video camera on a tripod stand 
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Hospital pharmacy experiment 
• A public hospital dispensary setting 
• 2 video cameras on tripod stands 
• Mock prescriptions 
• Medicines corresponding to the afore-mentioned prescriptions 
• Mock patient identity cards 
• Mock patient folders 
• SASL interpretive services 
 
7.2.5 Study procedures 
Separate procedures are described for the demonstration workshops and hospital 
pharmacy experiment. The workshops for Deaf participants and pharmacists each 
lasted 3 hours respectively and were conducted on separate days. The hospital 
pharmacy usability experiment occurred a few days later, in the same week.  
Results were obtained via video recordings and from my field notes. In addition, 
Deaf participants and pharmacists were asked to complete usability questionnaires 
after the experiment. 
 
7.2.5.1 Demonstration workshop with pharmacists 
The same Microsoft PowerPoint® presentation used in the pilot study to 
demonstrate SignSupport to pharmacy students was used in the demonstration 
workshop for pharmacists. The presentation entailed a detailed explanation on the 
entire process of dispensing with SignSupport and included screen shots of the 
application. The screenshots were placed in a step-by-step format to illustrate how 
the application should be used. A three hour workshop was held during which the 
pharmacists navigated through the screens on SignSupport in a stepwise process. 
After the presentation pharmacists were asked to practice in pairs by means of a 
role-play from various pharmacy situations using the application. Feedback 
regarding the interface, usability and functionality of the application was taken both 
by covert observation, and a group feedback session held subsequent to the 
workshop. Pharmacy recommendations for future modification were also noted. 
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Steps 1-13 below describe the sequential process pertaining to the demonstration 
workshop for pharmacists. 
 
Step 1:  Use the Microsoft PowerPoint® presentation from the pilot 
study which incorporates SignSupport screen shots in a 
sequential stepwise fashion to demonstrate the application. 
Step 2:  Schedule a demonstration workshop with pharmacists for 3 
hours 
Step 3:   On the workshop day, seat all participants in a venue with a 
laptop and digital projector 
Step 4:  Project the afore-mentioned PowerPoint® presentation to 
conduct the demonstration presentation. 
Step 5:  Hand each pharmacist one Samsung® Galaxy phone on 
which SignSupport is installed. 
Step 6:  Allow participants time to ‘play’ with the application on the 
phone.  
Step 7:  Once participants have indicated that they have had enough 
time to explore the application, ask them to partner with 
another participant to form a pair. 
Step 8: Ask the participants to role-play by pretending that one 
participant is a pharmacist and another is a Deaf patient to 
whom the pharmacist is dispensing medicines. 
Step 9:  The ‘pharmacist’ pretends to dispense medicines to the 
‘patient’ using SignSupport. 
Step 10:  The ‘pharmacist’ and ‘patient’ switch roles and repeat step 9. 
Step 11:  Repeat steps 8-10 twice. 
Step 12:  Conduct a group feedback session and record participants 
perceptions of their experience in using SignSupport, 
feedback and suggestions for modification/improvement.  
Step 13:  Conclude the demonstration workshop by thanking 
participants for their time. 
 
 
 
 
 
253 
 
Three days after the demonstration workshop for pharmacists, a similar workshop 
was held for the Deaf participants. 
7.2.5.2 Demonstration workshop with Deaf participants 
A demonstration workshop was conducted for Deaf participants to introduce and 
provide instruction on how to use SignSupport. The workshop involved a detailed 
explanation on the entire process of receiving medicine instructions on 
SignSupport and included screen shots of the application. The duration of training 
was approximately 3 hours. During this time the Deaf participants were able to ask 
questions via the interpreter and were given the opportunity to familiarize 
themselves with the application. Steps 1-13 below describe the sequential process 
pertaining to the pilot usability experiment. 
 
Step 1:  Use the Microsoft PowerPoint® presentation for Deaf 
persons from the pilot study (prepared by the computer 
programmer) which incorporates SignSupport screen shots 
in a sequential stepwise fashion to demonstrate the 
application. 
Step 2:  Schedule a demonstration workshop with Deaf participants 
and a SASL interpreter for 3 hours 
Step 3:   On the workshop day prepare six demonstration  stations; 
each with a chair for the Deaf participant, another chair for a 
research assistant, a laptop on which the afore-mention 
PowerPoint® presentation appears and a smart phone on 
which SignSupport is installed.  
 Step 4:  Have one Deaf participant seated at each research station and 
a research assistant next to each Deaf participant.   
Step 5:  Each research assistant navigates through the presentation 
screens while a SASL interpreter translates the principal 
researcher’s (author) explanation of SignSupport for the 
Deaf participants. 
Step 6:  Once the presentation is completed, conduct a question and 
answer session via the SASL interpreter.   
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Step 7:  Allow participants time to ‘play’ with the application on the 
phone.  
Step 8:  Once participants have indicated that they have had enough 
time to explore the application, ask them to practice 
uploading their background medical history information with 
the assistance of the research assistant. 
Step 9: Ask the participants to role-play where the research assistant 
mimics a pharmacist’s role and the participant is  a Deaf 
patient to whom the pharmacist is dispensing medicines 
using SignSupport 
Step 10:  Repeat steps 8-9 thrice 
Step 11: The entire process is recorded on video by placing video 
cameras in a position to record the participants’ hands on the 
mobile phone to assess how they navigate through 
SignSupport screens. 
Step 12:  A group interview (via a SASL interpreter) is held with the 
Deaf participants to assess their opinions of SignSupport, 
feedback and suggestions for modification/improvement.  
Step 13:  Conclude the demonstration workshop by thanking 
participants for their time. 
Two days after the demonstration workshop for Deaf participants, the usability 
experiment was conducted at Tygerberg hospital pharmacy. 
 
7.2.5.3 SignSupport usability experiment: hospital pharmacy 
The last empirical activity of this thesis is the usability experimentation of 
SignSupport with pharmacists and Deaf participants during routine operational 
procedures at a public hospital pharmacy. This testing occurred through a 
simulation exercise during which pharmacists who are employed at the hospital 
pharmacy dispensed medicines to a Deaf patient who was called from the waiting 
room, in the same way that they would normally do during their day to day 
dispensing activities, except that they used SignSupport to provide medicine 
instructions to the patient. During the simulation exercise, mock prescriptions, and 
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pseudo patient identity cards were used to preclude the possible risks associated 
with patients taking medicines as per a dispensing device that was still in the 
evaluation phase.  Video recorders were set up at strategic positions to capture the 
dispensing interaction between the pharmacy student and Deaf patient from various 
angles. This was done to capture closely the hand-co-ordination of the pharmacist-
user with the application, and the facial gestures of the Deaf patient to indicate 
acceptability and understanding of instructions given. I conducted group 
discussions with pharmacists and Deaf participants in order to obtain feedback on 
the experience with regard to the usage and other aspects of SignSupport. Steps 1-
13 below describe the sequential process pertaining to the hospital usability 
experiment. 
 
Step 1:  Schedule an experiment day with Deaf persons and 
pharmacists for 3 hours  
Step 2:  Negotiate with pharmacy management to allow one semi-
private dispensing area in which to conduct the experiment. 
Step 3:   Prepare mock patient identity cards and mock prescriptions 
and collate medicines corresponding to these prescriptions 
Step 4:  On the experiment day, have Deaf participants be seated in 
the patient waiting area. With them are a SASL interpreter 
and two research assistants who manage the experiment 
from the patient waiting area by communicating with the 
pharmacists in the pharmacy.  
Step 5:  Hand each Deaf participant one Samsung® Galaxy phone on 
which SignSupport is installed and ask them to input their 
general medical history on the Background information 
screen. 
Step 6: Ask pharmacists to prepare the mock prescriptions by 
selecting and preparing the medicines corresponding to the 
prescriptions.   
Step 7:  Once the prescriptions are prepared, direct pharmacists to 
take their position at the dispensary counter, one at a time, to 
get ready to dispense the prescription.  
 
 
 
 
256 
 
Step 8: The pharmacist calls out the patient name  written on the 
mock prescription. 
Step 9: The SASL interpreter communicates to the Deaf patient 
whose name was called that their medicine is ready and they 
can now proceed to the dispensary counter with their phone 
in hand. When they reach the counter, they hand the phone 
to the pharmacist.  
Step 10: The pharmacist dispenses the medicines to the Deaf patient 
using SignSupport. 
Step 11:  The Deaf patient is directed by the interpreter to return to 
his/her seat in the waiting room 
Step 12: Steps 7-11 is repeated with each pharmacist and a different 
patient. 
Step 13: The entire process is recorded on video by placing video 
cameras in a position to record participants’ hands on the 
mobile phone to assess how they navigate through 
SignSupport screens. 
Step 14:  Separate group feedback sessions are held with Deaf 
participants (via a SASL interpreter) and pharmacists to 
assess their opinions on the dispensing experience and 
SignSupport. In addition, they are asked to complete a 
questionnaire on SignSupport. 
 
7.2.6 Data analysis 
Data analysis occurred separately for each data set emerging from the 
demonstration workshops and hospital experiment. The demonstration workshops 
yielded workshop field notes form the pharmacist’s workshop and Deaf 
participants’ workshop, while the   hospital experiment yielded three data sets: (i) 
video logs, (ii) group discussion notes and (iii) usability questionnaires from both 
pharmacy students and Deaf participants.  Figure 1 below illustrates the data sets 
generated from each research activity.  
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Figure 28: Data sets generated from  hospital study activities 
 
 
 
 
 
 
 
 
 
 
 
 
 
Field notes, video logs and group discussion notes from the demonstration 
workshop and usability experiment were analysed in terms of Srivasta’s  (2009) 
three question framework. The author noted common themes emerging from these 
data sets. Questionnaire data was input into Microsoft Excel® to obtain frequency 
scores for responses that indicate positivity, negativity and uncertainty toward 
SignSupport.  
 
7.2.7 Results 
Results are presented separately for data emerging from the demonstration 
workshop for pharmacists, the demonstration workshop for Deaf participants (both 
workshops yielded field notes) and for the hospital experiment (which generated 
video logs, group discussion notes and questionnaires).  
7.2.7.1 Demonstration workshops: pharmacists 
Pharmacists exhibited an overall positive stance with regards to SignSupport. They 
felt that the concept was valid and of vital importance to improving communication 
during their dispensing interactions with the Deaf persons. The presentation which 
introduced SignSupport was understood and well-received by all the pharmacists. 
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No confusion or hesitation during the presentation and no questions were asked. 
All the pharmacists (n=5) were enthusiastic about the application and indicated that 
they were keen to see how it works. When asked to ‘play’ with the application and 
role-play in pairs, all the pharmacist (n=5) found SignSupport easy to use and 
indicated that it was appropriate for dispensing procedures. All the participants 
were able to navigate from the start to the end with minimal hesitation. Spelling 
errors were not encountered and pharmacists (n=4) were pleased that all the 
medicine names were pre-loaded, indicating that it would save time during 
dispensing. Difficulty arose at two sections: 
1. Omitted medical conditions:  The study finding with regard to omitted 
medical conditions found in the pilot study emerged once again. Pharmacists 
(n=2) recognized that several medical conditions were excluded from the 
application even though the list of illnesses/symptoms in the first version of 
SignSupport was expanded in first iterative modification of the application. 
When attempting to select a medical condition pertaining to the purpose of 
medicine therapy, pharmacists encountered a situation in which the medical 
condition they were attempting to select was not available from the preloaded 
options. One pharmacist attempted to select the condition ‘urinary tract 
infection,’ while another attempted to select the condition ‘migraine.’ Neither 
condition was available in the application, because appropriate SASL signs do 
not exist to precisely articulate these terms. Nonetheless, these particular terms 
can be replaced in SignSupport with the terms ‘bladder infection’ and ‘pain’ 
respectively, which are programmed in the application.  
 
At this point, I realized that pharmacists could not reasonably  be expected to 
know which medical conditions do and do not have equivalent SASL signs , 
consequently trying to select an illness/ symptom would be guessing game and 
a time-consuming exercise. To alleviate the guess-work, the researcher 
enquired from the pharmacists whether providing them with a list of conditions 
available on the application would solve this problem. They replied that it 
would be useful, and that such a list should be kept at the pharmacy. One 
pharmacist suggested that it would be worthwhile to compile a brief instruction 
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booklet for SignSupport, since they do not see Deaf patients every day which 
might cause them to forget how to use the application. It would also assist for 
pharmacists encountering SignSupport for the first time.   
  
2. Photograph screen: Three of the five pharmacists hesitated at the screen 
which prompts them to take a photograph of the prescribed medicine. They 
misinterpreted the screen prompt after the medicine picture was taken and were 
unsure whether or not the picture had been saved. The same hesitation was 
encountered during the pilot study, and can be expected since taking a medicine 
photograph is not a typical feature of the dispensing process. However, the 
pharmacists were easily able to move along to subsequent screens with only 
verbal instruction form the researcher with regard to how to proceed after the 
photograph was taken.   
 
Three days subsequent to the demonstration workshop for pharmacists, a similar 
workshop was conducted for Deaf participants.  
 
7.2.7.2 Demonstration workshops with Deaf participants 
The demonstration workshop for Deaf participants (n=6) was conducted with the 
assistance of a DeafSA SASL interpreter. During the initial stage of the workshop, 
all the Deaf participants (n=6) were intrigued by SignSupport and enthusiastic 
about how it would improve their communication with pharmacists and their 
understanding of medicine instructions. As the workshop proceeded, Deaf 
participants navigated the application in a manner that exceeded expectation; they 
seemed to be more familiar with smart phone technology than the Deaf sample in 
the pilot experiment. Five of the six participants navigated the screens with no 
hesitation and were able to input their background medical history without 
intervention from the researcher.  This indicates that the SASL videos which 
directed them with regard to how to use their medicines are likely to be effective 
and understandable. The sixth Deaf participant was the only one who experienced 
problems. The same participant was confused with regard to whether she had to 
include past illnesses in the background portfolio. The SASL interpreter informed 
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the researcher that this participant was from a different Deaf community whose 
SASL was of a different dialect, hence the reason for her problematic experience of 
SignSupport. One of the reasons the author chose to use a rural-based community 
was to ascertain whether dialectal differences would impact the usability of 
SignSupport, thus this was a significant finding. However, for the other five 
participants, who were of a different dialect to the pilot study group, there seemed 
to be no difficulty as they were all able to navigate the application with ease.  
 
The demonstration workshop proceeded with asking the participants to play with 
the application and role-play pharmacy scenarios with a partner. This all continued 
smoothly and positively except for the same afore-mentioned participant who had 
dialectal difficulties. In spite of these difficulties, she was able to navigate the 
application but hesitated at certain points, causing her to ask for assistance. To 
conclude the workshop, the researcher informed the participants of the imminent 
hospital experiment and briefed them of the logistical arrangements and of what to 
expect. One Deaf participant raised her hand and indicated that she had a question. 
She signed to the interpreter that she has a problem with SignSupport; that: “it is 
okay and works fine, but how can it help me when I have to go to the chemist 
(pharmacy) to go ask for help when my baby is sick?” 
 
Her question received categorical agreement from all the other Deaf participants 
and was reminiscent of the dissatisfaction expressed by the Deaf sample after the 
usability experiment in the pilot study. The pilot study Deaf sample also 
complained that SignSupport cannot assist them when they approach a community 
pharmacist with a minor ailment. This is a limitation of SignSupport since the 
application was primarily designed to provide medicine instructions for 
prescription medicines. The interaction between the Deaf participants then evolved 
into a discussion pertaining to their experiences at community pharmacies and of 
how they frequently left the pharmacy without assistance or incorrect information 
because the pharmacist could not understand them. As was the case in the pilot 
study, this finding was not directly related to SignSupport as treatment for minor 
ailments within the ambit of community pharmacy is not within the scope of the 
application. It does however, once again allude to  the lack of access to health-
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related information and primary care services experienced by Deaf people. Two 
days after the demonstration workshop, I coordinated the usability experiment at 
Tygerberg hospital.  
 
7.2.7.3 Hospital usability experiment  
Data from the hospital usability experiment included video logs of the experiment, 
group discussion notes and questionnaire data from Deaf participants and 
pharmacists. Results emerging from each data set are discussed separately below.  
 
Video logs   
Video footage revealed that majority of the pharmacists (n=4) seemed confident 
when dispensing to the Deaf patients using SignSupport were able to navigate the 
application easily. Hand-to-screen co-ordination with the phones proceeded 
smoothly and with minimal hesitation for pharmacists and Deaf persons. Facial 
expression and hand-co-ordination indicated confidence and assurance when 
navigating SignSupport for all but one pharmacist. The transition from the paper 
prescription to selecting instructions on SignSupport occurred effortlessly and 
without indecision for four of the five pharmacists.  
 
One pharmacist was experiencing some difficulty with regard to the patient 
background screen, on which a pharmacist would be informed whether of the 
patient’s weight, whether the patient is on concomitant medical treatment, 
experiences allergies, pregnancy status, whether the patient smokes or drinks 
alcohol and has access to clean water and daily meals. The pharmacist who was 
having trouble at this screen was unhappy that the information with regard to 
allergies and concomitant treatment did not specify the exact allergy the patient 
experiences (it only indicates if a food or medicine allergy is present but not what 
the patient is allergic to) or the exact medicines the patient was taking 
concomitantly. The application does however in the event of a positive allergy or 
concomitant treatment, prompt the pharmacist to check the patient folder; this is a 
function pharmacist normally do anyway. However, for this pharmacist, it seemed 
that she did not want to proceed unless that information was available on 
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SignSupport, which is unrealistic to expect since Deaf people themselves input that 
information and may not be linguistically able to name their allergy or medicines.  
The problem this pharmacist had was not with navigating SignSupport, but that she 
seemed to be unwilling to use SignSupport further without getting the allergy 
related answers she wanted. The researcher advised her to touch on the forward 
arrow, which she did, and was then able to effortlessly proceed through the 
application to the end of the pharmacist interface.  
 
 Another pharmacist hesitated briefly when encountering the screen on which she 
was asked to take a photograph of the medicine, but soon and without intervention 
realised what she needed to do and proceeded to subsequent screens. Apart from 
this hesitation and the afore-mentioned discontent with the allergy-specific 
information, all the pharmacists were able to navigate the entire application form 
start to finish without intervention. The average dispensing patient-interaction time 
using SignSupport was 4 minutes 18 seconds. This is expectedly longer than 
published dispensing time for patient counselling during normal dispensing without 
SignSupport, which was estimated in South Africa to be 1 minute, 14 seconds 
(Lubbe and Steyn, 2010). However it is shorter than the dispensing time recorded 
in the pilot experiment (4 minutes, 30 seconds). All the pharmacists indicated that 
the time taken to dispense on SignSupport was reasonable and would be 
appropriate in their daily dispensing activity. Table 18 below depicts the dispensing 
time per medicine and total prescription dispensing time using SignSupport during 
the hospital experiment.  
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Table 18: SignSupport dispensing time per item and per prescription 
 
Pharmacist’s 
code name 
assigned  
Time taken (minutes) 
1st item 2nd item Total 
     PhV 01:96 01:02 02:98 
     PhW 02:00 01:00 03:00 
     PhX 04:47 01:49 05:96 
    PhY 02:93 01:78 04:71 
     PhZ 01:48 01:59 03:07 
Average 
dispensing time 
  04:18 
 
 
Four of the five pharmacists appeared enthusiastic with regard to using the 
application to communicate with Deaf patients and closed the patient counselling 
session confidently. The Deaf participants and pharmacists handled the application 
with ease as they were seen to navigate through the application without hesitation. 
The majority of pharmacists photographed the medicine in a manner that allowed 
the patient to clearly differentiate between the different medicines. The role-plays 
progressed smoothly indicating that SignSupport follows a systematic dispensing 
sequence. The same was also noted in the pilot study. Deaf participants also 
seemed enthusiastic and appeared to understand the SASL videos on their phones 
pertaining to instructions for their medicines. This positivity toward SignSupport 
was also evident in the group discussion during which all participants were given 
the opportunity to express their opinions of and experience with SignSupport. 
 
Group discussion 
Short discussions were held with pharmacists and Deaf participants subsequent to 
the experiment to glean an overall impression of their experience of the dispensing 
interaction using SignSupport. All the pharmacists (n=5)  reported that the 
dispensing process using SignSupport was easy; however one pharmacist indicate 
that she was unhappy that she application did not give her specific details of the 
patient’s allergy. Pharmacists (n=5) commented that the application took very little 
time to navigate and that it followed a logical dispensing sequence with which they 
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were familiar. As was the case in the pilot study, all the pharmacists (n=5) 
commented that the review screen was necessary as it reminded them of all the 
instructions they had selected on previous screens. Four of the five pharmacists 
commented that they appreciated that SignSupport allowed them to select warnings 
and recommendations. All pharmacists agreed that they would rather dispense to 
Deaf patients with SignSupport than without it. 
 
All Deaf participants (n=6) reported that they understood the instructions on the 
SASL videos and that the videos would diminish uncertainty with regard to when 
and how to use medicines.   They were optimistic about the application and the 
study and requested the researcher to return to Paarl as soon as possible to provide 
feedback on the study results.  The session with the Deaf community ended on a 
positive note, Deaf participants appreciated that they were included in the study 
despite being from a rural town. Subsequent to the group interview session, 
pharmacy student participants and Deaf participants were each asked to complete a 
short usability questionnaire about their opinion of SignSupport.  
 
Questionnaire results 
All the participants (pharmacists and Deaf participants) completed usability 
questionnaires which were based on Likert-scale type closed ended questions 
which measures positive (yes), negative(no) or uncertain/neutral (unsure) responses 
to questions about their opinion of SignSupport. The same questionnaires used in 
the pilot study were administered to the pharmacist group and the Deaf participant 
group. The questions were structured in a simplistic manner to allow the 
participants to concisely and confidentially articulate their perception of 
SignSupport to compensate for the possibility that they may not wanted to have 
shared this perception in the group discussion. Below, the questionnaire results are 
presented as a comparative between the pilot study and hospital experiment to 
highlight the similarity between the findings of the two studies, which were 
targeted at different pharmacist and Deaf samples and conducted in a different 
context.  
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(i) Pharmacist questionnaire responses 
The total pharmacist sample (100%, n=5) agreed that SignSupport was a useful 
intervention in dispensing to Deaf patients, that the application made it easier to 
assist Deaf patients and is able to facilitate communication with them and that they 
will recommend the application to their colleagues The same hundred percent 
positive response for these questions was found in the pilot study.  The only 
difference between the studies was noted in the question regarding whether the 
pharmacists felt that SignSupport would improve patient adherence. In the pilot 
study an 87.5 % positive response was found, with a 12.5 % negative response. In 
the hospital experiment, a 100% positive response was found, indicating that all the 
pharmacists are of the opinion that SignSupport will improve patient adherence. 
Overall, there were no negative responses and no neutral responses across the 
questions all the questions for all respondents. A hundred percent positivity was 
found indicating that the pharmacists were optimistic about using SignSupport and 
would be likely use it in their professional practice in the future. Table 19 below 
depicts pharmacists’ questionnaire results as a comparative between the pilot and 
hospital usability experiments; this is followed by a graphical presentation 
illustrating a comparative analysis between positive, negative and neutral 
questionnaire responses for the two studies. 
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Table 19: Hospital experiment questionnaire responses: pharmacists 
 
Questions 
Pilot study 
responses(n=8) 
Hospital 
experiment 
responses(n=5) 
YES NO YES NO 
n % n % n % n % 
1. 
Do you find SignSupport useful when 
dispensing to Deaf patients? 
8 100 0 0 5 100 0 0 
2. 
 
Do you feel that SignSupport would make it 
easier when dealing with Deaf patients? 
8 100 0 0 5 100 0 0 
3. 
 Do you think that SignSupport would 
facilitate and improve patient adherence? 
7 87.5 1 12.5 5 100 0 0 
4. 
 
 
Is SignSupport works an effective way to 
facilitate communication between the 
pharmacist and the Deaf patient? 
8 100 0 0 5 100 0 0 
5. 
 
 Would you recommend SignSupport to 
colleagues? 
8 100 0 0 5 100 0 0 
 
 
Figure 29:  Comparative graphical representation of positive, negative and 
neutral responses: pharmacist questionnaire 
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(ii) Deaf participant questionnaire responses 
The SASL interpreter translated Deaf patient responses to questionnaire items. In 
both the pilot and hospital experiments, all Deaf participants (100%)  indicated 
their approval of SignSupport, that the application makes it easy to receive 
information and understand medicine instructions, that it could assist them to 
adhere to their medicine regimens and that they enjoy using the application. These 
results indicate that SignSupport is likely to be used by Deaf people as they 
approve of its user functionality. The hospital experiment yielded an increase in 
positive responses for questions relating to whether the participants felt that the 
application maintains their confidentiality, facilitates ease of understanding 
medicine usage and whether participants felt that the experimental session was 
successful, all of which generated a hundred percent positive response.  
 
Across all ten questions posed to 5 participants, only two negative responses were 
obtained; these include one negative response with regard to whether the 
participant would tell others about SignSupport, and one negative response with 
regard to whether the application is useful. This respondent further questioned the 
usefulness of the application in terms of the context in which SignSupport is 
intended to be used; the participant expressed that there may be need for an 
application such as SignSupport in a retail pharmacy setting. Overall, compared to 
the pilot usability responses, a higher positivity response percentage was found in 
the hospital experiment, indicating that the iterative modifications completed after 
the pilot experiment resulted in a positive effect in terms of participant usability. 
Table 20 below illustrates Deaf participant questionnaire responses for the hospital 
usability experiment as a comparative to results for the same questionnaire 
administered in the pilot study. The comparison illustrates the similarities in results 
obtained across the two studies. This is followed by a graphical illustration which 
depicts a comparison of the percentage of positive and negative responses. 
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Table 20:  Comparison of Deaf participant responses obtained for pilot 
study (n=8) and hospital experiment (n=6) 
 
 
 
 
Questions 
Pilot study 
responses (n=8) 
Hospital 
experiment 
responses (n=6) 
YES NO YES NO 
n % n % n % n % 
 
1. Do you like SignSupport? 8 100 0 0 6 100 0 0 
2. 
 
Do you feel that your confidentiality is 
being protected when using 
SignSupport®? 
7 87.5 1 12.5 6 100 0 0 
3. 
 
Do you think SignSupport will make it 
easier for you to understand how to take 
your medication? 
7 87.5 1 12.5 6 100 0 0 
4. Do you feel that SignSupport is easy to 
understand? 8 100 0 0 6 100 0 
0 
5. Will this application help assist you 
with adhering to your medication? 8 100 0 0 6 100 0 
0 
6. 
Do you feel that it was easier to receive 
information with the use of 
SignSupport®? 
8 100 0 0 6 100 0 0 
7.  Do you feel this session was a success? 7 87.5 1 12.5 6 100 0 0 
8.  Will you tell others about SignSupport? 8 100 0 0 5 83 1 17 
9.  Did you enjoy this application? 8 100 0 0 6 100 0 0 
10. Did you find SignSupport® useful? 7 87.5 1 12.5 5 83 1 17 
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Figure 30:  Graphical representation of positive and negative responses: 
Deaf participant questionnaire 
 
 
 
 
 
 
 
 
 
7.2.8 Discussion  
The hospital usability evaluation followed the same progression as the pilot study, 
commencing with separate demonstration workshops targeted at pharmacist 
participants and Deaf participants, followed by a usability experiment during which 
the two participant groups merged in a simulation exercise to test SignSupport in a 
hospital pharmacy.   
 
The demonstration workshop for pharmacists was well received by all participants 
and provided an overview of and orientation to SignSupport. All the pharmacists 
were enthusiastic about SignSupport and seemed keen to work with it. Echoing the 
findings of the pilot study, pharmacists once again recognized that not all 
symptoms/illnesses were loaded onto SignSupport and commented that it would 
create a problem in a real-world context if a pharmacist was attempting to use 
SignSupport but was not able to find the medical condition pertaining to the 
purpose of the medicines. The same finding occurred in spite of the fact that the 
additional symptoms and illnesses were added during the first iteration of 
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SignSupport. It became apparent that the problem being experienced was not that 
pharmacists were not selecting the correct conditions, but rather that they could not  
reasonably be expected to predict which medical conditions are and are not loaded 
in SignSupport as a result of the condition having or not having an equivalent 
SASL word. Consequently, attempting to select an illness/symptom would be a  
guessing game. Providing pharmacists with a list of conditions available on the 
application would assist them to know which conditions are appropriate to select. 
Furthermore, one pharmacist suggested that it would be useful to have a concisely 
worded instruction booklet for SignSupport. The demonstration workshop ended 
positively, with all the pharmacists agreeing to participate in the imminent hospital 
usability experiment.  
 
The demonstration workshop for Deaf participants was well-received and 
proceeded as planned without any difficulties. Despite being from a rural town with 
a different lingual demographic, participants navigated the technology well and 
were easily able to upload their medical history onto the application. One 
participant struggled with the SASL videos; the interpreter explained that she was 
from a different SASL dialect background than the other participants. This 
indicates that SignSupport may need to be tailored to different communities by 
incorporating SASL videos which is indigenous to that specific community.   
 
The usability experiment was conducted in a real-world public hospital pharmacy 
and comprised a simulation exercise during which pharmacists were asked to 
dispense medicines to Deaf patients who presented a prescription at the pharmacy 
and were waiting on their name to be called to collect their medicine. The 
pharmacist was asked to use SignSupport to provide medicine instructions to the 
patient.  In the simulation, the pharmacist would use SignSupport to communicate 
the medicine instructions to the patient. Video logs and the group discussion notes 
indicated that pharmacists and Deaf participants experienced a positive dispensing 
interaction using SignSupport. Video footage revealed that pharmacists navigated 
the application well and without hesitation. Hand-screen co-ordination occurred 
seamlessly and the pharmacists generally appeared confident and self-assured that 
the Deaf patient understood their medicine instructions.   One pharmacist indicated 
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that she was unhappy about the limitation to allergy-specific information that 
SignSupport provided on the background screen, the other pharmacists indicated 
this was not a problem as they were able to retrieve such information from a patient 
file.  
 
All pharmacists were able to take appropriate photographs of the medicine, and 
navigate the application from start to end with zero or minimal hesitation. In 
addition, all pharmacists commented that the application was logically organized 
and found not to be time consuming, hence could easily fit into their regular 
practice patterns. As was the case in the pilot study, all pharmacists indicated that 
they would prefer to dispense to a Deaf patient with SignSupport rather than 
without. There was no mention of the ‘awkward silence’ or lack of feedback that 
was reported by pharmacy students in the pilot study, even though neither of these 
problems was addressed in the previously mentioned iteration. This implies that the 
pharmaceutical care process and dyadic system of communication may not occur as 
frequently in the real-world context, possibly due to high workloads, hence the 
silence or lack of feedback are not as disturbing to practicing pharmacists as they 
are to the pharmacy students who have been taught to apply pharmaceutical care 
and establish mutual relationships with patients. This situation highlights a 
drawback of SignSupport; that the application facilitates one-way medicine 
instruction but is limited in the provision of pharmaceutical care which is 
dependent on a two-way communication pattern.  
 
All the Deaf participants indicated that they found SignSupport to be easy to 
follow, that it facilitated their understanding of how to use their medicines and that 
it would assist them to adhere to their medicine regimens. One participant had 
experienced problems related to the SASL dialect on SignSupport. Deaf 
participants appreciated the sign-language format and did not experience any 
problems specific to the medicine administration instructions. As was the case in 
the pilot study, all participants were able to input their medical history questions 
without difficulty. Additional concerns expressed by Deaf participants were not 
directly related to SignSupport. These concerns include the lack of access to 
general healthcare information and restricted access to primary health services as a 
 
 
 
 
272 
 
result of  the communication barriers they face in attempting to seek primary 
healthcare services. This finding occurred in both the pilot study and hospital 
experiment.  
 
Results from the questionnaire responses for pharmacist participants and Deaf 
participants across the pilot study and hospital experiment are remarkably similar, 
despite having different participants and different study sites. For both studies and 
both participant groups, the response to SignSupport was overwhelmingly positive. 
A marginally higher percentage of positive response was achieved in the hospital 
experiment, indicating that the first iterative modifications were necessary and 
well-received by participants. The similarity in results between the two studies 
strengthens the validity of findings and is indicative of procedural quality of 
measurements.  
 
Generally, pilot user evaluation results indicate that SignSupport is acceptable to 
pharmacists and Deaf participants and that the application is capable of facilitating 
the communication of medicine instructions. The application was found to be easy 
to use, logically sequenced and able to meet the need the user needs of both 
pharmacists and the Deaf community.  Despite its success in this regard, 
SignSupport is unable to facilitate pharmaceutical care and as it does not allow for 
a dyadic system of communication. Both the pilot and hospital evaluations 
unearthed significant problems which Deaf people face with regard to healthcare 
services. These include the lack of access to healthcare information in a medium 
that they can understand, and severely limited access to primary healthcare services 
as result of their inability to communicate and seek healthcare at this level. These 
problems are not within the scope of SignSupport, but can significantly impact the 
health status of the Deaf community and must be addressed with urgency.   
 
 Apart from its contextual limitation, the Deaf community did not express any 
functional usability problems with the application. Pharmacists reported one 
problem; that they were not easily able to find a medical condition, illness or 
symptom to select as a purpose for medicines. This problem exists because there is 
a limited number of medical conditions and symptoms for which there is an 
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equivalent SASL ‘word.’ This problem can be addressed by providing a list of the 
conditions programmed in SignSupport to the pharmacists, who are then able to 
match the purpose they wish to select, to one that is available in the application. 
For example, SignSupport has no option for peptic ulcer, but the pharmacist could 
select ‘heartburn’ to indicate to the patient the purpose for taking the medicine.  
 
7.2.9 Second design iteration 
Findings from the hospital user evaluation generated the following 
recommendations to the research team for modification to SignSupport: 
• On the pharmacist interface, include medicine combination formulations in 
the list of medicines which can be selected, for example, Rifafour® is 
combination therapy for tuberculosis. The application currently only allows 
a pharmacist to select single-ingredient formulations, thereby excluding 
combination formulations. (this problem was identified by a research 
assistant) 
• There are no iterative recommendations for the Deaf user interface. 
The pharmacist at Tygerberg hospital identified a further recommendation to 
compile a brief instruction booklet for SignSupport, which incorporates screenshots 
and a list of the symptoms and illnesses available on the application.  
 
7.2.10 Conclusion 
All study objectives articulated for the usability evaluations (pilot and hospital 
experiment) of SignSupport were achieved.  Study procedures were appropriate 
and experiments progressed as planned.  SignSupport was found to be a useful and 
applicable assistive technology for Deaf people in the context of providing 
medicine instructions during the dispensing process at public sector institutional 
pharmacies. The application is able to carry a pharmacist-patient interaction from 
commencement to conclusion for oral solid dosage forms.  While SignSupport can 
successfully communicate medicine instructions to a Deaf patient in signed 
language, it does not facilitate dyadic communication necessary to provide 
pharmaceutical care. 
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Usability evaluations enabled the researchers to identify problems in the system 
and effect the necessary iterative modifications to remedy these problems. 
Usability testing subsequent to the first iteration generated largely positive usability 
results, with a hundred percent positivity scores achieved for majority of questions 
posed to both pharmacists and Deaf persons. Success of study endeavors depended 
heavily on the contribution of SASL interpreters who were the anchors and 
mediators of the study. 
 
The system in its current form is a fully functional and useful prototype, but is not 
yet market-ready. Market readiness can be achieved by populating the prototype 
with all other dosage forms for self-administration and applying usability tests for 
all additions. Once this has been completed, the device must be subjected to 
independent quality control evaluations registered with all applicable medicine and 
technological authorities to authorize its use in South Africa. The researchers 
continue to work on SignSupport with the aim of availing the application to the 
Deaf community of South Africa in the near foreseeable future.  
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CHAPTER EIGHT 
 
DISCUSSION 
 
___________________________________________________________________ 
 
The three previous chapters (five, six and seven) have presented the outcomes of 
several conceptual and empirical processes which constitute this dissertation. Each 
outcome was presented and discussed in the context of its implications for 
SignSupport development and iteration and imminent research objectives.  This 
penultimate chapter delivers a broader discussion on the themes emerging from the 
SignSupport project, including a review of the chosen methodology, the strengths 
and limitations of the study, the ramifications thereof and implications on policy 
reform and social redress for the Deaf communities. In addition, health information 
accessibility for Deaf persons and the existing fissures in social competency related 
to pharmacy curricula and higher education priorities are explored. A related list of 
recommendations to address these issues closes the chapter.  
 
___________________________________________________________________ 
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8. Introduction 
This chapter aims to deliver a general discussion of reflections, lessons and 
implications emerging from this thesis. Divided into four sections, the first section 
provides a deliberation of the research strategies used to design and evaluate 
SignSupport.  I discuss the dynamics of the multidisciplinary collaboration, the 
combined employment of qualitative and participatory action methodologies and 
the strengths and limitations of this study. Furthermore, issues relating to working 
with the Deaf community and our dependence on signed language interpreters are 
described.  
 
The second section deals with the difficulties encountered in the provision of 
equitable and efficient medicine-related health services for Deaf people in South 
Africa and I highlight the advantages and shortcomings of the choice of a mobile 
phone intervention to facilitate communication between Deaf patients and 
pharmacists. The third section explores the specific roles of pharmacists and 
pharmacy faculty as potential change agents to find resolutions to the medicine-
related problems faced by Deaf people and marginalized society groups in general. 
The fourth and final section outlines future work on SignSupport and continuing 
initiatives with Deaf communities in the Western Cape.  
 
8.1 RESEARCH METHODS 
SignSupport was built on a foundation comprising three fundamental elements: (i) 
a multidisciplinary collaboration between research partners with vastly different 
fields of expertise, (ii) an intricate dependence on the Deaf community, 
pharmacists and signed language interpreters to develop and progress the study and 
(iii) qualitative, participatory and community-based co-design strategies. The 
implications of each of these elements for the research progression are described 
below. 
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8.1.1 Multi-disciplinary collaboration 
Combination of skills 
The collaborative effort of researchers who hold pharmacy, computer programming 
and industrial design expertise was essential to building SignSupport. Their 
collective knowledge and skills were interwoven and employed at each stage of 
development and evaluation. Moreover, the interdependence of the triad research 
partnership encouraged learning across our respective professional boundaries with 
regard to the requisites of an assistive mobile phone application to facilitate patient 
counselling for Deaf persons.  For example, as the pharmacist partner, I was the 
last member to join the team and prior to my involvement; the blueprint for 
SignSupport consisted only of very basic medicine directions that were intended to 
form the entire application (e.g. Take 1 tablet three times per day). Neither the 
computer programmer nor the industrial design engineer were aware of the 
importance of communicating background medical information, warnings and 
recommendations or the many permutations and additional instructions of medicine 
information. Similarly, neither the pharmacist nor the computer programmer 
possessed the skills to design SignSupport’s screens and icons using pictures and 
colors in a manner that could cognitively be understood for members of the Deaf 
community. In addition, neither the pharmacist nor the industrial design engineer 
was able to program SignSupport onto computer software in order for it to become 
a tangible and functional application.  Thus each member of the collaborative team 
depended immensely on the remaining two members to work synergistically to 
achieve our collective goal of creating SignSupport. 
 
Healthy conflict  
While there was some conflict between the three partners, such conflict was always 
a result of the desire of each partner to optimize our own specific professional 
perspectives. It was inevitable that working in a team consisting of diverse skills 
and backgrounds, that difference in approach and opinions would lead to conflict 
situations during the investigative process. The resolution of our conflicts came 
with the realization that our collaborative effort would require each of us to be open 
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to negotiation and that it was not always in the interest of the Deaf community to 
be rigid in our perspectives. At the first conflict situation, the pharmacist (I) was at 
the verge of concluding my involvement in the project unless the application 
contained all the pharmacy-specific information that I deemed necessary. At the 
same time, the computer programmer was of the opinion that it was unrealistic and 
not feasible to include patient greetings and other ‘unnecessary’ courtesies due to 
the coding complexities and storage limitations of the phones. By combining our 
professional knowledge and perspectives, we were able to attain flexibility by 
working through the conflict to find a solution that was suitable for both partners. If 
the computer programmer was not part of the collaboration, the pharmacist may 
have designed an all-inclusive application which was not operationally practical in 
terms of coding and the mobile phone storage capacity. On the other hand, without 
the pharmacist, SignSupport would likely only have contained basic medicine 
instructions, without medical history, warnings and recommendations or a review 
screen.   
 
In the greater scheme of things, the conflict which we experienced and the 
resolution thereof  led to reflection that inter-professional collaborations should 
form a core component in pharmacy training, focusing on contextualized learning 
where professional flexibility, embracing differences and negotiating skills could 
be developed in order to equip pharmacy graduates with the skill sets to enter into  
collaborative projects.  
 
Team support 
Perhaps the most valuable aspect of the collaboration was that, for each partner, 
there were always two other partners who could motivate the researcher who was 
stumbling across a hurdle. Inevitably each partner was required to reassess their 
professional contribution relative to the common overarching goal of an assistive 
communication device for the Deaf community.  
 
This project was highly sensitive: once I became immersed in the Deaf community 
culture and understood their daily struggle and frustration in all spheres of life and 
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particularly at health facilities, I was angered and frustrated that society, the 
government, health authorities and academia were not doing enough to alleviate 
their plight. In such moments of aggravation and despair, my co-dependence on the 
research partners to share in my frustration and understand what we were 
collectively working towards was an immense comfort enabled us to find solace in 
sharing our frustration and creating an impetus that paved the way for successive 
accomplishment of each phase of the project.  
 
The multidisciplinary collaboration approach offered an opportunity to combine 
different skills and areas of knowledge. It also allowed me access to human 
resources in areas where my proficiency in digital technology and industrial design 
was limited.   In addition, it allowed me to glean motivation and inspiration from 
team members and the emotional support and stimulus to navigate through a highly 
complex and exhaustive research process. Yet another advantage to the 
collaboration was that it rendered me accountable to the two other members of the 
team if I did not meet research deadlines.  
 
In pursuing research, many masters and doctoral thesis candidates do not complete 
their projects. In a team situation, one does not have the option of delaying or 
extending project deadlines because the timelines and funding commitments of 
respective team members are at stake. In this way, the collaboration ensured that I 
met all research deadlines in the stipulated time and did not defer from my own 
timeline or the project timeline in any way.  I have no doubt that the multi-
disciplinary collaboration strengthened the project and provided the necessary 
resources to see the project through to completion.  
 
Academic silos 
In spite of the many advantages of collaborative projects, they are often not fully 
supported by academic infrastructure. During several encounters in this research 
journey, I was questioned about the appropriateness and ethics of submitting a 
collaborative project as a doctoral thesis. My response that I was only submitting 
the ‘pharmacy perspectives’ of the project and work that I did, seemed to carry 
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little weight as a counter-argument.  Even in submitting this dissertation, I, as all 
other doctoral candidates, was requested to submit a signed declaration that the 
work submitted is mine only. Frankly, this did not sit well with me, because even 
though all the work I reported on was led and conducted by myself (assisted by 
research assistants, team members, Deaf community partners and pharmacist 
partners), it would not have reached fruition without the valuable and essential 
input of the computer programmer or the industrial designer.  It is unfortunate that, 
contrary to collaborative efforts, the typical nature of academic and empirical 
projects is to work in a silo so as to ensure ownership of data. Perhaps such a 
stance could only discourage academics from working collaboratively and to the 
jeopardy of society at large who can benefit from collaborative efforts.  
 
A project of this nature which aims at social change is very difficult, if not 
impossible, to achieve without the contribution of multi-disciplinary partners.  
Inclusive research involves people who may otherwise be seen as subjects for the 
research, become equal partners in the process of inquiry (Johnson, 2009). In this 
regard, the Deaf community partners actively shaped the requisites for developing a 
digital technology prototype. The involvement of multiple researchers is 
encouraged to engage in technological assessment (Shah, 2007).  In my experience, 
professionals often prefer to practice in their own areas of expertise with strong 
reluctance to venture into other fields of practice.  
 
The isolating nature of academic work has received substantial attention. Linton 
(2009) describes a “silo effect”, which speaks to the isolation of academics in their 
own areas of focus, with minimal interaction with the “academic neighbourhood” 
and even less with the outside world to which they should be more responsive. This 
can be accounted for by the pressures faced by academics in class preparation, 
grading and research and publication, among others. Even more so, academic silos 
are encouraged by faculty infrastructure, as the majority of institutions of higher 
learning “place little value on teamwork among faculty members (Linton, 2009).” 
In appraisals and concerns of tenure, little attention is given to collaborative work 
to engage on issues of social justice. Instead, publications and peer recognition 
carry the most weight, while making a significant impact in social change is “seen 
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as a distraction” (Manning, 2014; Riaz, 2013). Moreover, Surowiecki (2004) warns 
that this “silo effect” is damaging to the academic project because people are not as 
productive when working alone as they may be when collaborating with others.  
While doing what one has been trained to do and fulfilling professional norms 
should not be negated, society perhaps loses out on very powerful solutions and 
interventions which could result from multiple professional’s groups collaborating 
to address social quandaries.  
 
Are professional silos of practice creating a barrier to addressing social problems? 
Literature suggests the affirmative. In light of the known immensity of social 
injustices facing humanity, urgent attention must be given to re-integrate the 
academic project as mechanism of social transformation.   
 
8.1.2 Combining qualitative and participatory action research methods 
During the very early stages of this research, I intended to undertake a quantitative 
study with Deaf people to gain statistically significant data that would inform the 
pharmacy design features of SignSupport. However, in reviewing the literature of 
similar studies with Deaf people, I found that published studies were largely 
anecdotal and qualitative in nature. This was due to a number of reasons. Firstly, 
Deaf people belong to small, marginalized communities and have very specific 
preferences. Their small and scattered numbers renders statistically based studies 
impractical. Secondly, Deaf people often exhibit limited levels of literacy and can 
neither fill out a questionnaire nor provide a verbal response as is normally the case 
with statistically based studies with human subjects. Instead, every piece of data 
from the Deaf community is obtained via a signed language interpreter. This makes 
the data collection process much more time consuming and much slower than is 
normally the case. To expect thousands of surveys answered out by Deaf people as 
would be a requisite for an inference–based study is simply unrealistic.  
 
Thirdly, Deafness is uncontestably heterogeneous. Deaf people differ in their 
degree of Deafness, levels of literacy and cognitive capability. Furthermore, one 
Deaf community may differ vastly to the next in terms of signed language dialect 
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and cultural values and societal norms. A statistically based study with such largely 
different individuals and communities may not yield statistically significant data 
sets.   
 
Lastly, the type of information I was hoping to glean from the Deaf community 
was about their opinions, experiences and daily behavioral patterns. Quantitative 
inquiry produces objective data.  We required in-depth  insights into the 
experiences of Deaf people and natural behaviour patterns of pharmacists to 
influence SignSupport user features. Research into experiences and behavioural 
patterns require subjective, rather than objective data generated through 
quantitative study. Qualitative strategies allowed me to create simulation exercises 
in which overt and covert observations and in-depth interviews were adequate to 
glean the data I required to inform SignSupport. Much of the empirical activities of 
this thesis used simulation in the form of role-plays to obtain user needs and 
usability data on SignSupport. I described the organisation of such role-plays in a 
series of stepwise processes throughout the thesis. While role-plays are logistically 
cumbersome to set up and require participation from several partners, it allowed the 
research team a front-seat view into how pharmacists and Deaf persons behave in 
real-world situations. Possible alternative methods to obtain the same information 
include surveys of interviews which question the participants with regard to how 
they would behave in a dispensing situation. These methods however would not 
provide the depth of insight that I was able to glean by watching video footage of 
the body language, hand-screen co-ordination and general attitude toward the study 
proceedings.  
 
Qualitative methods provided insight into the belief systems and behaviors of the 
Deaf community. However, we were not able to achieve such data without 
immersing ourselves within the community and becoming members of their social 
circle. Deaf people exhibit a strong sense of identity and cultural connectedness. 
Tending to interact in a closed social group with other Deaf people who 
communicate in signed language, they do not easily share their beliefs and opinions 
with ‘outsiders’. In order to break these social barriers and gain the necessary buy-
in from the Deaf community, I chose a participatory action approach of which 
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participation is central element. Earlier in this thesis, I quoted the slogan of South 
Africa’s disability movement: “Nothing about us, without us.” In actively 
involving Deaf people at every stage of this research, not only as participants, but 
as co-designers of SignSupport, the research team adopted the same slogan as our 
motto. It inspired us to include the Deaf community in every decision and seek 
their approval for every aspect of SignSupport’s development.  
 
A high level of participation was achieved throughout this study. At each stage, 
from conceptualization to implementation, the input of Deaf persons and/or 
pharmacy students/pharmacists was incorporated into research and design 
processes. The very idea for SignSupport was sketched out by the Deaf 
community, whilst all pharmaceutical elements were contributed through research 
with pharmacy students and pharmacists. The prototype was evaluated by Deaf 
participants, pharmacy students and practicing pharmacists and their feedback was 
incorporated into the first iteration, resulting in SignSupport version 2. The process 
was repeated, again with both participant groups to inform the second iteration. In 
combinations with qualitative techniques, participatory action research methods 
were employed in the framework of community based co-design, a design strategy 
in which both the researchers and users of a device collaborate as the design team.  
 
The successful usability results reported in the previous chapter is attributed to the 
rigorous input and involvement of both Deaf participants and pharmacists. I am 
doubtful that such positive outcomes would have been achieved without their input. 
An alternative to designing the application without input from the users may have 
resulted in very different usability results. Furthermore, active user participation 
ensured high levels of receptiveness and acceptability of the prototype.  
This complex study employed several different methods including interviews, 
observations, simulations, participatory design and questionnaires. While 
questionnaires are typically a quantitative method, I integrated it in a qualitative 
approach, allowing the participants an additional opportunity to express their 
opinions via a confidential route and concise manner. The questionnaires not only 
served this purpose well, but allowed me to compare usability findings from the 
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pilot study to the hospital experiment. Interestingly, questionnaire results across the 
two studies, which involved different participants and sites and was done two years 
apart (pilot study in 2013 and hospital experiment in 2015) were remarkably 
similar, adding validity to findings and implying that usability testing achieved 
saturation of data. The employment of multiple methods proved useful in allowing 
the research team to assess SignSupport form various standpoints.  
 
Strengths and limitations of this study 
A significant strength of the research process was the contribution and combined 
skills of the multi-disciplinary partners. Not only did it allow us to brainstorm the 
most appropriate design strategies for SignSupport and its evaluation methods, but 
it also provided the necessary support and motivation to see the study through to 
completion.  Another strength was the high level of and rigorous participation from 
study participants (Deaf people and pharmacists). This enabled us to truly find 
design solutions and research strategies that were acceptable to our participant 
groups, thereby ensuring their buy-in and goodwill throughout study proceedings. 
Through the application of multiple sampling techniques to ensure representation 
from urban and rural Deaf communities, and prospective pharmacists with little 
experience and practicing pharmacists with high levels of experience, this study 
was able to detect independent usability results for SignSupport. Additionally, the 
accuracy of study findings was supported through the strong similarities in results 
between the two groups. Finally, the exhaustive list of strategies to ensure validity 
and reliability of study findings helped to enhance the strength and quality of 
deductions made from research outcomes.  
 
There are a number of limitations to the study. Although this is a primarily 
qualitative study and participant numbers were within the norms of those employed 
in usability testing, the low participation rate remains a weakness. Due the small 
and scattered numbers of Deaf people, the study could be implemented on a 
national level (not even provincial or municipal); this however would mean that 
modified versions of SignSupport need to be created to suit all the possible 
different dialects of SignSupport in the country.  This highlights another study 
limitation in that the application was only evaluated in the Western Cape region, 
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and thus was only tested for provincially common SASL dialects. Furthermore, 
SignSupport was only evaluated in a public sector tertiary hospital pharmacy. This 
was done because the Deaf community indicated that they mostly frequent such 
facilities to collect their medicine. Further studies should evaluate the applicability 
of Sign support in other institutional pharmacy settings.  
 
Finally, the unique psychosocial and socioeconomic footprint of South African 
marginalized communities, rendered by apartheid policies to be of a lower income 
group and poor educational status as described in the preliminary chapters of this 
dissertation, may have influenced the acceptability and usability findings of 
SignSupport to some extent as very different usability results may be attained with 
Deaf communities abroad.  As such, the findings generated from this research may 
have limited extrapolative clout for universal pharmacy contexts.  
 
8.1.3 Conducting research with the Deaf community  
The research team unanimously agreed that we would not attempt to design 
SignSupport without rigorous input and feedback from the Deaf community. 
However, not any of the researchers were fluent in signed language; consequently 
communication with the Deaf community was achieved through the interpretive 
services of SASL interpreters.   The prospect of doing so was met with reluctance.  
 
Sign language interpretation in data collection 
Not only was I hesitant due to the ethical and confidentiality implications of 
conducting research via a third party, but the logistical  inconvenience and expense 
of hiring interpreters and the fear that these interpreters would not ‘fit in’ and be 
accepted by our participant group magnified my resistance.  The dearth in 
published research with Deaf communities may be owing to similar reluctance by 
researchers to conduct studies via signed language interpreters. In reality however, 
the SASL interpreters were not only essential to the study progression, but they 
also provided a buffer to ease the tensions that exist between speaking and non-
speaking groups. For example, the researchers were reluctant to talk to one another 
during the study processes, so as to avoid causing the Deaf community to feel 
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excluded an as if we were speaking about them (deafness paranoia). With their 
presence however, the SASL interpreters could interpret whatever we were saying, 
even loose conversation that did not involve the research, and often the Deaf 
community responded via the interpreter. I also observed that all the interpreters 
became SASL interpreters due to having family members who are Deaf. As a 
result, they are able to understand the nuances of the Deaf community and were an 
indispensable information resource and a guide for the researchers throughout the 
study.  
 
Ethical issues were curtailed by having the sign language interpreters sign non-
disclosure agreements and the same participant information and consent documents 
as the participants. This study could not have progressed without the services of 
SASL interpreters unfortunately they are a scarce resource worldwide and 
concerted efforts should be made to train and employ interpreters not only in health 
facilities but also in academic endeavors with Deaf communities.   
 
Deaf community context 
Apart from undertaking all research-related endeavors via a third party (SASL 
interpreters), the specific cultural behaviors of Deaf people was another obstacle to 
surmount. Several psychosocial barriers were encountered in our study with the 
Deaf community. These included the strong sense of cultural connectedness within 
Deaf communities (which causes them to display reluctance in interacting with 
‘outsiders’); their diminished literacy capabilities; their impartiality to lip-reading 
and accommodation of their socio-economic circumstances. 
 
These factors had significant ramifications for study processes.  To overcome the 
reluctance among Deaf participants to engage in meaningful interactions with 
researchers, we had to invest significant amounts of time and effort in immersing 
ourselves in their community, building trust and familiarity until we were able to 
intuitively sense that they had become open to participation in the project and 
interaction with us.  While this initially delayed study proceedings, the time 
invested was well worth it as the research process ensued smoothly and without 
incident. In addition, it empowered the researchers with the skills and capability to 
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continue their work with the Deaf community well beyond the perimeters of this 
thesis. As researchers, our way of engaging with the Deaf community led to us 
unpacking the experiences of an isolated community relative to our own world 
view. By recognizing differences in our social, cultural and professional practices, 
we could contribute to a dialogical process that acknowledges the co-existence of 
different rationalities.  
 
Diminished literacy capability meant that we did not use typical methods of data 
collection. At no point did we rely on written or spoken means to obtain data. All 
responses from the Deaf community were given in signed language and translated 
for us as data by SASL interpreters. In a world where Deaf people are frequently 
forced to communicate in a language with which they are unfamiliar, this 
consideration was well appreciated by our Deaf participants who were notably 
relieved that they were not required to speak, lip-read or write anything. Even 
informed consent was taken by video recording a show of hands that they agreed to 
participate in the study.  
 
The Deaf communities, with whom we conducted research, were typically of a low 
socio-economic stature. In the initial stages of the research, many of them indicated 
concern with regard to whether they could afford the taxi or train fare to reach the 
research destination.  They were pleased by an offer from the research team to take 
care of all transport and meal costs. While this may be seen as an unethical 
incentive, it was crucial to ensuring study participation and creating a harmonious 
platform for meaningful engagement.  
 
 
8.2 PROVISION OF HEALTHCARE SERVICES FOR DEAF 
COMMUNITIES 
 
This section delves into difficulties encountered in the delivery of efficient and 
equitable healthcare services for Deaf people in South Africa. I explore the choice 
of mobile phone technology to alleviate some of these problems and suggest 
additional solutions to ensure acceptable levels of healthcare service delivery.  
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8.2.1 Disparities in healthcare services for Deaf people 
Findings from the literature and from this thesis suggest that the health care system 
in South Africa is failing to deliver equal and efficient healthcare services to Deaf 
people. Not only is the  healthcare system  inadequate to cater for  the specialized 
needs of Deaf people,  but society at large and academia too are failing to connect 
with Deaf communities to resolve their frustration and helplessness. One such 
example is that of waiting areas in public sector healthcare facilities. Not during the 
study, or in any prior experience did I observe any signed or pictorial information 
or instructions of how to proceed within the facilities. Literature about the 
frustration and struggles of Deaf people in waiting rooms in immense and 
unambiguous, with a plethora of reports of Deaf patrons waiting all day long only 
to not receive any services at all (Reeves et al., 2002; Iezzoni et al., 2004; Ubido et 
al., 2002, Kritzinger et al., 2014, Valios and Vale, 2004).  Similar situations occur 
in postal offices, banks and other situations where Deaf people are required to 
queue. Yet, with sophisticated technology at our disposal, this continues to be a 
problem for Deaf communities. When healthcare services are not available in a 
language that can be understood by patrons, it is clearly obvious that the plethora of 
health policy advocating for ‘equal rights’ and ‘equitable services’ for all citizens 
are clearly failing at an implementation level.  
 
8.2.2 Medicine-related problems faced by Deaf people 
In this thesis I have reported on at least three cases in which Deaf people did not 
use their medicines because they did not know the purpose thereof. Similarly, I 
quoted an author who reported on a case of a rape victim who received 
prophylactic therapy for HIV/ AIDS which she did not use because she had no idea 
of why she had to take the medicine. Subsequently, she was diagnosed as being 
HIV positive. These scenarios illustrate how the health-seeking behavior of Deaf 
people is negatively affected by the inability of healthcare staff to communicate 
with them in sign language. In addition, Deaf people often use medicines 
incorrectly and are more reliant on their own misconstrued instructions of using 
medicine than they are reliant on medicine instructions relayed to them by 
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pharmacists. As a result, they have many misconceptions with regard to how to use 
medicines, consequently taking medicines incorrectly and compromising their 
therapeutic outcomes (Ferguson  &  Liu, 2015; Haricharan et al., 2010; Reeves  et 
al., 2002). Once again, the right to healthcare is negated. 
 
8.2.3 Lack of access to healthcare information 
Perhaps the most significant observation of this thesis is the lack of access to 
general healthcare information faced by Deaf people. In a world where mainstream 
society relies heavily on media including television, radio, internet and printed 
media to glean general information on healthcare such as healthy lifestyles, eating 
habits, sexual behaviours etc., the Deaf community are wholly excluded. They 
cannot hear, therefore radio and television do not serve as sources of information, 
and their limited literacy prevents them from gleaning such information form the 
internet or printed media. From my observations throughout the research process, 
Deaf people really are ‘in the dark’ with regard to healthcare information. 
 
 Even the risks of pregnancy and sexually transmitted disease associated with 
sexual habits are unknown to many Deaf people. During both usability evaluations 
of SignSupport, Deaf participants indicated their approval of the application but 
desperately wanted a resource where they could find answers with regard to their 
healthcare questions for themselves and their family members. In modern times, we 
tend to do a web search on any question which we may ponder about. For most 
Deaf people, these resources are unusable due to their literacy deficits. And even 
when they are forced to seek healthcare services because they have no other option 
to find answers, healthcare professionals are unable to communicate with them. 
This lack of access to healthcare information is a critical issue that needs to be 
addressed with urgency. Pharmacists, along with other healthcare professionals 
would be failing in their professional obligation in not addressing the health care 
information needs of Deaf patients.   
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8.2.4 Lack of Deaf awareness among health care providers 
The problems that plague Deaf people are immense and may need a concerted and 
joint effort from the government, the healthcare sector and academia to combine 
skills and resources to address these issues.  The first step toward ensuring equal 
services is to eradicate the lack of Deaf awareness exhibited by healthcare 
professionals. Both from the reviewed literature (Huntington et al., 1995; Lomas, 
1998; Moola, 2010)  and in the findings from this dissertation, a common theme is 
that Deafness is not recognized nor understood by healthcare professionals. Being 
an ‘invisible disability,’ people often to not recognize that a person is in fact Deaf. 
Even when such recognition does occur, healthcare workers often have no idea that 
many Deaf people cannot lip-read and are unable to understand written instructions 
due to their literacy deficits. In the context of a healthcare facility, it is no wonder 
that Deaf people wait all day without being seen to and receive suboptimal services 
that do not cater for their special needs. 
 
 Personally, I too as a junior pharmacist working at a public hospital was unaware 
of the specific issues faced by Deaf people. When I interacted with a Deaf person, I 
attempted to speak as slowly as possible because I assumed they could lip-read. I 
also typed exhaustively long instruction labels for the medicines I was dispensing 
in the hope that they would face no ambiguity in understanding the instructions. I 
was wholly unaware that many Deaf people have reading difficulties.  Deaf 
awareness must be entrenched among healthcare workers. This can occur through 
inclusion of Deaf awareness in healthcare curricula, educational campaigns and 
symposia. Only when a healthcare worker is aware of what Deafness means will 
they have the motivation and knowledge to implement practical solutions to 
alleviate the difficulties faced by Deaf people at healthcare facilities.    
 
8.2.5 Policy implementation-an imperative for disability service delivery 
In addition to creating Deaf awareness, there must be an effort to implement human 
rights and disability policy. South Africa in particular has respectable policy in 
place to support all disabled people but such policy fails at an implementation 
 
 
 
 
291 
 
level. With regard to the Deaf community, legislation does not mandate signed 
language interpretive services at hospitals; neither does it specify any other 
disability specific services. Dialogues must be entered with authorities to ensure 
government adheres to and implement their policies and are held accountable 
should they fail to do so. Some suggestions to implement their policy for Deaf 
people are to mandate accessibility to sign-language interpretive services at all 
healthcare facilities. In addition, investing resources into infrastructure specific for 
Deaf people should be prioritized; this may include systems similar to those seen at 
fast-food outlets, where patrons are given a disk which vibrates accompanied with 
flickering lights to indicate that their order is ready to be collected. Similar disks 
should be provided to Deaf people at the reception and handed in at waiting rooms 
to indicate to staff and Deaf patients that it is their turn to either consult with the 
doctor or to collect their medicine. Another plausible suggestion is to include 
television screens in the waiting areas which run videos of sign language 
interpreters providing health-related information. This would mean that while 
waiting to be seen, Deaf people will be able to glean such information in their own 
language and may consequently learn the ambient healthcare information provided 
on mainstream television, radio and internet to which they are not normally privy.  
The availability of sign language interpreters, vibrating disks in waiting rooms and 
television screens broadcasting information in sign-language can potentially 
immensely improve the healthcare experience of Deaf people and perhaps even re-
integrate them into the healthcare system in a way that they feel like part of the 
system instead of as an outsider that nobody seems to see or hear. Perhaps such 
measures may alter their health seeking behaviors and even desegregate them from 
mainstream society.  
 
8.3  A MOBILE PHONE INTERVENTION AS AN OPTION TO 
FACILITATE COMMUNICATION BETWEEN DEAF PATIENTS 
AND PHARMACISTS 
 
SignSupport is a mobile phone application crafted to assist Deaf people in their 
interaction with pharmacists, with the overarching goal of positively impacting 
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their medicine-related health outcomes. This dissertation is centered on the design 
and evaluation of SignSupport in this regard.  
 
8.3.1 SignSupport usability evaluation 
Both a pilot study and real-world experimentation of SignSupport yielded 
overwhelmingly positive results. Pharmacists reported that the application was easy 
to navigate and that it would easily fit into their regular practice activities.  They 
were confident that it has the capability to accurately translate medicine 
instructions into signed language, but requested that they be provided with a short 
instruction manual should they have any practical problems with the application. 
Dispensing time using SignSupport does not differ greatly compared to regular 
dispensing. In a resource constrained, high workload environment this is crucial to 
ensure the acceptability of the application. Deaf participants also indicated their 
approval of the application. In particular they appreciated the sign language format 
and that they were not at all required to use spoken or written language when using 
SignSupport. In addition, they expressed appreciation for the autonomy and 
independence they were afforded by using the application. 
 
8.3.2 Mobile phone technology  
The choice of mobile phone technology as a medium to achieve these goals was 
found to be appropriate and had many advantages. All participants (pharmacists 
and Deaf community) were familiar with smart phone technology and were easily 
able to use the application. Majority of the Deaf participants own their own 
smartphones and would be able to download the application if it were available in 
their play store. Being on mobile phones, the application is in a compact package 
that is easily portable for Deaf people; this feature is essential for the daily 
reminders to take medicines that are input into the phones by pharmacists. Lastly, 
all the phones were able to play the SASL videos clearly and with no delay, 
indicating that the technology is compatible with that of mid-range commercially 
available smart phones.  
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8.3.3 SignSupport limitations 
In spite of these positive findings, evaluation of SignSupport highlighted a number 
of limitations. The first limitation is that SignSupport is context specific for 
hospital pharmacy, and while it can be easily adapted to accommodate a 
prescription scenario in a retail pharmacy, it is not suited to a situation in which a 
patient seeks health advice and treatment for a minor ailment. Such a service entails 
primary health care which is integral to the health system in South Africa, where 
resources or capacity to treat people at a tertiary care level is severely limited. 
Moreover, Deaf community members are desperate to have somebody to be able to 
assist them at the primary care level, which often does not happen due to the 
existing communication barriers. SignSupport cannot be adapted to accommodate 
such services; the prototype would fail for reasons similar to the faults of the 
Looijestein-Mutemwa doctor-Deaf patient prototype; the domain of possible 
interactions between a pharmacist and a patient seeking ambulatory care is simply 
too large to be contained in SignSupport. Just as SignSupport was designed to 
bridge the communication gaps existing in the dispensing of prescription 
medicines, alternative methods should be explored to facilitate the provision of 
over-the-counter medicines for minor ailments.  
 
Secondly, the application is not able to achieve a dyadic interaction between a 
pharmacist and Deaf patient. This implies that SignSupport is unable to achieve a 
two-way system of communication, incorporating receiver (Deaf person) feedback, 
response and questions to the message (medicine instructions) given buy the sender 
(pharmacist). With regard to pharmacists’ professional practice philosophy, this 
means that pharmaceutical care, which depends on mutual engagement between 
pharmacist and patient, cannot truly be achieved. Instead, SignSupport is able to 
accomplish only an aspect of pharmaceutical care: the communication of medicine 
instructions. While this is a significant accomplishment and a core duty of 
pharmacist which is very difficult to fulfil without SignSupport, cognizance must 
be taken of the fact that we must continue to strive for pharmaceutical care 
provision and equitable and efficient service delivery for Deaf people.   
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8.4  LOOKING FORWARD: PHARMACISTS AND PHARMACY 
FACULTY AS CHANGE AGENTS TO SEEK SOLUTIONS TO THE 
MEDICINE-RELATED PROBLEMS FACED BY DEAF 
COMMUNITIES 
This dissertation aimed to craft a solution for the linguistic barrier that is evident 
between pharmacists and Deaf patients. During our investigation, we were 
confronted with the reality that the barriers that exist are not only linguistic, but 
also sociological and psychological. One of the main barriers that exist is from the 
pharmacists and other health care practitioners is the lack of Deaf awareness. 
Healthcare personnel are not able to meet the needs of patient if they are unaware 
of what those needs are. This can be illustrated in the waiting room scenario and in 
the patient counselling situation. In waiting rooms Deaf people wait all day without 
being seen to. Deafness is not visible, personnel do not recognize that the person 
sitting there all day is Deaf and unable to hear their name being called or query 
how much longer their prescription will take to be processed.  During their 
consultation at the healthcare facilities and pharmacies, doctors and nurses and 
pharmacists may not understand the complexities of Deafness. Such complexities 
include literacy and cognitive deficits, inability or unwillingness to lip-read and the 
nuances of Deaf culture.  Furthermore, the heterogeneity of Deafness means that 
Deaf people cannot all be treated in the same manner, negating a one-size fits all 
solution. The reviewed literature and findings from this thesis have indicated this 
lack of Deaf awareness. Consequently, healthcare professionals do not respond 
appropriately to Deaf people. They talk more slowly in the hopes that the Deaf 
person can lip-read, and provide spoken written treatment consent form and 
healthcare instructions as though the Deaf person is able to hear and read 
proficiently. The importance of experiential and service-oriented curricula that 
target patrons with disabilities should be prioritized in institutions of higher 
learning.  
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8.4.1 Experiential and service-oriented curricula 
The solution to the problems faced by Deaf communities in relation to health care 
may plausibly lie in the reform of the academic curricula of healthcare 
professionals, including pharmacists. In the mandatory undergraduate curriculum 
and embedded in social accountability of pharmacy schools, Deaf awareness must 
be prioritized thereby empowering graduates with the knowledge and skills to 
appropriately provide medicine-related care to Deaf people. It is enormous injustice 
that healthcare workers are not specifically trained in handling the needs and 
complexities associated with disabled groups. Pharmacy schools in particular 
should aspire to become socially accountable. Research, education and service 
activities of pharmacy schools should be aligned with social accountability criteria 
and principles of equity, quality, relevance and cost-effectiveness (Boelen et al., 
2012). 
 
Smith et al (2010) report that while cultural competency has been adopted as a 
focus area in education, ethnic and racial demographics are called attention to and 
alternative cultures, including disabled groups have typically been 
underrepresented.  Pharmacy education has recognized the importance of cultural 
competency training as a means of diminishing health disparities. This is evident in 
initiatives by various colleges and schools of pharmacy to include such training in 
their curricula. However, few institutions identify disability as a culture (Smith et 
al., 2010), with even fewer providing disability-specific education. Moreover, even 
if disability-specific training is incorporated into curricula, such training must not 
comprise wholly of didactic, classroom type teaching. To truly understand the 
nuances of disabled culture such as the Deaf community, learning must be 
experiential in nature. This may include service-learning, community-based 
learning or inter-professional service experiences which are combined with other 
healthcare students. The diversity of cultural competency training methods that are 
already embedded in many schools of pharmacy worldwide indicates that the 
specific cultural issues which affect the medicine–related needs of the Deaf 
community can be addressed in the professional curriculum. In doing so, pharmacy 
students can learn about the needs of Deaf people and may be trained to adopt 
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constructive approaches in an attempt to ease their experience at health care 
facilities.  
 
 In my experience working with Deaf communities over the past few years, I 
believe that even minor practice change by pharmacists, such as realizing that the 
person in the waiting room is Deaf and will probably not hear their name being 
called, or recognizing that the Deaf person cannot understand written instructions 
well and using alternative methods of instruction, can have potentially positive 
impact on patient health seeking behavior and even quality of life.   
 
This dissertation has demonstrated that glaring gaps and inequalities exist in the 
provision of healthcare services for Deaf people. Healthcare professionals are 
failing to provide the services so desperately needed by this community. In the 
broader perspective,  Frenk et al., 2010 indicate that this failure to provide services 
appropriate to communities is a global and widespread phenomenon.  Causal to this 
trend is the failure of professional education to keep pace with changing and 
escalating health challenges, not localized to any one group or community (Frenk 
at al., 2010 ).  This calls for global reform by way of a universal social movement 
to adapt core competencies of graduating healthcare professionals with competency 
based–curricula that is responsive to changing health needs, rather than curricula 
that is dominated by static and outdated course-work (Frenk et al., 2010). With 
increasing technological advances, pharmacists have the potential to become agents 
of change in provision of pharmaceutical care for people with disability.  
 
8.4.2 Pharmacists as change agents 
In modern day society, medicines are an important commodity upon which society 
relies for their health and wellbeing as it enables the treatment of acute and chronic 
medical conditions. Accordingly, pharmacists play significant roles in society not 
only as the custodians of medicines but also a convenient and accessible resource 
for health-related information and advice. Often situated within communities, they 
serve as the first port-of-call for people requiring health-related attention and are 
typically respected and trusted members of society with strong connections to the 
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communities they serve. This renders pharmacists well placed to affect social 
change with regard to health-related quandaries, both for mainstream society and 
marginalized groups. For the Deaf community, the prospect for change is even 
better when pharmacists have been trained about the characteristics of Deafness 
and the nuances of Deaf culture.  
 
This dissertation has created a strong case for social transformation with regard to 
the healthcare of Deaf people. Such change must be effected both within the Deaf 
community themselves and with the practice behaviors of health care professionals. 
With regard to the Deaf community, pharmacists are required to interact more 
closely to breakdown the misconceptions they have about using medicines. More 
specifically, pharmacists are pivotal in providing the health-related information 
which Deaf community so desperately requires. Such an initiative could inform and 
motivate Deaf people towards positive health outcomes. The barriers faced by Deaf 
people in healthcare are not only lingual; it is also psychological and psychosocial.  
As a dependable and trustworthy information resource for the Deaf community, 
pharmacists can encourage Deaf people to interact more readily with hearing 
society and so too, encourage the hearing members of the community to learn about 
Deafness and create awareness for the plight of Deaf people. 
 
8.4.3 The role of higher education in social redress 
Universities are globally recognized as institutions of higher learning and 
knowledge production and transfer. They are lesser known for another important 
role; that of being centers for social transformation. The academic project is not 
only about intellectual effort, but also about critical engagement, connectedness 
with society, inclusiveness and about using the knowledge that is produced for the 
betterment of people’s lives. Yet, universities are dichotomously polarized 
institutions. One the one hand, the focus is the ‘pure science.’ It is about generating 
new knowledge, about maximizing publications as a source of revenue and about 
networking with international societies and partners securing large-scale funding 
for research. On the other hand is the ethical project, which includes engaging with 
communities, creating a culture of connectedness and social accountability in order 
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to dismantle the inequalities and injustices that exist in society. This is especially 
important in South Africa, which, twenty years into its democracy, remains one of 
the most unequitable and socio-economically divided countries the world over. 
This inequality suggests that universities are failing at fulfilling their dual roles, 
that the intellectual project is prioritized over the ethical project. If this were not 
indeed the case, a community would not suffer the plight and remain an ignored 
and unheard voice as the Deaf communities have been for the past decades.  
 
The unfortunate reality in South Africa is that, like the Deaf community many 
minority groups and marginalized societies suffer social, educational, economic, 
linguistic injustices. This dissertation has only examined the quandaries of the Deaf 
community. As a multidisciplinary group, we have used the resources of the 
university and tapped into the skill sets of various individuals at institution of 
higher learning and within the community itself to find solutions. Our team 
continues to engage with Deaf communities in the Western Cape to seek 
resolutions for the issues that SignSupport could not solve. Such efforts require 
rigorous and continued efforts in the field, engaging with communities to create 
tangible solutions aimed at social redress. Universities battle to acknowledge such 
efforts in a manner that is equivalent to the acknowledgment afforded to the 
production and dissertation of new ‘scientific’ knowledge. This is regrettable, and 
if universities are to fulfil their fundamental role of societal transformation they 
must prioritize work aimed at social redress and work which applies their 
institutional knowledge and skill for benefit of marginalized communities. 
 
8.5  FUTURE WORK and CONTINUING INVOLVEMENT WITH DEAF 
COMMUNITY PARTNERS  
While this dissertation is approaching its conclusion, several initiatives continue to 
run with the SignSupport project and with Deaf communities in the Western Cape. 
Below I briefly outline these initiatives and future endeavors which are in the 
pipeline: 
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• Work with Deaf communities in the Western Cape continues. Members of 
the research team have established relationships with additional rural-based 
Deaf communities outside of Cape Town. We also continue our affiliations 
with the DCCT and DeafSA Paarl, who have eagerly requested to know the 
outcomes of this study.  Symposia to disseminate the study findings to these 
Deaf communities are scheduled for January 2016. 
 
• As a result of the finding from this thesis that Deaf people experience 
marked limitations in access to healthcare information, SignSupport is 
being modified to include videos on healthcare information topics including 
diabetes, healthy sexual behaviours, HIV/AIDS and sexually transmitted 
diseases, chronic illnesses, asthma etc.  
 
• Randomised control trials are planned in which Deaf people take actual 
medicines as per SignSupport-assisted instructions with a view to have the 
application registered by the relevant medical and health authorities in 
South Africa. This would enable the application to become market–ready 
and commercially available. 
 
• While SignSupport is the main thrust of this thesis, major findings which 
are not related to SignSupport have emerged. These include the difficulties 
experienced by Deaf people at health care facilities, the lack of Deaf 
awareness by health care providers, and the lack of access to healthcare 
information experienced by Deaf people. I plan to disseminate these 
findings at conferences targeted at healthcare professionals including 
pharmacists, and at pharmacy academia. I also hope to disseminate such 
findings to the nursing community and the medical community.  
• Being an academic staff member at UWC School of Pharmacy, I intend to 
embed Deaf awareness training within the school’s experiential learning 
program. Outcomes from these initiatives will be shared with other schools 
of pharmacy in the country in the hope that they entrench similar programs 
in their curricula.  
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CHAPTER NINE 
 
CONCLUSION AND RECOMMENDATIONS 
 
___________________________________________________________________ 
 
The purpose of this closing chapter is to reconcile the findings of this dissertation 
with the primary research objectives. In addition, I deliver a list of 
recommendations for prospective related studies and a proposed follow-up plan to 
advance SignSupport to a market-ready finalized version.  
___________________________________________________________________ 
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 9.1 Distillation of findings 
The evidence demonstrated in this thesis has shown that glaring inequities exist in 
the provision of medicine-related care services to people in Deaf communities. 
Deaf people experience numerous challenges including attitudinal barriers of 
healthcare personnel, a lack of Deaf awareness and suboptimal service delivery, all 
of which impact their health-seeking behavior and the attainment of positive 
therapeutic outcomes. Poor pharmaceutical service delivery, amongst other 
challenges such as general lack of literacy, has translated to Deaf patients taking 
medicines incorrectly or not at all, misconceptions with regard to the use of 
medicines and non-adherence to treatment.   
 
To address these issues, a multi-disciplinary effort was undertaken to design and 
evaluate a mobile phone intervention to facilitate communication between 
pharmacists and Deaf people.  From these efforts, we were able to successfully 
extract a dialogue pattern typically exhibited by pharmacists during dispensing 
interactions  to build a communication structure for the mobile phone intervention.  
Thereafter, I undertook the conceptual processes of elucidating a medicines 
database and a symptoms/illnesses database to program into our intervention. The 
next step was to verify SASL videos which translate the communication structure 
and illness/ symptoms names into sign language for the information of Deaf 
patients.  The collation of the afore-mentioned dialogue pattern, medicines 
database, symptoms/illnesses database and verified videos culminated in the first 
functional version of our intervention, called SignSupport. 
 
 Iterative usability tests of SignSupport in a simulated dispensary and a real-world 
hospital pharmacy revealed positive and remarkably similar results. Both 
pharmacists and Deaf people indicated their approval of the application and 
indicated that they would most likely use it in the future. While evaluation of 
SignSupport was found to be effective in the purpose for which it was designed, 
study findings highlighted its limitations in interaction between a pharmacist and 
patient. Such limitations include that it does not allow for a dyadic mode of 
communication and as such and is not able to facilitate the provision of 
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pharmaceutical care. Although not within the scope of SignSupport, Deaf 
participants were disappointed that the application is not able to provide 
generalized healthcare information. This was identified as a completing study 
finding; Deaf people are desperate for access to healthcare information in a 
medium and language that they can understand.  
 
This thesis and the literature have indicated that attention must be called to 
healthcare service provision to Deaf people. I have discussed policy 
implementation and the role of pharmacists and pharmacy faculty in addressing the 
health disparities for Deaf people. The literature has demonstrated that involving 
practicing professionals and institutions of higher learning bodes well for initiatives 
geared toward social transformation.  
 
9.2 Recommendations for SignSupport 
With a view to advance SignSupport to a market-ready version appropriate for 
implementation and use by Deaf people, the following recommendations are 
proposed: 
a) Populate SignSupport programming infrastructure with additional dosage 
forms, in the same way that we incorporated tablets and capsules.  
b) Add combination dosage forms to the program.  
c) After accomplishing (a) and (b), subject the application to usability 
experimentation to detect any problems with the system. 
d) Once completed, present the application and usability results thereof to the 
relevant statutory authority which may deem it necessary to register as a 
medical device. Even if this is not the case, obtain the necessary regulatory 
permission to make SignSupport commercially available as an application 
that can be downloaded on commercially available phones.  
e) Continue to evaluate SignSupport by users and have a system in place to 
maintain and upgrade the application as necessary.  
 
 
 
 
 
 
 
303 
 
9.3 Recommendations beyond SignSupport 
Findings from this study have brought to light  a several issues faced by the Deaf 
community which  are beyond the scope of SignSupport  and warrant  further 
research and continued interactions with the Deaf community to address these 
issues.  As such, the following recommendations are proposed: 
 
a.) Establish sign-language interpreter roles in healthcare facilities 
Findings in the literature and from this thesis create a substantial case for the 
inclusion of sign-language interpreters at healthcare facilities. Deaf people 
uncontestably prefer to interact with healthcare professionals with the assistance of 
sign-language interpreters and the many medicine and health-related problems they 
encounter presents a strong case for this.  The South African government needs to 
be made aware of this, and also that they are failing to implement their policies 
with respect to the specific need s of the Deaf community. Alternatively, authorities 
should look toward up-skilling healthcare staff to learn sign-language and assess 
the feasibility and practicality thereof.  
 
b.)  Undergraduate pharmacy training 
Pharmacists possess generic skills to provide patient counselling.  They however 
lack the awareness of Deafness to recognize that they must adapt these skills to 
suite the specific characteristics of the Deaf community which results in poor 
application of their skills in interactions with Deaf patients. To gain such 
awareness, they must be afforded opportunities to engage meaningfully and 
critically to recognize their own skills deficits and identify the struggles faced by 
the Deaf community. This can occur through experiential and service-orientated 
initiatives which afford students the opportunity to immerse themselves in the Deaf 
community. 
 
c.)  Establish meaningful connections between pharmacists and Deaf 
communities 
As custodians of medicine and trusted members of society, pharmacists are 
conveniently and ideally placed to provide healthcare services and information to 
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Deaf people. Through continued professional development which is mandatory for 
pharmacists in South Africa, they can develop the skills and solutions they require 
to interact more readily with Deaf people. The Deaf community is desperate for 
access to health-related information since they are unable to glean such information 
from the means typically used by the hearing society (radio, television, printed 
media, internet etc.).  In this regard, pharmacists are an untapped resource and their 
potential for meaningful engagement with Deaf people as providers of such 
information is plausibly significant.  
 
d.)  Embed inclusive research in institutions of higher learning as vehicles for 
social change  
This dissertation has merely presented a case of one marginalized community who 
urgently require the attention of efforts of professionals, society and academia to 
alleviate the enormous health disparities they face on a daily basis.  Universities 
have the resources and multiple skill levels to address such problems, not only for 
Deaf people but for many other forgotten communities who can benefit from the 
varied skills and services of such institutions.  Social accountability must be 
embedded as a core activity of universities and such endeavors must be given equal 
acknowledgement as knowledge production and publication of research. Attempts 
at social redress can be greatly improved by the active and continued involvement 
of institutions of higher learning through research, education and service. 
Furthermore, dismantling academic silos has the potential to enrich and improve 
not only the lives of the societies we serve, but also challenge the status quo of 
academia.  
 
9.4 Concluding remarks 
In the early chapters of this thesis I presented comparison of a hearing baby and a 
Deaf baby, painting a picture of the numerous and varied social, psychological, 
socio-economic, developmental and emotional struggles of Deaf people throughout 
their lifespan. SignSupport was successfully developed as a novel intervention 
capable of communicating medicine instructions to Deaf people in a manner 
acceptable to the Deaf community and pharmacists in the Western Cape Province 
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of South Africa.  Through SignSupport, this thesis has merely presented one 
potential avenue of support; the truth of the matter is far more can be done for the 
Deaf community not only to improve their health status, but also to re-integrate 
them into society as equally important members. The future health and wellbeing 
of the Deaf community hinges on human efforts to alleviate their struggles 
However, this will remain a mere ideology unless pharmacists, other healthcare 
professionals and pharmacy faculty mobilize their efforts behind this strategy.  
 
   _____________________________________________________________ 
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APPENDIX A:  ROLES, AFFILIATIONS AND PARTNERS  
 
 Role Affiliation Supervisor Co-researchers 
Mariam Parker Pharmacist 
Member 
UWC School of 
Pharmacy 
Angeni Bheeki 
William 
Tucker 
Assistant  researchers: 
Golden. T 
Gusha.S 
Higgins.K, 
Mack. L 
Made. S 
Mnguni. N 
Ahmed. N 
Chen. ST 
De Kock. K 
Potelwa.A 
Sehume B 
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Julius.E 
Mashaba. C 
Mohammed. M 
Moola, M 
Smith, N 
Michael 
Mothlabi 
Computer 
programmer 
UWC Computer 
Science 
Meryl Glaser 
William 
Tucker 
 N/A 
Prang 
Chininthorn 
Industrial design 
member 
Delft University 
of Technology 
(Netherlands) 
William 
Tucker 
Adinda 
Freudenthal  
N/A 
DCCT Input in design 
and preliminary 
testing 
DEAFSA Meryl Glaser N/A 
Paarl DEAFSA Hospital testing DEAFSA N/A N/A 
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APPENDIX B: SCOPE OF WORK
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Programming 
aspects 
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Prospective 
student 
Collate pharmaceutical 
aspects to inform design of 
application 
Obtain Deaf community 
insights/ experiences with 
medicine use 
Design application to aid pharmaceutical 
communication in dispensing medicines to 
Deaf people. Record SASL videos 
Design and programme application to assist 
pharmaceutical communication for other dosage 
forms of medicines 
Chininthorn: 
Design 
aspects 
Parker: 
Pharmacy 
aspects Test the application with pharmacist users 
Programme application onto mobile cellular 
smart-phone to aid pharmaceutical 
communication in dispensing medicines (oral 
solid dosage forms) to Deaf people 
Design pharmaceutical 
pictograms for Deaf users 
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APPENDIX C: PARTICIPANT INFORMATION SHEET (Baseline study) 
 
 
 
  
Investigating medicine use in the Deaf community: toward informing a mobile cellular 
phone pharmaceutical application for Deaf users and pharmacists 
Background:  
 
You are invited to partake in a research study Medicine use in the deaf community. Before 
deciding to participate in this study, it is important that you understand why the research is 
being done and what it will involve. Please take your time to read the following information 
carefully. Please ask the researcher to clarify any unclear information. 
 
Purpose of the Research: 
This research study is designed to obtain information that may possibly inform a mobile 
application on Android media to enable communication between a pharmacist and a deaf 
patient. The data from this research will be used to explore medicine use by obtaining 
information from the deaf patients, to highlight the possible challenges faced by deaf 
patients regarding access to health care information, to possibly improve adherence to 
medicine use in deaf patients, to highlight possible successful mechanisms regarding 
medicine use in deaf patients 
 
Study Procedure:  
Your expected time commitment for this study is: time (1 hour 30 minutes) 
The study will be conducted in the form of a focus group interview/ key informant 
interview/ simulated dispensing role-play format. 
 
Risks:  
There are no risks of participating in this study. Everything you say to us will be kept 
confidential. Interviews will be tape recorded and responses will also be recorded in writing 
but no names will be used in transcription of the data thereby ensuring confidentiality, you 
may decline to answer any or all questions and you may terminate your involvement at any 
time if you choose. The same applies for the simulated role-plays which will be video 
recorded.  
There will be no direct benefit to you for your participation in this study. However, we hope 
that the information obtained from this study may help the health pharmacists and health 
care workers to improve service deliveries to the facilities. 
 
Confidentiality:  
We assure you that every effort will be made by the researcher to maintain your 
confidentiality including the following:  
• Assigning code names/numbers for participants that will be used on all researcher notes 
and documents.  
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• Notes, interview transcriptions, video recordings and transcribed notes  and any other 
identifying participant information will be kept in a locked file cabinet in the personal 
possession of the researcher. When no longer necessary for research, all materials will 
be destroyed. 
• The researcher and the members of the researcher’s committee will review the 
researcher’s collected data. Information from this research will be used solely for the 
purpose of this study and any publications that may result from this study. Any final 
publication will contain the names of the organizations and researchers that have 
consented to participate in this study (unless they have requested anonymity): all other 
participants involved in this study will not be identified and their anonymity will be 
maintained  
 
Each participant has the opportunity to obtain a transcribed copy of their interview. 
Participants should request a copy of the interview if desired.  
 
Person to Contact:  
Should you have any questions about the research or any related matters, please contact 
the researcher at the details below. 
 
Voluntary Participation:  
Your participation in this study is voluntary; it is up to you to decide whether or not to take 
part in this study. If you do decide to take part in this study, you will be asked to sign a 
consent form. If you take part in this study, you are still free to withdraw at any time 
without reason. You are free to not answer any question or questions if you choose. This 
will not affect the relationship you have with the researcher.  
 
Unforeseeable Risks:  
There may be risks that are not anticipated. However every effort will be made to minimize 
any risks.  
 
Costs to Subject:  
There are no costs to you for your participation in this study  
 
Compensation:  
There is no monetary compensation to you for your participation in this study.  
 
Principal Investigator: Ms M. B. Parker 
Department: Pharmacy Practice   
E-mail:  mbparker@uwc.ac.za 
 
Signature: ____________________     Date: ____________________ 
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APPENDIX D: CONSENT FORM (Baseline study) 
 
 
 
Title: Investigating medicine use in the Deaf community: 
toward informing a mobile cellular phone 
pharmaceutical application for Deaf users and 
pharmacists 
 
 
Declaration by participant: 
By signing below, I …………………………………..…………. agree to take part in a research study 
entitled: Investigating medicine use in the Deaf community: toward informing a cellular 
phone mobile pharmaceutical application for Deaf users and pharmacists 
 
I declare that: 
• I fully understand the consent form and it is signed a language with which I am fluent 
and comfortable. 
• I understand that taking part in this study is voluntary and I have not been pressurised to 
take part. 
•  I may choose to leave the study at any time and will not be penalised or prejudiced in 
any way. 
•  I understand that I will be given a copy of this consent form upon request 
• I voluntarily agree to take part in this study (Investigating medicine use in the Deaf 
community: toward informing a cellular phone mobile pharmaceutical application for 
Deaf users and pharmacists) 
 
Signed at (place) ......................…........…………..on (date)…………....……….. 2012 
 
...........................................                 ...................................... 
Signature of participant            Signature of witness 
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APPENDIX E:   DECLARATION OF PARTICIPANT INFORMATION BY 
INTERPRETER (Baseline study) 
 
 
 
 
 
 
Title: Investigating medicine use in the Deaf community: 
toward informing a cellular phone mobile 
pharmaceutical application for Deaf users and 
pharmacists 
 
 
I (name) ……………………………………………..……… declare that: 
• I assisted the investigator (name) ………………………………………. to explain the 
information in this document to (name of participant) 
………………………….…………….. using the language medium of South African Sign 
Language. 
• We encouraged him/her to ask questions and took adequate time to answer them. 
• I conveyed a factually correct version of what was related to me. 
• I am satisfied that the participant fully understands the content of this informed 
consent document and has had all his/her questions satisfactorily answered. 
• I shall keep all information conveyed to me by the participants confidential. 
 
Signed at (place)......................…........……………..on (date)…………....………2012 
 
.....................................................         .................................................... 
Signature of interpreter     Signature of witness 
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APPENDIX F:   FOCUS GROUP GUIDELINE (Baseline study) 
 
 
 
Title: Investigating medicine use in the Deaf community: 
toward informing a mobile cellular 
phonepharmaceutical application for Deaf users and 
pharmacists 
 
 
Background questions: 
1. Where do you live? 
2. What is your age? 
3. How long have you been Deaf? 
4. What is your level of schooling? Primary, secondary or tertiary? 
5. Do you make use of the public or private health sector? 
 
Focus group guidelines: 
1. How often do you interact with a health care provider with respect to receiving 
medication? 
2. How often do you go to the pharmacy and speak to the pharmacist? 
3. Describe your experience when going to the pharmacy? 
4. Are you on any medication? 
5. What type of medication are you on? (chronic/acute)? 
6. Do you know what your medication is for? 
7. How do you take your medication? 
8. When do you take your medication? 
9. Do you take them regularly and on time as instructed? 
10. Who told you how to take your medication? 
11. Is it difficult to take your medication? 
12. What are the difficulties? Why? 
13. How can a pharmacist make it easier for you to take your medication? 
14. Which communication style do you prefer: signing or lip-reading? Why? 
15. Do you prefer the use of pictograms? 
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APPENDIX G:   KEY INFORMANT INTERVIEW GUIDELINE (Baseline study) 
 
 
 
Title: Investigating medicine use in the Deaf community: 
toward informing a mobile cellular phone 
pharmaceutical application for Deaf users and 
pharmacists 
 
1. Do you think Deaf people use medicines correctly? 
2. Who instructs them on how to use medicines? 
3. Are there any misconceptions of the Deaf regarding medicine use? 
4. Are there any challenges of the Deaf with regard to medicine use? 
5. What do they know about their medication? 
6. Which communication method do you feel is most effective when you communicate 
with the Deaf, lip reading, signing?  
7. Do you think that pictograms are effective when communicating with the Deaf? 
8. What do you think plays a role in having a positive outcome when using medicine? 
9. How are they able to use their medication correctly? 
10. Do you think that there is or should be a relationship between the Deaf patient and 
a pharmacist? 
11. What do you think the relationship is like between a Deaf patient and a pharmacist? 
12. What do you think the relationship should be like between a Deaf patient and a 
pharmacist should be like? 
13. What do you think can be done by pharmacists to improve the quality of life of Deaf 
individuals? 
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APPENDIX H:   OSCE CHECKLIST FOR DIALOGUE PATTERN (Baseline 
study) 
 
OSCE (Modified) Points 
 
STEP A:  
1. Greeting 
2. Confirm identification 
3. Clarification of the problem 
 
STEP B: General history 
4. Age 
5. Physiological  status (weight etc. ) 
6. Allergies and Reactions to drugs 
7. Previous and Current illness 
8. Medicines were taken in the last 6 months 
9. Current medication 
 
STEP C: Social professional information 
 
10. Access to water and meals 
11. History of Illnesses in the family 
12. Smoking/exposure to smoking and alcohol  use 
13. Diet (in relation to specific disease) 
 
STEP D: Clinical reasoning  
14. Explanation of current problems 
15. Reassure patient 
16. Relevant Drug and non-drug treatment 
17. Directions for use  
18. Warning and recommendations 
19. Test recall 
20. Follow-up (if necessary) 
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APPENDIX I:   PARTICIPANT INFORMATION SHEET FOR PHARMACY 
STUDENTS/PHARMACISTS  
 
Title: Testing and modification of SignSupport®: a mobile phone application 
prototype for Deaf users and pharmacists 
 
Background:  
You are invited to partake in a research study on SignSupport use in a pharmacy 
environment. Before deciding to participate in this study, it is important that you understand 
why the research is being done and what it will involve. Please take your time to read the 
following information carefully. Please ask the researcher to clarify any unclear information. 
 
Purpose of the Research  
This research study is designed to obtain information that would determine usability and 
improve the mobile application, SignSupport, on Android media to enable communication 
between a pharmacist and a deaf patient. The data from this research will be used to explore 
SignSupport use by obtaining information from pharmacy students/pharmacists and to 
highlight the possible challenges faced by the students regarding the dispensing of medication 
to Deaf participants whilst using the mobile application on site in a simulated/ real world 
hospital dispensary, simulating the dispensing of fictitious prescriptions to a Deaf person. 
 
Study Procedure:  
Your expected time commitment for this study is: 
The study will be conducted in the form of a role-play in which you (the pharmacy 
student/pharmacist) will be dispensing medication to a deaf patient in a simulated/ real world 
dispensary while using the mobile application. The entire role-play will be recorded. 
 
Risks:  
There are no foreseeable risks associated with participation in this study. Everything you do 
will be kept confidential and will be video recorded and no names will be used in 
transcription of the data thereby ensuring confidentiality. You may terminate your 
involvement at any time, provided that you have notified the research members 24 hours in 
advance of your intent to terminate your participation.  
Confidentiality:  
We assure you that every effort will be made by the researcher to maintain your 
confidentiality including the following:  
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Assigning code names/numbers for participants that will be used on all researcher notes and 
documents.  
Notes, interview transcriptions, transcribed notes and any other identifying participant 
information will be kept in a locked file cabinet in the personal possession of the researcher. 
When no longer necessary for research, all materials will be destroyed through shredding. 
The researcher and the members of the researcher’s committee will review the researcher’s 
collected data. Information from this research will be used solely for the purpose of this study 
and any publications that may result from this study. Any final publication will contain the 
names of the organizations/researchers that have consented to participate in this study (unless 
requested anonymity): all other participants involved in this study will not be identified and 
their anonymity will be maintained. 
 
Person to Contact:  
Should you have any questions about the research or any related matters, please contact the 
researcher at the details below.  
Voluntary Participation:  
Your participation in this study is voluntary; it is up to you to decide whether or not to take 
part in this study. If you do decide to take part in this study, you will be asked to sign an 
informed consent form.  
 
Unforeseeable Risks:  
There may be risks that are not anticipated. However every effort will be made to minimize 
any risks pertaining to or arising from this study.  
Costs to Subject: There are no costs to you for your participation in this study.  
 
Compensation:  
There is no monetary compensation to you for your participation in this study. A certificate of 
acknowledgement will be given at the end of the research study to acknowledge your 
participation. 
 
Principal Investigator:  Ms M. B. Parker 
Department:   Pharmacy Practice   
E-mail:    mbparker@uwc.ac.za 
Contact number:   083 650 1644 
 
Signature:  ____________________ 
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APPENDIX J:   INFORMED CONSENT DOCUMENT FOR PHARMACY 
STUDENTS/PHARMACISTS  
 
 
 
Date:       ____________________ 
Title: Trial testing and modification of SignSupport®: a mobile phone application 
prototype for Deaf users and pharmacists 
 
 
DECLARATION BY PARTICIPANT 
By signing below, I (full name) …………………………………..…………. agree to take 
part in a research study entitled: Trial testing and modification of SignSupport®: a mobile 
phone application prototype for Deaf users and pharmacists 
I declare that: 
• I fully understand the consent form and it is signed in a language with which I am 
fluent and comfortable. 
• I have had a chance to ask questions and all my questions have been adequately 
answered. 
• I understand that taking part in this study is voluntary and I have not been pressurised 
to take part. 
• I may choose to leave the study at any time given that I notify the researcher 24 hours 
in advance and will not be penalised or prejudiced in any way. 
• I understand that I will be given a copy of this consent form. 
• I voluntarily agree to take part in this study: Trial testing and modification of 
SignSupport®: a mobile phone application prototype for Deaf users and pharmacists 
 
Signed at (place) ......................…........….on (date)…………....……….. 2015 
 
…….............................. 
Signature of participant  
 
..................................... 
 Signature of witness 
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APPENDIX K:   DECLARATION BY INTERPRETER 
 
 
 
Title: Trial testing and modification of SignSupport®: a mobile phone application 
prototype for Deaf users and pharmacists 
 
I (full names) ……………………………………………..……… declare that: 
• I assisted the investigator (name) ………………………………………. to explain the 
Information in this document to (name of 
participant)……………..……………………………..using the language medium of 
South African Sign Language. 
• We encouraged him/her to ask questions and took adequate time to answer them. 
• I conveyed a factually correct version of what was related to me. 
• I am satisfied that the participant fully understands the content of this informed 
consent document and has had all his/her questions satisfactorily answered. 
• I shall keep all information conveyed to me by the participants and investigators 
confidential. 
 
Signed at (place) ......................…........……..on (date)…………....……2015. 
  
 
................................................... 
Signature of participant     
 
 
................................................ 
 Signature of witness 
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APPENDIX L:   PARTICIPANT INFORMATION SHEET AND INFORMED 
CONSENT DOCUMENT FOR DEAF COMMUNITY  
 
 
 
Title: Trial testing and modification of SignSupport®: a mobile phone application 
prototype for Deaf users and pharmacists 
 
Background:  
You are invited to partake in a research study on SignSupport® use in pharmacy 
environment: The experiences, challenges, and triumphs. Before deciding to participate in 
this study, it is important that you understand why the research is being conducted and what it 
will involve. Please take your time to read the following information carefully. Please ask the 
researcher to clarify any unclear information. 
Purpose of the Research  
This research study is designed to obtain information that would determine usability and 
improve the mobile application, SignSupport®, on Android media to enable communication 
between a pharmacist and a deaf participant. The data from this research will be used to 
explore SignSupport® use by obtaining information from the pharmacists and to highlight the 
possible challenges faced by the students regarding the dispensing of medication to Deaf 
participants whilst using the mobile application on site in a virtual dispensary. 
Study Procedure:  
Your expected time commitment for this study is: 
The study will be conducted in the form of a role-play whereby the pharmacy student will be 
dispensing medication to a deaf patient in a virtual dispensary while using the mobile 
application. The entire role-play will be recorded. 
Risks:  
There are no risks of participating in this study. Everything you do will be kept confidential 
and will be video recorded and no names will be used in transcription of the data thereby 
ensuring confidentiality. You may terminate your involvement at any time, provided that you 
have notified the research members 24 hours in advance to the termination of participation.  
Confidentiality:  
We assure you that every effort will be made by the researcher to maintain your 
confidentiality including the following:  
Assigning code names/numbers for participants that will be used on all researcher notes and 
documents.  
Notes, interview transcriptions, transcribed notes and any other identifying participant 
information will be kept in a locked file cabinet in the personal possession of the researcher. 
When no longer necessary for research, all materials will be destroyed. 
 
 
 
 
341 
 
The researcher and the members of the researcher’s committee will review the researcher’s 
collected data. Information from this research will be used solely for the purpose of this study 
and any publications that may result from this study. Any final publication will contain the 
names of the public figures that have consented to participate in this study (unless a public 
figure participant has requested anonymity): all other participants involved in this study will 
not be identified and their anonymity will be maintained  
Person to Contact: 
Should you have any questions about the research or any related matters, please contact the 
researcher at the details below 
 
Voluntary Participation:  
Your participation in this study is voluntary; it is up to you to decide whether or not to take 
part in this study. If you do decide to take part in this study, you will be asked to sign a 
consent form.  
 
Unforeseeable Risks:  
There may be risks that are not anticipated. However every effort will be made to minimize 
any risks.  
Costs to Subject: There are no costs to you for your participation in this study  
 
Compensation:  
There is no monetary compensation to you for your participation in this study.  
Principal Investigator:  Ms M. B. Parker 
Department:   Pharmacy Practice   
E-mail:    mbparker@uwc.ac.za 
Contact number:   083 650 1644 
 
Signature: ____________________ 
Date:  ____________________ 
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APPENDIX M:   QUESTIONNAIRE FOR PHARMACY STUDENTS/ 
PHARMACISTS (Post-intervention study) 
 
 
 
Title: Trial testing and modification of SignSupport®: a mobile phone application 
prototype for Deaf users and pharmacists 
 
 
 
YES  NO  MAYBE 
1. Do you find SignSupport® useful to you as the 
pharmacist when dispensing to Deaf patients?    
2. Do you feel that SignSupport® would make it easier 
when dealing with Deaf patients in the future?    
3. Do you think that SignSupport® would facilitate and 
improve patient adherence?    
4. Would you say that the way which SignSupport® 
works is an effective way to facilitate communication 
between the pharmacist and Deaf patient? 
   
5. Would you recommend SignSupport® to your 
colleagues?      
 
1. How did you experience helping a Deaf patient while using SignSupport®? 
________________________________________________________________________
______________________________________________________ 
2. While dispensing to Deaf patients using SignSupport®, was there any challenges that 
you faced? If so, please explain. 
________________________________________________________________________
______________________________________________________ 
 
3. In future encounters with Deaf patients, would you communicate with Deaf patients 
with/without SignSupport® and why? 
________________________________________________________________________
________________________________________________________________________ 
 
4. Using SignSupport®, how would you rate your service as a pharmacist to Deaf 
patients? 
________________________________________________________________________ 
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5. Other comments that you would like to add concerning SignSupport®. 
________________________________________________________________________
________________________________________________________________________
______ 
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APPENDIX N:   QUESTIONNAIRE FOR DEAF PARTICIPANTS (Post-
intervention study) 
 
 
 
Title: Trial testing and modification of SignSupport: a 
mobile phone application prototype for Deaf users 
and pharmacists 
Mark the appropriate answer with an X 
 YES  NO  MAYBE 
1. Do you like SignSupport?     
2. Do you feel that your confidentiality is 
being protected when using SignSupport®? 
   
3. Do you think SignSupport will make it 
easier for you to understand how to take 
your medication? 
   
4. Do you feel that the application was easy 
to understand? 
   
5. Will this application help assist you with 
adhering to your medication? 
   
6. Do you feel that it was easier receiving 
information with the use of SignSupport®? 
   
7. Do you feel that this session was a 
success? 
   
8. Will you tell others about this application 
and research study? 
   
9. Did you enjoy this experience?    
10. Did you find SignSupport® useful?    
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APPENDIX O:   DEMONSTRATION WORKSHOP PRESENTATION  FOR 
PHARMACY STUDENTS/PHARMACISTS (Post-intervention 
study) 
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APPENDIX P:   VIDEO OBSERVATION NOTES (INCLUDING 
TRANSCRIPTS): DEMONSTRATION WORKSHOP 
PRESENTATION FOR /PHARMACISTS (Post-intervention 
study) 
Date:    6 August 2015 
Time started:  8h00 
Duration:   1 hour and 30 minutes 
Time ended:  9h30 
Brief description: The video observation notes below describe the first exposure of the 
pharmacists to the mobile phone application SignSupport®. These video observation notes 
consists of a description of five videos in which pharmacists (n=5), research assistants as well 
the principal researcher (pharmacist) are all present during this exposure. During the 
exposure session, pharmacists were introduced to SignSupport® and asked to navigate the 
application on Huawei® and Samsung® smart phones. The purpose of this observation was 
bi-fold: 
(i) To introduce the application to pharmacists and 
(ii) To observe pharmacists using and navigating the application in a workshop-type 
setting, where they are able to ask the researchers questions or for assistance 
should they encounter problems. 
The workshop was recorded by video and notes taken. 
Pharmacist n=5 Code Name Assigned 
1 V 
2 W 
3 X 
4 Y 
5 Z 
 
Fourth year pharmacy students (research 
assistants; RA) 
Code Name Assigned 
Tamsin Arendse RA1 
Elana Julius  RA2 
Cebile Mashaba RA3 
Mohseen Mohammed  RA4 
Maryam Moola RA5 
Nerissa Smith  RA6 
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Video 1: 
Summary 
Researchers welcomed and introduced themselves to the pharmacists; pharmacists were given 
background to the study, information sheets, and consent was obtained for participation in the 
study. 
The principal researcher (pharmacist) welcomed and introduced herself to the pharmacists, 
stated her position in the study as the principal researcher (pharmacist) from the School of 
Pharmacy of the University of the Western Cape. The principal researcher (pharmacist) then 
introduced the research assistants as fellow researchers of the SignSupport® application. She 
then handed over to RA6 who did a brief presentation on the SignSupport® mobile phone 
application SignSupport, followed by a brief overview of the study and what was the 
pharmacists could expect during the training workshop and on the experiment day. 
The research assistants (RA’s) led the rest of the workshop by firstly informing the 
pharmacists about the background of SignSupport® and the objectives of the current study. 
RA5 then explained the information sheet, which informed the pharmacists of their 
involvement in the study. It was also mentioned that no foreseeable risks or costs were 
identified. The pharmacists were informed that they may withdraw from the study at any time 
they wish to do so, giving 24hrs notice to the researchers. The consent form was also 
explained and subsequently signed by all the pharmacists. 
The consent form explained to the pharmacists stated the following: 
• Their participation was completely voluntary,  
• They were not forced to partake in the study. 
• All information was to be kept confidential and known only by the researchers. 
Thereafter the pharmacists were given the platform to clarify and uncertainties and ask any 
questions. They were then asked to sign their consent on the consent form. 
 
Video 2: 
Summary 
All pharmacists (n=5) were given phones with SignSupport® and asked to navigate through 
the mobile phone application. One pharmacist raised an issue, thereafter the principal 
researcher (pharmacist) dealt with any issues that arose. 
All phones were shown at the same time 
• All pharmacists were receptive to the application 
• All pharmacists using the mobile phone application navigated through the screens on 
the mobile phone application swiftly and without hesitation. 
• The screen which prompted a photo to be taken, elicited a common issue amongst the 
pharmacists. There was confusion and hesitation on how to proceed after taking the 
photo. 
• The screen which required the medicine dispensing instructions was followed 
properly and swiftly. 
• The recommendation and warning screens were navigated accurately and swiftly. 
Camera focuses in on one particular pharmacist 
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Pharmacist “W” was confused as a result of misinterpreting the “return” button as a way to 
review the selection made. 
Camera zooms out, and all phones were shown at the same time 
• All Pharmacists were able to save and finish.  
• The principal researcher clarified that a “meal time” was used to indicate the time of 
use of a particular medication as well as an alarm system linked to the specific Deaf 
patient’s medication time. 
• She explained that exact specification on when the meal was to be taken (Morning, 
Afternoon, and Night) was not practical due to the space limitations on the mobile 
application. Therefore the patients are able to set an alarm for medication taken in the 
night, afternoon, or morning. 
 
Video 3: 
Summary 
Camera focuses on one particular pharmacist; the pharmacist incurs an error by mistakenly 
selecting an incorrect icon. 
Pharmacist “X” was prompted by the mobile phone application regarding the validity of the 
script and whether or not the identification card given matched the identification number on 
the script. Pharmacist “X” selected “No”, this lead to a screen with three options which could 
be relayed to a Deaf participant. Pharmacist “X” then navigated back to the patient ID 
validity screen and selected “yes” 
 
Video 4: 
Summary 
Camera focuses on one particular pharmacist, the pharmacist enquired about the list of 
conditions available loaded on the mobile phone application. 
Pharmacist “V” was looking for a particular condition and could not find the condition she 
was searching for on the mobile phone application. The principal researcher explained to 
pharmacist “V” that the conditions must be in layman’s terms which may be interpreted into 
sign language. (E.g. hypertension stored as heart disease) and therefore had to be named 
accordingly.  
Pharmacist “V” then asked for a list of conditions that are on the mobile phone application 
and how they are named, to be made available to the pharmacist. Other than that pharmacist 
“V” navigated through the application from start to finish swiftly and without hesitation. 
  Video 5: 
Summary 
Four pharmacists were generally able to navigate SignSupport®, three issues were raised. 
Camera focuses on each pharmacist: 
Pharmacist “W” navigated through the mobile phone application SignSupport® swiftly and 
without hesitation. 
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Pharmacist “Y” came late thus missed out on the introductory session. When she came to the 
condition screen she searched for the word ‘hypertension’, which the application saved as the 
condition ‘heart disease’. Overall pharmacist “Y” experienced slight hesitation whilst 
navigating through the application. 
Pharmacist “V” asked why conditions are not listed per system, and the principal researcher 
explained about the different dialects existing within Sign Language. 
Pharmacist “X” navigated through the application swiftly and without hesitation. When 
pharmacist “X” came to the camera screen, pharmacist “X” pressed the forward icon instead 
of the camera icon to take a picture of the medication. 
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APPENDIX Q:   VIDEO OBSERVATION NOTES (INCLUDING 
TRANSCRIPTS): DEMONSTRATION WORKSHOP 
PRESENTATION FOR  DEAF COMMUNITY : Post-intervention 
study 
Date:    11 August 2015 
Time started:  10h30 
Duration:   2 hours and 30 minutes 
Time ended:  13h00 
 
Brief description: The video observation notes below describe the first exposure of the Deaf 
participants to the mobile phone application SignSupport®. These video observation notes 
consists of a description of three videos in which Deaf participants (n=6), research assistants 
as well the principal researcher (pharmacist) are all present during this exposure whereby the 
Deaf are trained on how to use the mobile phone application as well as what the experiment 
will entail: 
 
Deaf n=6 Code Name Assigned 
Participant 1 A 
Participant 2 B 
Participant 3 C 
Participant 4 D 
Participant 5 E 
Participant 6 F 
Interpreter IF 
 
Fourth year pharmacy students (research 
assistants; RA) 
Code Name Assigned 
Tamsin Arendse RA1 
Elana Julius RA2 
Cebile Mashaba RA3 
Mohseen Mohammed RA4 
Maryam Moola RA5 
Nerissa Smith RA6 
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Video 1:  
Summary 
Researchers welcomed and introduced themselves to the Deaf participants; Deaf participants 
were given background to the study, information sheets and consent was obtained for 
participation in the study. Deaf participants were then allowed to navigate through the 
SignSupport® application. 
 
Via an interpreter, the principal researcher (pharmacist) welcomed and introduced herself as a 
pharmacist and PhD student at the University of the Western Cape. The principal researcher 
(pharmacist) also mentioned that she is currently working on a mobile phone application that 
allows pharmacists to communicate medicine instruction with Deaf patients in a way that 
they will understand how to take their medication once they have left the pharmacy. The 
principal researcher (pharmacist) stressed the importance of taking their medication properly, 
she then asked whether they understood and the participants responded by nodding their 
heads.  
The principal researcher (pharmacist) introduced the research group as fourth year pharmacy 
students and then explained that each pharmacy student will sit with one participant and that 
they will assist the Deaf participant, where needed, to navigate through the SignSupport® 
application on the mobile phone.  
RA1 explained the purpose of the visit by the researchers; which was to provide training, 
inform participants of the aim of the mobile phone application SignSupport and the aim of 
the experiment; which is to test the usability and functionality of the application for future 
use in a pharmacy. RA2 explained what their involvement would be and mentioned that there 
would be no foreseeable risks and no cost involved. The Deaf participants were also made 
aware that they have the right to withdraw their participation at any time if they wish to do 
so. They respond by nodding their heads. 
The principal researcher (pharmacist) then explained the consent form and stated the 
following: 
• That their participation is completely voluntary and that no one is forcing them to 
partake in the study. 
• That all their information will be kept confidential and only known by the researchers; 
after which she then asked them if they are willing to partake in the study. They were 
required to raise their hands to show that they agree to partake in the study.  
• They all then raised their hands and kept it in the air for the camera to record it.  
Consent forms were then filled in and signed by the Deaf participants and the research 
assistants as witnesses. The researcher assistants also ticked off the consent forms to show 
that consent was given. 
The Deaf participants navigated through the screens of the mobile phone application with a 
pharmacy student. It was mentioned that once they understood the application they can say 
whether, in their opinion, they feel that such an application would help them with 
communication in a pharmacy. 
The Deaf participants navigated through the screens of the mobile phone application swiftly 
without hesitation. When clarity was needed, the Deaf participant would sign to the 
interpreter. They would get attention by waving or raising their hands or tapping on each 
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other’s shoulder. Participant “D” had difficulty with understanding the video as participant 
“D” is of a different dialect than the interpreter on the SignSupport® application. 
Participant “A” wanted to know whether all the participants would know the end result of the 
experiment. 
 
Video 2: 
Summary 
Burning issues were raised and discussed. 
The Deaf participants were asked to navigate through the phone and identify problems 
(burning issues) that they may have experienced.  
Burning issues:  
• How would they know the milligrams of the tablets to take and how would they know 
if the medicine is dangerous or not. 
• Whether they would be able to see the expiry date of the medicine.  
• Participant “D” was confused about whether cancer was a past illness that she should 
maybe mention in her patient details; she was unsure about the past illness being 
checked in the patient file. 
• Participant “D” had difficulty understanding the SASL dialect displayed and she 
needed the interpreter to translate the sign language video she had viewed on the 
SignSupport® application. 
• Participant “E” wanted to know whether they could smoke 24 hours after taking the 
medication. It was then explained by the principal researcher (pharmacist) that the 
pharmacist dispensing the medication to the Deaf will enter recommendations and 
warnings regarding their medication instruction and in this way the Deaf user/patient 
would know whether they are allowed or not allowed to smoke. 
•  
The principal researcher (pharmacist) then explained to the participants that the mobile phone 
application will indicate how many tablets should to be taken; the dispensing pharmacist will 
also take a picture of each medication dispensed, its packet  as well as enter warnings and 
recommendations for the Deaf to view. 
The Deaf participants were then given refreshments before continuing with the exposure 
workshop, where each participant was allowed to familiarize themselves with the 
SignSupport application.   
 
 
Video 3: 
Summary 
Deaf participants were informed regarding experiment day. 
The participants were then allowed to navigate through the phone once more, after which the 
participants taught the research assistant how to sign their names and certain phrases such as 
“thank you”, “nice to meet you”. 
RA1 then provided in-depth information regarding the hospital experiment: 
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• The time the participants would be picked up from DeafSA and the time the 
participants should be at Tygerberg Hospital 
• The participants would go straight to the waiting room of the hospital until their 
names were called by the dispensing pharmacist. 
• After the pharmacist calls each Deaf participant, the participant would go up to the 
dispensing window and hand the phone to the pharmacist followed by their mock 
patient ID card. 
• The medicine instructions regarding the dispensed medication would be loaded onto 
the phone and handed back to the Deaf participant.  
• The expected time that the participants would be dropped off at DeafSA after the 
experiment  
• Lunch would be provided to them after the experiment. 
All the participants agreed that they would participate in the experiment. The principal 
researcher (pharmacist) then thanked them. 
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APPENDIX R:   VIDEO OBSERVATION NOTES (INCLUDING 
TRANSCRIPTS): HOSPITAL STUDY EXPERIMENT FOR 
PHARMACISTS AND DEAF PARTICPIAPNTS  
 
 
Date:    13 August 2015 
Time started:  09h00 
Duration:    2 hours and 30 minutes 
Time ended:  11h30 
 
 
Brief description: The video observation notes below describe the experiment at Tygerberg 
Hospital pharmacy from the pharmacist’s point of view. After experimental set up was 
completed, all pharmacists where briefed, thereafter the experiment commenced. This 
involved the pharmacist dispensing medication to the Deaf participants via the SignSupport 
mobile phone application relaying the medicine instructions. These video observation notes 
consists of a description of four videos in which Deaf participants (n=6) and pharmacists 
(n=5) are all present during this experiment. 
 
Pharmacists n=5 Code Name Assigned 
Pharmacist 1 V 
Pharmacist 2 W 
Pharmacist 3 X 
Pharmacist 4 Y 
Pharmacist 5 Z 
 
 
 
Video Participants involved 
 
1 
W and A 
V and B 
X and C 
2 Y and D 
3 Z and E 
4 W and F 
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Pharmacist’s 
code name 
assigned  
Time taken (minutes) 
1st item 2nd item Total 
V 01:96 01:02 02:98 
W 02:00 01:00 03:00 
X 04:47 01:49 05:96 
Y 02:93 01:78 04:71 
Z 01:48 01:59 03:07 
 
Video 1: 
Summary 
Camera focuses on 3 pharmacists, of whom two pharmacists navigated through the screens of 
the mobile phone application without hesitation, whereas one pharmacist was observed to 
have experienced difficulties.  
Pharmacist “W” navigated through the screens of the mobile phone application swiftly and 
without hesitation. Pharmacist “W” followed the application instructions and no hesitation 
was observed throughout the dispensing of the medicine. Pharmacist “W” took the picture of 
the medicine in a manner that the patient could clearly differentiate between two or more 
medicines and knew when to hand over the phone to the Deaf participant in time to view the 
signed video loaded on the mobile phone application. 
Pharmacist “V” navigated through the screens of the mobile phone application thoroughly 
and without hesitation. Pharmacist “V” followed the application instructions and no 
hesitation was observed throughout the dispensing of the medicine. Pharmacist “V” took the 
picture of the medicine in a manner that the patient could clearly differentiate between two or 
more medicines and knew when to hand over the phone to the Deaf participant in time to 
view the signed video loaded on the mobile phone application. 
Pharmacist “X” hesitated from the beginning, difficulty was observed in the process of 
operating the mobile phone application to get to the “Get ready to dispense” screen. The 
following occurred: 
• Hesitated at the “Get ready to dispense” screen, selected the X icon instead of the tick. 
Thereafter the first paragraph was selected, indicating that the patient should wait at 
the counter while the pharmacists checked the patient file. The pharmacist placed the 
phone on the desk and walked away. 
• The pharmacist enquired about allergy prompt, whereby the application indicated that 
the patient had an allergy but no further details were given as to what type of allergy. 
Participant was then advised by the research team that an indication of a patient 
allergy should just prompt one to look at the patient’s hospital folder, where more 
details will be specified. Pharmacist returned and continued with the dispensing 
process. 
• Had difficulty in deciding how to take the picture of the medicine. 
Pharmacist “X” took the picture of the medicine in a manner in which the patient could 
clearly differentiate between two or more medicines. The second time around pharmacist “X” 
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knew when to hand over the phone to the Deaf participant in time to view the signed video 
loaded on the mobile phone application. 
 
Video 2: 
Summary 
Camera focuses on one pharmacist experiencing difficulties with the “Type of treatment”, 
“Camera” and “Medicine instruction” screens. 
Pharmacist “Y” hesitated on the “welcome screen” and delayed showing the patient the video 
on time. After commencing the dispensing process of the first item, pharmacist “Y” hesitated 
at the following screens: 
• Type of treatment screen  
• Camera screen, pharmacist did not know how to proceed after taking the first picture 
and therefore took another picture. 
• Medicine instruction screen, when dispensing the second item, pharmacist “Y” 
hesitated at the camera screen once more and took two pictures of the medication. 
However it was observed that Pharmacist “Y” was faster with medicine instructions. 
Video 3: 
Summary 
Camera focuses on one pharmacist and is observed to have navigated through the screens of 
the mobile phone application without hesitation. 
Pharmacist “Z” navigated through the screens of the mobile phone application without 
hesitation. Pharmacist “Z” followed the application instructions and no hesitation was 
observed throughout the dispensing of the medicine. Pharmacist “Z” took the picture of the 
medicine in a manner that the patient could clearly differentiate between two or more 
medicines and knew when to hand over the phone to the Deaf participant in time to view the 
signed video loaded on the mobile phone application. 
Video 4:   
Summary 
Camera focuses on one pharmacist and is observed to have navigated through the screens of 
the mobile phone application swiftly and without hesitation. 
Pharmacist “W” navigated through the screens of the mobile phone application swiftly and 
without hesitation. Pharmacist “W” followed the application instructions and no hesitation 
was observed throughout the dispensing of the medicine. Pharmacist “W” took the picture of 
the medicine in a manner that the patient could clearly differentiate between two or more 
medicines and knew when to hand over the phone to the Deaf participant in time to view the 
signed video loaded on the mobile phone application. 
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Video Observation Notes (Including transcripts): Deaf Experiment day 
Date:    13 August 2015 
Time started:  09h00 
Duration:   2 hours and 30 minutes 
Time ended:  11h30 
 
Brief description: The video observation notes below describe the experiment at Tygerberg 
Hospital pharmacy from the Deaf participant’s view. This involved the pharmacist dispensing 
medication to the Deaf participants via the SignSupport mobile phone application relaying 
the medicine instructions. These video observation notes consists of a description of four 
videos in which Deaf participants (n=6) and pharmacists (n=5) are all present during this 
experiment. 
 
Deaf participants  Code Name Assigned 
Participant 1 A 
Participant 2 B 
Participant 3 C 
Participant 4 D 
Participant 5 E 
Participant 6 F 
 
Video 1:  
Summary 
Three Deaf participants navigated through the screens of the mobile phone application. One 
Deaf participant encountered some issues and two Deaf participants navigated through the 
screens swiftly and easily. 
Participant “A” navigated through the screens of the mobile phone application without 
hesitation. “A” watched each video and was able to progress to next screen.  
Participant “B” navigated through the screens of the mobile phone application without 
hesitation. ”B” watched each video and was able to progress to next screen.   
Participant “C” did not hesitate whilst navigating through the screens of the mobile phone 
application but did not follow the sign language videos, however did the following: 
• Viewed the introduction video, which the pharmacist was supposed to do 
• Proceeded with the screens on the mobile application after viewing introduction video 
of which the pharmacist was supposed to do so. 
The pharmacist was then not able to view the patient history and had to go back to view the 
patient history screen. Initially participant “C” viewed the prescription review with the 
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pharmacist help but thereafter navigated through the screens of the mobile application 
without hesitation. 
Video 2:  
Summary  
Camera focused on one Deaf participant navigating through the mobile phone application. 
Participant “D” navigated through the screens of the mobile phone application without 
hesitation. 
Video 3: 
Summary  
Camera focuses on one Deaf participant whereby some issues were identified.  
Participant “E” did not hesitate with navigating through the screens of the mobile phone 
application but hesitation was observed due to the following: 
• Reviewed the first item of the script three times. 
• Was thorough in viewing the prescription review after the third attempt but navigated 
through without viewing the videos. 
• Selected patient background icon to re-enter his personal information. 
Video 4: 
Summary  
Camera focused on one Deaf participant and no problems were observed. 
Participant “F” navigated through the screens of the mobile application through without 
hesitation. Participant “F” watched each video and was able to progress to the next screen.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
364 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
